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Abstract 
The development of template directed synthesis towards the formation of interlocked 
architectures has allowed for the synthesis of a variety of rotaxanes. Chapter 1 covers the 
history of rotaxanes including their nomenclature and methods of formation. An overview of 
the intermolecular interactions used to facilitate the synthesis of these architectures is 
described and examples of template directed synthesis and properties of rotaxanes are 
discussed.  
 
In Chapter 2 the use of the Diels-Alder reaction towards formation of rotaxanes in a 
‘threading followed by stoppering’ protocol is covered. The synthesis of [n]rotaxanes is 
described with secondary ammonium ions, a novel perimidine benzimidazole and 
bispyridinium binding templates integrated into threads.  
 
In Chapter 3 a novel binding template was developed, incorporating a triazole into a 
dibenzylammonium binding motif. Binding studies were carried out and [n]rotaxanes were 
synthesised using this motif with the groups Diels-Alder ‘threading followed by stoppering’ 
protocol. 
 
Chapter 4 discusses the modification of the DB24C8 macrocycle with the aim to enhance 
binding interactions with a variety of binding motifs. Two macrocycles were successfully 
synthesised and their binding affinities calculated with known and novel binding templates 
investigated in the previous chapters. 
 
The work in this thesis shows a Diels-Alder stoppering reaction can be successfully used to 
synthesise [n]rotaxanes with a variety of binding templates including novel templates 
discovered during this project.  During the work it was also revealed that modifications to 
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known binding templates can provide an enhancement in binding interactions in comparison 
to their unmodified predecessors. 
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1. Supramolecular Chemistry  
Supramolecular chemistry is an area which has expanded and diversified over recent years. 
It concerns the self assembly of molecules using weak and reversible, non-covalent bonding 
interactions into larger more complex structures. Two or more molecules can interact to give 
a supramolecular structure when there is selective recognition or ‘complementarity’ between 
them. Some examples that use this concept include molecular recognition and self assembly, 
host-guest chemistry, protein folding and the synthesis of mechanically interlocked 
structures. 
Supramolecular chemistry was first recognised in the late 1800’s when Emil Fischer 
described the binding of enzyme-substrate complexes in the ‘lock and key’ terminology, 
introducing ideas such as molecular recognition and host-guest chemistry.
1 It wasn’t until the 
late 1900’s that any major breakthroughs came to light. In 1987 the chemists Pedersen, 
Cram and Lehn won the Nobel Prize for their work in the area, helping to define the 
importance and principals of supramolecular chemistry.
2
 
Weak intermolecular interactions are of great importance in biological structures. One 
famous example is in the formation of the DNA double helix held together by 
complimentary hydrogen bonding between the two inter-coiled strands.  
There are a number of key weak intermolecular forces used in the formation of 
supramolecular structures. These include hydrogen bonding,
3-4
 Van der Waals forces,
5
 π-π 
interactions,
6-8
 electrostatic interactions,
9
 ion-dipole interactions,
10-11
 hydrophobic forces
12-14
 
and metal coordination.
15-17
 In comparison to covalent bonds, these interactions are much 
weaker, but when multiple weaker interactions are collated it can allow binding that is both 
strong and selective to drive the self assembly process. 
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Using self assembly, highly complex, novel structures can be created from relatively simple 
starting materials highlighted by examples of  interlocked complexes such as catenanes,
18-20
 
rotaxanes
21
 and knots.
22-26
 
1.2 Rotaxanes 
The word rotaxane is derived from the Latin words rota and axis, which mean ‘wheel’ and 
‘axle’.27 They are molecules consisting of an axle which is threaded through a macrocycle; it 
is prevented from slipping off the axle using large end groups to act as bulky stoppers. The 
end groups of the axle are selected to be adequately large enough to prevent the macrocycle 
slipping off and the components of such compounds are mechanically interlocked. 
Pseudorotaxanes have no bulky stoppers and the macrocycle is free to slip off the axle. It is 
weak non covalent interactions between the thread and macrocycle that direct the threading 
process. 
 
Figure 1.1 Nomenclature of pseudorotaxanes and rotaxanes. 
The nomenclature of rotaxanes provides information on the number of components that are 
non-covalently interlinked by the use of the prefix [n], which is followed by the complex 
name; pseudorotaxane or rotaxane (Figure 1.1). For example a [2]pseudorotaxane would be 
composed of a macrocycle on an axle, which is free to slip off whereas a [3]rotaxane would 
consist of two macrocycles on an axle with bulky stoppers preventing the macrocycle from 
unthreading. Alternatively a [3]rotaxane can be comprised of two stoppered axles through a 
single macrocycle.
28
 
1.3 Early Methods of Synthesis 
Early methods of rotaxane synthesis were based on a statistical approach. Harrison
29
 
reported the first synthesis of a rotaxane based upon the statistical probability of 
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pseudorotaxane formation then the addition of stoppers to trap the macrocycle onto the 
thread. This was carried out by attaching the macrocycle to a solid support phase, then 
treating the supported macrocycle with the thread and reactive groups that can form 
stoppers. Even with more than 60 threading and stoppering cycles performed on the support, 
yields of the rotaxane, of only 6% were obtained. Even so, these experiments were the first 
to produced evidence for the formation of these mechanically interlocked architectures. Up 
until the early 80’s, attempts at rotaxane formation were still relying on the chance 
interaction of thread and crown. This was clearly not an efficient way to synthesise 
rotaxanes and in the last three decades there has been much more emphasis on ‘directed’ 
synthesis of these supramolecular complexes. 
1.4 Self Assembly Approaches to Rotaxane Synthesis  
The development of both directed and self assembly approaches to rotaxanes, led to 
improved yields and interest grew in their potential applications. There are three general 
methods to forming rotaxanes via the self assembly approach; these include threading 
followed by stoppering, clipping and slipping (Figure 1.2).
30
 
 
Figure 1.2 Schematic representations of self assembly methods toward the synthesis of rotaxanes.  
In the first approach, the macrocycle is threaded onto the axle and bulky stoppers are 
attached to prevent the macrocycle from unthreading. The clipping approach utilises a 
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preformed stoppered axle and a macrocycle precursor is ‘clipped’ around it. In the slipping 
approach the axle and macrocycle are preformed and heat is applied to distort the 
macrocycle so that it can pass over one of the stoppers. Once cooled the macrocycle is 
trapped on the thread.  
The slippage approach requires the precise tuning of the macrocycle cavity and stopper size. 
Enough thermal energy needs to be added to the system to allow the macrocycle to squeeze 
it over the stoppers. On cooling the macrocycle can’t surmount the steric barrier of the 
stopper.  
1.5 Non-Metal Templates 
The use and manipulation of intermolecular forces has provided an abundance of 
mechanically interlocked molecules. There are many examples of metal ligand interactions 
used to template the synthesis of rotaxanes and catenanes. This thesis focuses on the 
assembly of rotaxanes using the interactions between crown ethers and ammonium or 
pyridinium templates. 
1.5.1 Hydrogen bonding 
Hydrogen bonding is an important interaction found in nature and is used to assemble DNA 
double helix and the secondary structure of peptides. Synthetic chemists have used hydrogen 
bonding to construct rotaxanes and catenanes. One of the more widely used templates for 
rotaxane formation is the secondary ammonium ion binding site which interacts with crown 
ether type macrocycles primarily through hydrogen bonding. This binding template was first 
investigated by both Busch
31
 and Stoddart.
21,32
 Busch has developed a thread with an 
anthracene moiety at one terminal end and a primary amine on the other. Incorporated in the 
thread is a secondary ammonium ion available for binding with dibenzo-24-crown-8 
(DB24C8). The macrocycle is trapped onto the axle in an acylating reaction to give rotaxane 
1.04 shown in Scheme 1.1. The solid state structure of the rotaxane showed the hydrogen 
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bonding between the ammonium ion hydrogen’s and crown ether oxygen atoms that 
template the interlocking of the two components.  
 
 
Scheme 1.1 Interfacial synthesis of rotaxane 1.04, facilitated by hydrogen bonding in a ‘threading followed by 
stoppering’ protocol.31 
Stoddart
32-33
 incorporated both one and two ammonium binding sites into axles. In a 
‘threading followed by stoppering’ protocol with DB24C8 the group successfully 
synthesised both [2] and [3]rotaxanes using this binding motif Figure 1.3. 
 
Figure 1.3 [3]Rotaxane containing two secondary ammonium ion binding sites.  
Hydrogen bonding is also a valuable interaction in the synthesis of amide containing 
rotaxanes. Tetralactam macrocycles were originally developed by Hunter
34
 and Vögtle
35
 
towards the synthesis of catenanes. Leigh
36
 discovered a catenane synthesis from two simple 
reagents and initially exploited this approach in a clipping strategy where the amide groups 
are used to both construct the macrocycle and direct rotaxane formation with an amide 
template.
37
 p-Xylylenediamine and isophthaloyl dichloride provide the macrocycle. The 
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presence of an amide containing thread in the reaction solution acts as an auxiliary for the 
macrocycle to form around and provides an axle for rotaxane formation all mediated by 
hydrogen bonding (Scheme 1.2).  
 
Scheme 1.2 Leigh’s use of hydrogen bonding to synthesise [2]rotaxane 1.08. 
Further development of the amide binding template towards the synthesis of higher order 
rotaxanes has been realised by Vögtle. Synthesis of a [3]rotaxane composed of two 
tetralactam macrocycles and a thread with two amide stations was successfully achieved 
however yields of the [3]rotaxane were very low.
38
 More recently the group has created 
complex architectures utilising threads with amide binding site and sulfonamide wheels 
where the wheels are capable of bridging to one another when more than one is present.
39
 
1.5.2 π-π Interactions 
The use of π-π interactions to form rotaxanes has been employed by a number of groups. 
This relies on using a π electron deficient component and a complimentary π electron rich 
component. A recent review by Stoddart has discussed the importance of this intermolecular 
interaction in the formation of mechanically interlocked structures.
40
 Work carried out by 
Stoddart in the early 90’s has shown how utilisation of these interactions can form 
rotaxanes.
41
 The cavity of the electron deficient cyclobis(paraquat-p-phenylene) (CBPQT
4+
) 
macrocycle 1.09 has been shown to bind with the electron rich 1,5-dimethoxynaphthalene 
(DNP). There are both face to face and edge to face π-π interactions observed in the solid 
state structure of the pseudorotaxane. As well as binding with dihydroxynaphthalenes the 
  Chapter 1 
8 
 
CBPQT
4+
 macrocycle 1.09  has also been shown to bind with biphenyl
42
 and the π-electron 
donor tetrathiafulvalene (TTF) unit.
43
 Stoddart has successfully produced a number of 
rotaxanes using this macrocycle including [2]rotaxane 1.10 shown in Figure 1.4.
44
  
 
Figure 1.4 Stoddart [2]rotaxane 1.10 with a DNP binding site and CBPQT4+ macrocycle.  
The Becher
45
 group have also used CBPQT
4+
 macrocycle to synthesise [2]rotaxanes with 
multiple TTF binding sites as shown in Figure 1.5. The CBPQT
4+
 macrocycle can ‘shuttle’ 
from one TTF site to the other. Threads with up to three stations were synthesised containing 
TTF binding sites. 
 
Figure 1.5 Becher group [2]rotaxane with two TTF units and a CBPQT4+ macrocycle. 
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Other groups have exploited the use of π-π interactions in the formation of interlocked 
structures. Loeb and co-workers
46
 developed the bispyridinium template which has been 
shown to have excellent binding via both π stacking and hydrogen bonding interactions with 
crown ether type macrocycles. This binding motif has been successfully used to synthesise a 
number of mechanically interlocked architectures. Loeb and co-workers have also used the 
bispyridinium template to design more intricate supramolecular structures. Using  
functionalised DB24C8 he was able to synthesise a variety of branched higher order 
[n]rotaxanes (n = 2-4) and an example (1.13) is shown in Figure 1.6.
47
  
 
Figure 1.6 Loeb branched [n]rotaxane. 
Other groups have utilised the bispyridinium template in order to synthesise a molecular 
shuttle. Stoddart and co workers
48
 have synthesised an axle with two binding sites; a 1,2-bis-
(pyridinium)ethane site and a secondary dialkylammonium site. DB24C8 is known to bind 
both of these motifs and with the use of pH they were able to exert some control over the 
position of the macrocycle on the axle shown in Scheme 1.3. The two sites have different 
binding affinities with DB24C8 with the Ka of the secondary dibenzylammonium 
hexafluorophosphate site at 420 M
-1
 and the 1,2-bis-(pyridinium)ethane 
hexafluorophosphate site at 167 M
-1
. When both sites are charged, the DB24C8 resides 
predominantly over the ammonium binding site. The ammonium site can be deprotonated 
with Hunig’s base then the macrocycle favours the 1,2-bis-(pyridinium)ethane site. 
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Reprotonation of the ammonium site can be carried out with TFA causing the crown ether to 
sit predominantly back at the ammonium site as monitored by 
1
H NMR.  
 
Scheme 1.3 A pH switchable rotaxane.48 
1.5.3 Anion Template 
Anion binding templates can also be used in order to synthesise mechanically interlocked 
structures. Recent work by P. D. Beer
49
 has shown rotaxane formation via a chloride anion 
recognition template using a clipping method. This was performed by taking a stoppered 
pyridinium chloride ion pair ‘thread’ with two porphyrin ring stoppers. Carrying out ring 
closing metathesis (RCM) of the acyclic bis-vinyl-functionalised isophthalamide produced 
the rotaxane 1.20 in a 30% yield. The chloride template in the interlocked system can be 
exchanged for other ions. With this system the group has successfully developed a number 
of [2]rotaxanes with porphryin incorporated into the thread and the macrocycle. The Beer 
group have also used this anion template approach to synthesise a variety of [2] catenanes
50-
51
 and [2]rotaxanes.
52-53
 Further work using anion templates allowed groups to synthesise 
molecular shuttles
54
 and molecular machines.
55
 Developing supramolecular structures 
templated by anions is an interesting area as ions play an essential role in many biological 
and medical processes.  
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Scheme 1.4 Beer porphyrin stoppered [2]rotaxane 1.20 formed by anion templation. Reagents and conditions: i) 
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDAC), Hydroxybenzotriazole (HOBt), 4-
Dimethylaminopyridine (DMAP), CH2Cl2, 0˚C, 10 min, RT, 48h, 59%; ii) MeI, dimethylformamide (DMF), 
70˚C, 40 mins; iii) NaCl, CH2Cl2/H2O, 95%; iv) Grubbs’ 2
nd generation catalyst, CH2Cl2, RT, 24h, 30%; v) 
NH4PF6, CH2Cl2/H2O, 100%.
49 
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1.5.4 Hydrophobic Interactions 
Hydrophobic interactions comprise a further weak force that can be exploited in the 
synthesis of rotaxanes. One of the most notable macrocyclic structures that takes advantage 
of these interactions are cyclodextrins. They consist of a hydrophobic cavity and a 
hydrophilic exterior. The first report of cyclodextrins used in the synthesis of rotaxanes 
using hydrophobic effects as the driving force was by Ogino
56
. Taking either α or β 
cyclodextrin, the macrocycle was threaded over a 1,10 diaminododecane chain and end 
capped with a bis(ethylenediamine)cobalt(III) complex to provide the bulky stopper groups 
forming a [2]rotaxane.  
 
Cyclodextrin containing rotaxanes have a wide variety of applications including their use as 
long lasting dyes. This is a result of the dye functionalised axle being ‘protected’ by the 
macrocycle surrounding it, blocking interactions with other molecules giving it an enhanced 
stability. An example of rotaxanes used as dyes has been reported by Anderson et al. 57 
Cyanine dyes have potential applications such as their use in photographic sensitizers, laser 
dyes and biological fluorescence probes, but they suffer from a low photochemical stability. 
To overcome this limitation, a rotaxane was developed in which the chromophore was 
trapped inside a cyclodextrin cavity. These rotaxanes showed enhanced fluorescence and 
photostability in several different solvents.  
 
Further work by Anderson et al, also addressed some key questions to improve the 
understanding of such complexes.
58
 This included studies on the binding of the dye and the 
chromophore lifetime when encapsulated within cyclodextrin. In this instance, a 
chlorotriazine-functionalised azo dye was synthesised and used for the experiments. When 
encapsulated, it was found that it had increased stability to bleaching but there was no 
prevention of the dye binding to a cellulose surface (cotton cloth). 
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1.6 Methods of Formation 
Template-directed synthetic methods to produce rotaxanes have been developed to enhance 
yields of these mechanically interlocked structures. They use specific non-covalent 
interactions between the components holding them in the appropriate orientation to produce 
the rotaxane. Both covalent and non-covalent approaches have been used as the concluding 
step in rotaxanes synthesis. As discussed earlier there are three general methods towards the 
synthesis of rotaxanes. After reviewing some of the different interactions that are required to 
form these structures, we now look into more detail at the synthetic protocols that provide us 
with such mechanically interlocked architectures.  
1.6.1 Template Directed Synthesis via the ‘Threading Followed by Stoppering’ 
Approach 
One of the more successful and widely used approaches to the synthesis of rotaxanes, is 
‘threading followed by stoppering’. It involves a kinetically controlled reaction, where the 
axle and macrocycle are synthesised separately and the macrocycle is then threaded onto the 
axle exploiting intermolecular forces to produce an intermediate pseudorotaxane. This is 
then transformed into a rotaxane by the covalent attachment of bulky stopper groups, onto 
the ends of the axle.
59
 We have seen an example of this previously by Stoddart and Fyfe
33 
involving the threading of DB24C8, onto an axle containing a secondary dialkylammonium 
moiety. The crown is held in place as a result of the weak, non-covalent hydrogen bonds 
with the axle. The pseudorotaxane is stoppered when the azido terminating ends are reacted 
with acetylenedicarboxylate in a 1,3-dipolar cycloaddition to give rotaxane 1.05. Stoddart 
has also used the Cu(I) catalysed 1,3-dipolar cycloaddition reaction ‘CuAAC click 
chemistry’ in order to generate stoppers.60 [2]Pseudorotaxane 1.21 was formed from a thread 
containing a DNP binding site and the CBPQT
4+
 macrocycle. Addition of a propargyl 
functionalised bulky stopper group 1.22 in the presence of ascorbic acid and CuSO4.5H2O in 
DMF allowed the ‘click’ reaction to proceed providing [2]rotaxane 1.23 in an 82% yield. 
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Scheme 1.5 Synthesis of [2]rotaxane 1.23 via the ‘threading followed by stoppering’ protocol. a) DMF, 
CBPQT4+, -10˚C; b) CuSO4.5H2O, DMF, -10˚C, 82%. 
There have been numerous reports of rotaxanes synthesised using the ‘threading followed by 
stoppering’ approach, but there are still a restricted number of chemical reactions that can be 
used to create the stopper. This is because many reaction conditions that could be used to 
introduce stopper groups include the use of polar solvents, high temperatures, the presence 
of a strong base or produce competitive hydrogen bonding counter ions. This makes them 
unsuitable as these may lead to dissociation of the pseudorotaxane complex, producing low 
yields of rotaxanes.
61
 
Triphenylphosphine (PPh3) can also be utilised as the bulky stopper group in a ‘threading 
followed by stoppering’ as shown by Stoddart.62 A dibenzyl ammonium binding motif 
containing aryl p-bromomethyl groups incorporated can be threaded with DB24C8 in 
acetonitrile. Once the pseudorotaxane 1.25 was formed the stopper forming reaction was 
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carried out by the addition of PPh3 which attacks the bromomethyl groups of the interlocked 
axle (Scheme 1.6).  
 
Scheme 1.6 Stoddart synthesis of [2]rotaxane using triphosphonium ‘stoppers’ via the ‘threading followed by 
stoppering’ protocol. Reagents and conditions; a) CH2Cl2, CH3CN, DB24C8; b) PPh3, NH4PF6, H2O, 55%. 
Stoddart has further exploited this method to synthesise dendrimers with rotaxane like 
branches.
63
 In this case after the original ‘stoppering reaction’ with PPh3, a ‘stopper 
exchange’ reaction was then performed utilising a bulky aldehyde in a Wittig reaction and 
gave the new rotaxane in high yield. 
 
Zheng and co-workers
64
 have also taken advantage of the ‘threading followed by stoppering’ 
protocol utilising an ammonium ion binding motif and the DB24C8 macrocycle. The thiol-
ene coupling reaction was used to attach bulky stopper groups to the terminating ends of the 
axle trapping the macrocycle into place. A similar approach was first used by Takata
65
 in 
1999, however, low yields were observed due to the high temperature requirement of the 
reaction which was found to destabilise the delicate intermolecular forces between 
components.  In Zheng’s work,64 the bulky stoppers were added to the thiols of the 
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pseudorotaxane in CH2Cl2 after irradiation with a UV lamp (λex = 365nm) at room 
temperature under inert conditions to give the [2]rotaxane in a 75% yield (Scheme 1.7).  
 
Scheme 1.7 Synthesis of [2]rotaxane 1.29 via a thiol-ene stoppering reaction. Reagents and conditions: a) 
CH2Cl2, DB24C8, UV Irradiation (λex=365nm), RT, 1h, 75%. 
Cycloaddition reactions have been shown to be useful in the synthesis of rotaxanes 
especially when incorporating stoppers onto pseudorotaxanes in the ‘threading followed by 
stoppering' protocol. We have seen Stoddart
66
 report the copper catalysed azide-alkyne 
reaction now commonly referred to as ‘click chemistry’ to stopper ammonium centred 
rotaxanes. Bohmer
67
 has also used a cycloaddition reaction to create rotaxanes. He was able 
to heat a pseudorotaxane containing maleimide end groups with a functionalised anthracene 
to trap the interlocked complex as its Diels-Alder product in toluene at 100˚C. 
Takata
68-69
 et al have utilised the Diels-Alder reaction to incorporate C60 onto rotaxanes 
producing a variety of C60 containing interlocked compounds. The fullerene could be added 
to both the wheel and axle of the rotaxane.  The LUMO level of C60 is low enough to 
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undergo the Diels-Alder reaction so it can be introduced onto the pseudorotaxane according 
to the ‘threading followed by stoppering’ approach. The sulfolene can act as a masked diene 
on the ammonium ion axle trapping the crown wheel by a Diels-Alder reaction with C60 at 
80°C to afford the C60 rotaxane 1.31 in a 33% yield (Scheme 1.8).
68
  
 
Scheme 1.8 Synthesis of [2]rotaxane 1.31. Reagents and conditions: a) 1,2-Dichlorobenzene, C60, 80˚C, 33%. 
1.6.2   Template-Directed Synthesis via the Clipping Approach 
In 2001, Stoddart
70
 reported the template directed synthesis of a [2]rotaxane in a clipping 
approach under thermodynamic control. The kinetically stable [2]rotaxane was isolated and 
characterised (Scheme 1.9).  The procedure involved synthesising a macrocycle from two 
components in a condensation reaction, while encompassing a templating NH2
+
 group of a 
dialkylammonium ion with bulky stoppers at each end of the axle. This provided a rotaxane 
consisting of a dumbbell-shaped template surrounded by a macrocyclic diimine. These 
imino bonds can also be reduced giving a robust diamine macrocycle. 
From analysis, it was found that the [2]rotaxane was the thermodynamic product, but did 
revert gradually back to its original components when removed from the reaction mixture. 
The dumbbell-shaped axle interacts with the centre of the macrocycle stabilised by N-H
…
O 
and N-H
…N hydrogen bonding and π-π stacking interactions. This is an excellent example of 
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a template directed approach using clipping, producing a [2]rotaxane under thermodynamic 
control. Stoddart has used this approach to synthesise [n]rotaxanes where ‘n’ is up to 11.30 
 
Scheme 1.9 Synthesis of [2]rotaxane 1.34 via the ‘clipping’ approach.  
1.6.3 Self-Assembly Approach via Slipping  
A further protocol for the synthesis of [n]rotaxanes is a relatively simple self assembly 
approach, known as ‘slipping’.71-72 The macrocycle cavity must be large enough to allow the 
stoppered ends of an axle to pass through, once an appropriate amount of thermal energy has 
been introduced to the system. Raymo and Stoddart,
73 
have described the synthesis of 
[n]rotaxanes (up to n = 4) using this method, as well as describing the kinetics of the 
process. Upon heating together a stoppered axle with a macrocycle in solution, the 
macrocycle can ‘slip’74 over the bulky terminal end group to produce the molecular 
assembly. Once cooled, the macrocycle is trapped on the thread as it doesn’t have the 
thermal energy to surmount the steric barrier provided by the stoppers (Figure 1.7). The 
rotaxane formed is both kinetically and thermodynamically stable at the lower temperature. 
Lowering the stability of the rotaxane, for example by changing the polarity of the solvent, 
can make the free components more favourable so now the addition of enough thermal 
energy favours the ‘slipping off’ direction.  
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 ∆G≠off 
 ∆G≠on 
 ∆G˚ 
 
Figure 1.7 Schematic of the ‘slipping’ protocol. 
1.6.4 Threading Followed by Swelling Approach 
Chiu et al
75
 have described a novel method of stopper forming reactions in rotaxane 
synthesis. The ‘threading followed by swelling’ approach involves swelling of the terminal 
group on the axle of a pseudorotaxane complex, enlarging it sufficiently to prevent the 
macrocycle from slipping off. This approach has some unique features including the 
enlargement of the terminal group is attained without any additional atoms or functional 
groups having to be added during rotaxane formation. The macrocycle must be able to pass 
over the terminal end of the axle before, but not after swelling, and the swelling process 
should be conducted under controllable conditions. Using a cis-1-[(Z)-alk-1’-enyl]-2-
vinylcyclopropane moiety for the swelling reaction, the thread (1.36) containing a 
dibenzylammonium ion was threaded by a macrocycle 1.35. The [2]pseudorotaxane 1.37 
was then converted to a [2]rotaxane 1.38 by heating the complex converting the cis-1-[(Z)-
alk-1’-enyl]-2-vinylcyclopropane moiety into a bulky cycloheptadiene group through a Cope 
rearrangement under relatively mild reaction condition and good yields (Scheme 1.10).  
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Scheme 1.10 Synthesis of [2]rotaxane 1.38 via  the ‘threading followed by swelling’ approach. 
1.7 Potential Uses and Scientific Interest 
In recent years, there has been a significant development in supramolecular chemistry. The 
emergence of molecular machinery and highly complex self-assembled structures are 
becoming more apparent. As a result of such research, a number of advances have 
materialised in the use of such structures in nanotechnology. Interlocked compounds such as 
catenanes and rotaxanes are one such area of importance.
76
 Rotaxanes in particular are 
receiving much interest in new research as they have the ability to act as molecular machines 
and switches,
77
 valves, insulated wires,
78
 drug delivery vehicles,
79
 wheels,
80
 scaffolds
81
 and 
in nanoelectronics.
82
 Exploiting the week intermolecular forces we have seen many 
examples of the synthesis of these structures come to light over the last three decades. 
1.7.1 Valves 
Stoddart
78
, has developed rotaxanes that are able to act as valves, trapping and releasing 
molecules under chemical and light control. These then have applications in sensors and 
controlled drug release. Using pH stimulation and competitive binding in order to control 
‘gatekeeper supermolecules’, the openings of nanosized pores on silica particles were able to 
be regulated.  
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1.7.2 Wheels 
Investigating configurational entropy of protein-ligand interactions to measure complex 
stability, Smithrud
80 
used host-guest complexes, rather than the traditional lock-and-key or 
induced-fit model. Rotaxane axles act as the synthetic hosts, with bulky calixarenes and 
cyclophanes used as ‘stoppers’. Attaching functional groups to the macrocycle (wheel) 
allowed guest recognition. The host-guest association was measured in both water and 
DMSO.  The binding sites were arranged over several parts of the axle to create a 
relationship between guest association and conformational changes that occur as the wheel 
moves between each site. The hosts use several conformations to bind guests so are excellent 
models of protein binding domains. From these studies, an increase in entropy of binding 
has been observed on addition of the wheel to the host. Increasing motion of the wheel is 
thought to be where this originates from, showing favourable configurational entropy which 
aids complex formation. 
1.7.3 Molecular Switches 
The relative movement of the interlocked components of a rotaxane can be modulated in a 
controlled manner in the development of molecular switches and shuttles. There is great 
interest is such complexes with research into several methods of stimulation including 
chemical, electrochemical and photochemical processes. Stoddart et al
83
 reported one of the 
first [2]rotaxanes to act as a ‘molecular shuttle’. They described the complex as a 
tetracationic “bead” that shuttles between two identical “stations”. It consisted of a CBPQT4+ 
macrocycle acting as the “bead” on a polyether thread with hydroquinol units to act as the 
“stations”. The ends of the rotaxane were stoppered by large triisopropylsilyl groups 
preventing the macrocycle from slipping off. (Scheme 1.11) The shuttling motion was 
temperature dependant with a large free energy of activation (13 kcal mol
-1
). Changes in the 
rate of the macrocycle shuttling were measured using variable temperature 
1
H NMR. 
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Scheme 1.11 Stoddart’s first example of a molecular shuttle. 
A molecular shuttle has recently been reported by Li and co-workers
84
 to drive a multilevel 
fluorescence switch. It is a [2]rotaxane prepared by a thermodynamically controlled, 
template induced clipping method. The thread has two recognition sites which are separated 
by a phenyl unit, these are -NH2
+
- and an amide. When protonated, the macrocycle binds to 
the -NH2
+
- region through a variety of non-covalent interactions. When the ammonium ion is 
deprotonated, the macrocycle prefers to hydrogen bond to the amide region. Addition of 
either Li
+
 or Zn
2+
 ions to the system then controls the movement from one recognition site to 
the other. All three processes result in a fluorescent response (Figure 1.8) and it is pH 
dependant and reversible.  
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Figure 1.8 A pH switchable molecular switch. 
The Stoddart group have successfully synthesised a bistable [2]rotaxane which can be 
controlled thermodynamically. The macrocyclic ring structure is the π electron deficient 
CBPQT
4+
 ring and the axle contains two different π electron accepting moieties which are a 
TTF and DNP units. The CBPQT
4+ 
macrocycle was threaded onto an axle with two 
terminating azide groups. The bulky stoppers were attached in a ‘CuAAC’ reaction to give 
the bistable [2]rotaxane. The position of the macrocycle could be controlled via oxidation 
and reduction of the TTF unit (Scheme 1.12).
85
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Scheme 1.12 Schematic of a bistable [2]rotaxane. 
A more recent example of this molecular switch has been created by Stoddart.
86
 They have 
further developed the bistable [2]rotaxane with a CBPQT
4+
 π electron deficient macrocycle 
and the axle again containing the TTF and DNP units. Located in the central part of the axle 
is a 3,5,3’,5’-tetramethylazobenzene (TMeAB) unit which is photoactive and can change 
between its cis and trans conformations. In the axle’s neutral form the CBPQT4+ macrocycle 
resides over the more π electron rich TTF unit. Upon oxidation the CBPQT4+ is ‘switched’ to 
the DNP moiety. The ‘switching’ process is also controlled by the photo induced 
isomerisation of TMeAB unit. When in the trans configuration the CBPQT
4+ 
macrocycle can 
move freely between stations. Once in the cis configuration the macrocycle now has a much 
larger energy barrier to overcome due to steric hindrance which provides further control of 
the macrocycle position. 
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1.8 Transition Metal Strategy 
Metal templating strategies have been a key area in synthesising interlocked architectures. 
Using transition metals towards templating the synthesis of supramolecular molecules has 
been advantageous. Early work by Sauvage and co-workers
87
 utilised a transition metal to 
orientate ligands in an exact position to facilitate the formation of a macrocycle by covalent 
bond formation leading to the construction of a catenane.  
There has been much work using copper (I) as the templating metal due to its preferred 
tetrahedral co-ordination geometry. It holds the two components in an appropriate 
orientation to allow further reactions to occur forming the desired interlocked structures. An 
early example shown by Sauvage
88
 has taken two diphenol ligands around the metal ion Cu
+ 
and reacting with 1,14-diiodo-3,6,9,12-tetraoxatetradecane to give a metallocatanene in a 
27% yield (Scheme 1.13). A final demetallation with tetramethylammonium cyanide gives 
the two interlocked macrocycles. The same method has also been successfully used towards 
the synthesis of [n]rotaxanes
89-90
 and other catenane systems.
91-92
 Further development in this 
area has seen these interlocked structures synthesised in much higher yields.
93
 A variety of 
transition metals can be used in the formation of these supramolecular structures including 
palladium
94
 and ruthenium.
95
  
 
Scheme 1.13 Reagents and conditions: a) Cu(MeCN)4.BF4; b) DMF, 1,14-diiodo-3,6,9,12-tetraoxatetradecane, 
26%. 
Other groups have used the transition metal template strategy to synthesise molecular 
architectures. In 2006 the Leigh group developed the active template approach where the 
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metal acts as both the template and catalyst.
96-97
 For the reaction to proceed, it requires a 
catalytically active metal centre incorporated into a macrocycle that will allow covalent bond 
formation to occur in the cavity of the ring. A schematic representation of the reaction is 
shown in Figure 1.9. In this case a stoichiometric quantity of the metal can be added to 
‘stitch’ the components together. A covalent bond forming step takes place followed by 
demetallation to give the interlocked structure. This reaction has also been achieved using 
catalytic amounts of metal. A range of reactions are able to be exploited to synthesise 
rotaxanes in the active template metal approach. These include the CuAAC click reaction,
96
 
Cu mediated alkyne homocouplings (Glaser reaction)
98-99
 and palladium catalysed cross 
coupling reactions.
100
 There has also been success synthesising catenanes using the active 
metal template approach using the CuAAC reaction
101
 and Glaser homocoupling reaction.
102
 
 
Figure 1.9 Schematic representation of the active metal template protocol. i) Metal addition; ii) Complexation 
and covalent bond formation; iii) Demetallation and [2]rotaxane formation.  
More recently Goldup
103
 has also used the active template approach towards synthesising 
rotaxanes first pioneered by Leigh.
96,104
 Using the widely exploited CuAAC reaction and 
applying it to the active template approach the group have used the copper(I) catalysed 
azide-alkyne click active template reaction (CuAAC-AT) to synthesise a variety of 
molecular architectures in high yields. This method has been successful varying the chain 
length and stopper size and the macrocycle cavity to produce supramolecular structures.  
More complex architectures such as molecular shuttles
105
 can be synthesised using a metal 
template protocol. In 2007 Leigh has shown how ‘CuAAC click chemistry’ can be used to 
create these structures. In this approach a 2,6-bis[alkyloxy)methyl]pyridine macrocycle was 
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used as the ligand with a Cu(MeCN)4PF6 metal catalyst and a diazide. The two cycloaddition 
reactions that occur provide a bistriazole thread with an encompassing macrocycle giving 
[2]rotaxane 1.52 in a 74% yield. Demetallation is performed with KCN and the macrocycle 
is free to move along the length of the thread. This was confirmed by 
1
H NMR where 
shielding was observed on several proton signals of the thread. Reintroducing Cu(I) to the 
system provided fast shuttling between the two triazole stations (Scheme 1.14). However 
addition of PdCl2 shows two distinct peaks for the triazole indicating the macrocycle is in a 
fixed position on the thread and can no longer shuttle between the sites. 
 
Scheme 1.14 Reagents and conditions: a) Cu(MeCN)4PF6 (1 equiv), CD2Cl2(90%)/CD3CN(10%), 25˚C, 5 min, 
>99%. 
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1.9 Summary and Outlook 
Over the last few decades we have seen significant developments in the synthesis of 
supramolecular structures. It has been shown how you can take advantage of intermolecular 
interactions to enhance binding by using a combination of these interactions. Further 
exploitation of intermolecular forces allows us to produce a variety of molecules where 
controlling the position of components can be manipulated by stimulating the system to 
provide a response. Due to these advances much more complex architectures have been 
synthesised including molecular machines, wheels and valves. There is great importance in 
understanding and further developing this area of chemistry as many structures in nature 
make use of intermolecular interactions including DNA, protein tertiary structures and 
enzyme-substrate binding. 
We have seen there are several routes towards the synthesis of rotaxanes including self 
assembly methods and template directed synthesis showing varying degrees of success. In 
this thesis a novel route to synthesising rotaxanes via the ‘threading followed by stoppering’ 
protocol using the Diels-Alder reaction is explored. We have successfully created a variety 
of molecular architectures using this reaction which is desirable due to its benign reaction 
conditions. We also want to develop ways to enhance the binding interactions between axles 
and macrocycles. Synthesising novel binding templates containing a combination of 
intermolecular interactions will also be investigated as well as synthesis of novel 
macrocycles. Merging these ideas we would like to create a library of threads and 
macrocycles with the ability to construct a variety of molecular machines and switches.  
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Chapter 2 - Synthesis of [2] and [3]Rotaxanes Using a 
‘Diels-Alder Approach to Threading Followed by 
Stoppering’. 
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2. Synopsis 
The introduction in Chapter 1 covers a general overview of rotaxanes and their synthesis. In 
particular focus is on the different intermolecular interactions and methods used to self 
assemble rotaxanes. This chapter describes the use of the Diels-Alder reaction in order to 
synthesise rotaxanes via the ‘threading followed by stoppering’ approach. A protected 
maleimide unit was incorporating into an axle containing the well known ammonium ion 
template. The retro Diels-Alder reaction was performed to deprotect the maleimide allowing 
DB24C8 to thread onto the axle and bind with the ammonium template. The stopper forming 
reaction was carried out on addition of cyclopentadiene trapping DB24C8 onto the axle. 
The presence of the bridgehead group was found to be critical for the moiety to act as an 
effective stopper. Investigations with the flat phthalimide analogue have shown that 
unthreading can occur under more extreme conditions. 
 
As well as applying the Diels-Alder approach to ‘threading followed by stoppering’ with 
ammonium ion motifs, the group has previously developed a novel bisbenzimidazole binding 
template that shows significant binding with DB24C8. A modified binding template is 
reported with better binding activity and additional functional potential suitable for 
incorporation into molecular machines simply by substituting one of the benzimidazoles for 
a perimidine group (Figure 2.1). An improved binding interaction was found with this 
template in comparison to the bisbenzimidazole and we were successfully able to synthesise 
a [2]rotaxane with this binding site as the axle.   
 
Figure 2.1 Bisbenzimidazole and perimidine benzimidazole binding templates. 
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The bispyridinium ethane binding template developed by Loeb and an unreported 
bispyridinium methane unit which also binds DB24C8 were successfully transformed into 
rotaxanes using the Diels-Alder approach to synthesise [2]rotaxanes (Figure 2.2).
46
 
 
Figure 2.2 Unsymmetrical [2]rotaxane 2.01 and symmetrical [2]rotaxane 2.02. 
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2.1 Introduction 
 
As discussed in the original introduction, cycloaddition reactions are ideal for stopper 
formation as they can occur under mild conditions, spontaneously without catalyst, so not 
interfering with the weak interactions holding the pseudorotaxane together. There are several 
examples of cycloaddition reactions in the production of rotaxanes and other interlocked 
compounds. The thermal azide/alkyne click reaction,
33
 the Cu catalysed click reaction,
106
 the 
nitrile N-oxides of Takata
107
 and the nitrone of Philp
108
 are examples of the breadth of the 
chemistry possible for stopper formation using this approach. By the very nature of 1,3-
diopoles these approaches introduce a level of asymmetry into the thread and hence 
rotaxane, making analysis more complex. Additionally, conditions to form the 1,3-dipoles 
and/or catalysts for their addition can complicate the yields and isolation of the interlocked 
compounds.    
 
The Diels-Alder reaction discovered in 1928
109
 has found wide synthetic application.
110
 It is 
a [4+2] cycloaddition reaction that occurs between an alkene or alkyne acting as the 
dienophile, and a conjugated diene to form an unsaturated six membered ring. It has all the 
advantages highlighted for the other cycloaddition reactions but the possibility of 
symmetrical systems making analysis simpler. Additionally, the Diels-Alder reaction can be 
reversible at room temperature offering the potential of rotaxane synthesis under 
thermodynamic control. We envisioned that the Diels-Alder reaction of a maleimide with a 
cyclic diene would be a suitable starting point.  As well as having a plane of symmetry, these 
adducts produce a 3-dimensional stopper molecule from 2-dimensional precursors. The 
hybridization of the orbitals changes from sp
2
 to sp
3 
(Figure 2.3) and additional steric bulk is 
produced by formation of a bridged skeleton. 
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Figure 2.3 The Diels-Alder ‘stopper formation’ reaction. 
The Diels-Alder approach to ‘threading followed by stoppering’ has been successfully used 
by Takata
 
introducing buckminsterfullerene (C60) as a bulky stopper, trapping a dibenzo-24-
crown-8 (DB24C8) macrocycle on an ammonium ion template though at rather high 
temperatures. It has also been exploited by Bohmer in the synthesis of interlocked capsules, 
but remains under utilised as a facile synthesis of rotaxanes by a ‘threading followed by 
Diels-Alder stopper formation’. 
A simple but efficient binding motif for the synthesis of rotaxanes is via the interaction of 
DB24C8 with a secondary ammonium ion. Initially investigated by Busch, it binds primarily 
through hydrogen bonding between the crown oxygens and the NH’s.31 This binding motif 
has been further developed by Stoddart and has been used to synthesise a range of 
rotaxanes
21,32
 and towards the synthesis of a variety of molecular architectures.
111-113
 Herein 
we report the use of threads incorporating a secondary ammonium binding motif and a 
protected Diels-Alder maleimide unit in the synthesis of rotaxanes. 
2.2 Synthesis of [n]rotaxanes with Ammonium Ion Binding Motifs 
 
The group has developed a Diels-Alder motif in order to synthesise rotaxanes in a ‘threading 
followed by stoppering’ protocol. To carry this out, a maleimide dieneophile must be 
incorporated onto the terminating end of a suitable axle. To insert the sensitive maleimide 
into the thread, a pre-stopper approach was developed where the maleimide was introduced 
in a protected form as the furan Diels-Alder adduct, the synthesis of which was carried out 
as shown in Scheme 2.1. The exo anhydride from the Diels-Alder reaction of furan and 
maleic anhydride (2.03) was reacted in EtOH at 0˚C, with ethanolamine, to give alcohol 2.04 
in an 84% yield. 
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Scheme 2.1 Synthesis of the Diels-Alder adduct. Reagents and conditions: a) Et2O, RT, 48h, 72%; b) EtOH, 
NEt3, 0→70°C; 24h, 84%. 
We then wanted to apply the Diels-Alder ‘threading followed by stoppering’ strategy 
towards the synthesis of rotaxanes with a secondary ammonium ion binding motif. 
Beginning with 4-(aminomethyl)benzoic acid, the amine was protected using di-tert-butyl 
dicarbonate providing compound 2.05. An esterification reaction was then carried out with 
the Diels-Alder ‘gate’ using PyBOP (Figure 2.4) as a coupling agent in CH2Cl2 with 
triethylamine to give new compound 2.06. Finally the amine was deprotected using 
trifluoroacetic acid (TFA) furnishing the amine 2.07 (Scheme 2.2).  
 
Scheme 2.2 Reagents and conditions: a) Di-tert-butyl dicarbonate, dioxane, aq. NaOH 1M, 0˚C, 48 h; b) CH2Cl2, 
NEt3, PyBOP, RT, 24h, 65%; c) CH2Cl2, TFA, RT, 24 h, 92%. 
PyBOP was used as the coupling reagent in the esterification but is more commonly used to 
synthesise peptides.
114
 Other useful coupling agents including phosphonium reagents such as 
benzotriazole-1-yl-oxy-tris-(dimethylamino)-phosphonium hexafluorophosphate (BOP) and 
benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate  (PyBOP), and 
uronium reagents such as o-benzotriazole-N,N,N’,N’-tetramethyluronium hexafluoro-
phosphate (HBTU) and carbodiimides such as N,N'-dicyclohexylcarbodiimide (DCC) 
(Figure 2.4) were also screened but PyBOP provided the best yields and the simplest work 
up in the esterification shown in Scheme 2.2. 
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Figure 2.4 Coupling reagents that can be used in esterification reactions. 
Reductive amination of the amine 2.07 was then carried out on reaction with 3,5-
dimethylbenzaldehyde to give the intermediate imine 2.08 which was reduced using sodium 
cyanoborohydride giving the neutral thread 2.09 in the final step with 93% yield (Scheme 
2.3).  
 
Scheme 2.3 Reagents and conditions: a) MeOH, RT, 24h, 98%; b) MeOH, AcOH, NaBH3CN (1.1 equiv), RT, 
2h, 93%. 
To generate the template to induce binding between crown and thread, the amine was 
converted into the ammonium salt. A weakly or non-coordinating counter-ion such as ClO4
-
, 
PF6
-
 and BF4
-
 are key to enhance the interaction between macrocycle and axle.
115
 Using a 
stronger coordinating ion, for instance Cl
-
 competes with the macrocycle to interact with the 
cationic thread thus inhibiting pseudorotaxane formation as Cl
-
 is a good hydrogen bond 
acceptor. A weakly co-ordinating counter ion does not compete with the hydrogen bonding 
interactions that template the threading. π-π Stacking interactions between the thread and the 
macrocycle also take part in pseudorotaxane formation. Although not the best non-
competing counter ion the ClO4
-
 is more thermally stable than PF6
-
 which is important 
during the thermal retro Diels-Alder reaction to reveal the maleimide pre-stopper.
116-117
 The 
ClO4
- 
salt of the thread was generated by protonating the amine with perchloric acid (HClO4) 
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to give compound 2.10. The formation of the ClO4
-
 salt was confirmed by a shift in the 
benzylic CH2’s on formation of the dibenzyl ammonium ion and a peak observed at 1094 
cm
-1
 in the IR corresponding to the ClO4.
118
 
The retro Diels-Alder reaction of the furan adduct, opened the ‘gate’ to reveal the maleimide 
so the DB24C8 can thread onto the ammonium ion template. The maleimide end of the 
thread is sufficiently sized to slip through the cavity of the macrocycle. Microwave heating 
the ClO4
- 
salt thread 2.10 in acetonitrile was the most efficient method to produce furan and 
the maleimide thread 2.11 shown in Scheme 2.4.  
 
Scheme 2.4 Reagents and conditions: a) CH3CN, MW, 150W, 110 ˚C, 3h, 78 %. 
The choice of solvent is important to consider when creating a pseudorotaxane. Acetonitrile 
was the preferred solvent as it can dissolve the thread easily and is not too polar so that it 
interferes with the weak interactions between the crown and thread.
61
 To form the 
pseudorotaxane (2.12), two equivalents of DB24C8 were added to push the equilibrium 
towards complex formation and after 48 hours no free thread (2.11) was observed by 
1
H 
NMR. Once the DB24C8 has threaded onto the axle, bulky stoppers must be attached to 
prevent it from slipping back off. The Diels-Alder reaction was implemented using 
cyclopentadiene which forms a stopper on the maleimide end of the thread once the 
macrocycle is in place. Cyclopentadiene is used to create this bulky stopper as it reacts 
quickly, produces only one of the possible isomers and forms the bulky bridged adduct.
119
  
Dicyclopentadiene was heated to crack the dimer into the monomer cyclopentadiene. This 
was then added to the pseudorotaxane 2.12 at room temperature to perform the Diels-Alder 
reaction producing only the endo complex 2.13 (Scheme 2.5). Excess cyclopentadiene was 
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removed in vacuo. The rotaxane was characterised by high field NMR and HRMS with the 
[2.13-ClO4]
+
 ion peak appearing at m/z 907.4378. 
 
Scheme 2.5 Synthesis of [2]rotaxane 2.13. Reagents and conditions: a) CH3CN, cyclopentadiene, RT, 50%. 
Confirmation of the endo stereochemistry was provided by independent synthesis of the 
thread from the known endo adduct of maleic anhydride with cyclopentadiene to give 2.14. 
Only the endo conformation is observed as this is the kinetic product whereas in the reaction 
of furan and maleic anhydride only the thermodynamic exo product precipitates from the 
reaction medium. The synthesis of a comparison thread from the [2]rotaxane (2.13) is shown 
in Scheme 2.6. Reacting the cyclopentadiene maleimide adduct with ethanolamine gave the 
endo imide alcohol (2.15). An esterification reaction between the alcohol 2.15 and acid 2.05 
gave the resulting compound 2.16. Deprotection of the amine was carried out using TFA to 
form 2.17. The imine 2.18 was synthesised in MeOH with 3,5-dimethylbenzaldehyde and 
reduced using sodium cyanoborohydride. Finally the ClO4
-
 salt 2.19 was formed by 
protonating the amine with HClO4. 
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Scheme 2.6 Synthesis of comparison thread 2.19. Reagents and conditions: a) EtOAc, Pet. Ether (60-80˚C), 0˚C, 
3h, 71%; b) EtOH, NEt3, 0˚C→70˚C, 37%; c) CH2Cl2, NEt3, DMAP, PyBOP, 0˚C→RT, 48h, 45%; d) CH2Cl2, 
TFA, RT, 24h, 85%; e) MeOH, NaBH3CN, HOAc, RT, 81%; f) HClO4, RT, 97%. 
A stacking diagram comparing the 
1
H NMR of the free thread 2.19 and DB24C8 with the 
[2]rotaxane 2.13 is shown in Figure 2.5. In rotaxane 2.13 the aromatic hydrogens of both 
crown and thread are shifted upfield as they become shielded due to the proximity of their π 
systems. The CH2’s adjacent to the ammonium ion of the thread show a shift downfield due 
to hydrogen bonding with the oxygens of the crown ether. They also become more complex 
multiplets due to coupling with the NH2
+
. Now that the thread is encompassed within the 
crown, the hydrogens of the NH2
+
 undergo a slow exchange on the NMR timescale and are 
able to express the coupling with the adjacent hydrogens.
32
 The imide and dimethylphenyl 
stopper portions of the thread are relatively unaffected in the rotaxane indicating the 
DB24C8 macrocycle is situated predominantly over the ammonium region of the thread.  
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Figure 2.5 
1H NMR (400 MHz, CD3CN, 300K) stacking plot of i) DB24C8; ii) [2]Rotaxane 2.13 and iii) 
Comparison thread 2.19. 
 2.2.1 Higher Order Rotaxanes 
To exploit the simplicity of the Diels-Alder ‘threading followed by stoppering’ approach the 
synthesis of higher order rotaxanes containing two ammonium ion templates was explored. 
This was done by taking the Diels-Alder adduct (2.04) in an esterification reaction with 4-
carboxybenzaldehyde providing compound 2.20. Taking two equivalents of this and reacting 
with p-xylylenediamine, the diimine was obtained (2.21). This was reduced using sodium 
cyanoborohydride giving the new diamine 2.22 seen in Scheme 2.7. 
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Scheme 2.7 Synthesis of neutral thread. Reagents and conditions: a) CH2Cl2, N,N,N',N'-
tetramethylchloroformamidinium hexafluorophosphate, NEt3, DMAP,  RT, 48h, 64%; b) MeOH, RT, 24h, 92%; 
c) MeOH, NaBH3CN, HOAc, RT, 78%. 
The neutral thread was converted to its ClO4
-
 salt (2.23) using HClO4 and the retro Diels-
Alder reaction was carried out under microwave irradiation in acetonitrile revealing both 
maleimides and generating axle 2.24 in a quantitative yield. Five equivalents of DB24C8 
were added to the axle dissolved in deuterated acetonitrile to drive the reaction towards 
[3]pseudorotaxane formation. After 48 hours the [3]pseudorotaxane formation had reached 
completion as determined by 
1
H NMR with no free thread observed. The [3]pseudorotaxane 
could also be observed via ESI-mass spectrometry with a peak seen at m/z 774.7 which 
relates to the [2.25-2ClO4]
2+
 ion. The macrocycles were trapped onto the axle with the 
addition of cyclopentadiene to the system providing the [3]rotaxane 2.26 in a 73% yield as 
shown in Scheme 2.8. 
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Scheme 2.8 Synthesis of [3]rotaxane 2.26. Reagents and conditions: a) CH3CN, MW, 150W, 110 ˚C, 3h, 100%; 
b) CD3CN, DB24C8 (5 equiv), RT, 48h; c) CH3CN, cyclopentadiene, RT, 73%. 
Again the comparison thread was synthesised via the same synthetic pathway using the 
cyclopentadiene maleimide Diels-Alder alcohol 2.15. Reacting this with 4-
carboxybenzaldehyde gave intermediate aldehyde 2.27 and the imine 2.28 was formed with 
p-xylylenediamine in MeOH. Reduction of the imine was carried out and finally protonation 
with HClO4 gave ClO4
-
 salt 2.30 (Scheme 2.9). 
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Scheme 2.9 Synthesis of comparison thread 2.30. Reagents and conditions: a) CH2Cl2, N,N,N',N'-
tetramethylchloroformamidinium-hexafluorophosphate, NEt3, DMAP, RT, 72h, 75%; b) MeOH, RT, 2h, 83%; c) 
MeOH, CHCl3, NaBH3CN, HOAc, RT, 24h, 92%; d) CH2Cl2, HClO4, RT, 79%. 
The 
1
H NMR stacking plot of [3]rotaxane 2.26, thread 2.30 and DB24C8 is shown in Figure 
2.6. In the rotaxane the aromatic protons including the central phenyl ring of the thread are 
shifted upfield due to the close proximity of the aromatic rings of the crown. For the same 
reason the crown aromatic protons are also shifted upfield. The crown ether CH2‘s are 
recorded as complex multiplets as each interlocked crown now has two distinct faces in the 
[3]rotaxane. Shielding effects are seen on these crown CH2 protons. The CH2NH2
+
CH2 
recognition unit of the thread is shifted downfield and take on the characteristic splitting 
pattern
32
 whilst the Diels-Alder stopper portion of the thread remains relatively unaffected.  
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Figure 2.6 
1H NMR (400 MHz, CD3CN, 300K) stacking plot of i) DB24C8; ii) [3]Rotaxane 2.26 and iii) 
Comparison thread 2.30. 
2.2.2 Synthesis of a Short Diels-Alder Stopper Rotaxane 
Shortening the chain length between the recognition unit and maleimide pre stopper was 
investigated to determine how this would affect both yield and rate of rotaxane formation. A 
[2]rotaxane was synthesised incorporating a Diels-Alder gate with no alkyl spacer between 
the ester and imide. In this case the thread was synthesised from benzaldehyde and 4-
(aminomethyl)benzoic acid, and the imine formed (2.31) was reduced using sodium 
borohydride (Scheme 2.10). As the maleimide group had not been included in the molecule 
at this stage, it was possible to use sodium borohydride to reduce the imine. The reaction 
could also be performed using sodium cyanoborohydride and worked with no significant 
differences in yields of reaction. 
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Scheme 2.10 Synthesis of neutral thread 2.35. Reagents and conditions: a) MeOH, RT, 48h, 93%; b) MeOH, 
THF, NaBH4, 0˚C→RT, 24h, 33%; c) THF, di-tert-butyl dicarbonate, reflux, 24h, 94%; d) CH2Cl2, N,N,N',N'-
tetramethylchloroformamidinium hexafluorophosphate, NEt3, DMAP, 0˚C→RT, 7%; e) CH2Cl2, TFA, RT, 2h, 
98%. 
The amine was protected using di-tert-butyl dicarbonate (2.33) and the esterification could 
then be performed with the commercially available short Diels-Alder stopper alcohol exo-N-
hydroxy-7-oxabicyclo[2.2.1]hept-5-ene-2,3-dicarboximide. It was then necessary to 
deprotect amine 2.34 and this was carried out using TFA to provide the neutral axle 2.35 
shown in Scheme 2.10 in a 98% yield. 
 
Scheme 2.11 Synthesis of [2]rotaxane 2.39. Reagents and conditions: a) CH3CN, MW, 150W, 110˚C, 3h, 34 %; 
b) CD3CN, DB24C8, 60 ˚C, 1 month; c) CH3CN, cyclopentadiene, RT, 85%. 
The neutral axle was converted to the ClO4
-
 ammonium ion (2.36) with HClO4 and the retro 
Diels-Alder reaction was performed under microwave conditions to give the open gate axle 
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2.37. Two equivalents of DB24C8 were added to the axle in deuterated acetonitrile to push 
equilibrium towards pseudorotaxane formation (2.38). The threading rate of this axle was 
much slower than the axle with the alkyl chain between the ester and maleimide (2.11) at 
similar concentration. The close proximity of the three carbonyl groups probably presents a 
greater barrier to the threading of the DB24C8. In this case the reaction required heating in 
order to generate the pseudorotaxane so the macrocycle could surmount the steric barrier. 
Once pseudorotaxane formation was ≥ 95%, the macrocycle was trapped onto the axle using 
cyclopentadiene in a Diels-Alder reaction giving the [2]rotaxane 2.39 shown in Scheme 
2.11. The comparison thread was not obtained due to low reaction yields and difficulties in 
purification in the esterification of acid 2.33 and alcohol endo-N-hydroxy-5-norbornene-2,3-
dicarboximide. However the [2]rotaxane was successfully characterised by IR and ESI-MS 
giving the expected [2.39-ClO4]
+
 peak at m/z 879.4068. Also observing the 
1
H NMR the two 
methylenes of the CH2NH2
+
CH2
 
unit were seen to shift downfield to 4.88 and 4.54 ppm from 
4.34 and 4.19 ppm and undertake the characteristic splitting patterns of the encompassed 
thread.
32
 Other notable shifts were observed in the 
1
H NMR spectra in comparison to free 
maleimide axle 2.37 including shielding upfield of the aromatic portions of both axle and 
DB24C8 and a complicated splitting pattern of the crown ether CH2‘s. 
2.2.3 Investigating the Stopper Size 
 
In previous studies it has been found that the threading of DB24C8 over the maleimide 
stopper was not instantaneous but required time to reach equilibrium. This suggests DB24C8 
is only just able to thread over the maleimide end of the axle. It is likely that the two 
carbonyls of the imide provide both a steric and electronic barrier to the threading of the 
macrocycle. It was postulated that the bridging CH2 and sp
3
 hybridisation provided by the 
Diels-Alder reaction of the maleimide with cyclopentadiene might not be required and 
simpler (smaller) substituents would be just as effective as stoppers. Therefore a stopper 
functionalised with a phthalimide moiety was investigated to see if this was also able to act 
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as a stopper. It is known that macrocycles with 24 atom cavities have the ability to fit over 
the benzene ring so it’s possible to see if it’s the presence of the carbonyls alongside the 
phenyl group that allow it to act as a stopper. N-(2-Hydroxyethyl)phthalimide was reacted 
with 4-carboxybenzaldehyde to provide the aldehyde 2.40. Aldehyde 2.40 was then reacted 
with amine 2.07 giving the imine 2.41 which was reduced carefully with sodium 
cyanoborohydride followed to completion by thin layer chromatography (TLC). This gave 
the neutral unsymmetrical thread 2.42 shown in Scheme 2.12 and no over-reduction of the 
carbonyl imide was observed. 
 
Scheme 2.12 Reagents and conditions: a) CH2Cl2, N,N,N',N'-tetramethylchloroformamidinium 
hexafluorophosphate, NEt3, DMAP, 0˚C→RT, 24h, 75%; b) MeOH, RT, 24h, 100%; c) MeOH, CH2Cl2, 
NaBH3CN, RT, 1h, 78%. 
The thread was converted to the ClO4
-
 salt (2.43) and the retro Diels-Alder reaction 
performed by refluxing in a mixture of acetonitrile and toluene to give 2.44. The 
[2]pseudorotaxane 2.45 was again made by adding two equivalents of DB24C8 to push 
pseudorotaxane formation followed by 
1
H NMR. The stoppering Diels-Alder reaction was 
carried out with cyclopentadiene to trap the macrocycle onto the axle (Scheme 2.13). The 
[2]rotaxane (2.46) was left to stand in deuterated acetonitrile for two weeks and no 
dissociation of the complex was observed. The reaction was then heated to 60˚C and after 
one month there was still no decomplexation observed indicating the [2]rotaxane is stable in 
this solvent. 
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Scheme 2.13 Synthesis of [2]rotaxane 2.46. Reagents and conditions: a) CH3CN, toluene, reflux, 96h, 86%; b) 
CD3CN, DB24C8 (2 equiv), 48h; c) CH3CN, cyclopentadiene, RT, 85% 
The comparison axle was synthesised taking the deprotected maleimide thread (2.44) and 
cyclopentadiene in a Diels-Alder reaction to give new thread 2.47 in a 72% yield (Scheme 
2.14). We were then able to compare this thread’s 1H NMR shifts to the interlocked 
[2]rotaxane spectra. Significant shifts in both the aromatic and aliphatic regions of the thread 
were observed. The methylenes of the CH2NH2
+
CH2 unit are shifted downfield by 0.42 ppm 
due to hydrogen bonding with the crown ether oxygens and appear as a multiplet from 
coupling with hydrogens of the ammonium NH2
+
. The signal for the aromatic hydrogens of 
both axle and DB24C8 are shifted upfield due to interactions with each other and the crown 
ether CH2’s become complex multiplets. 
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Scheme 2.14 Synthesis of thread 2.47. Reagents and conditions: a) CH3CN, compound 2.44, cyclopentadiene, 
RT, 72%. 
The stability of the [2]rotaxane was further examined by recording the 
1
H NMR spectra in a 
more polar solvent that would disrupt the intermolecular interactions between the two 
components. The [2]rotaxane 2.46 was dissolved in DMSO-d6 and monitored by 
1
H NMR at 
room temperature. After 5 days there was no change observed in the spectra. The reaction 
was then warmed to 40˚C and in this instance unthreading of the macrocycle was observed 
by 
1
H NMR. After one month of heating, the macrocycle had completely dissociated from 
the axle. The 
1
H NMR spectra can be seen in Figure 2.7. It is apparent that in a polar solvent 
the disruption of the delicate intermolecular interactions between macrocycle and axle is 
sufficient to enable decomplexation. In DMSO-d6, the disruption of the binding interaction 
between the ammonium ion and the crown favours the free components, though the very 
slow rate of unthreading highlights the considerable barrier that the macrocycle encounters 
when threading/dethreading over the phthalimide moiety. 
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Figure 2.7 1H NMR spectra of a) [2]pseudorotaxane 2.46 in DMSO-d6, RT; b) [2]pseudorotaxane 2.46 in 
DMSO-d6, 40˚C, 2 weeks; c) [2]pseudorotaxane 2.46 in DMSO-d6, 40˚C, 1 month. 
In Figure 2.7, spectrum a) shows [2]pseudorotaxane 2.46 dissolved in DMSO-d6. 
Characteristic peaks indicating complex formation are observed. Most notably the CH2’s 
situated next to the NH2 have shifted downfield with their distinctive splitting pattern, and 
the CH2‘s of DB24C8 have taken on the very complex splitting pattern. The DMSO-d6 
solvent disrupts the hydrogen bonding interaction between the crown and thread meaning 
the crown no longer predominantly resides over the CH2NH2
+
CH2 unit but spends longer 
residence time over all the thread. This is exemplified by small shifts of the peaks associated 
with the stopper region of the thread. You can see in spectrum b) after two weeks of heating 
at 40˚C in DMSO-d6, a second set of peaks have appeared which correspond to the free 
thread and DB24C8. Finally in spectrum c) the [2]pseudorotaxane 2.46 has completely 
dissociated after one month in DMSO-d6 at 40˚C to give a spectra of the free thread and 
DB24C8. The shifts of the free thread in this spectra are identical to endo thread 2.47 made 
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for comparison purposes and show that no maleimide 2.44 from the retro Diels-Alder 
reaction could be detected. The dethreading is shown in Scheme 2.15. 
 
Scheme 2.15 Reagents and conditions: a) DMSO-d6, 1 month, 40˚C. 
Finally the ClO4
-
 thread 2.47 and DB24C8 were dissolved in deuterated acetonitrile and the 
reaction monitored at 40˚C by 1H NMR. After following the reaction for several weeks, no 
threading occurred indicating that a retro Diels-Alder reaction is not responsible for the 
unthreading and that the phthalimide group presents a formidable barrier to 
threading/dethreading of DB24C8. As DB24C8 is known to thread over a benzene ring and 
we have shown it can thread over a maleimide, the presence of the two carbonyl groups and 
the benzene ring presents a considerable barrier to the passage of the macrocycle.  
2.3 Perimidine Benzimidazole Binding Motif 
 
The development of new templates for rotaxane formation can yield both a better 
understanding of the threading process and new components for incorporation into rotaxane 
based molecular machines. Many interlocking structures have been reported utilising both 
secondary ammonium ions and quarternised pyridines. A bisbenzimidazole template (Figure 
2.8) has been previously disclosed that combines the π-stacking abilities of the electron 
deficient pyridinium and hydrogen bonding capabilities of the ammonium ions. This 
template has shown significant binding to DB24C8 via these interactions.
120
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Figure 2.8 The bisbenzimidazole template. 
Work by Li
120 
has shown that unfunctionalised bisbenzimidazole templates can be 
synthesised readily from the acid catalyzed condensation of 1,2-phenylenediamine and 
succinic acid, as shown in Scheme 2.16. With the thread having two recognition sites joined 
by a short linker, the bisbenzimidazolium cation can interact with both electron rich 
aromatic rings of the DB24C8 crown, as well as hydrogen bonding to either face of the 
macrocycle to position the thread within its cavity as shown by the solid state structure of 
pseudorotaxane 2.49.  
 
Scheme 2.16 Synthesis of the bisbenzimidazole template and X-Ray crystallography structure. 
Previous work has also found that introducing an electron withdrawing group onto the 
benzimidazole such as an ester can increase the binding interaction. The ester group offers 
the possibility of modification to create a wide variety of stopper groups acting as the 
terminating end of the axle for the synthesis of rotaxanes. Routes towards functionalised 
threads starting from suitably functionalised o-phenyldiamine has proved to be challenging 
due to the difficulty of finding a functionalised benzimidazole which can withstand the harsh 
synthetic conditions of the reaction to make the benzimidazole ring. A milder and 
asymmetric route has been discovered where the functionalised benzimidazole groups are 
introduced consecutively yielding [2]rotaxanes using this binding motif.
119
  
  Chapter 2 
52 
 
To further explore the bisbenzimidazole motif, one of the benzimidazole moieties was 
replaced with a perimidine group (Figure 2.9). Perimidines and their derivatives were 
discovered in the early 1900s by Sachs.
121
 They are useful as dye intermediates
122-123
 and can 
also be found in a number of biologically active compounds.
124-125
  Paragamian and co 
workers have also spent time optimising the synthesis of these structures and investigated 
their pharmacological activity.
126
 
 
Figure 2.9 The perimidine template. 
One of the key reasons we were interested in incorporating this novel moiety into the 
binding motif, is the redox ability of this molecular system as demonstrated for hydrogen 
bonded charge transfer complexes. Nakasuji et al
127-128
 has explored this ability in order to 
develop new conducting organic molecular based materials. The 1,3 diazanaphthalene 
system is isoelectronic with the phenalenyl anion. The phenalenyl has three states shown in 
Figure 2.10. It is an odd-alternate hydrocarbon π-electron system and has high 
thermodynamic stability.  
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Figure 2.10 The three phenalenyl redox species and the isoelectronic 1,3-diazaphenalene compound. 
As well as these electronic characteristics, the perimidine has both proton donor and proton 
acceptor functionalities and can form hydrogen bonds. Due to these characteristics, its 
similarity to the functionality in a benzimidazole and the possibility to act as a stopper, we 
were interested in incorporating this system into the binding motif of a rotaxane with the 
potential of controlling the interaction between the macrocycle and the axle using its redox 
activity. This also gives the opportunity to exploit the Diels-Alder ‘threading followed by 
stoppering’ approach to form rotaxanes with this binding motif. 
2.3.1 Synthesis of Perimidine Pseudorotaxanes and Rotaxanes 
The simple perimidine modified template has been synthesised within the group. The 
unfunctionalised perimidine benzimidazole thread is formed by reacting 1,8-
diaminonaphthalene with succinic anhydride in HOAc to provide the resulting acid 2.50 in a 
95% yield. Further reaction with trifluoroacetic anhydride (TFAA) in CH2Cl2 provided an 
intermediate lactam which was immediately reacted with the 1,2-phenylenediamine giving 
the neutral thread 2.51. Conversion of this to the ClO4
-
 salt 2.52 provided a template with an 
increased π surface and novel hydrogen donor in the form of the perimidinyl cation. The 
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binding template was characterised using NMR and HRMS with the mass ion occurring at 
313.1444 corresponding to the [2.52-H.2ClO4]
+
. The IR spectra also shows an absorption at 
1053 cm
-1
 which is characteristic for the ClO4
- 
counterion. 
 
Scheme 2.17 Reagents and conditions: a) HOAc, 70˚C, 24 h, 95%; b) i) CH2Cl2, TFAA, RT, 24h; ii) HOAc, o-
phenylenediamine, 70˚C, 48h, 74%; c) MeOH, HClO4, 46%; d) CH3CN, DB24C8 (1 equiv). 
Equimolar quantities of the thread 2.52 and DB24C8 were dissolved in deuterated 
acetonitrile and the pseudorotaxane was formed. Formation of the pseudorotaxane 2.53 was 
confirmed by 
1
H NMR and ESI-mass spectrometry. The binding constant was measured 
using the single point method
129
 at 2 mmol and found to be 1055 M
-1
, a two fold increase 
from the simple bisbenzimidazole thread (490 M
-1
). This showed that the perimidine thread 
had a much stronger interaction with the DB24C8 than its simple counterpart suggesting 
heightened π-stacking and hydrogen bonding capabilities. Over time, suitable crystals for X-
ray crystallography grew from the NMR sample and the solid state structure of 
[2]pseudorotaxane 2.53 was obtained and is shown in Figure 2.11. The structure obviously 
differs from the solid state structure of the bisbenzimidazole pseudorotaxane 2.49 but it was 
surprising to see the uneven nature of the interaction of the two hydrogen bond donating 
units with the crown. The benzimidozolium ion has only one NH interaction with the crown. 
Both NH’s of the perimidinium ion have short contacts to the crown oxygens. Additionally, 
the dioxybenzene of the crown is almost parallel to the plane of the perimidine π system. 
The benzimidazole and crown π systems are slightly orientated away from each other 
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suggesting a weaker π stacking interaction and the NH of the benzimidazolium cation is 
hydrogen bonded to a ClO4 counter ion (not shown in image). 
 
Figure 2.11 Solid state structure side on view of [2]pseudorotaxane 2.53 showing hydrogen bonding between the 
thread NHs and crown ether oxygens. C white; O red; N blue; H pale blue. ClO4 counter ions have been removed 
for clarity. 
As a simple modification to increase the hydrogen bonding ability of the benzimidazole, 
thread 2.54 was constructed. Acid 2.50 was again reacted at room temperature with TFAA in 
CH2Cl2 to give an intermediate lactam, followed by addition of 3,4-diaminobenzophenone in 
HOAc providing the neutral thread (2.54). Reacting this with HClO4 in MeOH provided the 
ClO4
-
 salt 2.55. The [2]pseudorotaxane 2.56 was then generated taking equimolar quantities 
of thread and DB24C8 in deuterated acetonitrile at 2 mmol. The binding constant was found 
to be 995 M
-1
 calculated using the single point method at 2 mmol.
129
 It seems there is little 
effect on binding by the substitution of electron withdrawing groups on the benzimidazole 
moiety. 
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Scheme 2.18 Reagents and conditions: a) i) CH2Cl2, TFAA, RT, 24h, 65%; ii) HOAc, 3,4-
diaminobenzophenone, 70˚C, 48h, 65%; b) MeOH, HClO4, 50%; c) CH3CN, DB24C8 (1 equiv), RT. 
The formation of the [2]pseudorotaxane 2.56 was confirmed by 
1
H NMR, ESI-mass 
spectrometry and an x-ray crystal structure was obtained (Figure 2.12). In contrast to the 
solid state structure of 2.53 (Figure 2.11), the hydrogen bonding pattern between thread and 
crown in the solid state more closely resembles that of the symmetrical bisbenzimidozolium 
threads
120
 with one NH on each heterocycle forming a bifurcated hydrogen bond to the 
crown oxygens and the other interacting with the ClO4
-
 counter ion. Differences between the 
two cationic units of the thread are apparent in the π stacking interaction with the crown. The 
perimidine and dioxybenzene of the crown have planar π systems whereas the 
benzimidazole and dioxybenzene are again slightly orientated away. This picture is 
complicated by the benzophenone substituent not being parallel to the benzimidazole which 
could be interfering with the π stacking interactions. In an effort to further investigate the 
effect of substitution the modification of this template into a maleimide functionalised thread 
for rotaxane formation was an obvious avenue for exploration. 
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Figure 2.12 Solid state structure of [2]pseudorotaxane 2.56 showing the interlocked nature of crown and thread. 
Hydrogens have been omitted for clarity except the NH’s involved in hydrogen bonding interactions with the 
crown and ClO4 counter ions. C white; O red; N blue; Cl green. 
The synthesis of a thread suitable the Diels-Alder strategy was carried out to generate 
rotaxanes via the ‘threading followed by stoppering’ approach. Again started by reaction of 
acid 2.50 with TFAA in CH2Cl2, a further reaction with 3,4-diaminobenzoic acid provided 
the new acid functionalised binding motif 2.57. At this stage, incorporation of the Diels-
Alder adduct was undertaken in an esterification reaction with the acid. Using the coupling 
agent HBTU in a solution of CH2Cl2 and NEt3 the neutral thread was synthesised. Although 
chromatography and several methods of purification were attempted, we were unable to 
isolate the neutral thread for characterisation. The most significant problem encountered in 
the ester synthesis was the solubility of acid 2.57. A variety of reaction conditions were 
investigated in order to improve efficiency of this reaction. The acid 2.57 was found to be 
soluble in solvents such as DMAc and DMF but formation of the ester either did not occur 
or yields of product were very low under these conditions. Using a mixture of CH2Cl2 and 
NEt3 was found to be the best solvent/base system for the reaction. Stirring these with the 
acid 2.57, 4-dimethylaminopyridine (DMAP) and coupling agent HBTU overnight then 
addition of alcohol 2.04 gave the most efficient synthesis of the axle. Conversion of the 
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crude material into the ClO4
-
 salt was carried out immediately in MeOH with the addition of 
HClO4 to give thread 2.58 (Scheme 2.19). To enable the DB24C8 to thread, a retro Diels-
Alder reaction to remove the furan was necessary. This was undertaken using microwave 
heating to generate 2.58 in a 55% yield after purification via recrystallisation. 
 
Scheme 2.19 Reagents and conditions: a) i) CH2Cl2, TFAA, RT, 12h; ii) HOAc, 70˚C, 48h, 43%; b) i) CH2Cl2, 
NEt3, Alcohol 2.04, DMAP, HBTU, RT, 72h; ii) MeOH, HClO4, RT, 12%; c) CH3CN, MW, 150W, 110 ˚C, 3h, 
55%. 
The DB24C8 was now able access the binding motif of the axle by threading over the 
maleimide functional group to provide us with the intermediate pseudorotaxane structure 
2.60. After 48 hours using two equivalents of DB24C8 the reaction had reached equilibrium 
in favour of pseudorotaxane formation observed by 
1
H NMR. A stoppering reaction was 
then performed in order to prevent the macrocycle from slipping off the axle. This was done 
using cyclopentadiene at room temperature to give only the kinetically preferred endo 
isomer of the [2]rotaxane 2.61 (Scheme 2.20). Isolation of the [2]rotaxane proved difficult 
and the stability of the material was poor although there is proof of the interlocked structure 
by both appropriate shifts in 
1
H NMR and ESI-MS with a peak seen at m/z 994.4233 relating 
to the expected [2.61-ClO4]
+
 species. Synthesis of the comparison thread was hampered by 
the low solubility and reactivity of this system. 
 
During isolation of the [2]rotaxane 2.61 by column chromatography, 
1
H NMR analysis of a 
pure fraction gave a spectra rather more complex than expected. There was a doubling of the 
peaks associated with the benzimidazole group. From previous work on the 
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bisbenzimidazole rotaxane
119
 it was found that the basicity of the bisbenzimidazole rotaxane 
is much less than the ammonium rotaxanes where there is an enhanced pKa due to the 
stability of the ammonium ion buried in the rotaxane complex. The bisbenzimidazole has the 
NH’s exposed outside either face of the crown and additionally the heterocyclic ring is not 
as basic as a secondary amine. In simple substituted benzimidazoles, the tautomerism of the 
hydrogen can be slow on the 
1
H NMR timescale leading to a broadening or doubling of 
signals (Figure 2.13).
130
 This inter-conversion of the benzimidazole inside the cavity of a 
crown slows this tautomerism even further.  
 
Figure 2.13 Tautomerism of functionalised benzimidazole. 
Rotaxane 2.60 must have been neutralised following silica gel column chromatography. VT-
NMR was carried out on the [2]rotaxane but it did not provide any better resolution of these 
peaks and affected the stability of the compound. However addition of TFA to the sample 
reprotonates this moiety and once again we see a single set of sharp peaks corresponding to 
the charged benzimidazole disalt of the [2]rotaxane.  
 
Scheme 2.20 Reagents and conditions: a) CH3CN, DB24C8 (2 equiv), RT; b) CH3CN, cyclopentadiene, RT, 
34%. 
  Chapter 2 
60 
 
Due to the problems associated with the synthesis and purification of these materials, the 
focus of the work shifted to exploiting the ‘threading followed by Diels-Alder stoppering 
approach’ to rotaxane formation with other systems. 
2.4 BisPyridinium Functionalised Rotaxanes 
As we have previously seen, development of novel templates can lead to a greater 
understanding of the interlocking process and provide new and improved applications for 
rotaxanes. In Chapter 1 the Loeb groups development of a bispyridinium template (Figure 
2.14) which has been shown to have excellent binding with crown ether macrocycles was 
discussed.
46
 The axle and macrocycle bind through N
+…. O interactions and C-H…. O 
hydrogen bonding. The interaction can be enhanced by the addition of π-π stacking 
interactions by the incorporation of a benzene ring into the macrocycle i.e. benzo-24-crown-
8 (B24C8) and DB24C8. Varying substituents on the bispyridinium template also has an 
impact on binding. Adding an electron withdrawing group such as CO2Et at the 3 or 4 
position of the pyridinium causes the binding interaction between template and macrocycle 
to increase greatly (Figure 2.14). This is a result of removing electron density from the 
pyridinium ring making it more electron poor thus enhancing its interaction with the electron 
rich catechol ring of the macrocycle and increasing the hydrogen binding ability of the 
pyridinium α-CH’s. 
 
Figure 2.14 1,2-bis(pyridinium)ethane binding template. 
Since the initial discovery of the binding motif, it has been used to synthesise a variety of 
supramolecular complexes including pseudorotaxanes,
131-132
 rotaxanes,
133-136
 metal organic 
frameworks
137
 and molecular shuttles.
138
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2.4.1 Synthesis of Rotaxanes Incorporating Bispyridinium Binding Motifs 
As we have seen, the bispyridinium functionality has been successfully used as a binding 
motif by Loeb and others and we wanted to use this binding motif to showcase the groups’ 
Diels-Alder ‘threading followed by stoppering’ approach in rotaxane synthesis. Nicotinic 
acid was converted to its acid chloride 2.62 and reacted with the Diels-Alder stopper under 
basic conditions to give ester 2.63 (Scheme 2.21). The ester was observed by both NMR and 
IR showing a peak at 1688 cm
-1
 corresponding to an ester carbonyl. The ESI-HRMS also 
provided evidence of synthesis of this ester showing m/z 315.0978 for the [2.63+H]
+
 ion.  
 
Scheme 2.21 Reagents and conditions: a) SOCl2, DMF, RT, 24h, quant; b) CH2Cl2, NEt3, 0˚C→RT, 48h, 58%. 
Using 1,2-dibromoethane, synthesis of unsymmetrical bispyridinium thread was successfully 
performed. Introduction of a stopper by reacting nicotinic acid chloride with 3,5-dimethyl 
phenol provided ester 2.64. Subsequent reactions in acetonitrile with 1,2-dibromoethane at 
60˚C produced the bromide salt 2.65.  Reacting this with pyridinium ester 2.63 in 
acetonitrile provided the dibromide salt 2.66 shown in Scheme 2.22. Conversion to the ClO4
-
 
salt 2.67 via an ion exchange reaction was successful using sodium perchlorate and finally 
the retro Diels-Alder reaction was carried out by refluxing 2.67 in acetonitrile unmasking the 
maleimide moiety to give axle 2.68.  
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Scheme 2.22 Reagents and conditions: a) CH3CN, 1,2-dibromoethane, 60 ˚C, 72h, 24%; b) CH3CN, 60 ˚C, 72 h, 
48%; c) H2O, NaClO4, RT, 73%; d) CH3CN, reflux, 24h, 36%. 
The axle 2.68 was dissolved in deuterated acetonitrile and two equivalents of DB24C8 were 
added forming pseudorotaxane 2.69. The effects of the macrocycle encompassing the axle 
can be seen clearly in the 
1
H NMR with several significant shifts in peaks observed. The 
final stage is to trap the macrocycle onto the axle in a ‘stoppering’ reaction giving rotaxane 
2.70 shown in Scheme 2.23. Freshly distilled cyclopentadiene was added to the 
pseudorotaxane 2.69 in acetonitrile generating the bulky stopper. This provided us with new 
[2]rotaxane 2.01 in a 58% yield. 
 
Scheme 2.23 Reactants and reagents: a) CH3CN, cyclopentadiene, 58%. 
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A comparison thread with the endo conformation from the known endo alcohol 2.15
139
 was 
also synthesised by reacting with nicotinic acid chloride shown in Scheme 2.24. The product 
formation was confirmed by NMR and ESI-HRMS with a single peak at 313.1182 in 
concordance with the [2.70+H]
+
 species. 
 
Scheme 2.24 Reagents and conditions: a) SOCl2, DMF, 24h, RT, quant; b) CH2Cl2, NEt3, 0˚C→RT, 48h, 18%. 
The comparison thread was successfully synthesised reacting the bromide salt 2.65 with 
pyridinium 2.70 to form new dibromide salt 2.71. Conversion to the ClO4
-
 salt was carried 
out in an ion exchange reaction using a concentrated aqueous solution of sodium perchlorate 
to give the thread 2.72. 
 
Scheme 2.25 Reagents and conditions: a) CH3CN, 60 ˚C, 72h, 55%; b) H2O, NaClO4, RT, 47%. 
Comparison of the 
1
H NMR spectra of the [2]rotaxane 2.01 is shown in Figure 2.15,  the 
peaks associated with the dimethylphenyl and the Diels-Alder stopper portions of the thread 
are relatively unaffected by the presence of the macrocycle encompassing the axle. The α-
aromatic protons of the bispyridinium motif are seen to shift downfield due to hydrogen 
bonding between these and the crown ether oxygens. The aromatic protons of DB24C8 are 
shifted upfield and separate into two multiplets and the ethylene CH2’s of the macrocycle are 
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seen to form two broad singlets. The ethylene spacer situated in the binding motif shows a 
considerable shift downfield due to hydrogen bonding with the crown ether oxygens. The 
shift of the two triplets corresponding to the ester chain of the stopper are relatively 
unaffected by the axle being encompassed by the macrocycle.  
 
Figure 2.15 
1H NMR (400 MHz, CD3CN, 300K) stacking plot of i) DB24C8 ii) [2]rotaxane 2.01 and iii) 
comparison thread 2.72. 
The solid state structure was also obtained of the [2]rotaxane 2.01 shown in Figure 2.16. The 
structure confirms the endo conformation of the Diels-Alder stopper portion of the thread 
and highlights how the thread 2.72 and DB24C8 take on a conformation to provide π 
stacking between the two interlocked components in the solid state. 
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Figure 2.16 Solid state structure of [2]rotaxane 2.01 in an orientation to highlight the pi stacking interactions and 
the endo stereochemistry of the imide stopper. Only the hydrogens of the Diels-Alder stopper are retained to 
emphasise the stereochemistry. C white; N blue; O red; H pale blue. ClO4 counter ions have been removed for 
clarity.  
After successfully synthesising a [2]rotaxane with a bispyridinium ethane binding motif 
using the groups’ Diels-Alder ‘gate’ in a ‘threading followed by stoppering’ protocol, we 
wanted to take further advantage of this strategy. A bispyridinium methane template has 
been developed by the group
140
 based on a simple modification of the Loeb bispyridinium 
ethane motif.
46
 Taking the previously synthesised ester pyridinium 2.63 in an SN2 reaction 
with an excess of dibromomethane in DMF provided a bispyridinium bromine salt 2.73 
symmetrically functionalised with Diels-Alder gates. The pyridinium protons are shifted 
downfield due to the nitrogen becoming charged. The central CH2 appears at 7.61 due to its 
location between the two quarternised nitrogens. 
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Scheme 2.26 Reagents and conditions: a) CH2Br2, DMF, 60˚C, 48h, 55%. 
Attempts at forming the thread using the isonicotinic ester 2.75 were also carried out but 
proved unsuccessful when reacted with dibromomethane. This lack of reactivity is probably 
because the pyrimidine nitrogen is less nucleophilic due to the presence of the ester in the 4-
position of 2.75 (Scheme 2.27). 
 
Scheme 2.27 Reagents and conditions: a) SOCl2, DMF, RT, quant; b) CH2Cl2, NEt3, 0˚C→RT, 48h, 58%; c) 
CH2Br2, DMF, 60 ˚C, 48h. 
To enhance binding of the macrocycle to the thread, the bispyridinium moiety was converted 
into a salt with a weakly co-ordinating counter ion. The ClO4
- 
salt of the nicotinate axle 2.73 
was generated in an ion exchange reaction by mixing a saturated solution of sodium 
perchlorate with a saturated solution of thread 2.73 to precipitate 2.76 from solution.  
The ‘gate’ is opened by generating the maleimide pre-stopper via a retro Diels-Alder 
reaction making the terminating end of the thread sufficiently sized to slip through the cavity 
of the macrocycle. This was done simply by heating the ClO4
- 
salt thread 2.76 in acetonitrile 
at reflux to produce the maleimide thread 2.77 and furan as a by-product (Scheme 2.28).  
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Scheme 2.28 Retro Diels-Alder reaction of the bispyridinium ClO4
- thread 2.76. Reagents and conditions: a) 
CH3CN, 110˚C, 150W, 3h, 46%. 
Originally the unmasking of the maleimide was carried out by refluxing the perchlorate 
thread 2.77 in acetonitrile. Problems were encountered when undergoing the retro Diels-
Alder reaction. Hydrolysis of the axle occurred regenerating the initial pyridine ester 2.63. 
This problem was partially overcome by carrying out the reaction in a microwave at 110˚C 
in a greatly reduced time of 3 hours in acetonitrile. The solvent and furan generated were 
removed in vacuo. The increase in the retro Diels-Alder rate by microwave heating reduced 
the amount of hydrolysis observed.  
The thread was then dissolved in deuterated acetonitrile with two equivalents of DB24C8 to 
push the threading of the crown to > 90% (by 
1
H NMR) to produce pseudorotaxane 2.78. 
Once the DB24C8 was threaded onto the axle, the Diels-Alder reaction was implemented 
using freshly cracked cyclopentadiene forming the bulky stopper to trap the macrocycle onto 
the axle to give rotaxane 2.02 (Scheme 2.29). Excess cyclopentadiene was removed in 
vacuo. Purifying the [2]rotaxane proved difficult due to the instability of the compound and 
only a small amount was isolated with some minor impurities visible in 
1
H NMR (Figure 
2.17). Rotaxane formation was also confirmed by ESI-HRMS with the [2.02-2ClO4]
2+
 ion 
occuring at 543.2285. 
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Scheme 2.29 Reagents and conditions; a) CH3CN, cyclopentadiene, RT, 57% 
Again the comparison thread was synthesised from the cyclopentadiene stoppered 
pyridinium 2.70. Reacting this with dibromomethane gives thread 2.79 and this is converted 
to the ClO4
- 
salt 2.80 on reacting with aqueous sodium perchlorate (Scheme 2.30) to the give 
disalt in a 29% yield. 
 
Scheme 2.30 Reagents and conditions: a) CH2Br2, DMF, 60˚C, 48h, 13%; b) H2O, NaClO4, RT, 29%. 
A stacking plot of the 
1
H NMR of crown, thread and rotaxane is shown in Figure 2.17. Once 
the axle is encompassed by the macrocycle the α pyridyl protons are shifted downfield as 
they hydrogen bond with the crown oxygens. There is a shielding effect on the aromatic 
protons of the crown caused by its close proximity to the π system of the thread. The central 
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CH2 is also shifted downfield. There is little or no effect observed for the stopper portion of 
the thread showing that the crown mainly resides over the bispyridinium template.  
 
Figure 2.17 
1H NMR (400 MHz, CD3CN, 300K) stacking plot of i) DB24C8 ii) [2]Rotaxane 2.02 and iii) 
Comparison thread 2.79. 
Due to the low yields and hydrolysis problems encountered during the retro Diels-Alder 
reaction, the stability of the Br
-
 and ClO4
-
 threads were investigated. The Br
-
 thread was 
dissolved in D2O and left to stand at room temperature monitoring by 
1
H NMR. After one 
day the hydrolysed pyridine begins to form highlighting the instability of this compound in 
water. The stability of the ClO4
-
 salt was also examined. It was dissolved in deuterated 
acetonitrile and after a week at room temperature only a trace of thread hydrolysis was 
observed. The ClO4
-
 salt is relatively stable at room temperature but breaks down during the 
thermal retro Diels-Alder reaction probably due to residual water in the reaction system.  
Attempts to improve the synthesis by undertaking the retro Diels-Alder reaction before 
formation of the salt by reaction of maleimide 2.81 in dibromomethane and DMF were 
unsuccessful (Scheme 2.31). Only small amounts of starting material were recovered on 
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analysis. This failed presumably because the maleimide is prone to Michael addition and 
polymerization.  
 
Scheme 2.31 Attempted synthesis of the retro Diels-Alder thread. Reagents and conditions: a) CH2Br2, DMF, 
60˚C.  
2.5 Conclusion 
The Diels-Alder reaction has been successfully exploited to synthesise a number of 
rotaxanes in a ‘threading followed by stoppering’ protocol with a variety of binding motifs. 
The ammonium ion template has been used with promising results to synthesise [2] and 
[3]rotaxanes using this approach. We have found that removing the alkyl spacer between the 
maleimide and ester unit significantly reduces the threading rate of the macrocycle. It has 
also been found that replacing the bridged six membered ring, with the flat sp
2
 hybridized 
phthalimide moiety compromises its ability to act as a stopper for DB24C8 macrocycle 
under relatively harsh conditions. Unfortunately when dissolving the [2]rotaxane in DMSO 
and heating to 40 ˚C this disrupts the intermolecular interactions and unthreading of the 
macrocycle occurs. 
 
Synthesis of a novel binding motif has also been achieved which has been shown to have 
promising binding affinities with crown ether macrocycles. Substituting a perimidine moiety 
into the bisbenzimidazole template gave a two fold increase in the binding interaction 
between the two components from 490 M
-1
 to 1055 M
-1
. Addition of the electron 
withdrawing benzophenone functional group to the benzimidazole side of the template did 
not make a significant difference in binding interaction between the thread and DB24C8. 
Using the perimidine template, a [2]rotaxane 2.61 was successfully synthesised with a Diels-
Alder ‘gate’ incorporated into the axle. Several sets of reaction conditions were attempted to 
synthesise this axle but yields of the esterification reaction were still very low. As a result, 
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only small amounts of the rotaxane were obtained and so far we have not been able to 
synthesise enough material to investigate its properties. 
The Diels-Alder reaction has also been applied to achieve rotaxanes incorporating with 
bispyridinium binding motifs in a ‘threading followed by stoppering’ approach. It was found 
that when there was only one CH2 connecting the two pyridine nitrogens, problems occurred 
during the retro Diels-Alder reaction when considerable hydrolysis of thread 2.76 was 
observed. Using the known 1,2-pyridinium ethane motif, the rotaxane synthesis was more 
successful and no hydrolysis was observed during rotaxane formation and isolation. The 
rotaxane was synthesised and the solid state crystal structure was obtained proving the endo 
conformation of the cyclopentadiene functionalised maleimide adduct. 
2.6 General Experimental 
All experiments were carried out in fume hoods, adhering to general laboratory safety 
protocols and risk assessments (COSHH). Reagents and chemicals were purchased from 
Sigma Aldrich, Lancaster, TCI or Alfa Aesar and used without further purification. 
Solutions used to generate the appropriate ammonium salts were made up by diluting 
commercial samples of the appropriate acid. Approximately 10% HClO4 solution was made 
by carefully adding 10 mL HClO4 to 70 mL water. Approximately 10% 
hexafluorophosphoric acid was made by carefully adding 6.5 mL of acid to 65 mL water. 
 
1
H NMR and 
13
C NMR spectra were recorded on a Bruker Avance DRX 400 MHz fourier 
transform machine at room temperature (298 K) unless otherwise stated. Chemical shifts are 
quoted in parts per million downfield of tetramethylsilane. Solvents were used as an internal 
standard when assigning NMR spectra (δH: CDCl3 7.26 ppm, CD3CN 1.94 ppm, CD3OD 
3.31 ppm, DMSO-d6 2.50 ppm, D2O 4.79 ppm; δC: CDCl3 77.1 ppm, CD3CN 118.7 ppm, 
CD3OD 49.0 ppm, DMSO-d6 39.5 ppm. Coupling constants, J, are given in Hz. 
13
C NMR 
spectra were recorded with broadband proton decoupling and spectra assigned on the basis 
of pendant, 3D COSY , HMQC and HMBC spectra. Infra-red spectra were recorded on an 
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Avatar 320. Thin Layer Chromatography (TLC) was performed using silica (0.25 mm) 
coated alumina 149 plates. ESI mass spectra were obtained on a Bruker Esquire 2000 mass 
spectrometer coupled with an Agilent 1100 HPLC (without a column) as the delivery 
system. Accurate mass spectra were obtained using a Bruker micro-TOF ESI attached to a 
time of flight (TOF) analyser. CHN elemental analyses were carried out by Warwick 
Analytical Services. Melting points were determined using a Stuart SMP10 melting point 
machine.  
2.6.1 Experimental Section 
2.03 
 
Synthesised according to a modified literature procedure.
141
 Maleic anhydride (10 g, 102 
mmol) was dissolved in Et2O (50 mL) until a clear solution was obtained. Furan (7.4 mL, 
102 mmol) was added to the mixture and it was left to stand at room temperature for 48 h. A 
white precipitate formed which was filtered and washed with petroleum ether to provide 
white crystals (12.14 g, 73.1 mmol, 72%). 
1
H NMR (300 MHz, 298 K, CDCl3) δH 6.59 (br s, 
2H, CH=CH), 5.48 (br s, 2H, 2 CHO), 3.20 (br s, 2H, 2 CHCO); 
13
C NMR (75 MHz, 298 K, 
CDCl3) δC 170.3 (C=O), 137.3 (CH=CH), 81.6 (CHO), 48.1 (CHCO); IR ν cm
-1 
3033 
(saturated C-H), 1779 (anhydride C=O), 1211 (C-O). 
2.04 
 
Synthesised according to a modified literature procedure.
142
 Anhydride 2.03 (5 g, 28 mmol) 
was dissolved in EtOH (50 mL). The solution was cooled to 0°C and a solution of 
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ethanolamine (1.8 mL, 30 mmol) and NEt3 (4.2 mL, 30 mmol) in EtOH (10 mL) was added 
dropwise to the solution and left to stir for 30 minutes. It was then heated overnight at 70°C. 
Solvent was partially removed in vacuo until the product began to precipitate. It was then 
cooled to 0°C for 5 minutes and filtered and washed with ice cold EtOH to provide a light 
pink solid (5.43 g, 26 mmol, 84%). 
1
H NMR (300 MHz, 298 K, CD3CN) δH 6.51 (br s,2H, 
CH=CH), 5.12 (s, 2H, 2 CHO), 3.51 (t, 2H, J = 6.0 Hz, CH2CH2O), 3.54 (t, 2H, J = 6.0 Hz, 
CH2CH2N), 2.90 (br s, 2H, 2 CHCO), 2.24 (br s, 1H, OH); 
13
C NMR (75 MHz, 298 K, 
CD3CN) δC 171.0 (C=O),136.1 (CH=CH), 80.5 (CHO), 58.0 (CH2CH2O), 47.1 (CHCO), 
40.5 (CH2CH2N); IR ν cm
-1
 3472 (OH), 1682 (imide C=O); MS (ESI
+
): m/z 231.9 
[2.04+Na]
+
. 
2.05 
 
Synthesised according to a modified literature procedure.
143
 To an ice cooled solution 4-
aminomethylbenzoic acid (1 g, 6.62 mmol) in dioxane (15 mL) and aqueous sodium 
hydroxide 1M (15 mL) was added a solution of di-tert-butyl dicarbonate (2.17 g, 10 mmol) 
dissolved in dioxane (5 mL). The mixture was stirred for 48 h, acidified to pH 4 with HCl 
4M and extracted with CH2Cl2 (2 x 20 mL). The organic layers were collected, washed with 
brine (15 mL) and dried over MgSO4. The solution was filtered and concentrated in vacuo to 
provide a white solid ( 750 mg, 3.00 mmol, 45%). m.p. 162-163°C; 
1
H NMR (400 MHz, 298 
K, CD3OD) δH  7.90 (d, J = 8.2 Hz, 2H, 2 ArCH), 7.35 (d, J = 8.2Hz, 2H, 2 ArCH), 4.20 (br 
s, 2H, CH2), 1.41 (s, 9H, 3 CH3); 
13
C NMR (100 MHz, 298 K, CD3OD) δC 167.2 (COOH), 
155.8 (NHCOO), 145.3 (ArC), 129.3 (ArCH), 129.1 (ArC), 126.9 (ArCH), 77.9 (C(CH3)3), 
43.2 (CH2), 28.2 (CH3); IR ν cm
-1
 3349 (NH), 2980 (saturated CH), 1679 (ester C=O), 1611 
(imide C=O); MS (ESI
+
): m/z 274.1 [2.05+Na]
+
. 
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2.06 
 
Amine 2.05 (700 mg, 2.78 mmol) was dissolved in dry CH2Cl2 with alcohol 2.04 (583 mg, 
2.78 mmol), PyBOP (1.74g, 3.34mmol) and NEt3 (0.8 L, 5.57mmol). The mixture was 
stirred overnight at room temperature, and then washed with water (15 mL), saturated citric 
acid (15 mL), saturated sodium carbonate (15 mL), water (15 mL) and brine (15 mL). The 
organic layer was dried with MgSO4, filtered off and concentrated in vacuo and the white 
solid recyrstallised from EtOAc (797 mg, 1.80 mmol, 65%).  m.p.  93-94 ˚C; 1H NMR (400 
MHz, 298 K, CD3OD) δH  7.96 (d, J = 8.2 Hz, 2H, 2 ArCH), 7.35 (d, J = 8.2Hz, 2H, 2 
ArCH), 6.52 (s, 2H, CH=CH), 5.26 (s, 2H, 2 CHO), 4.46 (t, J = 6.3Hz, 2H, CH2CH2O), 3.37 
(m, 2H, CH2-NHBoc), 3.92 (t, J = 6.3Hz, 2H, CH2CH2N), 2.88 (s, 2H, 2 CHCO), 1.49 (s, 
9H, 3 CH3); 
13
C NMR (100 MHz, 298 K, CD3OD) δC 176.0 (imide C=O), 166.0 (COO), 
155.7 (ArC), 144.5 (ArC), 136.5 (CH=CH), 130.1 (ArCH), 127.2 (ArCH), 128.8 (ArC), 80.9 
(C(CH3)3), 77.4 (CHO), 61.3 (CH2CH2O), 47.5 (CHCO), 44.3 (CH2NHBoc), 37.8 
(CH2CH2N), 28.4 (CH3); IR ν cm
-1
 3311 (NH), 1700 (imide and ester C=O), 1677 
(carbamate C=O); CHN Analysis Calc. for C12H12N2O4: C, 58.06; H, 4.87; N, 11.29. Found: 
C 57.92; H 4.86; N 11.26%. 
2.07 
 
2.06 (535mg, 1.21 mmol) was stirred overnight in a 1:1 solution of CH2Cl2:TFA (5 mL). 
The solvent was removed in vacuo; the residue was diluted with CH2Cl2 and washed with 
saturated sodium bicarbonate (2 x10 mL) and brine (10 mL). The organic layer was dried 
with MgSO4, filtered and concentrated in vacuo to afford a white precipitate (380 mg, 1.11 
mmol, 92%). m.p. 144-145 °C; 
1
H NMR (400 MHz, 298 K, CDCl3) δH  7.88 (d, 2H, J  = 8.2 
  Chapter 2 
75 
 
Hz, 2 ArCH), 7.30 (d, 2H, J  = 8.2 Hz, 2 ArCH), 6.43 (s, 2H, CH=CH), 5.17 (s, 2H, 2 CHO), 
4.37 (t, 2H, J  = 5.4 Hz, CH2CH2O), 3.86 (s, 2H, CH2NH2), 3.83 (t, 2H, J  = 5.4Hz, 
CH2CH2N), 2.79 (s, 2H, 2 CHCO), 1.95 (br s, 2H, NH2); 
13
C NMR (100 MHz, 298 K, 
CDCl3) δC 176.0 (imide C=O), 166.0 (COO), 148.2 (ArC), 136.6 (CH=CH), 130.1 (ArCH), 
128.4 (ArC), 127.0 (ArCH), 80.9 (CHO), 61.2 (CH2CH2O), 47.5 (CHCO), 46.0 (CH2NH2), 
37.9 (CH2CH2N); IR ν cm
-1
 3403 (NH2), 1718 (imide C=O), 1605 (C-O); HRMS (ESI
+
): m/z 
found 343.1285 calc for C18H19N2O5 343.1288 [2.07+H]
+
. 
2.08 
 
2.07 (130 mg, 0.38 mmol) was dissolved in hot MeOH (5 mL). 3,5-dimethylbenzaldehyde 
(50 mg, 0.37 mmol) was added and the solution allowed to cool and stirred at room 
temperature for 24 h. The reaction was diluted with water (20 mL) and extracted with 
CH2Cl2 (3 x 15 mL). The combined organic extracts were dried over MgSO4, filtered and 
solvent removed in vacuo to provide a pale yellow solid (170 mg, 0.37 mmol, 98%). m.p. 
140-141°C; 
1
H NMR (400 MHz, 298 K, CDCl3) δH 8.18 (s, 1H, CH-N=C), 7.80 (d, 2H, J = 
8.2 Hz, 2 ArCH), 7.24 (s, 2H, 2 ArCH), 7.23 (d, 2H, J = 8.2 Hz, 2 ArCH), 6.92 (s, 1H, 
ArCH), 6.32 (s, 2H, CH=CH), 5.07 (s, 2H, 2 CHO), 4.67 (s, 2H, CH2-N=C), 4.27 (t, 2H, J = 
5.4 Hz, CH2CH2O), 3.74 (t, 2H, J = 5.4 Hz, CH2CH2N), 2.69 (s, 2H, 2 CHCO), 2.19 (s, 6H, 
2 CH3);
13
C NMR (100 MHz, 298 K, CDCl3) δC 175.4 (imide C=O), 165.6 (COO), 162.6 
(CH=N), 144.3 (ArC), 137.7 (ArC), 135.9 (CH=CH), 135.2 (ArC), 132.1 (ArCH), 129.3 
(ArCH), 127.7 (ArC), 127.2 (ArCH), 125.5 (ArCH), 80.3 (CHO), 64.0 (CH2-N=C), 60.6 
(CH2CH2O), 46.8 (CHCO), 37.2 (CH2CH2N), 21.1 (CH3); IR ν cm
-1
 3001 (saturated C-H), 
1695 (imide and ester C=O), 1644 (C=N); MS (ESI
+
): m/z 459.1 [2.08+H]
+
; CHN analysis 
found, C 70.65, H 5.84, N 5.57 calc for C27H26N2O5 C 70.73, H 5.72, N 6.11%.  
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2.09 
 
To the imine 2.08 (200 mg, 0.44 mmol) dissolved in MeOH (2 mL), sodium 
cyanoborohydride (30 mg, 0.48 mmol) was added and one drop of HOAc. The reaction was 
monitored by TLC. The reaction mixture was partitioned between CH2Cl2 (10 mL) and 
water (10 mL). The organic layer was dried over MgSO4, filtered and the solvent removed in 
vacuo to provide a yellow solid used without further purification (190 mg, 0.41 mmol, 93%). 
m.p. 115-116°C; 
1
H NMR (400 MHz, 298 K, CDCl3) δH 7.89 (d, 2H, J = 8.2 Hz, 2 ArCH), 
7.32 (d, 2H, J = 8.2 Hz, 2 ArCH), 6.86 (s, 2H, 2 ArCH), 6.83 (s, 1H, ArCH), 6.41 (s, 2H, 
CH=CH), 5.16 (s, 2H, 2 CHO), 4.36 (t, 2H, J = 5.4 Hz, CH2CH2O), 4.17 (br s, 1H, NH), 
3.82 (t, 2H, J = 5.4 Hz, CH2CH2N), 3.78 (s, 2H, CH2NH), 3.66 (s, 2H, CH2NH), 2.78 (s, 2H, 
2 CHCO), 2.23 (s, 6H, 2 CH3); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 176.0 (imide C=O), 
166.1 (COO), 144.7 (ArC), 138.7 (ArC), 138.1 (ArC), 136.5 (CH=CH), 129.9 (ArCH), 
129.0 (ArCH), 128.7 (ArC), 128.3 (ArCH), 126.2  (ArCH), 80.9 (CHO), 61.2 (CH2CH2O), 
52.6 (CH2NH), 52.2 (CH2NH), 47.5 (CHCO), 37.9 (CH2CH2N), 21.3 (CH3); IR ν cm
-1
 2965 
(saturated C-H), 1699 (imide and ester C=O), 1607 (C-O stretching). 
2.10 
 
The amine 2.09 (100 mg, 0.22 mmol) was dissolved in CH2Cl2 (10 mL) and washed with an 
aqueous solution of HClO4 (10%) (2 x 10 mL). The organic layer was dried over MgSO4, 
filtered and concentrated in vacuo to afford the ClO4
-
 salt (120 mg, 0.21 mmol, 97 %). m.p. 
92-93 °C; 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.02 (d, 2H, J = 8.2 Hz, 2 ArCH), 7.61 (d, 
2H, J = 8.2 Hz, 2 ArCH), 7.13 (m, 3H, 3 ArCH),  6.52 (s, 2H, CH=CH), 5.11 (s, 2H, 2 
CHO), 4.39 (t, 2H, J = 5.4 Hz, CH2CH2O), 4.33 (s, 2H, CH2NH2
+
), 4.23 (s, 2H, CH2NH2
+
), 
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3.82 (t, 2H, J = 5.4 Hz, CH2CH2N), 2.90 (s, 2H, 2 CHCO), 2.35 (s, 6H, 2 CH3); 
13
C NMR 
(100 MHz, 298 K, CD3CN) δC 176.3 (imide C=O), 166.2 (COO), 138.5 (ArC), 136.3 (ArC), 
136.1 (CH=CH), 135.1 (ArC), 130.8 (ArCH), 130.0 (ArCH), 129.8 (ArC), 129.5 (ArCH), 
127.5  (ArCH), 80.6 (CHO), 61.1 (CH2CH2O), 51.4 (CH2NH2
+
), 50.5 (CH2NH2
+
), 47.1 
(CHCO), 36.9 (CH2CH2N), 19.9 (CH3); IR ν cm
-1
 3093 (saturated C-H), 1694 (imide and 
ester C=O), 1094 (ClO4); HRMS (ESI
+
): m/z found, 461.2082 calc for C27H29N2O5 461.2071 
[2.10-ClO4]
+
.  
2.11 
 
The ClO4
-
 salt 2.10 (50 mg, 0.11 mmol) was heated under microwave irradiation in 
acetonitrile (1 mL) (150W, 110 °C, 3 h). The solvent was removed in vacuo to provide an 
off-white solid used without further purification (42 mg, 0.085 mmol, 78 %). m.p. 64-65°C;
 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.03 (d, 2H, J = 8.3 Hz, 2 ArCH), 7.60 (d, 2H, J = 
8.3 Hz, 2 ArCH), 7.15  (s, 1H, ArCH), 7.11 (s, 2H, 2 ArCH), 6.81 (s, 2H, CH=CH), 4.44 (t, 
2H, J = 5.3 Hz, CH2CH2O), 4.31 (s, 2H, CH2NH2
+
), 4.21 (s, 2H, CH2NH2
+
), 3.88 (t, 2H, J = 
5.3 Hz, CH2CH2N), 2.36 (s, 6H, 2 CH3), 2.23 (br s, 2H, NH2
+
); 
13
C NMR (100 MHz, 298 K, 
CD3CN) δC 170.6 (imide C=O), 165.1 (COO), 138.5 (ArC), 136.1 (ArC), 134.1 (CH=CH), 
130.8 (ArCH), 130.2 (ArC), 130.1 (ArCH), 129.7 (ArC), 129.5 (ArCH), 127.6 (ArCH), 62.2 
(CH2CH2O), 51.3 (CH2NH2
+
), 50.4 (CH2NH2
+
), 36.2 (CH2CH2N), 19.9 (CH3); IR ν cm
-1
 
3502 (NH2), 1746 (imide and ester C=O), 1051 (ClO4); HRMS (ESI
+
): m/z found, 393.1817 
calc for C23H25N2O4 393.1809 [2.11-ClO4]
+
.  
2.12 
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Thread 2.11 (10 mg, 0.02 mmol) and DB24C8 (18 mg, 0.04 mmol) were dissolved in 
deuterated acetonitrile (0.5 mL). The reaction was followed by 
1
H NMR until 
pseudorotaxane formation reached completion. Pseudorotaxane 2.12 
1
H NMR (400 MHz, 
298 K, CD3CN) δH 7.69 (d, 2H, J = 8.5Hz,  2 ArCH), 7.46 (d, 2H, J = 8.5Hz,  2 ArCH), 
7.94-6.78 (m, 13H,  2 CH=CH,  3 ArCH,  8 crown ArCH), 4.81-4.78 (m, 2H,  
CH2NH2
+
), 4.57-4.54 (m, 2H,  CH2NH2
+
), 4.36 (t, 2H, J = 5.3Hz,  CH2CH2O), 4.06-4.03 
(m, 8H,  4 OCH2), 3.84-3.76 (m, 10H,  4 OCH2 and CH2CH2N), 3.56 (s, 8H,  4 OCH2), 
2.19 (s, 6H,  2 CH3); Also contains unthreaded DB24C8 
1
H NMR (400 MHz, 298 K, 
CD3CN) δH 6.93-6.90 (m, 8H, 8 ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 8H, 4 OCH2), 3.72 
(s, 8H, 4 OCH2); HRMS (ESI
+
): m/z found, 841.3964 calc for C47H57N2O12 841.3906 [2.12-
ClO4]
+
. 
2.13 
 
To the pseudorotaxane 2.12 (19 mg, 0.02mmol) in acetonitrile (2 mL), freshly distilled 
cyclopentadiene (0.1 mL, excess) was added. Excess cyclopentadiene and solvent was 
removed in vacuo. Purification via flash chromatography (SiO2: CH2Cl2 to CH2Cl2/MeOH 
9:1) gave a white foam (10 mg, 0.01 mmol, 50 %). 
1
H NMR (400 MHz, 298 K, CD3CN) δH 
7.75 (d, 2H, J = 8.0 Hz,  2 ArCH), 7.64 (br s, 2H,  +NH2),  7.52 (d, 2H, J = 8.0 Hz,  2 
ArCH), 6.92 (s, 2H,  2 ArCH), 6.85-6.79 (m, 9H,  ArCH and  8 crown ArCH), 5.88 (br 
s, 2H,  CH=CH), 4.81 (m, 2H,  CH2NH2
+
), 4.53 (m, 2H,  CH2NH2
+
), 4.27 (t, 2H, J = 5.3 
Hz,  CH2CH2O), 4.05 (m, 8H,  4 OCH2), 3.61 (m, 8H,  4 OCH2), 3.69 (t, 2H, J = 5.3 
Hz,  CH2CH2N), 3.59 (br s, 8H,  4 OCH2), 3.29 (br s, 2H,  2 CHCO), 3.25 (br s, 2H,  
2 CHCH2), 2.15 (s, 6H,  2 CH3), 1.61 (d, 1H, J = 9.0 Hz, CHH), 1.57 (d, 1H, J = 9.0 Hz, 
CHH); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 178.9 (imide C=O), 166.6 (ester C=O), 
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148.7 (ArC), 139.7 (ArC), 138.7 (ArC), 135.6 (CH=CH), 133.0 (ArC), 131.7 (ArCH), 131.6 
(ArC), 131.0 (ArCH), 130.8 (ArCH), 128.2 (ArCH), 122.6 (ArCH), 113.8 (ArCH), 71.9 
(OCH2), 71.5 (OCH2), 69.3 (OCH2), 63.0 (CH2CH2O), 54.1 (CH2NH2
+
), 53.3 (bridgehead 
CH2), 53.1 (CH2NH2
+
), 46.9 (CHCH2CH), 46.1 (CHO), 38.2 (CH2CH2N), 21.6 (CH3); IR ν 
cm
-1
 2874 (saturated C-H), 1698 (ester and imide C=O), 1253 (C-O), 1084 (ClO4); HRMS 
(ESI
+
): m/z found, 907.4378 calc for C52H63N2O12 907.4376 [2.13-ClO4]
+
. 
2.14 
 
Synthesised according to a modified literature procedure.
144
 Maleic anhydride, (16 g, 163 
mmol) was dissolved in EtOAc (50 mL) and petroleum ether (60-80˚C) (50 mL) and the 
solution cooled to 0°C. Cyclopentadiene (12 g, 187 mmol) was added carefully to the 
solution and stirred for 3 h. The precipitate formed was filtered and washed with petroleum 
ether (60-80°C) to provide white crystals (19.10 g, 116 mmol, 71%). 
1
H NMR (300 MHz, 
298 K, CDCl3) δH 6.30 (br s, 2H, CH=CH), 3.57 (br s, 2H, 2 CHCO), 3.49 (br s, 2H, 2 
CHCH2), 1.76 (d, 1H, J = 9.0 Hz, CHH), 1.56 (d, 1H, J = 9.0 Hz, CHH); 
13
C NMR (75 
MHz, 298 K, CDCl3) δC 170.8 (imide C=O), 134.9 (CH=CH), 52.1 (bridgehead CH2), 46.5 
(CHCH2), 45.4 (CHCO); MS (ESI
+
): m/z 165.0 [2.14+H]
+
. 
2.15 
 
Synthesised according to a modified literature procedure.
139
 2.14 (5g, 30 mmol) was 
dissolved in EtOH (25 mL) and cooled to 0˚C. Ethanolamine (1.8 mL, 30 mmol) and NEt3 
(4.2 mL, 30 mmol) in EtOH (25 mL) were added dropwise to the stirring solution. The 
resulting mixture was heated to 70˚C overnight. The EtOH was removed in vacuo to provide 
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an oil which was taken up in CHCl3 (30 mL) and partitioned with water (10 mL). It was 
washed with HCl 1M (3 x 20 mL). The organic layer was dried over MgSO4, filtered and the 
product was obtained by precipitation on the addition of Et2O. The white crystals were 
filtered (2.25 g, 10.9 mmol, 37%). 
1
H NMR (300 MHz, 298 K, CD3CN) δH 6.05 (s, 2H, 
CH=CH), 3.44 (t, 2H,
 
J = 5.5 Hz, CH2CH2OH), 3.36 (t, 2H, J = 5.5 Hz, CH2CH2N), 3.27 (br 
s, 4H,
 
2 CHCH2 and 2 CHCO), 1.62 (d, 1H, J = 8.5 Hz, CHH), 1.56 (d, 1H, J = 8.5 Hz, 
CHH); 
13
C NMR (75 MHz, 298 K, CD3CN) δC 177.8 (imide C=O), 134.3 (CH=CH), 58.5 
(CH2CH2OH), 51.5 (bridgehead CH2), 45.4 (CHCH2), 44.5 (CHCO), 40.2 (CH2CH2N); IR ν 
cm
-1 
3508 (OH), 3015 (saturated C-H), 1756 (imide C=O); HRMS (ESI
+
): found, 230.0791, 
calc. for C11H13NO3Na 230.0788 [2.15+Na]
+
. 
2.16 
 
The alcohol 2.15 (165 mg, 0.8 mmol) and acid 2.05 (200 mg, 0.8 mmol) were dissolved in 
CH2Cl2 (10 mL). The reaction was cooled to 0°C then PyBOP (499 mg, 1 mmol) and NEt3 
(0.22 mL, 1.6 mmol) were added. The reaction was warmed to room temperature and stirred 
for 48 h. The reaction was diluted with CH2Cl2 (15 mL) and washed with water (15 mL), 
saturated citric acid (15 mL), saturated sodium carbonate (15 mL) and brine (15 mL). The 
organic layer was dried over MgSO4, filtered and solvent removed in vacuo. The crude 
product was purified via flash chromatography (SiO2: EtOAc) to give a colourless oil (160 
mg, 0.36 mmol, 45 %). 
1
H NMR (400 MHz, 298 K, CDCl3) 7.94 (d, 2H, J = 8.0 Hz, 2 
ArCH), 7.34 (d, 2H, J = 8.0 Hz, 2 ArCH), 5.96 (s, 2H, CH=CH), 4.35 (br s, 2H, CH2NH), 
4.30 (t, 2H, J = 5.3 Hz, CH2CH2O), 3.76 (t, 2H, , J = 5.3 Hz, CH2CH2N), 3.35 (br s, 2H, 2 
CHCO), 3.26 (br s, 2H, 2 CHCH2), 1.67 (d, 1H, J = 8.5 Hz, CHH), 1.51 (d, 1H, J = 8.5 Hz, 
CHH), 1.44 (s, 9H, 3 CH3); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 177.3 (imide C=O), 
165.9 (COO), 155.9 (carbamate C=O), 144.5 (ArCH), 135.1 (ArC), 134.3 (CH=CH), 129.9 
(ArCH), 128.6 (ArC), 127.1 (ArCH), 61.6 (CH2CH2O), 52.1 (bridgehead CH2), 45.7 
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(CHCH2), 44.8 (CHCO), 44.2 (CH2NH), 37.1 (CH2CH2N), 28.3 (CH3); IR ν cm
-1
 2975 
(saturated C-H), 1694 (imide and ester C=O), 1270 (C-O); HRMS (ESI
+
): m/z found, 
463.1835 calc for C24H28N2NaO6 463.1840 [2.16+Na]
+
.  
2.17 
 
2.16 (150 mg, 0.34 mmol) was dissolved in CH2Cl2 (2 mL) and TFA (1 mL) and stirred at 
room temperature for 24 h. The reaction mixture was diluted with CH2Cl2 (10 mL) and 
washed with a saturated aq. sodium carbonate (2 x 15 mL) and brine (15 mL). The organic 
layer was dried over MgSO4, filtered and solvent removed in vacuo to give the product as a 
colourless oil (100 mg, 0.29 mmol, 85 %). 
1
H NMR (400 MHz, 298 K, CDCl3) 7.94 (d, 2H, 
J = 8.0 Hz, 2 ArCH), 7.38 (d, 2H, J = 8.0 Hz, 2 ArCH), 5.96 (s, 2H, CH=CH), 4.10 (t, 2H, J 
= 5.0 Hz, CH2CH2O), 3.92 (s, 2H, CH2NH2), 3.75 (t, 2H, J = 5.0 Hz, CH2CH2N), 3.33 (s, 
2H, 2 CHCO),  3.25 (s, 2H, 2 CHCH2), 2.33 (br s, 2H, NH2), 1.66 (d, 1H, J = 8.5 Hz, CHH), 
1.50 (d, 1H, J = 8.5 Hz, CHH); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 177.4 (imide C=O), 
165.9 (COO), 147.7 (ArC), 134.2 (CH=CH), 129.9 (ArCH), 128.3 (ArC), 127.1 (ArCH), 
61.6 (CH2CH2O), 52.1 (bridgehead CH2), 45.8 (CH2NH2), 45.7 (CHCH2), 44.8 (CHCO), 
37.1 (CH2CH2N); IR ν cm
-1
 2993 (saturated C-H), 1692 (ester C=O), 1271 (C-O); HRMS 
(ESI
+
): m/z found, 341.1490 calc for C19H21N2O4 341.1496 [2.17+H]
+
.  
2.18 
 
Amine 2.17 (120 mg, 0.35 mmol) and 3,5-dimethylbenzaldehyde (0.49 ml, 0.36 mmol) were 
dissolved in MeOH (5 mL) and stirred at room temperature for 24 h. Sodium 
cyanoborohydride (24 mg, 0.4 mmol) and HOAc (0.1 mL) were added and the reaction 
stirred at room temperature for a further 24 h. The reaction was diluted with water (15 mL) 
and extracted with CH2Cl2 (2 x 20 mL). The combined organic extracts were dried over 
  Chapter 2 
82 
 
MgSO4, filtered and concentrated in vacuo. The crude product was purified via flash 
chromatography (SiO2: CH2Cl2 to CH2Cl2:MeOH; 95:5) to give a colourless oil (130 mg, 
0.28 mmol, 81 %). 
1
H NMR (400 MHz, 298 K, CDCl3) δH 7.96 (d, 2H, J = 8.5 Hz, 2 ArCH), 
7.46 (d, 2H, J = 8.5 Hz, 2 ArCH), 6.97 (s, 2H, 2 ArCH), 6.95 (s, 1H, ArCH), 6.29 (s, 1H, 
NH), 5.98 (s, 2H, CH=CH), 4.31 (t, 2H, J = 5.3 Hz, CH2CH2O), 3.94 (s, 2H, CH2NH), 3.83 
(s, 2H, CH2NH), 3.75 (t, 2H, J = 5.3 Hz, CH2CH2N), 3.34 (s, 2H, 2 CHCO), 3.27(s, 2H, 2 
CHCH2), 2.30 (s, 6H, 2 CH3), 1.69 (d, 1H, J = 8.5 Hz, CHH), 1.52 (d, 1H, J = 8.5 Hz, 
CHH); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 177.4 (imide C=O), 165.7 (COO), 140.2 
(ArC), 138.5 (ArC), 134.2 (CH=CH), 130.1 (ArCH), 130.0 (ArCH), 129.6(0) (ArC), 
129.5(7) (ArC), 129.1 (ArCH), 126.9 (ArCH), 61.7 (CH2CH2O), 52.1 (CH2NH), 51.6 
(bridgehead CH2), 50.9 (CH2NH), 45.8 (CHCH2), 44.9 (CHCO), 37.1 (CH2CH2N), 21.2 
(CH3); IR ν cm
-1
 2940 (saturated C-H), 1697 (imide and ester C=O), 1253 (C-O); HRMS 
(ESI
+
): m/z found, 459.2274 calc for C28H31N2O4 459.2278 [2.18+H]
+
.  
2.19 
 
The thread 2.18 (25 mg, 0.05 mmol) was dissolved in CH2Cl2 (5 mL) and washed with a 
10% aqueous solution of HClO4 (2 x 10 mL). The organic layer was dried over MgSO4, 
filtered and solvent removed in vacuo to provide the product as a white solid (27 mg, 0.048 
mmol, 97 %). m.p. 84-87°C; 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.01 (d, 2H, J = 8.0 
Hz, 2 ArCH), 7.57 (d, 2H, J = 8.5 Hz, 2 ArCH), 7.10 (s, 1H, ArCH), 7.06 (s, 2H, 2 ArCH), 
5.92 (s, 2H, CH=CH), 4.28 (t, 2H, J = 5.3 Hz, CH2CH2O), 4.27 (s, 2H, CH2NH2
+
), 4.16 (s, 
2H, CH2NH2
+
), 3.66 (t, 2H, J = 5.3 Hz, CH2CH2N), 3.27 (s, 2H, 2 CHCO), 3.23 (br s, 2H, 2 
CHCH2), 2.31 (s, 6H, 2 CH3), 1.58 (d, 1H, J = 8.5 Hz, CHH), 1.52 (d, 1H, J = 8.5 Hz, 
CHH); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 175.1 (imide C=O), 166.7 (COO), 140.3 
(ArC), 136.8 (ArC), 136.5  (ArC), 135.7 (CH=CH), 132.4 (ArCH), 131.8 (ArCH), 131.5 
(ArC), 131.3 (ArCH), 129.1 (ArCH), 63.3 (CH2CH2O), 53.1 (CH2NH2
+
), 53.0 (bridgehead 
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CH2), 52.1 (CH2NH2
+
), 47.0 (CHCH2), 46.0 (CHCO), 38.2 (CH2CH2N), 21.6 (CH3); IR ν 
cm
-1
 2979 (saturated C-H), 1699 (ester and imide C=O), 1244 (C-O); HRMS (ESI
+
): m/z 
found, 459.2279 calc for C28H31N2O4 459.2278 [2.19+H]
+
. 
2.20 
 
The Diels-Alder adduct 2.04 (2.95g, 14.1 mmol) and 4-carboxybenzaldehyde (2g, 13.3 
mmol) were dissolved in CH2Cl2 (50 mL). The N,N,N',N'-tetramethylchloroformamidinium-
hexafluorophosphate (4.28g, 14.1 mmol) was added to the stirring solution along with NEt3 
(4 mL) and DMAP (10mg, cat.). The solution was stirred at room temperature for 48 h. The 
organic layer was washed with water (20 mL), saturated sodium bicarbonate solution (20 
mL), saturated citric acid (20 mL), water (20 mL) and brine (20 mL). The solution was dried 
over MgSO4, filtered and the solvent removed in vacuo. The crude pale yellow solid was 
recrystallised from EtOAc to give a white powder (2.88 g, 8.44 mmol, 64 %). m.p. 139 - 
140°C; 
1
H NMR (400 MHz, 298 K, CD3CN) δH  10.12 (s, 1H, COH), 8.18 (d, 2H, J = 8.5 
Hz, 2 ArCH), 7.97 (d, 2H, J = 8.5 Hz, 2 ArCH), 6.53 (s, 2H, CH=CH), 5.26 (s, 2H, 2 CHO), 
4.52 (t, 2H, J = 5.3 Hz, CH2CH2O), 3.96 (t, 2H, J = 5.3 Hz CH2CH2N), 2.90 (s, 2H, 2 
CHCO); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 191.5 (COH), 176.0 (imide C=O), 166.1 
(COO), 136.6 (ArC), 134.8 (ArC), 130.3 (ArCH), 129.5 (ArCH), 80.9 (CHO), 61.8 
(CH2CH2O), 47.5 (CHCO), 37.8 (CH2CH2N); IR ν cm
-1
 2976 (saturated C-H), 1689.5 (ester 
and imide C=O); HRMS (ESI
+
): m/z 364.0792 calc for C18H15NO6Na 364.0792 [2.20+Na]
+
; 
CHN Analysis Found: C 63.10; H 4.46; N 4.15. Calc. for C18H15NO6: C 63.34; H 4.43; N 
4.10%. 
2.21 
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2.20 (800 mg, 2.35 mmol) was stirred in hot MeOH (8 mL) with p-xylylenediamine (150 
mg, 1.10 mmol) for 2 h. A white precipitate was collected and washed in ice cold MeOH 
(800mg, 1.01 mmol, 92 %). m.p. 148-149˚C; 1H NMR (400 MHz, 298 K, CDCl 3) δH  8.42 
(s, 2H, 2 CH=N), 8.02 (d, J = 8.4 Hz, 4H, 4 ArCH), 7.96 (d, J = 8.4 Hz, 4H, 4 ArCH), 7.33 
(s, 4H, 4 ArCH), 6.49 (s, 4H, 2 CH=CH), 5.23 (s, 4H, 4 CHO), 4.84 (s, 4H, 2 CH2-N=C), 
4.46 (d, J = 5.3Hz, 4H, 2 CH2CH2O), 3.91 (t, J  = 5.3Hz, 2H, 2 CH2CH2N), 2.86 (s, 4H, 4 
CHCO); 
13
C NMR (100 MHz, 298 K, CDCl3) δC  176.1 (imide C=O), 165.9 (COO), 161.2 
(CH=N), 140.0 (ArC), 137.6 (ArC), 136.5 (CH=CH), 131.5 (ArC), 130.0 (ArCH), 128.3 
(ArCH), 128.2 (ArCH), 80.9 (CHO), 64.8 (CH2-N=C), 61.4 (CH2CH2O), 47.5 (CHC), 37.8 
(CH2CH2N); IR ν cm
-1 
2845 (saturated C-H), 1701 (imide and ester C=O), 1639 (C=N); MS 
(ESI
+
): m/z 805.1 [2.21+Na]
+
. 
2.22 
 
The imine 2.21 (700 mg, 0.9 mmol) was dissolved in CHCl3 (7.5 mL) and MeOH (7.5 mL). 
Sodium cyanoborohydride (62 mg, 1 mmol) was added to the stirring solution along with 3 
drops of HOAc. The solution was left to stir at room temperature for 24 h. Water (20 mL) 
was added and the solution extracted with CHCl3 (3 x 15 mL). The combined organic 
extracts were dried over MgSO4, filtered and the solvent removed to produce a white foam 
(550 mg, 0.70 mmol, 78 %). m.p. 137-138°C; 
1
H NMR (400 MHz, 298 K, CDCl3) δH 7.96 
(d, 4H, J = 8.0 Hz, 4 ArCH), 7.42 (d, 4H, J = 8.0 Hz, 4 ArCH), 7.31 (s, 4H, 4 ArCH), 6.50 
(s, 4H, 4 CH=CH), 5.25 (s, 4H, 4 CHO), 4.45 (t, 4H, J = 5.0 Hz, 2 CH2CH2O), 3.91 (t, 4H, J 
= 5.0 Hz, 2 CH2CH2N), 3.86 (s, 4H, 2 CH2NH), 3.80 (s, 4H, 2 CH2NH), 2.87 (s, 4H, 4 
CHCO); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 175.9 (imide C=O), 166.1 (COO), 145.6 
(ArC), 138.7 (ArC), 136.5 (CH=CH), 129.8 (ArCH), 128.4 (ArC), 128.3 (ArCH), 128.0 
(ArCH), 80.9 (CHO), 61.7 (CH2CH2O), 52.8 (CH2NH), 52.6 (CH2NH), 47.4 (CHCO), 37.8 
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(CH2CH2N); IR ν cm
-1 
3339 (NH stretching), 2957 (saturated C-H), 1694 (ester and imide 
C=O); HRMS (ESI
+
) m/z: found, 787.300 calc for C44H43N4O10 787.2974 [2.22+H]
+
. 
2.23 
 
2.22 (450 mg, 0.57 mmol) was dissolved in CH2Cl2 (10 mL).  The organic layer was washed 
with a 10% aqueous solution of HClO4. A white precipitate formed in the aqueous layer 
which was filtered and washed with water (250 mg, 0.25 mmol, 44 %). m.p. 129-130°C 
(decomp.); 
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.99 (d, 4H, J = 8.0 Hz, 4 ArCH), 7.59 
(d, 4H, J = 8.0 Hz, 4 ArCH), 7.54 (s, 4H, 4 ArCH), 7.39 (br s, 4H, 2 NH2), 6.49 (s, 4H, 
CH=CH), 5.08 (s, 4H, 4 CHO), 4.38 (t, 4H, J = 5.0 Hz, 2 CH2CH2O), 4.33 (8H, m, 2 
CH2NH2 and 2 CH2CH2N), 3.80 (s, 4H, 2 CH2NH2
+
), 2.87 (s, 4H, 4 CHCO); 
13
C NMR (100 
MHz, 298 K, CD3CN) δC 177.9 (imide C=O), 166.7 (COO), 137.8 (CH=CH), 136.5 (ArC), 
133.3 (ArC), 132.6 (ArC), 132.2 (ArCH), 131.8 (ArCH), 131.3 (ArCH), 82.3 (CHO), 62.8 
(CH2CH2O), 52.42 (2 CH2NH2
+
CH2), 48.8 (CHCO), 38.6 (CH2CH2N); IR ν cm
-1 
3013 
(saturated CH), 1722 (ester and imide C=O), 1612 (C-O), 1078 (ClO4); HRMS (ESI
+
): m/z 
found, 787.2967 calc for C44H43N4O10 787.2974 [2.23-HClO4]
+
; CHN Analysis Found: C 
53.12; H 4.42; N 5.66. Calc. for C44H44N4O18Cl2: C, 53.30; H, 4.49; N, 5.67%. 
2.24 
 
The thread 2.23 (100 mg, 0.10 mmol) was dissolved in acetonitrile (2 mL) and heated under 
microwave irradiation (150W, 3 h, 110˚C). The solvent was removed in vacuo to give a 
beige solid (85 mg, 0.1 mmol, 100 %). m.p. 235-237 °C (decomp.); 
1
H NMR (400 MHz, 298 
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K, CD3CN) δH 8.02 (d, 4H, J = 8.0 Hz, 4 ArCH), 7.63 (d, 4H, J = 8.0 Hz, 4 ArCH), 7.58 (s, 
4H, 4 ArCH), 6.80 (s, 4H, 2 CH=CH), 4.42 (t, 4H, J = 5.0 Hz, 2 CH2CH2O), 4.35 (4H, m, 2 
CH2NH2
+
), 4.32 (m, 4H, 2 CH2NH2
+
), 3.87 (t, 4H, J = 5.0 Hz, 2 CH2CH2N); 
13
C NMR (100 
MHz, 298 K, CD3CN) δC 172.3 (imide C=O), 166.8 (COO), 136.6 (ArC), 135.8 (CH=CH), 
133.3 (ArC), 132.5 (ArC), 132.2 (ArCH), 131.8 (ArCH), 131.3 (ArCH), 63.9 (CH2CH2O), 
52.4 (CH2NH2
+
), 52.3 (CH2NH2
+
), 37.9 (CH2CH2N); IR ν cm
-1 
3099 (saturated C-H), 1708 
(ester and imide C=O), 1574 (NH2); HRMS (ESI
+
): m/z found, 651.2456 calc for 
C36H35N4O8 651.2449 [2.24-H.2ClO4]
+
. 
2.25 
 
The thread 2.24 (10 mg, 0.012 mmol) was dissolved in deuterated acetonitrile. DB24C8 (21 
mg, 0.05 mmol, 4 equiv.) was added to the solution and the extent of  threading followed by 
1
H NMR. Pseudorotaxane 2.25 
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.71 (d, 4H, J = 8.0 
Hz,  4 ArCH), 7.43 (d, 4H, J = 8.0 Hz,  4 ArCH), 7.03 (s, 4H,  4 ArCH), 6.80-6.69 (m, 
20H,  16 crown ArCH and  4 CH=CH), 4.70 (m, 4H,   2 CH2NH2
+
), 4.56 (m, 4H,  2 
CH2NH2
+
), 4.36 (t, 4H, J = 5.0 Hz,  2 CH2CH2O), 3.96 (m, 16H,  8 OCH2), 3.82-3.64 (m, 
18H,  7 OCH2 and  2 CH2CH2N),  3.56 (s, 18H,  9 OCH2); Also contains unthreaded 
DB24C8 
1
H NMR (400 MHz, 298 K, CD3CN) δH 6.93 (m, 8H, 8 ArCH), 4.14 (m, 8H, 4 
OCH2), 3.83 (m, 8H, 4 OCH2), 3.72 (s, 8H, 4 OCH2); MS (ESI
+
): m/z found 774.7 calc for 
C84H100N4O24
2+
 774.4 [2.25-2ClO4]
2+
. 
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2.26 
 
To the pseudorotaxane 2.25 in acetonitrile (2 mL), freshly distilled cyclopentadiene (0.1 mL, 
excess) was added. The solvent and excess cyclopentadiene were immediately removed in 
vacuo. The solid was extracted with hot benzene (5 x 2 mL) to leave the rotaxane 2.26 (15 
mg, 0.008 mmol, 73 %). 
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.77 (d, 4H, J = 8.5 Hz,  
4 ArCH), 7.49 (d, 4H, J = 8.0 Hz,  4 ArCH), 6.97 (s, 4H,  4 ArCH), 6.83-6.72 (m, 16H, 
 16 crown ArCH), 5.88 (m, 4H,  4 CH=CH),  4.72 (m, 4H,   2 CH2NH2
+
), 4.52 (m, 4H, 
  2 CH2NH2
+
), 4.25 (t, 4H, J = 5.0 Hz,  2 CH2CH2O), 4.03-3.95 (m, 16 H,  6 OCH2 and 
 2 CH2CH2N),  3.77 (m, 8H,  4 OCH2), 3.66 (m, 12H,  6 OCH2), 3.59-3.53 (m, 16H,  
8 OCH2),  3.26 (m, 4H,  4 CHCO), 3.20 (m, 4H,  4 CHCH2), 1.56 (d, 2H, J = 8.5 Hz,  2 
CHH), 1.51 (d, 2H, J = 8.5 Hz,  2 CHH); 13C NMR (100 MHz, 298 K, CD3CN) δC 178.9 
(imide C=O), 166.6 (COO), 148.7 (ArC), 138.4 (ArC), 135.6 (CH=CH), 133.8 (ArC), 131.8 
(ArC), 131.0 (ArCH), 130.9 (ArCH), 130.8 (ArCH), 122.6 (ArCH), 113.8 (ArCH), 72.0 
(OCH2), 71.5 (OCH2), 69.2 (OCH2), 63.0 (CH2CH2O), 53.4 (CH2NH2
+
), 53.3 (bridgehead 
CH2), 53.1 (CH2NH2
+
), 46.9 (CHCH2CH), 46.1 (CHCO), 38.2 (CH2CH2N); IR ν cm
-1
 2979 
(saturated C-H), 1699 (ester and imide C=O), 1609 (C-O), 1073 (ClO4); HRMS (ESI
+
): m/z 
840.3835 calc for C94H112N4O24 840.3828 [2.26-2ClO4]
2+
. 
2.27 
 
2.15 (0.74 g, 3.6 mmol) was dissolved in CH2Cl2 (20 mL). 4-Carboxybenzaldehyde (500 
mg, 3.3 mmol) was added along with the N,N,N',N'-tetramethylchloroformamidinium 
hexafluorophosphate (1.07 g, 3.8 mmol), NEt3 (1 mL) and DMAP (40mg, 0.33 mmol). The 
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solution was stirred for 72 h then washed with water (15 mL), saturated sodium carbonate 
solution (15 mL), saturated citric acid (15 mL), water (15 mL) and brine (15 mL). The 
organic layer was dried over MgSO4, filtered and the solvent removed in vacuo. The 
resulting yellow solid was taken up in Et2O and filtered to leave the product as a white solid 
(0.9 g, 2.7 mmol, 75 %). m.p. 120-122°C;
 1
H NMR (400 MHz, 298 K, CDCl3) δH 10.10 (s, 
1H, COH), 8.15 (d, 2H, J = 8.0 Hz, 2 ArCH), 7.96 (d, 2H, J = 8.0 Hz, 2 ArCH), 5.97 (s, 2H, 
CH=CH), 4.36 (t, 2H, J = 5.3 Hz, CH2CH2O), 3.79 (t, 2H, J = 5.3 Hz, CH2CH2N), 3.36 (s, 
2H, 2 CHCO), 3.28 (s, 2H, 2 CHCH2), 1.62 (d, 1H, J = 8.5 Hz, CHH), 1.58 (d, 1H, J = 8.5 
Hz, CHH); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 191.6 (COH), 177.4 (imide C=O), 165.2 
(COO), 139.3 (ArC), 134.7 (ArC), 134.4 (CH=CH), 130.3 (ArCH), 129.6 (ArCH), 62.4 
(CH2CH2O), 52.3 (bridgehead CH2), 45.9 (CHCH2CH), 44.9 (CHCO), 37.1 (CH2CH2N); IR 
ν cm-1 2947 (saturated C-H), 1723 (aldehyde C=O), 1688 (imide and ester C=O); HRMS 
(ESI
+
): found 362.0999 calc for C19H17NO5Na 362.1003 [2.27+Na]
+
.  
2.28 
 
The aldehyde 2.27 (200 mg, 0.59 mmol) was stirred in hot MeOH (8 mL) with p-
xylylenediamine (37.5 mg, 0.28 mmol) for 2 h. A white precipitate was collected and 
washed in ice cold MeOH (180 mg, 0.23 mmol, 83 %). m.p.: 159-162°C; 
1
H NMR (300 
MHz, 298 K, CDCl3) δH 8.44 (s, 2H, 2 CH=N), 8.04 (d, 4H, J = 8.5 Hz, 4 ArCH), 7.85 (d, 
4H, J = 8.5 Hz, 4 ArCH), 7.34 (s, 4H, 4 ArCH), 5.97 (s, 4H, 2 CH=CH), 4.86 (s, 4H, 2 
CH2N=CH), 4.34 (t, 4H, J = 5.5 Hz, 2 CH2CH2O), 3.97 (t, 4H, J = 5.5 Hz, 2 CH2CH2N), 
3.36 (br s, 4H, 4 CHCO), 3.28 (br s, 4H, 4 CHCH2), 1.71 (d, 2H, J = 9.0 Hz, 2 CHH), 1.52 
(d, 2H, J = 9.0 Hz, 2 CHH); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 177.7 (imide C=O), 
166.1 (COO), 161.2 (CH=N), 140.5 (ArC), 138.0 (ArC), 134.6 (CH=CH), 131.7 (ArC), 
130.3 (ArCH), 128.6 (ArCH), 128.5 (ArCH), 65.2 (CH2N=C), 62.2 (CH2CH2O), 52.5 
(bridgehead CH2), 46.1 (CHCH2CH), 45.3 (CHCO), 37.5 (CH2CH2N); IR ν cm
-1
 2985 
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(saturated C-H), 1693 (ester and imide C=O), 1640 (C=N); HRMS (ESI
+
): m/z 779.3095 calc 
for C46H43N4O8 779.3075 [2.28+H]
+
. 
2.29 
 
The imine 2.28 (100 mg, 0.13 mmol) was dissolved in MeOH (5 mL) and CHCl3 (5 mL). 
Sodium cyanoborohydride (9 mg, 0.14 mmol) and a few drops of HOAc were added to the 
solution. The reaction was stirred at room temperature for 24 h then diluted with water (20 
mL) and extracted with CHCl3 (3 x 15 mL). The combined organic extracts were dried over 
MgSO4, filtered and the solvent removed in vacuo to provide the product as an oil (90 mg, 
0.12 mmol, 92 %). 
1
H NMR (400 MHz, 298 K, CDCl3) δH 7.96 (d, 4H, J = 8.0 Hz, 4 ArCH), 
7.44 (d, 4H, J = 8.0 Hz, 4 ArCH), 7.31 (s, 4H, 4 ArCH), 5.98 (s, 4H, 2 CH=CH), 4.31 (t, 4H, 
J = 5.0 Hz, 2 CH2CH2O), 3.90 (s, 4H, 2 CH2NH), 3.83 (s, 4H, 2 CH2NH), 3.76 (t, 4H, J = 
5.0 Hz, 2 CH2CH2N), 3.35 (s, 4H, 4 CHCO), 3.27 (s, 4H, 4 CHCH2), 1.76 (d, 2H, J = 8.5 
Hz, 2 CHH), 1.51 (d, 2H, J = 8.5 Hz, 2 CHH); 
13
C NMR (175 MHz, 298 K, CDCl3) δC 177.6 
(imide C=O), 166.3 (COO), 146.0 (ArC), 139.0 (ArC), 134.5 (CH=CH), 130.0 (ArCH), 
128.6 (ArCH), 128.5 (ArCH), 128.3 (ArC), 61.8 (CH2CH2O), 53.1 (CH2NH), 52.9 
(CH2NH), 52.4 (bridgehead CH2), 46.0 (CHCH2CH), 45.1 (CHCO), 37.4 (CH2CH2N); IR ν 
cm
-1
 2941 (saturated C-H), `1693 (ester and imide C=O), 1260 (C-O); HR MS (ESI
+
): m/z 
found, 783.3395 calc for C46H47N4O8 783.3388 [2.29+H]
+
. 
2.30 
 
The thread 2.29 (30 mg, 0.038 mmol) was dissolved in MeOH (1 mL) and HClO4 (70%) was 
added (0.1 mL). Water (5 mL) was added and the mixture extracted with CH2Cl2 (3 x 5 mL). 
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The organic layer was dried over MgSO4, filtered and solvent removed in vacuo providing a 
white solid which was recrystallised from acetonitrile/Et2O (29 mg, 0.03 mmol, 79 %). m.p. 
69-71°C (decomp.); 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.02 (d, 4H, J = 8.5 Hz, 4 
ArCH), 7.61 (d, 4H, J = 8.5 Hz, 4 ArCH), 7.55 (s, 4H, 4 ArCH), 7.39 (br s, 4H, 2 NH2
+
), 
5.94 (s, 4H, 2 CH=CH), 4.36-4.28 (m, 12H, 2 CH2CH2O and 4 CH2NH2
+
), 3.66 (t, 4H, J = 
5.0 Hz, 2 CH2CH2N), 3.27 (s, 4H, 4 CHCO), 3.24 (s, 4H, 4 CHCH2), 1.59 (d, 2H, J = 8.5 
Hz, 2 CHH), 1.53 (d, 2H, J = 8.5 Hz, 2 CHH); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 
179.1 (imide C=O), 166.7 (COO), 136.7 (ArC), 135.7 (CH=CH), 133.3 (ArC), 132.6 (ArC), 
132.2 (ArCH), 131.9 (ArCH), 131.3 (ArCH), 63.3 (CH2CH2O), 53.1 (bridgehead CH2), 52.5 
(CH2NH2
+
), 52.4 (CH2NH2
+
), 47.0 (CHCH2CH), 46.0 (CHCO), 38.2 (CH2CH2N); IR ν cm
-1
 
2982 (saturated C-H), 1685 (ester and imide C=O), 1095 (ClO4); HRMS (ESI
+
): found, m/z 
392.1727 calc for C46H48N4O8 392.1731 [2.30-2ClO4]
2+
. 
2.31 
 
Synthesised according to a modified literature procedure.
145
 4-Aminomethylbenzoic acid 
(0.25 g, 1.66 mmol) was dissolved in hot MeOH (10 mL). 3,5-Dimethylbenzaldehyde (0.225 
mL, 1.66 mmol) was added and the solution was stirred for 72 h. A white precipitate 
developed and was filtered and washed with ice cold MeOH (410 mg, 1.54 mmol, 93%). 
m.p. 194-195°C; 
1
H NMR (400 MHz, 298 K, DMSO-d6) δH 8.44 (s, 1H, N=CH), 7.91 (d, 
2H, J = 8.0 Hz, 2 ArCH), 7.43 (d, 2H, J = 8.0 Hz, 2 ArCH), 7.39 (s, 2H, 2 ArCH), 7.10 (s, 
1H, ArCH), 4.81 (s, 2H, CH2), 2.30 (s, 6H, 2 CH3); 
13
C NMR (100 MHz, 298 K, DMSO-d6) 
δC 167.4 (COO), 162.6 (N=CH), 144.6 (ArC), 137.8 (ArC), 135.9 (ArC), 132.3 (ArCH), 
129.8 (ArC), 129.4 (ArCH), 127.8 (ArCH), 125.8 (ArCH), 63.5 (CH2), 20.7 (CH3); IR ν cm
-1
 
2915 (saturated C-H), 1698 (C=N stretching), 1638 (acid C=O); HRMS (ESI
+
): m/z 
268.1352 calc for C17H18NO2 268.1332 [2.31+H]
+
. 
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2.32 
 
Synthesised according to a modified literature procedure.
145
 The imine 2.31 (300 mg, 1.12 
mmol) was dissolved in a solution of THF (5 mL) and MeOH (5 mL). The solution was 
cooled to 0°C and sodium borohydride (47 mg, 1.23 mmol) was added portion wise. After 
24 h the reaction was diluted with water (10 mL) and extracted with EtOAc (2 x 20 mL). 
The organic layers were dried over MgSO4, filtered and the solvent removed in vacuo to 
leave a white solid (100 mg, 0.37 mmol, 33%). m.p. 226-229°C; 
1
H NMR (400 MHz, 298 K, 
CD3OD) δH 8.00 (d, 2H, J = 8.0 Hz, 2 ArCH), 7.38 (d, 2H, J = 8.0 Hz, 2 ArCH), 6.97 (s, 2H, 
2 ArCH), 6.95 (s, 1H, ArCH), 3.88 (s, 2H, CH2NH), 3.78 (s, 2H, CH2NH), 2.29 (s, 6H, 2 
CH3); 
13
C NMR (100 MHz, 298 K, CD3OD) δC 166.5 (COO), 141.5 (ArC), 139.5 (ArC), 
138.4 (ArC), 130.9 (ArCH), 130.4 (ArCH), 129.5 (ArCH), 128.0 (ArC), 127.8 (ArCH), 53.3 
(CH2NH), 53.0 (CH2NH), 21.5 (CH3); HRMS (ESI
+
): m/z found, 270.1490 calc for 
C17H20NO2 270.1489 [2.32-ClO4]
+
.  
2.33 
 
The acid 2.32 (440 mg, 1.6 mmol) was heated in THF (20 mL) and di-tert-butyl dicarbonate 
(392 mg, 1.8 mmol) was added. The reaction was heated to reflux and followed by TLC 
(EtOAc:MeOH; 9:1). The THF was removed in vacuo and the crude oil partitioned between 
CH2Cl2 (10 mL) and water (10 mL). The aqueous layer was extracted with a further portion 
of CH2Cl2  (10 mL) and the combined organic extracts were dried over MgSO4, filtered and 
solvent removed in vacuo to provide a colourless oil used without further purification (540 
mg, 1.5 mmol, 94 %). 
1
H NMR (400 MHz, 298 K, CDCl3) δH  8.15 (d, 2H, J = 8.0 Hz, 2 
ArCH), 7.40 (br m, 2H, 2 ArCH), 6.96 (br s, 1H, ArCH), 6.86 (br m, 2H, 2 ArCH), 4.54-
4.36 (m, 4H, CH2NCH2), 2.32 (br s, 6H, 2 CH3), 1.55 (br s, 9H, 3 CH3); 
13
C NMR (100 
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MHz, 298 K, CDCl3) δC 171.0 (COOH), 156.0 (NCOO), 138.2 (ArC), 138.1 (ArC), 138.0 
(ArC), 130.7 (ArCH), 130.3 (ArCH), 129.8 (ArCH), 128.4 (ArC), 127.7 (rotamer ArCH), 
127.1 (rotamer ArCH), 125.8 (rotamer ArCH), 125.2 (rotamer ArCH), 80.4 (C(CH3)3), 49.7 
(CH2N), 49.6 (CH2N), 28.3 (boc-CH3), 21.2 (Ar-CH3); IR ν cm
-1
 2985 (saturated C-H), 1785 
(carbamate C=O), 1686 (ester C=O); HRMS (ESI
+
): m/z found 392.1833 calc for 
C22H27NO4Na 392.1832 [2.33+Na]
+
.  
2.34 
 
Compound 2.33 (640 mg, 1.7 mmol) was dissolved in CH2Cl2 (10 mL), then N,N,N',N'-
tetramethylchloroformamidinium hexafluorophosphate (584 mg, 2.04 mmol), NEt3 (0.437 
mL, 3.4 mmol) and DMAP (21 mg, 0.17 mmol) were added at 0˚C over 1 h. Alcohol exo-N-
hydroxy-7-oxabicyclo[2.2.1]hept-5-ene-2,3-dicarboximide (314 mg, 1.7 mmol) was added 
and stirred for a further 24 h. The solution was diluted with CH2Cl2 (20 mL) and washed 
with water (15 mL), saturated citric acid (15 mL), saturated sodium bicarbonate (15 mL) and 
brine (15 mL). The organic layer was dried over MgSO4, filtered and the solvent removed in 
vacuo. The solid was washed with Et2O and filtered to provide the product (60 mg, 0.11 
mmol, 7%). 
1
H NMR (400 MHz, 298 K, CDCl3) δH  8.09 (d, 2H, J = 8.5 Hz, 2 ArCH), 7.35-
7.31 (br d, 2H, 2 ArCH), 6.92 (s, 1H, ArCH), 6.84-6.79 (m, 2H, 2 ArCH), 6.57 (s, 2H, 
CH=CH), 5.40 (s, 2H, 2 CHO), 4.49-4.29 (m, 4H, CH2NH2
+
CH2), 2.97 (s, 2H, 2 CHC=O), 
2.30 (s, 6H, 2 CH3), 1.50 (m, 9H, 3 CH3); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 169.2 
(imide C=O), 169.1 (COO), 155.6 (NCOO), 144.6 (ArC), 138.4 (ArC), 137.6 (ArC), 136.5 
(CH=CH), 131.1 (ArCH), 129.3 (ArCH), 128.4 (rotamer ArCH), 127.6 (rotamer ArCH), 
126.1 (rotamer ArCH), 125.5 (rotamer ArCH), 124.1 (ArC), 80.8 (CHO), 80.7 (C(CH3)3), 
50.0 (broad signal, CH2NCH2), 44.7 (CHCO) 28.7 (Boc-CH3), 21.6 (CH3); IR ν cm
-1
 2870 
(saturated C-H), 1690 (ester C=O), 1611 (imide C=O), 1240 (C-O); HRMS (ESI
+
): m/z 
found, 555.2104 calc for C30H32N2O7Na 555.2102 [2.34+Na]
+
. 
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2.35 
 
Thread 2.34 (50 mg, 0.094 mmol) was dissolved in TFA (3 mL) and CH2Cl2 (3 mL) and the 
reaction was followed by TLC (CH2Cl2;MeOH; 9:1). The reaction mixture was diluted with 
CH2Cl2 (10 mL), washed with saturated sodium bicarbonate (2 x 10 mL) and water (2 x 10 
mL). The organic layer was dried over MgSO4, filtered and the solvent removed in vacuo 
providing a white solid (40 mg, 0.092 mmol, 98%). 
1
H NMR (400 MHz, 298 K, CDCl3) δH 
8.09 (d, 2H, J =8.0 Hz, 2 ArCH), 7.51 (d, 2H, J =8.0 Hz, 2 ArCH), 6.95 (s, 2H, 2 ArCH), 
6.92 (s, 1H, ArCH), 6.57 (s, 4H, CH=CH), 5.40 (br s, 2H, 2 CHO), 3.91 (s, 2H, CH2NH), 
3.74 (s, 2H, CH2NH), 2.97 (br s, 2H, 2 CHCO), 2.32 (s, 6H, 2 CH3); 
13
C NMR (100 MHz, 
298 K, CDCl3) δC 168.9 (imide C=O), 164.9 (COO), 148.3 (ArC), 138.0 (ArC), 138.0 (ArC), 
136.3 (CH=CH), 130.7 (ArCH), 128.8 (ArCH), 128.5 (ArCH), 126.1 (ArCH), 123.7 (ArC), 
80.5 (CHO), 52.8 (CH2NH), 52.4 (CH2NH), 44.5 (CHCO), 21.2 (CH3); HRMS (ESI
+
): m/z 
found, 433.1762 calc for C25H25N2O5 433.1758 [2.35+H]
+
.  
2.36 
 
Neutral thread 2.35 (40 mg, 0.092 mmol) was dissolved in CH2Cl2 (5 mL) and washed with 
a 10% aqueous solution of HClO4 (3 x 5 mL). The organic layer was dried over MgSO4, 
filtered and the solvent removed in vacuo. The resulting solid was recrystallised from 
acetonitrile/Et2O to provide the ClO4
-
 salt (10 mg, 0.19 mmol, 20%). m.p. 190-191°C 
(decomp.); 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.19 (d, 2H, J = 8.5 Hz, 2 ArCH), 7.66 
(d, 2H, J = 8.5 Hz, 2 ArCH), 7.12 (s, 1H, ArCH), 7.08 (s, 2H, 2 ArCH), 6.57 (s, 2H, 
CH=CH), 5.27 (s, 2H, 2 CHO), 4.34 (s, 2H, CH2NH2
+
), 4.19 (s, 2H, CH2NH2
+
), 3.05 (br s, 
2H, 2 CHCO), 2.33 (s, 6H, 2 CH3); 
13
C NMR (150 MHz, 298 K, CD3CN) δC 170.9 (imide 
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C=O), 166.3 (COO), 140.3 (ArC), 139.0 (ArC), 137.6 (CH=CH), 132.6 (ArCH), 132.4 
(ArCH), 132.1 (ArCH), 131.4 (ArC), 129.2 (ArCH), 127.4 (ArC), 81.2 (CHO), 53.0 
(CH2NH2
+
), 52.0 (CH2NH2
+
), 46.0 (CHCO), 21.6 (CH3); IR ν cm
-1 
3054 (saturated C-H), 
1741 (ester C=O), 1661 (imide C=O), 1056 (ClO4); HRMS (ESI
+
): m/z found, 433.1755 calc 
for C25H25N2O5 433.1758 [2.36-ClO4]
+
.  
2.37 
 
The ClO4
-
 salt 2.36 (10 mg, 0.019 mmol) was dissolved in acetonitrile (5 mL) and heated to 
reflux for 72 h. The solvent was removed in vacuo and the crude product recrystallised from 
acetonitrile/Et2O to provide a pale white solid (6 mg, 0.012 mmol, 68%). m.p. 202-203°C 
(decomp.); 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.21 (d, 2H, J =8.0 Hz, 2 ArCH), 7.69 
(d, 2H, J =8.0 Hz, 2 ArCH), 7.12 (s, 1H, ArCH), 7.08 (s, 2H, 2 ArCH), 6.98 (s, 2H, 
CH=CH), 4.34 (s, 2H, CH2NH2
+
), 4.19 (s, 2H, CH2NH2
+
), 2.33 (s, 6 H, 2 CH3); IR ν cm
-1 
3093 (saturated C-H), 1748 (ester C=O), 1613 (imide (C=O), 1051 (ClO4); MS (ESI
+
): m/z  
365.1 [2.37-ClO4]
+
. 
2.38 
 
Thread 2.37 (3 mg, 0.006 mmol) and DB24C8 (6 mg, 0.012 mmol) were dissolved in 
deuterated acetonitrile and heated to 60°C. The threading was followed by 
1
H NMR until the 
pseudorotaxane formed. Pseudorotaxane 2.38  
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.74 
(d, 2H, J =8.0 Hz,  2 ArCH), 7.52 (d, 2H, J =8.0 Hz,  2 ArCH), 6.96-6.88 (m, 13H,  3 
ArCH,  CH=CH and  8 crown ArCH), 4.91-4.88 (m, 2H,  CH2NH2), 4.58-4.54 (m, 2H, 
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 CH2NH2), 4.07-3.97 (m, 8H,  4 OCH2), 3.66 (m, 16H,  8 OCH2), 2.31 (s, 2H,  2 
CH3); Also contains unthreaded DB24C8 
1
H NMR (400 MHz, 298 K, CD3CN) δH 6.93 (m, 
8H, 8 ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 8H, 4 OCH2), 3.72 (s, 8H, 4 OCH2). 
2.39 
 
To the [2]pseudorotaxane 2.38 (5.5 mg, 0.006 mmol) a drop of freshly distilled 
cyclopentadiene (0.1 mL, excess) was added to the solution. The solvent and excess 
cyclopentadiene were removed in vacuo. The excess DB24C8 was removed by extracting 
the solid with benzene to give [2]rotaxane 2.39 (5 mg, 0.005 mmol, 85%). 
1
H NMR (400 
MHz, 298 K, CD3CN) δH 7.70 (d, 2H, J = 8.5 Hz,  2 ArCH), 7.50 (d, 2H, J = 8.5Hz,  2 
ArCH), 6.79 (s, 2H,  2 ArCH), 6.93 (s, 1H,  ArCH), 6.83-6.74 (m, 8H,  8 crown 
ArCH), 6.20 (s, 2H,  CH=CH), 4.86 (m, 2H,  CH2NH2
+
), 4.54 (m, 2H,  CH2NH2
+
), 
4.90-3.97 (m, 8H,  4 OCH2), 3.78 (t, 8H, J = 3.8 Hz,  4 OCH2), 3.96-3.57 (m, 8H,  4 
OCH2), 3.46 (br s, 2H,  2 CHCO), 3.39 (br s, 2H,  2 CHCH2), 2.18 (s, 6H,  2 CH3), 1.73 
(d, 1H, J = 8.5 Hz,  CHH), 1.59 (d, 1H, J = 9.5 Hz,  CHH); 13C NMR (150 MHz, 298 K, 
CD3CN) δC 171.7 (imide C=O), 159.8 (COO), 148.4 (ArC), 140.6 (ArC), 136.2 (CH=CH), 
133.0 (ArC), 131.8 (ArCH), 131.4 (ArCH), 129.1 (ArCH), 128.2 (ArCH), 122.6 (ArCH), 
113.6 (ArCH), 72.0 (OCH2), 71.5 (OCH2), 69.1 (OCH2), 54.1 (CH2NH2
+
), 53.1 (bridgehead 
CH2), 52.1 (CH2NH2
+
), 45.9 (CHCH2CH), 42.8 (CHCO), 21.6 (CH3); All quaternary ArC 
not observed.  IR ν cm-1 2920 (saturated C-H), 1735 (ester and imide C=O), 1097 (ClO4); 
HRMS (ESI
+
): m/z found, 879.4068 calc for C50H59N2O12 879.4063 [2.39-ClO4]
+
.  
2.40 
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4-Carboxybenzaldehyde (432 mg, 2.9 mmol) and N-(2-hydroxyethyl)phthalimide (500 mg, 
2.6 mmol) were dissolved in CH2Cl2 (10 mL). The N,N,N',N'-
tetramethylchloroformamidinium hexafluorophosphate (882 mg, 3.1 mmol) and NEt3 (0.44 
mL, 3.1 mmol) were added and the solution was stirred at room temperature for 48 h. The 
solution was diluted with CH2Cl2 (15 mL) and washed with water (20 mL), saturated citric 
acid (20 mL), saturated sodium bicarbonate (20 mL) and brine (20 mL). The organic layer 
was dried over MgSO4, filtered and the solvent removed in vacuo. The yellow solid was 
washed with Et2O and filtered to provide a pale yellow solid (700 mg, 2.17 mmol, 75%). 
m.p. 160-161˚C; 1H NMR (400 MHz, 298 K, CDCl3) δH  10.09 (s, 1H, COH), 8.15 (d, 2H, J 
= 8.0 Hz, 2 ArCH), 7.93 (d, 2H, J = 8.0 Hz, 2 ArCH), 7.87-7.85 (m, 2H, 2 Phthalimide-
ArCH), 7.75-7.72 (m, 2H, 2 Phthalimide-ArCH), 4.58 (t, 2H, J = 5.3 Hz, CH2CH2O), 4.14 (t, 
2H, J = 5.3 Hz, CH2CH2N); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 191.6 (COH), 168.1 
(imide C=O), 165.3 (COO), 139.2 (ArC), 134.6 (ArC), 134.2 (ArCH), 131.9 (ArC), 130.4 
(ArCH), 129.6 (ArCH), 123.5 (ArCH), 62.9 (CH2CH2O), 36.9 (CH2CH2N); IR ν cm
-1
 1770.1 
(aldehyde C=O), 1698 (imide and ester C=O); HRMS (ESI
+
): m/z found, 346.0684 calc for 
C18H13NO5Na 346.0686 [2.40+Na]
+
.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
2.41 
 
Amine 2.07 (200mg, 0.59 mmol) and aldehyde 2.40 (189 mg, 0.59 mmol) were dissolved in 
a mixture of MeOH (5 mL) and CH2Cl2 (5 mL) and stirred at room temperature. After 3 h 
the solvent was removed to give the imine as a yellow solid (381 mg, 0.59 mmol, 100%). 
1
H 
NMR (400 MHz, 298 K, CDCl3) δH  8.44 (s, 1H, CH=N), 8.04 (d, 2H, J = 8.0 Hz, 2 ArCH), 
7.98 (d, 2H, J = 8.0 Hz, 2 ArCH), 7.85 (m, 2H, 2 Phthalimide-ArCH), 7.83 (d, 2H, J = 8.0 
Hz, 2 ArCH), 7.73 (m, 2H, 2 Phthalimide-ArCH), 7.40 (d, 2H, J = 8.0 Hz, 2 ArCH), 6.49 (s, 
2H, CH=CH), 5.24 (s, 2H, 2 CHO), 4.88 (br s, 2H, CH2N=C), 4.56 (t, 2H, J = 5.3 Hz, 
CH2CH2O), 4.45 (t, 2H, J = 5.3 Hz, CH2CH2O), 4.13 (t, 2H, J = 5.3 Hz, CH2CH2N), 3.91 (t, 
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2H, J = 5.3 Hz, CH2CH2N), 2.86 (s, 2H, 2 CHCO); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 
176.3 (imide C=O), 168.4 (imide C=O), 166.4 (COO), 166.1 (COO), 161.8 (CH=N), 144.7 
(ArC), 140.2 (ArC), 136.8 (CH=CH), 134.4 (ArCH), 132.6 (ArC), 131.9 (ArC), 130.4 
(ArCH), 130.3 (ArCH), 128.8 (ArC), 128.5 (ArCH), 128.1 (ArCH), 123.7 (ArCH), 81.2 
(CHO), 64.9 (CH2CH2O), 62.8 (CH2CH2O), 61.5 (CH2N=C), 47.8 (CHCO), 38.1 
(CH2CH2N), 37.2 (CH2CH2N); HRMS (ESI
+
): m/z found, 648.2001 calc for C36H30N3O9Na 
648.1977 [2.41+Na]
+
.  
2.42 
 
The imine 2.41 (381 mg, 0.59 mmol) was dissolved in MeOH (5 mL) and CH2Cl2 (5 mL). 
Sodium cyanoborohydride (45 mg, 0.73 mmol) and HOAc (5 drops) were added and the 
solution was stirred at room temperature for 4 h. The solvent was removed in vacuo and the 
residue dissolved in water (10 mL) and extracted with EtOAc (2 x 20 mL). The combined 
organic layers were dried over MgSO4, filtered and the solvent removed in vacuo to provide 
an off-white solid (300 mg, 0.46 mmol, 78 %). m.p. 121-122˚C; 1H NMR (400 MHz, 298 K, 
CDCl3) δH  7.97 (d, 4H, J = 7.5 Hz, 4 ArCH), 7.87 (m, 2H, 2 Phthalimide-ArCH), 7.74 (m, 
2H, 2 Phthalimide-ArCH), 7.40 (d, 4H, J = 7.5 Hz, 4 ArCH), 6.51 (s, 2H, CH=CH), 5.25 (s, 
2H, 2 CHO), 4.55 (t, 2H, J = 5.3 Hz, CH2CH2O), 4.45 (t, 2H, J = 5.3 Hz, CH2CH2O), 4.13 (t, 
2H, J = 5.3 Hz, CH2CH2N), 4.01 (br s, 1H, NH), 3.91 (t, 2H, J = 5.3 Hz, CH2CH2N), 3.97 (s, 
4H, CH2NHCH2), 2.88 (s, 2H, 2 CHCO); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 176.1 
(imide C=O), 168.1 (imide C=O), 166.0 (COO), 165.9 (COO), 136.5 (CH=CH), 134.1 
(ArCH), 131.9 (ArC), 130.1 (ArCH), 130.0 (ArCH), 129.2 (ArC), 129.1 (ArC), 128.6 
(ArCH), 128.5 (ArCH), 123.5 (ArCH), 80.9 (CHO), 62.4 (CH2CH2O), 61.4 (CH2CH2O), 
51.8 (CH2NHCH2), 47.5 (CHCO), 37.9 (CH2CH2N), 37.0 (CH2CH2N); IR ν cm
-1
 3451 (NH), 
1694 (ester C=O), 1628 (imide C=O); HRMS (ESI
+
): m/z found, 650.2146 calc for 
C36H32N3O9 650.2133 [2.42+H]
+
.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
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2.43 
 
The neutral thread 2.42 (150 mg, 0.23 mmol) was dissolved in CH2Cl2 (5 mL). The organic 
layer was washed with an 10% aqueous solution of HClO4 (2 x 10 mL). The organic layer 
was dried over MgSO4 and solvent remove in vacuo. The crude solid was recrystallised from 
acetonitrile/Et2O to give a pale greenish solid (100 mg, 0.134 mmol, 58%). m.p. 78-80 ˚C 
(decomp.); 
1
H NMR (400 MHz, 298 K, CD3CN) δH  7.99 (d, 4H, J = 8.0 Hz, 4 ArCH), 7.83-
7.77 (m, 4H, 4 Phthalimide-ArCH), 7.59-7.55 (m, 4H, 4 ArCH), 6.49 (s, 2H, CH=CH), 5.08 
(s, 2H, 2 CHO), 4.51 (t, 2H, J =5.3 Hz, CH2CH2O), 4.38 (t, 2H, J =5.3 Hz, CH2CH2O), 4.32 
(s, 4H, CH2NH2
+
CH2), 4.02 (t, 2H, J =5.3 Hz, CH2CH2N),  3.80 (t, 2H, J =5.3 Hz, 
CH2CH2N), 2.87 (s, 2H, 2 CHCO); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 176.6 (imide 
C=O), 168.2 (imide C=O), 165.5 (COO), 165.3 (COO), 136.4 (CH=CH), 135.3 (ArC), 135.2 
(ArC), 134.3 (ArCH), 132.1 (ArC), 131.3 (ArC), 131.3 (ArC), 130.5 (ArCH), 130.4 (ArCH), 
129.9 (ArCH), 129.9 (ArCH), 122.9 (ArCH), 80.9 (CHO), 62.6 (CH2CH2O), 61.5 
(CH2CH2O), 51.1 (CH2NH2
+
CH2), 47.5 (CHCO), 37.3 (CH2CH2N), 36.8 (CH2CH2N); IR ν 
cm
-1
 3066 (NH), 1772 (Phthalimide C=O), 1694 (ester C=O), 1100 (ClO4); HRMS (ESI
+
): 
m/z found, 650.2130 calc for C36H32N3O9 650.2133 [2.43+H]
+
.  
2.44 
 
The thread 2.43 (50 mg, 0.07 mmol) was dissolved in acetonitrile (3 mL) and toluene (3 mL) 
and heated to reflux for 96 h. The solvent was removed in vacuo to provide a white powder 
(40 mg, 0.06 mmol, 86%). m.p. 102-104˚C; 1H NMR (400 MHz, 298 K, CD3CN) δH  8.01-
7.98 (m, 4H, 4 ArCH), 7.83-7.77 (m, 4H, 4 Phthalimide-ArCH), 7.58-7.55 (m, 4H, 4 ArCH), 
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6.77 (s, 2H, CH=CH), 4.51 (t, 2H, J =5.3 Hz, CH2CH2O), 4.40 (t, 2H, J =5.3 Hz, 
CH2CH2O), 4.31 (s, 4H, CH2NH2
+
CH2), 4.02 (t, 2H, J =5.0 Hz, CH2CH2N), 3.84 (t, 2H, J 
=5.3 Hz, CH2CH2N); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 170.9 (imide C=O), 168.2 
(imide C=O), 165.5 (COO), 165.4 (COO), 135.4 (ArC), 135.5 (ArC), 134.4 (CH=CH), 134.3 
(ArCH), 132.1 (ArC), 131.2 (ArC), 131.1 (ArC), 130.4(1) (ArCH), 130.3(7) (ArCH), 129.9 
(ArCH), 129.8 (ArCH), 122.9 (ArCH), 62.6 (CH2CH2O), 62.5 (CH2CH2O), 51.1 
(CH2NH2
+
CH2), 36.9 (CH2CH2N), 36.6 (CH2CH2N); IR ν cm
-1
 3100 (NH), 1695 (imide and 
ester C=O), 1102 (ClO4); HRMS (ESI
+
): m/z found, 604.1697 calc for C32H27N3O8Na 
604.1690 [2.44+Na]
+
. 
2.45 
 
Thread 2.44 (15 mg, 0.02 mmol) was dissolved in deuterated acetonitrile (0.5 mL) and 
DB24C8 (20 mg, 0.04 mmol) was added. The threading was monitored by 
1
H NMR. 
Threading was completed after 72 h to give the pseudorotaxane. Pseudorotaxane 2.45 
1
H 
NMR (400 MHz, 298 K, CD3CN) δH  7.84-7.82 (m, 2H,  2 ArCH), 7.83-7.77 (m, 2H,  2 
ArCH), 7.73-7.71 (m, 2H,  2 Phthalimide-ArCH), 7.67-7.65 (m, 2H,  2 Phthalimide-
ArCH), 7.45-7.43 (m, 2H,  2 ArCH), 7.40-7.38 (m, 2H,  2 ArCH), 6.78 (s, 2H,  
CH=CH), 6.73-6.68 (m, 8H,  8 crown ArCH), 4.78-4.75 (m, 4H,  2 CH2NH2), 4.46 (t, 
2H, J = 5.3 Hz,  CH2CH2O), 4.36 (t, 2H, J = 5.3 Hz,  CH2CH2O), 4.00-3.98 (m, 10H,  4 
OCH2 and  CH2CH2N), 3.83-3.81 (m, 2H,  CH2CH2N), 3.76-3.75 (m, 8H,  4 OCH2), 
3.58 (s, 8H,  4 OCH2); Also contains unthreaded DB24C8 
1
H NMR (400 MHz, 298 K, 
CD3CN) δH 6.93 (m, 8H, 8 ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 8H, 4 OCH2), 3.72 (s, 
8H, 4 OCH2); HRMS (ESI
+
): m/z found, 1030.4006 calc for C56H60N3O16 1030.3968 [2.45-
ClO4]
+
. 
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2.46 
 
To the [2]pseudorotaxane 2.45 (23 mg, 0.02 mmol) in acetonitrile, cyclopentadiene (0.1 mL, 
excess) was added and mixed. The solvent and excess cyclopentadiene was immediately 
removed in vacuo. The excess DB24C8 was removed by extracting with benzene to provide 
a beige solid (20 mg, 0.017 mmol, 85%) m.p. 102-104˚C; 1H NMR (500 MHz, 298 K, 
CD3CN) δH 7.85 (m, 2H,  2 ArCH), 7.80-7.78 (m, 4H,  4 Phthalimide-ArCH), 7.70 (br s, 
2H,  NH2), 7.64 (d, 2H, J = 8.2 Hz,  2 ArCH), 7.50 (d, 2H, J = 8.0 Hz,  2 ArCH), 7.38 
(d, 2H, J = 8.2 Hz,  2 ArCH), 6.72 (m, 8H,  8 crown ArCH), 5.89 (s, 2H,  CH=CH), 
4.82-4.75 (m, 4H,  CH2NH2
+
CH2), 4.46 (t, 2H, J = 4.4 Hz,  CH2CH2O), 4.26 (t, 2H, J = 
5.7 Hz,  CH2CH2O), 4.02-3.99 (m, 10H,  4 OCH2 and  CH2CH2N), 3.78-3.76 (m, 8H,  
4 OCH2), 3.65 (t, 2H, J = 5.7 Hz,  CH2CH2N), 3.62-3.56 (m, 8H,  4 OCH2), 3.26 (m, 2H, 
 CHCO), 3.21 (m, 2H,  CHCH2), 1.60 (d, 1H, J = 8.5 Hz,  CHH), 1.55 (d, 1H, J = 8.5 
Hz,  CHH); 13C NMR (125 MHz, 298 K, CD3CN) δC 178.9 (imide C=O), 169.5 (imide 
C=O), 166.6 (COO), 166.5 (COO), 148.5 (ArC), 138.4 (ArC), 138.0 (ArC), 135.7 (ArCH), 
135.6 (CH=CH), 133.5 (ArC), 131.8 (ArC), 131.6 (ArC), 131.0 (ArCH), 130.8 (ArCH), 
130.7 (ArCH), 130.7 (ArCH), 124.3 (ArCH), 122.5 (ArCH), 113.7 (ArCH), 72.0 (OCH2), 
71.6 (OCH2), 69.1 (OCH2), 63.5 (OCH2CH2N), 63.1 (OCH2CH2N), 53.5 (CH2NH2
+
), 53.4 
(bridgehead CH2), 53.1 (CH2NH2
+
), 47.0 (CHCH2), 46.1 (CHCO), 38.2 (OCH2CH2N), 38.2’ 
(OCH2CH2N); IR ν cm
-1
 2947 (saturated C-H), 1742 (phalamide C=O), 1696 (ester and 
imide C=O), 1081 (C-O); HRMS (ESI
+
): m/z found, 1096.4444 calc for C61H66N3O1 
1096.4438 [2.46-ClO4]
+
.  
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2.47 
 
Thread 2.44 (10 mg, 0.015 mmol) was dissolved in acetonitrile (1 mL) and cyclopentadiene 
(0.1 mL, excess) was added. The solvent and excess cyclopentadiene were removed in vacuo 
and the solid recrystallised from acetonitrile/Et2O to provide the thread (8 mg, 0.011 mmol, 
72%). 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.03-7.99 (m, 4H, 4 ArCH), 7.84-7.78 (m, 
4H, 4 Phthalimide-ArCH), 7.61-7.56 (m, 4H, 4 ArCH), 5.94 (s, 2H, CH=CH), 4.51 (t, 2H, J 
= 5.3 Hz, CH2CH2O), 4.32-4.28 (m, 6H, CH2CH2O and CH2NH2
+
CH2), 4.03 (t, 2H, J = 5.3 
Hz, CH2CH2N), 3.67 (t, 2H, J = 5.0 Hz, CH2CH2N), 3.28 (br s, 2H, 2 CHCO), 3.24 (br s, 
2H, 2 CHCH2), 1.59 (d, 1H, J =8.5 Hz, CHH), 1.56 (d, 1H, J =8.5 Hz, CHH); 
13
C NMR (100 
MHz, 298 K, CD3CN) δC 179.0 (imide C=O), 169.6 (imide C=O), 166.7 (COO), 166.6 
(COO), 136.7 (ArC), 136.6 (ArC), 135.7 (CH=CH), 135.6 (ArCH), 133.5 (ArC), 132.6 
(ArC), 132.6 (ArC), 131.8 (ArCH), 131.7 (ArCH), 131.3 (ArCH), 131.2 (ArCH), 124.3 
(ArCH), 62.9 (CH2CH2O), 63.3 (CH2CH2O), 53.1 (bridgehead CH2), 52.5 (CH2NH2
+
CH2), 
47.0 (CHCH2CH), 46.1 (CHCO), 38.3 (CH2CH2N), 38.2 (CH2CH2N); IR ν cm
-1
 2978 
(saturated C-H), 1694 (ester and imide C=O), 1099 (ClO4); HRMS (ESI
+
): m/z found, 
648.2345 calc for C37H34N3O8 648.2340 [2.47-ClO4]
+
.  
2.50 
 
1,8-Diaminonaphthalene (2 g, 12.6 mmol) was dissolved in HOAc (50 mL) and heated to 
70°C. To the stirring solution, succinic anhydride (1.33 g, 13.3 mmol) was added and stirred 
for 24 h. On cooling, a precipitate formed which was filtered and the solid washed with ice 
cold acetone (2.91 g, 12.1 mmol, 95%). m.p. 243-244˚C (decomp.); 1H NMR (400 MHz, 
298 K, DMSO-d6) δH  11.39 (br s, 2H, NH and OH), 7.12 (dd, 2H, J = 8.0 and J = 7.0 Hz,  
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Hz, 2 PerimidineCH), 6.99 (d, 2H, J = 8.0 Hz, 2 PerimidineCH), 6.40 (d, 2H, J = 7.0 Hz, 2 
PerimidineCH), 2.65 (t, 2H, J = 6.5 Hz, CH2CH2), 2.52 (t, 2H, J = 6.5 Hz, CH2CH2); 
13
C 
NMR (100 MHz, 298 K, DMSO-d6) δC 173.8 (COOH), 159.9 (ArC), 156.4 (ArC), 135.3 
(ArC), 128.6 (PerimidineCH), 128.6’ (PerimidineCH), 121.6 (ArC), 118.2 (PerimidineCH), 
30.0 (CH2CH2), 29.2 (CH2CH2); IR ν cm
-1
 2920 (br signal, OH), 1654 (acid C=O); HRMS 
(ESI
+
): m/z found, 241.0970 Calc for C14H13N2O2
+
 241.0977 [2.50+H]
+
. 
2.51 
 
To the acid 2.50 (250 mg, 1.04 mmol) in CH2Cl2 (10 mL) was added TFAA (1 mL) and the 
solid slowly dissolved to give a dark green solution. The solution was stirred at room 
temperature for 2 h and the solvent was removed in vacuo. The remaining TFAA was 
removed in vacuo using benzene as an azeotrope to give a black solid. The intermediate was 
dissolved in HOAc (20 mL) and o-phenylenediamine (124 mg, 1.15 mmol) was added. The 
resulting mixture was stirred at 70˚C for 24 h. The solution was cooled and HOAc removed 
in vacuo. The crude solid was recrystallised from CH2Cl2/petroleum ether to provide a 
yellow solid (240 mg, 0.77 mmol, 74%). m.p. 205-206˚C; 1H NMR (500 MHz, 298 K, 
CD3OD) δH  7.67 (d, 2H, J = 6.0 Hz, 2 ArCH), 7.43 (d, 2H, J = 6.0 Hz, 2 ArCH), 7.37 (d, 
2H, J = 8.5 Hz, 2 PerimidineCH), 7.30 (dd, 2H, J = 8.0 + 7.5 Hz, 2 PerimidineCH), 6.72 (d, 
2H, J = 7.5 Hz, 2 PerimidineCH), 3.61 (t, 2H, J = 7.5 Hz, CH2CH2), 3.18 (t, 2H, J = 7.5 Hz, 
CH2CH2); 
13
C NMR (125 MHz, 298 K, CD3OD) δC 161.5 (ArC), 153.2 (ArC), 136.7 (ArC), 
136.1 (ArC), 135.0 (ArC), 129.9 (PerimidineCH), 126.1 (ArCH), 124.2 (PerimidineCH), 
122.4 (ArC), 115.6 (2 ArCH), 109.6 (PerimidineCH), 31.2 (CH2CH2), 25.7 (CH2CH2); IR ν 
cm
-1
 2911 (saturated C-H), 1651 (C=N); HRMS (ESI
+
): m/z found, 313.1443 Calc for 
C20H17N4 313.1448 [2.51+H]
+
. 
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2.52 
 
Thread 2.51 (50 mg, 0.160 mmol) was dissolved in MeOH (0.5 mL) and HClO4 (70%) was 
added cautiously until a precipitate formed. The precipitate was filtered and washed with 
EtOAc to provide a pale green solid (38 mg, 0.074 mmol, 46%). m.p. 270-271°C (decomp.); 
1
H NMR (400 MHz, 298 K, CD3CN) δH 12.34 (br s, 2H, 2 NH), 10.56 (br s, 2H, 2 NH), 7.83 
(m, 2H, 2 ArCH), 7.64 (m, 2H, ArCH), 7.47 (d, 2H, J = 8.5 Hz, 2 PerimidineCH), 7.37 (dd, 
2H, J = 8.5 + 7.5 Hz, 2 PerimidineCH), 6.82 (d, 2H, J = 7.5 Hz, 2 PerimidineCH), 3.71 (t, 
2H, J = 7.5 Hz, CH2CH2), 3.17 (t, 2H, J = 7.5 Hz, CH2CH2); 
13
C NMR (175 MHz, 298 K, 
CD3CN) δC 160.8 (ArC), 151.5 (ArC), 135.9 (ArC), 133.0 (ArC), 131.9 (ArC), 130.0 
(PerimidineCH), 128.2 (ArCH), 124.9 (PerimidineCH), 121.8 (ArC), 115.4 (ArCH), 110.1 
(PerimidineCH), 30.4 (CH2CH2), 24.5 (CH2CH2); IR ν cm
-1
 3209 (br NH), 1646 (C=N), 
1053 (ClO4); HRMS (ESI
+
): m/z found, 313.1444 calc for C20H17N4 313.1448 [2.52-
H.2ClO4]
+
. 
2.53 
 
Thread 2.52 (10.3 mg, 0.2 mmol) and DB24C8 (9 mg, 0.2 mmol) were dissolved in 
deuterated acetonitrile (10 mL). Binding constant = 755 M
-1 
was calculated from the single 
point method
129
 by measuring the integration of ArCH protons for the free and bound crown 
at 6.93 ppm and 6.46 ppm respectively. Pseudorotaxane 2.53  
1
H NMR (400 MHz, 298 K, 
CD3CN) δH 10.67 (br s, 4H,   2 NH), 7.72 (m, 2H,  2 ArCH), 7.56 (m, 2H,  2 ArCH), 
7.12-7.04 (m, 4H,  4 PerimidineCH), 6.53 (m, 2H,  2 PerimidineCH), 6.46 (s, 8H,  8 
crown ArCH), 4.15-4.09 (m, 4H,  2  OCH2), 4.07-4.02 (m, 4H,  2 OCH2), 4.00-3.96 (m, 
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6H,  3 OCH2), 3.92-3.88 (m, 12H,  5 O-CH2 and  CH2CH2), 3.38 (m, 2H,  CH2CH2); 
Also contains unthreaded DB24C8 
1
H NMR (400 MHz, 298 K, CD3CN) δH 6.93 (m, 8H, 8 
ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 8H, 4 OCH2), 3.72 (s, 8H, 4 OCH2); and Thread 
2.52 
1
H NMR (400 MHz, 298 K, CD3CN) δH  7.83 (m, 2H, 2 ArCH), 7.65-7.62 (m, 2H, 
ArCH), 7.47 (d, 2H, J = 8.5 Hz, 2 PerimidineCH), 7.37 (dd, 2H, J = 8.5 Hz, J = 7.5 Hz, 2 
PerimidineCH), 6.82 (d, 2H, J = 7.5 Hz, 2 PerimidineCH), 3.71 (t, 2H, J = 7.5 Hz, CH2CH2), 
3.17 (t, 2H, J = 7.5 Hz, CH2CH2); HRMS (ESI
+
): m/z 761.3541 calc for C44H49N4O8 
761.3545 [2.53-H.2ClO4]
+
. 
2.54 
 
To a slurry of 2.50 (1 g, 4.2 mmol) in CH2Cl2 was added TFAA (1 mL). The solid gradually 
dissolved and the solution turned dark and was stirred overnight at room temperature. The 
solvent and TFAA were removed in vacuo and the oil provided was taken up in HOAc. 3,4-
Diaminobenzophenone (0.88 g, 4.2 mmol)  was added to the solution and it was heated at 
70°C for 48 h. The HOAc was removed in vacuo and the crude product washed with hot 
water (3 x 10mL). The crude product was then dissolved in boiling MeOH, filtered and the 
solvent removed in vacuo to provide a pale green solid (1.12g, 2.7 mmol, 65%). m.p. 196-
197˚C; 1H NMR (400 MHz, 298 K, DMSO- d6) δH  8.04 (s, 1H, BenzimidazoleCH), 7.66 (m, 
5H, 5 ArCH), 7.76 (d, 2H, J = 7.5 Hz, 2 ArCH), 7.54 (d, 2H, J = 7.5 Hz, 2 ArCH), 7.41 (d, 
2H, J = 8.5 Hz, 2 PerimidineCH), 7.33 (d, 2H,
 
J = 8.5 Hz,  2 PerimidineCH), 6.77 (d, 2H,
 
J = 
8.5 Hz, 2 PerimidineCH), 3.61 (t, 2H,
 
J = 7.5 Hz, CH2CH2), 3.23 (t, 2H, J = 7.5 Hz, 
CH2CH2); 
13
C NMR (100 MHz, 298 K, DMSO-d6) δC 198.3 (C=O), 162.1 (ArC), 156.1 
(ArC), 141.4 (ArC), 139.3 (ArC), 138.5 (ArC), 136.2 (ArC), 133.9 (ArC), 133.8 (ArC), 
133.6 (ArCH), 130.0 (PerimidineCH), 129.7 (ArCH), 129.5 (ArCH), 126.5 (ArCH), 124.2 
(ArCH), 121.8 (ArC), 119.0 (PerimidineCH), 115.3 (ArCH), 109.3 (PerimidineCH), 30.8 
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(CH2CH2), 26.1 (CH2CH2); IR ν cm
-1
 2801 (saturated C-H), 1654.6 (ketone C=O); MS 
(ESI
+
): m/z 417.2 [2.54+H]
+
.
 
2.55 
 
2.54 (50 mg, 0.12 mmol) was dissolved in the minimum amount of MeOH. HClO4 (70%) 
was added cautiously dropwise to the solution until a black precipitate appeared. The liquid 
was decanted off whilst warm and left to cool and crystallise. The grey precipitate was 
filtered and washed with ice cold MeOH (36 mg, 0.06 mmol, 50%). m.p. 179-180 C 
(decomp.);
 1
H NMR (400 MHz, 298 K, CD3CN) δH 12.74 (br s, 2H, 2 NH), 10.70 (br s, 2H, 
2 NH), 8.18 (s, 1H, BenzimidazoleCH), 8.01 (d, 1H, J = 8.6 Hz, BenzimidazoleCH), 7.93 (d, 
1H, J = 8.6 Hz, BenzimidazoleCH), 7.80 (d, 2H, J = 7.0 Hz, 2 ArCH), 7.71 (t, 1H, J = 7.5 
Hz, ArCH), 7.58 (t, 2H, J = 7.5 Hz, 2 ArCH), 7.45 (d, 2H, J = 8.5 Hz, 2 PerimidineCH), 
7.36 (m, 2H, 2 PerimidineCH), 6.83 (d, 2H, J = 8.0 Hz, 2 PerimidineCH), 3.78 (t, 2H, J = 
8.0 Hz, CH2CH2), 3.22 (t, 2H, J = 8.0 Hz, CH2CH2); 
13
C NMR (100 MHz, 298 K, CD3CN) 
δC 160.7 (C=O), 153.9 (ArC), 138.3 (ArC), 137.4 (ArC), 135.9 (ArC), 134.4 (ArCH), 134.3 
(ArC), 133.0 (ArC), 131.6 (ArC), 131.3 (ArCH), 130.0 (PerimidineCH), 129.9 (ArCH), 
129.5 (ArCH), 124.9 (ArCH), 123.9 (ArC), 121.8 (ArC), 117.7 (PerimidineCH), 115.6 
(ArCH), 110.1 (PerimidineCH), 30.3 (CH2CH2), 24.7 (CH2CH2); IR ν cm
-1 
3200 (NH), 1648 
(ketone C=O), 1070 (ClO4); HRMS (ESI
+
): m/z found, 417.1706 calc for C27H21N4O 
417.1710 [2.55-H.2ClO4]
+
. 
2.56 
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Thread 2.55 (12.3 mg, 0.02mmol) and DB24C8 (8.9 mg, 0.02mmol) were dissolved in 
deuterated acetonitrile (10mL) and pseudorotaxane formation was observed by 
1
H NMR. 
Binding constant = 995 M
-1 
was calculated from the single point method
129
 by measuring the 
integration of ArCH protons for the free and bound crown at 6.93 ppm and 6.48 ppm 
respectively. Pseudorotaxane 2.56 
1
H NMR (400 MHz, 298 K, CD3CN) δH 12.52 (br s, 1H, 
 NHH), 12.36 (br s, 1H,  NHH), 7.99 (m, 1H,  BenzimidazoleCH), 7.90 (m, 1H,  
BenzimidazoleCH), 7.82-7.70 (m, 3H,  3 ArCH), 7.63-7.57 (m, 3H,  3 ArCH), 7.16-7.15  
(m, 4H,  4 PerimidineCH), 6.60 (m, 2H,  2 PerimidineCH), 6.48 (s, 8H,  8 crown 
ArCH), 4.15-3.92 (m, 26 H,  12 OCH2 and  CH2CH2), 3.43-3.39 (m, 2H,  CH2CH2); 
Also contains unthreaded DB24C8 
1
H NMR (400 MHz, 298 K, CD3CN) δH 6.93 (m, 8H, 8 
ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 8H, 4 OCH2), 3.72 (s, 8H, 4 OCH2); and Thread 
2.55 
1
H NMR (400 MHz, 298 K, CD3CN) δH 12.74 (br s, 2H, 2 NH), 10.70 (br s, 2H, 2 NH), 
8.18 (s, 1H, BenzimidazoleCH), 8.01 (d, 1H, J = 8.6 Hz, BenzimidazoleCH), 7.93 (d, 1H, J 
= 8.6 Hz, BenzimidazoleCH), 7.80 (d, 2H, J = 7.0 Hz, 2 ArCH), 7.71 (t, 1H, J = 7.5 Hz, 
ArCH), 7.58 (t, 2H, J = 7.5 Hz, 2 ArCH), 7.45 (d, 2H, J = 8.5 Hz, 2 PerimidineCH), 7.36 (m, 
2H, 2 PerimidineCH), 6.83 (d, 2H, J = 8.0 Hz, 2 PerimidineCH), 3.78 (t, 2H, J = 8.0 Hz, 
CH2CH2), 3.22 (t, 2H, J = 8.0 Hz, CH2CH2); HRMS (ESI
+
): m/z found, 865.3812 calc for 
C51H53N4O9 865.3807 [2.56-H.2ClO4]
+
. 
2.57 
 
Acid 2.50 (2 g, 8.3 mmol) was dissolved in CH2Cl2 (20 mL) and TFAA (2 mL) and stirred at 
room temperature for 12 h. The CH2Cl2 and excess TFAA were removed in vacuo. The 
residue was dissolved in HOAc (40 mL) and 3,4-diaminobenzoic acid (1.33g, 8.7 mmol) 
was added. The solution was heated at 70°C for 48 h. The solution was cooled and the 
precipitate filtered and washed in HOAc and acetone. The green solid was recrystallised 
from MeOH/water (1.25g, 3.5 mmol, 43%). m.p. 237-238˚C; 1H NMR (400 MHz, 298 K, 
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DMSO-d6) δH  8.15 (s, 1H, BenzimidazoleCH), 7.85, (d, 1H, J = 8.5 Hz, BenzimidazoleCH), 
7.63 (d, 1H, J = 8.5 Hz, BenzimidazoleCH), 7.36 (m, 4H, 4 PerimidineCH), 6.77 (d, 2H, J = 
8.0 Hz, 2 PerimidineCH), 3.50 (t, 2H, J = 7.5 Hz, CH2CH2), 3.18 (t, 2H, J = 7.5 Hz, 
CH2CH2); 
13
C NMR (100 MHz, 298 K, DMSO-d6) δC 167.8 (COOH), 163.0 (ArC), 160.1 
(ArC), 155.4 (ArC), 138.1 (ArC), 134.9 (ArC), 134.4 (ArC), 128.6 (PerimidineCH), 124.4 
(ArC), 123.3 (ArCH), 121.2 (PerimidineCH), 120.4 (ArC), 116.6 (ArCH), 114.1 (ArCH), 
107.7 (PerimidineCH), 29.64 (CH2CH2), 24.74 (CH2CH2); IR ν cm
-1 
2778 (saturated C-H), 
1652 (acid C=O); HRMS (ESI
+
): m/z found, 357.1348 calc for C21H17N4O2 357.1352 
[2.57+H]
+
. 
2.58 
 
To a mixture of the acid 2.57 (200 mg, 0.56 mmol) in CH2Cl2 (5 mL) was added NEt3 (2 
mL, excess). The HBTU (255 mg, 0.67 mmol) was added and the reaction stirred for 24 h. 
The alcohol 2.04 (117 mg, 0.56 mmol) and DMAP (7 mg, 0.056 mmol) were added and 
stirred for a further 48 h. The reaction was followed by TLC (EtOAc:MeOH:H2O; 40:15:3). 
CH2Cl2 (20 mL) was added and the solution was washed with water (3 x 20 mL). The 
organic layer was dried over MgSO4, filtered and the solvent removed in vacuo. The residue 
was dissolved in CH2Cl2 and Et2O was added to form a precipitate and was filtered and 
washed with EtOAc. The solid was dissolved in MeOH and HClO4 (70%) (0.5 mL) was 
added cautiously. Water was added drop-wise to induce precipitation and the solid was 
filtered and washed with water (3mL) to provide a pale green solid (50 mg, 0.07 mmol, 
12%). m.p. 118-119°C; 
1
H NMR (700 MHz, 298 K, CD3CN) δH  8.33 (s, 1H, 
BenzimidazoleCH), 8.15 (d, 1H,
 
J = 8.5 Hz, BenzimidazoleCH), 7.88 (d, 1H,
 
J = 8.5 Hz, 
BenzimidazoleCH), 7.44 (d, 2H, J = 8.5 Hz, 2 PerimidineCH), 7.35 (dd, 2H, J = 8.5 Hz, J = 
8.0 Hz and 2 PerimidineCH), 6.82 (d, 2H, J = 8.0 Hz, 2 PerimidineCH), 6.48 (s, 2H, 
CH=CH), 5.09 (s, 2H, 2 CHO), 4.43 (t, 2H, J = 5.0 Hz, CH2CH2O), 3.83 (t, 2H, J = 5.0 Hz, 
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CH2CH2N), 3.77 (t, 2H, J = 8.0 Hz, CH2CH2), 3.23 (t, 2H, J = 8.0 Hz, CH2CH2), 2.89 (s, 2H, 
2 CHCO); 
13
C NMR (175 MHz, 298 K, CD3CN) δC 176.7 (imide C=O), 164.7 (COO), 159.3 
(ArC), 152.6 (ArC), 136.5 (CH=CH), 134.6 (ArC), 133.5 (ArC), 131.6 (ArC), 130.4 (ArC), 
128.8 (ArC), 128.7 (PerimidineCH), 127.6 (ArCH), 123.6 (PerimidineCH), 120.4 (ArC), 
115.9 (ArCH), 114.3 (ArCH), 108.8 (PerimidineCH), 80.9 (CHO), 61.9 (CH2CH2O), 47.5 
(CHCO), 37.2 (CH2CH2N), 28.9 (CH2CH2), 23.2 (CH2CH2); IR ν cm
-1
 3488 (br NH), 1697 
(ester and imide C=O), 1092 (ClO4); HRMS (ESI
+
): m/z found, 548.1929 calc. for 
C31H26N5O5 548.1928 [2.58-H.2ClO4]
+
. 
2.59 
 
Perchlorate thread 2.58 (30 mg, 0.04 mmol) was dissolved in acetonitrile and heated under 
microwave irradiation (3h, 150W, 110°C) and the reaction followed by TLC. The solvent 
was removed in vacuo and the yellow solid recrystallised from MeOH/water (15mg, 0.022 
mmol, 55%). m.p. 216-217°C (decomp.); 
1
H NMR (400 MHz, 298 K, CD3CN) δH  8.36 (s, 
1H, ArCH), 8.13 (d, 1H, J = 8.0 Hz, ArCH), 7.87 (d, 1H, J = 8.0 Hz, ArCH), 7.45 (d, 2H, J 
= 7.5 Hz, 2 PerimidineCH), 7.36 (t, 2H, J = 7.5 Hz, 2 PerimidineCH), 6.81 (d, 2H, J = 7.5 
Hz, PerimidineCH), 6.78 (s, 2H, CH=CH), 4.45 (t, 2H, J = 5.0 Hz, CH2CH2O), 3.88 (t, 2H, J 
= 5.0 Hz, CH2CH2N), 3.74 (t, 2H, J = 7.5 Hz, CH2CH2), 3.22 (t, 2H, J = 7.5 Hz, CH2CH2); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 169.8 (imide C=O), 165.4 (COO), 159.3 (ArC), 
157.5 (ArC), 147.6 (ArC), 143.9 (ArC), 135.9 (ArC), 135.8 (CH=CH), 132.9 (ArC), 130.1 
(PerimidineCH), 128.9 (ArCH), 128.0 (ArC), 125.0 (PerimidineCH), 123.6 (ArC), 117.3 
(ArCH), 115.7 (ArCH), 110.1 (PerimidineCH), 64.4 (CH2CH2O), 36.0 (CH2CH2N), 30.2 
(CH2CH2), 24.6 (CH2CH2); IR ν cm
-1
 3216 (N-H), 1707 (imide and ester C=O), 1093 (ClO4); 
HRMS (ESI
+
): m/z found, 480.1663 calc for C27H22N5O4 480.1666 [2.59-H.2ClO4]
+
. 
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2.60 
 
Thread 2.59 (10 mg, 0.015 mmol) was dissolved in deuterated acetonitrile and DB24C8 (13 
mg, 0.03 mmol, 2 equiv) was added. Pseudorotaxane formation was monitored by 
1
H NMR. 
Pseudorotaxane 2.60 
1
H NMR (400 MHz, 298 K, CD3CN) δH  10.73 (br s, 2H,  NH2), 
8.23 (s, 1H,  BenzimidazoleCH), 8.06 (t, 1H, J = 8.5 Hz,  PerimidineCH), 7.74 (d, 1H, J 
= 8.5 Hz,  BenzimidazoleCH), 7.40 (m, 1H,  BenzimidazoleCH), 7.15 (m, 2H, 2  
PerimidineCH), 6.81 (s, 2H,  CH=CH), 6.61 (m, 2H,  2 PerimidineCH), 6.48 (s, 8H,  8 
crown ArCH), 4.47 (t, 2H, J = 5.0 Hz,  CH2CH2O), 4.19-3.92 (m, 30 H,  12 OCH2 and  
2 CH2CH2), 3.45 (m, 2H,  CH2CH2); Also contains unthreaded DB24C8 
1
H NMR (400 
MHz, 298 K, CD3CN) δH 6.93 (m, 8H, 8 ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 8H, 4 
OCH2), 3.72 (s, 8H, 4 OCH2); MS (ESI
+
): m/z 930.0 [2.60-H.2ClO4]
+
. 
2.61 
 
To the pseudorotaxane 2.60 (16.5 mg, 0.015 mmol) in acetonitrile, freshly distilled 
cyclopentadiene (0.1 mL, excess) was added at room temperature and the solvent and excess 
cyclopentadiene removed immediately in vacuo. The resulting residue was purified via flash 
chromatography (SiO2: CH2Cl2:Acetone; 95:5 to CH2Cl2:MeOH; 95:5) to give a yellow oil 
(6 mg, 0.005 mmol, 34 %). 
1
H NMR (400 MHz, 298 K, CD3CN) δH  10.77 (br s,  NH), 8.24 
(br s, 1H,  isomer BenzimidazoleCH), 8.12 (br s, 1H,  isomer  BenzimidazoleCH), 7.87 
(br m, 1H,  isomer BenzimidazoleCH), 7.66 (br s, 1H,  isomer BenzimidazoleCH), 7.55 
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(br s,  isomer BenzimidazoleCH), 7.05 (dd, 2H, J = 7.0 + 8.0 Hz,  2 PerimidineCH), 6.97 
(d, 2H, J = 8.0 Hz,  2 PerimidineCH), 6.52 (d, 2H, J = 7.0 Hz,  2 PerimidineCH), 6.47 (s, 
8H,  8 crown ArCH), 5.99 (s, 2H,  CH=CH), 4.31 (t, 2H, J = 5.0 Hz,  CH2CH2O), 4.17-
4.13 (m, 4H,  CCH2CH2C and OCH2), 4.06-4.00 (m, 8H,  4 OCH2), 3.87-3.77 (m, 10H, 
 5 OCH2), 3.70 (m, 2H,  CH2CH2N), 3.63 (m, 4H,  2 OCH2), 3.41-3.37 (m, 2H,  
CCH2CH2C), 3.29 (br s, 2H,  2 CHCO), 3.25 (br s, 2H,  2 CHCH2), 1.59 (d, 1H, J = 9.0 
Hz,  CHH), 1.54 (d, 1H, J = 9.0 Hz,  CHH); 13C NMR (100 MHz, 298 K, CD3CN) δC 
177.7 (imide C=O), 147.2 (COO), 134.3 (CH=CH), 134.2 (ArC), 131.7 (ArC), 131.7’ (ArC), 
127.7 (PerimidineCH), 122.0 (ArCH), 121.4 (ArCH), 121.3 (ArCH), 120.5 (PerimidineCH), 
119.5 (ArC), 114.2 (ArCH), 114.01 (ArC), 111.6 (ArCH), 107.2 (PerimidineCH), 100.0 
(ArC), 70.6 (OCH2), 70.3 (OCH2), 69.3 (CH2CH2), 68.6 (CH2CH2), 68.4 (OCH2), 60.6 
(CH2CH2O), 51.7 (bridgehead CH2), 45.7 (CHCH2CH), 44.7 (CHCO), 37.1 (CH2CH2N), 
29.3 (CH2CH2), 24.3 (CH2CH2) ArC quaternary carbons not observed; IR ν cm
-1
 3222 (NH), 
2923 (saturated C-H), 1699 (ester C=O), 1655 (imide C=O), 1098 (ClO4); HRMS (ESI
+
): 
m/z found, 994.4235 calc for C56H60N5O12 994.4233 [2.61-ClO4]
+
.  
2.63 
 
To a mixture of nicotinic acid (2.0 g, 16 mmol) in thionyl chloride (20.0 mL, excess) was 
carefully added 3 drops of DMF. The mixture was stirred at room temperature overnight 
then the thionyl chloride was removed in vacuo while heating was maintained with an oil 
bath (40°C) to give a white powder that was used without further purification. To the 
nicotinoyl chloride in CH2Cl2 (20 mL), a solution of Diels-Alder alcohol 2.04 (3.74 g, 17.9 
mmol) and NEt3 (5 mL, 35.9 mmol) in CH2Cl2 (15 mL) was added dropwise over 10 
minutes. The mixture was stirred for 48 h. To the reaction mixture, a saturated solution of 
sodium carbonate (50 mL) was added and allowed to stir for 20 minutes. The mixture was 
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separated and the organic layer was washed with sodium carbonate (2 x 50 mL), dried over 
MgSO4, filtered and the solvent removed in vacuo to provide a white solid which was 
recrystallised from CH2Cl2/Et2O (2.97 g, 9.46 mmol, 58%). m.p. 83-84°C; 
1
H NMR (400 
MHz, 298 K, CDCl3) δH  9.14 (s, 1H, PyrCH-N), 8.87 (d, 1H, J = 7.0 Hz, PyrCH-N), 8.23 (d, 
1H, J = 7.0 Hz, PyrCH-C), 7.35 (t, 1H, J = 7.0 Hz, PyrCH), 6.50 (s, 2H, CH=CH), 5.22 (s, 
2H, 2 CHO), 4.48 (t, 2H, J = 5.0 Hz, CH2CH2O), 3.90 (t, 2H, J = 5.0 Hz, CH2CH2N), 2.86 
(s, 2H, 2 CHCO); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 176.0 (imide C=O), 165.0 (COO), 
153.6 (PyrCH), 151.1 (PyrCH), 137.1 (PyrCH) 136.5 (CH=CH), 125.7 (ArC), 123.3 
(PyrCH), 80.9 (CHO), 61.6 (CH2CH2O), 47.5 (CHCO), 37.7 (CH2CH2N); IR ν cm
-1
 3021 
(saturated C-H), 1688 (ester and imide C=O); HRMS (ESI
+
): m/z found, 315.0978 calculated 
for C16H15N4O5 315.0981 [2.63+H]
+
; 
2.64 
 
To a mixture of nicotinic acid (2.0 g, 16 mmol) in thionyl chloride (10.0 mL, excess) was 
carefully added 3 drops of DMF. The mixture was stirred at room temperature overnight 
then the thionyl chloride was removed in vacuo while heating was maintained with an oil 
bath (40˚C) to give a white powder that was used without further purification. To the 
nicotinoyl chloride in CH2Cl2 (20 mL), 3,5-dimethylphenol (2.4 g, 20 mmol) was added and 
the solution cooled to 0˚C. NEt3 (5.5 mL, 54 mmol) was diluted in CH2Cl2 (10 mL) and 
added to the cooled mixture over 30 minutes. The reaction mixture was warmed to room 
temperature and stirred overnight. Water (10 mL) was added to the solution and stirred for 
30 minutes then extracted with CH2Cl2 (2 x 10 mL). The organic layers were combined and 
washed with a 2M sodium hydroxide solution (3 x 20 mL). The organic extracts were dried 
over MgSO4, filtered and the solvent removed in vacuo to provide a yellow oil, which 
slowly crystallised on standing at room temperature (2.8 g, 12.5 mmol, 78 %). m.p. 53-54˚C; 
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1
H NMR (400 MHz, 298 K, CDCl3) δH  9.38 (s, 1H, PyrCH-N), 8.84 (d, 1H, J = 5.0 Hz, 
PyrCH-N), 8.43 (d, 1H, J = 8.0 Hz, PyrCH-C), 7.48 (m, 1H, PyrCH), 6.92 (br s, 1H, ArCH), 
6.84 (br s, 2H, 2 ArCH), 2.35 (s, 6H, 2 CH3); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 164.1 
(COO), 153.9 (ArCH), 151.3 (ArCH), 150.4 (ArC), 139.5 (ArCH), 137.5 (ArCH), 127.9 
(ArC), 125.8 (ArCH), 123.4 (ArCH), 119.1 (ArCH), 21.3 (CH3); IR ν cm
-1 
2915 (saturated 
C-H), 1728 (ester C=O), 1258 (C-O); HRMS (ESI
+
): found, 250.0838 calc for C14H13NO2Na 
250.0838 [2.64+Na]
+
; CHN Analysis Found: C 73.87; H 5.73; N 6.11. Calc. for C14H13NO2: 
C 73.99; H 5.77; N 6.16. 
2.65 
 
Compound 2.64 (1 g, 4.4 mmol) was dissolved in 1,2 dibromoethane (1 mL, excess) and 
acetonitrile (1 mL). It was heated at 60˚C for 72 h. The solution was cooled and the solvent 
removed in vacuo. EtOAc (20 mL) was added and the solution filtered to remove 
bispyridinium product. The liquors were left crystallise. The solution was filtered to provide 
a white solid (420 mg, 1.06 mmol, 24%). m.p. 192-193˚C; 1H NMR (400 MHz, 298 K, D2O) 
δH  9.75 (s, 1H, PyrCH-N), 9.30 (d, 1H, J = 8.0 Hz, PyrCH), 9.25 (d, 1H, J = 6.0 Hz, 
PyrCH), 8.38 (t, 1H, J = 8.0 + 6.0 Hz, PyrCH), 7.15 (s, 1H, ArCH), 7.00 (s, 2H, ArCH),  
5.22 (t, 2H,
 
J = 5.5 Hz, CH2N
+
),  4.09 (t, 2H, J = 5.5 Hz, CH2Br), 2.38 (s, 6H, 2 CH3); 
13
C 
NMR (100 MHz, 298 K, D2O) δC 161.9 (COO), 149.7 (ArC), 148.2 (ArCH), 146.9 (ArCH), 
146.4 (ArCH), 140.6 (ArC), 130.4 (ArC), 128.7 (ArCH), 128.6 (ArCH), 118.5 (ArCH), 62.6 
(CH2N
+
), 29.9 (CH2Br), 20.3 (CH3); IR ν cm
-1 
3013 (saturated C-H), 1741 (ester C=O), 1279 
(C-O); HRMS (ESI
+
): m/z found, 334.0441 calc for C16H17NO2Br
79
 334.0437 [2.65-Br]
+
; 
CHN Analysis Found: C 46.51; H 4.09; N 3.37. Calc. for C16H17Br2NO2: C 46.29; H 4.13; N 
3.37%. 
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2.66 
 
The bromide salt 2.65 (30 mg, 0.072 mmol) and nicotinate ester 2.63 (25 mg, 0.08 mmol) 
were dissolved in acetonitrile (2 mL) and heated to 60˚C for 72 h. The reaction was cooled 
and a precipitate formed which was filtered and washed with cold acetonitrile. The solid was 
collected and used without further purification (25 mg, 0.034 mmol, 48%). 
1
H NMR (400 
MHz, 298 K, DMSO-d6) δH  9.92 (s, 1H, PyrCH-N), 9.70 (s, 1H, PyrCH-N), 9.35 (dd, 2H, J 
= 7.5 Hz and 6.5 Hz, 2 PyrCH), 9.23 (d, 1H,  J = 8.5 Hz PyrCH), 8.88 (d, 1H,  J = 8.5 Hz 
PyrCH), 8.42 (dd, 2H, J = 8.2 Hz and 7.5 Hz, 2 PyrCH), 7.03 (s, 1H, ArCH), 6.96 (s, 2H, 2 
ArCH), 6.54 (s, 2H, CH=CH), 5.38 (4H, 2 CH2-N
+
), 5.11 (s, 2H, 2 CHCO), 4.48 (t, 2H, J = 
5.5 Hz, CH2CH2O), 3.80 (t, 2H, J = 5.5 Hz, CH2CH2N), 2.97 (s, 2H, 2 CHCO), 2.33 (s, 6H, 
2 CH3); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 176.8 (imide C=O), 161.5 (COO), 160.7 
(COO), 150.1 (ArC), 149.2 (ArCH), 149.1 (ArCH), 147.7 (ArCH), 147.2 (ArCH), 146.8 
(ArCH), 145.9 (ArCH), 139.5 (ArC), 136.7 (CH=CH), 130.1 (ArC), 130.0 (ArC), 128.9 
(ArCH), 128.8 (ArCH), 128.4 (ArCH), 119.0 (ArCH), 80.6 (CHO), 64.5 (N
+
-CH2CH2-N
+
), 
64.4 (N
+
-CH2CH2-N
+
), 62.9 (CH2CH2O), 47.4 (CHCO), 36.7 (CH2CH2N), 21.0 (CH3). 
2.67 
 
Bromide salt 2.66 (20 mg, 0.03 mmol) was dissolved in water (0.5 mL) and a saturated 
aqueous solution of sodium perchlorate (1 mL) was added. The white precipitate formed was 
filtered and washed with water and dried in the desiccator (17 mg, 0.022 mmol, 73 %).
1
H 
NMR (400 MHz, 298 K, CD3CN) δH  9.57 (s, 1H, PyrCH-N), 9.36 (s, 1H, PyrCH-N), 9.18 
(d, 1H, J = 8.0 Hz, PyrCH), 8.99-8.96 (m, 3H, 3 PyrCH), 8.33-8.25 (m, 2H, 2 PyrCH), 7.04 
(s, 1H, ArCH), 6.95 (s, 2H, 2 ArCH), 6.69 (s, 2H, CH=CH), 5.27 (s, 4H, 2 CH2-N
+
), 5.12 (s, 
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2H, 2 CHCO), 4.54 (t, 2H, J = 5.3 Hz, CH2CH2O), 3.84 (t, 2H, J = 5.3 Hz, CH2CH2N), 2.92 
(s, 2H, 2 CHCO), 2.36 (s, 6H, 2 CH3); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 178.2 (imide 
C=O), 162.1 (COO), 161.6 (COO), 151.6 (ArC), 149.9 (ArCH), 149.8 (ArCH), 148.9 
(ArCH), 148.5 (ArCH), 148.3 (ArCH), 148.2 (ArCH), 141.4 (ArC), 137.9 (CH=CH), 
132.8(4) (ArC), 132.8(1) (ArC), 131.0 (ArCH), 130.9 (ArCH), 129.7 (ArCH), 120.0 
(ArCH), 82.3 (CHO), 64.5 (N
+
-CH2CH2-N
+
), 64.4 (N
+
-CH2CH2-N
+
), 61.0 (CH2CH2O), 48.9 
(CHCO), 38.4 (CH2CH2N), 21.6 (CH3); CHN: Found C 49.07; H 3.79; N 5.44; Calc. for 
C32H31Cl2N3O15.H2O: C 48.87; H 4.23; N 5.34%. 
2.68 
 
The ClO4
-
 salt 2.67 (30 mg, 0.04 mmol) was dissolved in acetonitrile and heated to reflux for 
24 h. The solvent was removed in vacuo to provide a pale yellow solid recrystallised from 
CH3CN/Et2O (10 mg, 0.014 mmol, 36%). 
1
H NMR (400 MHz, 298 K, CD3CN) δH  9.57 (s, 
1H, PyrCH-N), 9.36 (s, 1H, PyrCH-N), 9.18 (d, 1H, J = 8.2 Hz, PyrCH), 8.90-9.00 (m, 3H, 3 
PyrCH), 8.25-8.34 (m, 2 H, 2 PyrCH), 7.05 (s, 1H, ArCH), 6.93 (s, 2H, 2 ArCH), 6.80 (s, 
2H, CH=CH), 5.26 (br s, 4H, 2 CH2N
+
), 4.51 (t, 2H, J = 5.0 Hz, CH2CH2O), 3.88 (t, 2H, J = 
5.0 Hz, CH2CH2N), 2.36 (s, 6H, 2 CH3); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 170.8 
(imide C=O), 160.6 (COO), 159.9 (COO), 149.8 (ArC), 148.3 (ArCH), 148.1 (ArCH), 147.3 
(ArCH), 146.8 (ArCH), 146.5 (ArCH), 139.5 (ArC), 136.2 (ArCH), 134.2 (CH=CH), 131.3 
(ArC), 131.2 (ArC), 129.3 (ArCH), 129.2(8) (ArCH), 128.1 (ArCH), 118.3 (ArCH), 64.3 
(CH2CH2O), 59.3 (N
+
-CH2CH2-N
+
), 59.2 (N
+
-CH2CH2-N
+
), 36.0 (CH2CH2N), 19.9 (CH3). 
2.69 
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Thread 2.68 (10 mg, 0.014 mmol) and DB24C8 (12.5 mg, 0.028 mmol) were dissolved in 
deuterated acetonitrile (0.5 mL). The reaction was monitored by 
1
H NMR to follow 
pseudorotaxane formation. Pseudorotaxane 2.69 
1
H NMR (400 MHz, 298 K, CD3CN) δH 
9.91 (s, 1H,  PyrCH-N), 9.72 (s, 1H,  PyrCH-N), 9.34 (d, 1H, J = 6.0 Hz,  PyrCH), 9.27 
(d, 1H, J = 6.0 Hz,  PyrCH), 8.56 (d, 1H, J = 8.0 Hz,  PyrCH), 8.35 (d, 1H, J = 8.0 Hz,  
PyrCH), 7.99 (t, 1H, J = 7.0 Hz,  PyrCH), 7.92 (t, 1H, J = 6.5 Hz,  PyrCH), 7.08 (s, 1H, 
 ArCH), 6.90 (m, 2H,  2 ArCH), 6.85 (s, 2H,  CH=CH), 6.82 (m, 4H, 4  crown 
ArCH), 6.71 (m, 4H,  4 crown ArCH), 5.63 (br s, 4H,  2 CH2N
+
), 4.49 (t, 2H, J = 5.0 Hz, 
 CH2CH2O), 4.00-3.98 (br m, 24H,  12 OCH2), 3.88 (t, 2H, J = 5.3 Hz,  CH2CH2N), 
2.41 (s, 6H,  2 CH3); Also contains unthreaded DB24C8 
1
H NMR (400 MHz, 298 K, 
CD3CN) δH 6.93 (m, 8H, 8 ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 8H, 4 OCH2), 3.72 (s, 
8H, 4 OCH2). 
2.01 
 
To pseudorotaxane 2.69 in acetonitrile (0.5 mL), freshly distilled cyclopentadiene (0.1 mL, 
excess) was added at room temperature. The excess cyclopentadiene and solvent were 
removed immediately in vacuo and the crude solid purified by precipitation in 
acetonitrile/Et2O to give the rotaxane (10 mg, 0.008 mmol, 58%). 
1
H NMR (400 MHz, 298 
K, CD3CN) δH 9.91 (s, 1H,  PyrCH-N), 9.75 (s, 1H,  PyrCH-N), 9.34 (d, 1H, J = 6.0 Hz, 
 PyrCH), 9.28 (d, 1H, J = 6.0 Hz,  PyrCH), 8.53 (d, 1H, J = 8.0 Hz,  PyrCH), 8.41 (d, 
1H, J = 8.0 Hz,  PyrCH), 7.99-7.93 (m, 2H,  2 PyrCH), 7.08 (s, 1H,  ArCH), 6.93 (s, 
2H,  2 ArCH), 6.82 (m, 4H,  4 crown ArCH), 6.68 (m, 4H,  4 crown ArCH), 6.01 (s, 
2H,  CH=CH), 5.65 (br s, 4H,  2 CH2N
+
), 4.38 (t, 2H, J = 5.0 Hz,  CH2CH2O), 4.02-
3.99 (br m, 24H,  12 OCH2), 3.70 (t, 2H, J = 5.3 Hz,  CH2CH2N), 3.33 (br s, 2H,  2 
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CHCO), 3.29 (br s, 2H,  2 CHCH2), 2.41 (s, 6H,  2 CH3), 1.65 (dd, 1H, J = 9.0 Hz,  
CHH), 1.58 (dd, 1H, J = 9.0 Hz,  CHH); 13C NMR (100 MHz, 298 K, CD3CN) δC 179.0 
(imide C=O), 162.5 (COO), 161.7 (COO), 151.3 (ArC), 151.0 (ArCH), 150.6 (ArCH), 148.9 
(ArCH),148.4 (ArCH), 148.1 (ArC), 146.8 (ArCH), 146.5 (ArCH), 141.6 (ArC), 135.8 
(CH=CH), 131.0 (ArC), 130.6 (ArC), 129.9 (ArCH), 129.5 (ArCH), 129.2 (ArCH), 122.6 
(ArCH), 120.1 (ArCH), 113.9 (ArCH), 71.8 (OCH2), 71.4 (OCH2), 68.9 (OCH2), 65.1 
(CH2CH2O), 60.1 (N
+
-CH2CH2-N
+
), 60.0 (N
+
-CH2CH2-N
+
), 53.2 (bridgehead CH2), 47.1 
(CHCH2CH), 46.1 (CHCO), 37.9 (CH2CH2N), 21.7 (CH3). 
2.70 
 
To a mixture of nicotinic acid (1.0 g, 8 mmol) in thionyl chloride (10.0 mL, excess) was 
carefully added 3 drops of DMF. The mixture was stirred at room temperature overnight 
then the thionyl chloride was removed at in vacuo while heating was maintained with an oil 
bath (40˚C) to give a white powder that was used without further purification. To the 
nicotinoyl chloride in CH2Cl2 (20 mL), a solution of 12 (1.85g, 9.5 mmol) and NEt3 (2.5 mL, 
35.9 mmol) in CH2Cl2 (15 mL) was added dropwise over 10 minutes. The mixture was 
stirred for 48 h at room temperature. To the reaction mixture, a saturated solution of sodium 
hydrogen carbonate (25 mL) was added and allowed to stir for 20 minutes. The mixture was 
separated and the organic layer was washed with aqueous sodium bicarbonate solution (2 x 
30 mL), dried over MgSO4, filtered and the solvent removed in vacuo to provide a white 
solid which was recrystallised from CH2Cl2/Et2O (0.45 g, 1.44 mmol, 18%). m.p. 101-
102˚C; 1H NMR (400 MHz, 298 K, CDCl3) δH  9.16 (s, 1H, PyrCH-N), 8.76 (d, 1H,  J = 5.0 
Hz, PyrCH), 8.24 (d, 1H, J = 8.0 Hz, PyrCH), 7.38 (dd, 1H, J = 8.0 + 5.0 Hz, PyrCH), 6.00 
(s, 2H, CH=CH), 4.36 (t, 2H, J = 5.0 Hz, CH2CH2O), 3.77 (t, 2H, J = 5.0 Hz, CH2CH2N), 
3.36 (s, 2H, 2 CHCO), 3.28 (s, 2H, 2 CHCH2), 1.69 (d, 1H, J = 9.0 Hz, CHH), 1.53 (d, 1H, J 
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= 9.0 Hz, CHH); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 177.4 (imide C=O), 164.5 (COO), 
153.6 (ArCH), 151.0 (ArCH), 137.1 (ArCH), 134.4 (CH=CH), 125.7 (ArC), 123.4 (ArCH), 
62.2 (CH2CH2O), 52.3 (bridgehead CH2), 45.8 (CHCH2CH), 44.9 (CHCO), 37.1 
(CH2CH2N); IR ν cm
-1 
2985 (saturated C-H), 1719 (imide C=O), 1686 (ester C=O); HRMS 
(ESI
+
): m/z found, 313.1182 calc for C17H17N2O4 313.1183 [2.70+H]
+
. 
2.71 
 
Bromine salt 2.70 (50 mg, 0.12 mmol) and ester (42 mg, 0.13 mmol) were dissolved in 
acetonitrile and heated to 60˚C for 72 h. A pale brown precipitate forms which is filtered and 
washed in acetonitrile (48 mg, 0.07 mmol, 55 %). 
1
H NMR (400 MHz, 298 K, D2O) δH 9.65 
(s, 1H, PyrCH-N), 9.45 (s, 1H, PyrCH-N), 9.30-9.21 (m, 3H, 3 PyrCH), 9.05 (d, 1H, J = 8.5 
Hz, PyrCH), 8.39-8.31 (m, 2H, 2 ArCH), 7.07 (s, 1H, ArCH), 6.89 (s, 2H, 2 ArCH), 5.89 (br 
s, 2H, CH=CH), 5.48 (br s, 4H, 2 CH2N
+
), 4.39 (t, 2H,  J = 5.0 Hz, CH2CH2O), 3.73 (t, 2H, J 
= 5.0 Hz, CH2CH2N), 3.38 (br s, 2H, CHCO), 3.22 (m, 2H, CHCH2), 2.29 (s, 6H, 2 CH3), 
1.59 (d, 1H, , J = 9.0 Hz, CHH), 1.49 (d, 1H, J = 9.0 Hz, CHH). 
2.72 
 
Bromide thread 2.71 (40 mg, 0.055 mmol) was dissolved in the minimum amount of water. 
A saturated solution of sodium perchlorate (0.5 mL) was added and a precipitate formed 
which was filtered and washed with water (20 mg, 0.026 mmol, 47%). 
1
H NMR (400 MHz, 
298 K, CD3CN) δH  9.60 (s, 1H, PyrCH-N), 9.39 (s, 1H, PyrCH-N), 9.19 (d, 1H, J = 8.0 Hz, 
PyrCH), 9.03 (d, 1H, J = 6.0 Hz, PyrCH), 9.00-8.97 (m, 2H, 2 PyrCH), 8.34-8.27 (m, 2H, 2 
PyrCH), 7.04 (s, 1H, ArCH), 6.94 (s, 2H, 2 ArCH), 6.00 (br s, 2H, CH=CH), 5.29 (br s, 4H, 
2 CH2N
+
), 4.39 (t, 2H, J = 5.3 Hz, CH2CH2O), 3.70 (t, 2H, J = 5.3 Hz, CH2CH2N), 3.33-3.32 
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(br s, 2H, CHCO), 3.26 (m, 2H, CHCH2), 2.35 (s, 6H, 2 CH3), 1.61 (d, 1H, J = 9.0 Hz, 
CHH), 1.52 (d, 1H, J = 9.0 Hz, CHH); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 178.1 
(imide C=O), 160.8 (COO), 160.7 (COO), 150.2 (ArC), 148.7 (ArCH), 148.5 (ArCH), 147.6 
(ArCH), 146.9 (ArCH), 146.8 (ArCH), 140.1 (ArC), 134.4 (CH=CH), 131.5(3) (ArC), 
131.5(0) (ArC), 129.7 (ArCH), 129.6 (ArCH), 128.4 (ArCH), 118.7 (ArCH), 64.1 
(CH2CH2O), 59.7 (N
+
-CH2CH2-N
+
), 51.9 (bridgehead CH2), 45.8 (CHCH2), 44.8 (CHCO), 
36.6 (CH2CH2N), 20.3 (CH3). 
2.73 
 
Compound 2.63 (500 mg, 1.6 mmol) was dissolved in dibromomethane (3 mL, excess) and 
DMF (1.5 mL) and was heated to 60°C for 48 h. The solution was cooled to room 
temperature and EtOAc (10 mL) was added to form a precipitate (355 mg, 0.442 mmol, 
55%). m.p. 190-191˚C (decomp.); 1H NMR (400 MHz, 298 K, D2O) δH  9.91 (s, 2H, 2 
PyrCH-N), 9.62 (d, 2H, J = 6.0 Hz, 2 PyrCH-N), 9.23 (d, 2H, J = 8.0 Hz, 2 PyrCH-C), 8.51 
(t, 2H, J = 6.0 + 8.0 Hz, 2 PyrCH), 7.61 (s, 2H, CH2) 6.58 (s, 4H, 2 CH=CH), 5.16 (s, 4H, 4 
CHO), 4.70 (t, 4H, J = 5.0 Hz, 2 CH2CH2O), 4.00 (t, 4H, J = 5.0 Hz, 2 CH2CH2N), 3.12 (s, 
4H, 4 CHCO); 
13
C NMR (100 MHz, 298 K, D2O) δC 179.2 (imide C=O), 161.3 (COO), 
149.6 (PyrCH), 148.6 (PyrCH), 146.9 (PyrCH), 136.4 (CH=CH), 131.54 (ArC), 130.1 
(PyrCH), 80.9 (CHO), 78.3 (CH2), 63.5 (CH2CH2O), 47.4 (CHCO), 37.6 (CH2CH2N); IR ν 
cm
-1
 2997 (C-H), 1742 (imide C=O), 1698 (ester C=O); HRMS (ESI
+
): m/z found 641.1910 
calc for C33H29N4O10 641.1878 [2.73-2Br+H]
+
. 
2.75 
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To a stirred mixture of isonicotinic acid (2.0 g, 16 mmol) and thionyl chloride (20.0 mL, 
excess) 3 drops of DMF were added. The mixture was stirred at room temperature overnight 
then the thionyl chloride was removed in vacuo while heating was maintained with an oil 
bath (40°C) to give a white powder that was used without further purification. To the 
isonicotinoyl chloride in CH2Cl2 (20 mL), a solution of 2.04 (3.74 g, 17.9 mmol) and NEt3 (5 
mL, 35.9 mmol) in CH2Cl2 (15 mL) was added dropwise over 10 minutes. The mixture was 
stirred for 48 h. To the reaction mixture, a saturated solution of sodium hydrogen carbonate 
(50 mL) was added and allowed to stir for 20 minutes. The mixture was separated and the 
organic layer washed with saturated sodium bicarbonate (2 x 50 mL), dried over MgSO4, 
filtered and the solvent removed in vacuo to provide a white solid which was recrystallised 
from CH2Cl2/isopropyl alcohol (3.17 g, 10.1 mmol, 62%). m.p. 146-147˚C; 
1
H NMR (400 
MHz, 298 K, CDCl3) δH  8.71 (d, 2H, J = 4.5 Hz, 2 PyrCH-N), 7.74 (d, 2H, J = 4.5 Hz, 2 
PyrCH-C), 6.44 (s, 2H, CH=CH), 5.16 (s, 2H, 2 CHO), 4.43 (t, 2H, J = 5.5 Hz, CH2CH2O), 
3.86 (t, 2H, J = 5.5 Hz, CH2CH2N), 2.81 (s, 2H, 2 CHCO); 
13
C NMR (100 MHz, 298 K, 
CDCl3) δC 176.0 (imide C=O), 164.8 (COO), 150.6 (PyrCH), 137.0 (ArC), 136.5 (CH=CH), 
122.9 (PyrCH), 81.0 (CHO), 62.0 (CH2CH2O), 47.5 (CHCO), 37.6 (CH2CH2N); IR ν cm
-1
 
1726 (ester C=O), 1694 (imide C=O); HRMS (ESI
+
): m/z: found 315.0974 calc for 
C16H15N4O5 315.0981 [2.75+H]
+
. 
2.76 
 
Compound 2.74 (50 mg, 0.062 mmol) was dissolved in water (0.5 mL). It was added to a 
solution of saturated sodium perchlorate (1 mL). A beige precipitate formed and was filtered 
and washed with water (20 mg, 0.024 mmol, 38 %). m.p. 173-174°C (decomp.); 
1
H NMR 
(400 MHz, 298 K, CD3CN) δH  9.56 (s, 2H, 2 PyrCH-N), 9.33 (d, 2H, J = 6.0 Hz, 2 PyrCH-
N), 9.10 (d, 2H, J = 8.0 Hz, 2 PyrCH-C), 8.38 (t, 2H, J = 6.0 + 8.0 Hz, 2 PyrCH), 7.17 (s, 
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2H, N
+
CH2N
+
), 6.50 (s, 4H, 2 CH=CH), 5.09 (s, 4H, 4 CHO), 4.54 (t, 4H, J = 5.0 Hz, 2 
CH2CH2O), 3.84 (t, 4H, J = 5.0 Hz, 2 CH2CH2N), 2.88 (s, 4H, 4 CHCO); 
13
C NMR (100 
MHz, 298 K, CD3CN) δC 176.5 (imide C=O), 159.9 (COO), 148.9 (PyrCH), 148.3 (PyrCH), 
146.6 (PyrCH), 135.9 (CH=CH), 131.2 (ArC), 129.5 (PyrCH), 80.4 (CHO), 77.5 (CH2), 62.9 
(CH2CH2O), 47.0 (CHCO), 36.5 (CH2CH2N); IR ν cm
-1
 3079 (saturated C-H), 1692 (ester 
and imide C=O), 1077 (ClO4). 
2.77 
 
2.76 (20 mg, 0.024 mmol) heated at 80˚C in a solution of acetonitrile and propionitrile under 
microwave irradiation (150 W, 110˚C, 3h) to give a beige precipitate, filtered and used 
without further purification (8 mg, 0.011 mmol, 46 %). 
1
H NMR (400 MHz, 298 K, CD3CN) 
δH  9.57 (s, 2H, 2 PyrCH-N), 9.31 (d, 2H, J = 6.0 Hz, 2 PyrCH-N), 9.11 (d, 2H, J = 8.0 Hz, 2 
PyrCH-C), 8.40 (dd, 2H, J = 6.0 + 8.0 Hz, 2 PyrCH), 7.21 (s, 2H, N
+
CH2N
+
), 6.79 (s, 4H, 2 
CH=CH), 4.50 (t, 4H, J = 5.0 Hz, 2 CH2CH2O), 3.88 (t, 4H, J = 5.0 Hz, 2 CH2CH2N). 
2.78 
 
Thread 2.77 (8 mg, 0.011 mmol) in deuterated acetonitrile, DB24C8 (9.8 mg, 0.022 mmol) 
was added and pseudorotaxane formation monitored by 
1
H NMR. Pseudorotaxane 2.78 
1
H 
NMR (400 MHz, 298 K, CD3CN) δH  9.85 (s, 2H,  2 PyrCH-N), 9.66 (d, 2H, J = 6.0 Hz ,  
2 PyrCH-N), 8.80 (d, 2H, J = 8.0 Hz ,  PyrCH-C), 8.20 (dd, 2H, J = 6.0 Hz, J = 8.0 Hz ,  
2 PyrCH), 7.45 (s, 2H,  N+CH2N
+
), 6.69 (br m, 4H, 4  crown ArCH), 6.81 (br m, 4H, 4  
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crown ArCH), 6.76 (s, 4H,  2 CH=CH), 4.43 (t, 4H, J = 5.0 Hz,  2 CH2CH2O), 4.01 (m, 
8H,  4 OCH2), 3.83 (t, 4H, J = 5.0 Hz,  2 CH2CH2N),  3.72-3.70 (m, 8H,  4 OCH2), 
3.41 (m, 8H,  4 OCH2). Also contains unthreaded DB24C8 
1
H NMR (400 MHz, 298 K, 
CD3CN) δH 6.93 (m, 8H, 8 ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 8H, 4 OCH2), 3.72 (s, 
8H, 4 OCH2). 
2.02 
 
To a solution of pseudorotaxane 2.78 in acetonitrile, freshly cracked cyclopentadiene (0.1 
mL, excess) was added. After 5 minutes, the solvent and excess cyclopentadiene were 
removed in vacuo to provide the rotaxane. The rotaxane was isolated by dissolving in 
acetonitrile and precipitating out the pure material with EtOAc (8 mg, 0.006 mmol, 57%). 
1
H 
NMR (400 MHz, 298 K, CD3CN) δH  9.88 (s, 2H, 2 PyrCH-N), 9.69 (d, 2H,
 
J = 6.0 Hz,  2 
PyrCH-N), 8.79 (d, 2H,
 
J = 8.0 Hz,  2 PyrCH-C), 8.22 (dd, 2H, J = 8.0 + 6.0 Hz,  2 
PyrCH), 7.47 (s, 1H,  N+CH2N
+
), 6.85 (s, 8H,  8 crown ArCH), 5.98 (s, 4H,  2 
CH=CH), 4.32 (t, 4H,
 
J = 5.5 Hz,  2 CH2CH2O), 4.04 (m, 8H,  4 OCH2), 3.73 (m, 8H,  
4 OCH2), 3.66 (t, 4H,
 
J = 5.5 Hz,  2 CH2CH2N), 3.60 (s, 4H,  4 CHO), 3.43 (s, 4H,  4 
CHCH2), 3.49 (m, 8H,  4 OCH2), 1.61 (d, 2H, J = 8.5 Hz,  CHH), 1.56 (d, 2H, J = 8.5 
Hz,  CHH); HRMS (ESI+): m/z found, 543.2285 calc for C59H66N4O16 543.2287 [2.02-
2ClO4]
2+
. 
2.79 
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Compound 2.70 (500 mg, 1.6 mmol) was dissolved in dibromomethane (3 mL, excess) and 
DMF (1.5 mL) and heated to 60˚C for 48 h. The solution was cooled and EtOAc (10 mL) 
was added to form a precipitate (150 mg, 0.208 mmol, 13%). 
1
H NMR (400 MHz, 298 K, 
D2O) δH  9.98 (s, 2H, PyrCH-N), 9.69 (d, 2H, J = 6.0 Hz, PyrCH-N), 9.30 (d, 2H, J = 8.0 Hz, 
PyrCH), 8.56 (dd, 2H, J = 8.0 + 6.0 Hz, PyrCH), 7.68 (s, 2H, N
+
CH2N
+
), 6.00 (s, 4H, 2 
CH=CH), 4.54 (t, 4H, J = 5.0 Hz, 2 CH2CH2O), 3.87 (t, 4H, J = 5.0 Hz, 2 CH2CH2N), 3.50 
(s, 4H, 4 CHCO), 3.30 (s, 4H, 4 CHCH2), 1.70 (d, 2H, J = 8.5 Hz, CHH), 1.63 (d, 2H, J = 
8.5 Hz, CHH); 
13
C NMR (100 MHz, 298 K, D2O) δC 181.4 (imide C=O), 161.3 (COO), 
149.7 (PyrCH), 148.7 (PyrCH), 148.6 (PyrCH), 134.3 (CH=CH), 131.6 (ArC), 130.2 
(PyrCH), 64.7 (CH2CH2O), 52.2 (bridgehead CH2), 45.8 (CHCH2CH), 44.8 (CHCO), 37.1 
(CH2CH2N). Central CH2 not observed in pendant 
13
C. 
2.80 
 
Dibromide thread 2.79 (100 mg, 0.13 mmol) was dissolved in the minimum amount of 
water. A saturated solution of sodium perchlorate (1 mL) was added to the solution allowed 
to precipitate, filtered and washed with water to provide white crystals (30 mg, 0.038 mmol, 
29%). 
1
H NMR (400 MHz, 298 K, CD3CN) δH  9.60 (s, 2H, PyrCH-N), 9.34 (d, 2H, J = 6.0 
Hz, PyrCH), 9.12 (d, 2H, J = 8.0 Hz, PyrCH), 8.43 (dd, 2H, J = 8.0 + 6.0 Hz, PyrCH), 7.21 
(s, 2H, CH2), 5.98 (s, 4H, 2 CH=CH), 4.39 (t, 4H, J = 5.0 Hz, CH2CH2O), 3.70 (t, 4H, J = 
5.0 Hz, CH2CH2N), 3.30 (br s, 4H, 4 CHCO), 3.24 (br s, 4H, 4 CHCH2), 1.16 (d, 2H, J = 8.5 
Hz, 2 CHH), 1.57 (d, 2H,
 
J = 8.5 Hz, 2 CHH); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 
177.7 (imide C=O), 159.5 (COO), 149.1 (ArCH), 148.1 (ArCH), 146.8 (ArCH), 134.1 
(CH=CH), 131.5 (ArC), 129.8 (ArCH), 78.2 (CH2), 64.1 (CH2CH2O), 51.5 (bridgehead 
CH2), 45.4 (CHCH2), 44.4 (CHCO), 36.2 (CH2CH2N); HRMS (ESI
+
): m/z found 319.1182 
calc for C35H34N4O8 319.1183 [2.80-2ClO4]
2+
. 
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2.81 
 
Compound 2.63 (0.5 g, 1.6 mmol) was heated in toluene at 90˚C for 5 days. The reaction 
was monitored by TLC (40:5:1; EtOAc:MeOH:H2O). The solvent was removed in vacuo to 
provide a beige solid (315 mg, 1.28 mmol, 80%). 
1
H NMR (400 MHz, 298 K, CDCl3) δH  
9.15 (s, 1H, PyrCH-N), 8.76 (d, 1H, J = 5.0 Hz, PyrCH), 8.25 (d, 1H, J = 8.0 Hz, PyrCH), 
7.38 (dd, 1H, J = 5.0 + 8.0 Hz, PyrCH), 6.74 (s, 2H, CH=CH), 4.49 (t, 2H, J = 5.0 Hz, 
CH2CH2O), 3.95 (t, 2H, J = 5.0 Hz, CH2CH2N); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 
170.4 (imide C=O), 165.1 (COO), 153.6 (PyrCH), 151.1 (PyrCH), 137.2 (PyrCH), 134.3 
(CH=CH), 125.6 (ArC), 123.4 (PyrCH), 62.6 (CH2CH2O), 36.8 (CH2CH2N); MS (ESI
+
): m/z 
247.0 [2.82+H]
+
. 
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Chapter 3 - Synthesis of [n]Rotaxanes using CuAAC 
‘Click Chemistry’ and the Diels-Alder Approach to 
‘Threading followed by Stoppering’. 
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3. Synopsis 
In Chapter 2 the use of incorporating our Diels-Alder ‘stopper’ to synthesise rotaxanes in a 
‘threading followed by stoppering’ protocol has been discussed with a variety of binding 
motifs. Thus far this method has been used on existing templates such as the bispyridinium 
and dibenzylammonium binding templates and on the new perimidine benzimidazole 
template. A novel ammonium template with a triazole incorporated into the binding site 
(Figure 3.1) has now been developed. The presence of the triazole enhances the binding 
between the axle and macrocycle in comparison to a simple dibenzylammonium template.  
 
Figure 3.1 Benyzlammonium triazole binding motif. 
Using this template a variety of [n]pseudorotaxanes and [n]rotaxanes have been 
synthesised. These were again created via the Diels-Alder ‘threading followed by 
stoppering’ protocol using click chemistry to incorporate the masked maleimide into the 
axle. Rotaxanes were also successfully synthesised simply using ‘CuAAC’ click conditions 
reported by Coutrot
106
 for stopper formation providing [n]rotaxanes with the new triazole 
binding motif in the axle. 
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3.1 Introduction 
3.1.1 The Cu(I)-Catalysed Terminal Alkyne-Azide 1,3-Dipolar Cycloaddition (CuAAC 
Reaction). 
Huisgen
146-148
 first investigated 1,3-dipolar cycloadditions in the early 60’s between 1,3 
dipolar compounds and a dipolarophile in order to synthesise five membered rings. 
Sharpless
149
 and Meldal
150
 further developed this idea using copper(I)-catalysed conditions 
more famously known as ‘CuAAC click chemistry’, which forms a triazole unit 
regioselectively between the two components. The ‘click chemistry’ concept is now widely 
used in synthetic chemistry to fabricate a wide variety of molecules as it is an effective way 
for the efficient coupling of two components. The reaction is commonly performed using 
alcohol and water solvent systems with a catalytic system generated from a Cu(II) salt and a 
reducing agent which in many cases is sodium ascorbate. This generates the required Cu(I) 
salt in situ catalysing the cycloaddition. The postulated catalytic cycle for this reaction is 
shown in Figure 3.2. 
 
Figure 3.2 Hypothesized Catalytic Cycle for ‘CuAAC’ Reaction.151 
The reactive intermediate in this mechanism is still under investigation. DFT calculation 
suggest a second copper centre is required for the reaction to proceed where the second 
copper forms a π-activated Cu acetylene.152 Recently Heaney proposed the reaction 
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progresses via a dinuclear alkynylcopper(I) ladderane complex.
153
 Further postulated 
transition states includes the alkyne and azide co-ordinated by different copper atoms.
154-155
 
There is the possibility that all of these pathways can feature in the ‘CuAAC’ mechanism 
with the transition state depending on a variety of factors including choice of solvents, 
ligands and reactants playing a part. 
3.1.2 ‘CuAAC’ in Rotaxane Formation 
There have been several examples of using the ‘CuAAC click’ reaction to attach the stopper 
groups in the synthesis of rotaxanes. Coutrot et al,
106,156
 have used this to synthesise a 
mannosyl [2]rotaxane molecular machine as well as a dimannosyl[c2]daisy chain molecular 
machine.
156
 Stoddart et al
157
 have also used ‘CuAAC click chemistry’ towards the synthesis 
of molecular machines. Early reports by Mock
158-159
 to facilitate the 1,3 dipolar 
cycloaddition of an ammonium functionalised azide and alkyne by confinement inside a 
macrocycle cavity have also been realised to synthesise [2]rotaxanes. It was found in this 
case that cucurbituril can enhance the reaction rate by acting as a catalyst providing the 
regiospecific triazole. Synthesis of rotaxanes consisting of multiple components can prove 
challenging but using ‘CuAAC click chemistry’ has several advantages.  
 
Click chemistry is not only useful towards the synthesis of threads; it has also shown 
potential to be used to generate triazole recognition sites on axles in order to bind with 
crown macrocycles. The Coutrot group were one of the first to show an alkylated triazole 
acting as a recognition site for a crown macrocycle.
160
 This group has synthesised molecular 
machines with the macrocycle shuttling between an alkylated triazole and an ammonium ion 
in a pH dependent manner. Li et al
161
 have also incorporated a triazole as a station for a 
molecular machine. It is thought that for the triazole to act as a recognition site for a crown 
like macrocycle it must be positively charged. When the ammonium ion template of the 
thread was neutralised, the macrocycle shuttled across to the neutral triazole station where it 
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participates in hydrogen bonding. The neutral triazole has a weaker interaction with the 
crown than the ammonium ion but better than the amine. 
 
Takata
107
 has also used the click concept in order to synthesise rotaxanes. This time taking 
the nitrile N-oxide as a replacement for the azide, they were able to perform click reactions 
not only with alkynes but also alkenes under mild conditions (Scheme 3.1). They 
successfully used this method to end cap several pseudorotaxanes in high yields as well as in 
the synthesis of a molecular shuttle. 
 
Scheme 3.1 Synthesis of the nitrile N-oxide thread for rotaxane synthesis.107 
3.2 Results and Discussion 
3.2.1 Synthesis of Pseudorotaxanes Using ‘CuAAC Click Chemistry’. 
As discussed previously, there have already been examples of using triazole subunits 
incorporated into ammonium salt threads for the synthesis of rotaxanes and we have seen 
Coutrot
156
 use this approach to synthesise molecular shuttles. Development of a ‘clickable’ 
unit containing a rotaxane forming template (ammonium ion) using the Diels-Alder gate 
could transform any azide into a suitable thread using the orthogonality of ‘CuAAC’.  
 
The effect of incorporating a triazole subunit adjacent to the ammonium ion was 
investigated. The benzyl azide, 3.06 was synthesised from benzyl chloride and sodium azide 
in EtOH. Reacting with alkyne 3.05 using ‘CuAAC click chemistry’ with CuSO4.5H2O and 
a sodium ascorbate as reducing agent was then executed providing the neutral thread (3.07) 
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with a secondary amine and a triazole in the vicinity of the binding motif. This was then 
converted to the ClO4
-
 salt on the addition of HClO4 (3.08) as shown in Scheme 3.2 
providing the new binding template that could interact with crown ether type macrocycles. 
Appropriate shifts of the benzyl CH2’s was observed in 
1
H NMR and an IR stretching 
frequency at 1060 cm
-1 
show the amine has been converted to the ClO4
-
 salt. 
 
Scheme 3.2 Reagents and conditions: a) EtOH, THF, H2O, CuSO4.5H2O, Sodium Ascorbate (NaAsc), RT, 24h, 
93%; b) MeOH, HClO4, RT, 54%. 
The thread 3.08 was then used as a binding motif for DB24C8 to generate pseudorotaxane 
3.10 (Figure 3.3). Pseudorotaxane formation was observed by 
1
H NMR and ESI-MS with the 
mass ion at 785.3 corresponding to [3.10-ClO4]
+
. Equimolar amounts of the thread and 
DB24C8 were added together at a 2 mmol concentration to provide a binding constant of 
820 M
-1 
measured via a single point method.
129
 The binding constant for the dibenzyl 
ammonium thread (3.09) with DB24C8 at 2 mmol is reported as 237 M
-1
.
162
 It was pleasing 
to find that this simple click derived ammonium ion thread gives almost a fourfold increase 
in the binding interaction with DB24C8 in comparison to the dibenzyl ammonium motif.  
 
Figure 3.3 [2]pseudorotaxane 3.10. 
Following the indication that incorporating triazoles into these threads increases binding 
affinity, the effect of having the triazole directly linked to the benzene ring was investigated 
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as it would then be conjugated with the aromatic system. This binding motif was created 
from propargyl amine 3.05 and 3,5-dimethyl phenyl azide (3.11), its formation was 
supported by 
1
H and 
13
C NMR and HRMS with peak seen at m/z 351.1808 corresponding 
with the [3.12+H]
+
 ion. The neutral thread (3.12) was converted to its ClO4
-
 salt using 
HClO4 (3.13) Scheme 3.3. 
 
Scheme 3.3 Reagents and conditions: a) EtOH, THF, H2O, CuSO4.5H2O, NaAsc, RT, 24h, 45%; b) MeOH, 
HClO4, 100%. 
Addition of DB24C8 in deuterated acetonitrile provided pseudorotaxane 3.14 (Figure 3.4) as 
well as unbound thread 3.13 and unbound DB24C8. Pseudorotaxane 3.14 was characterised 
by both 
1
H NMR and HRMS with the mass ion observed at m/z 799.3934 relating to [3.14-
ClO4]
+
. The binding constant was calculated from equimolar amounts of thread and crown at 
2 mmol concentration via the single point method.
129
 For this complex it was found to be 
1060 M
-1
 giving a 20% increase in binding compared to the un-conjugated triazole thread 
(3.08). 
 
Figure 3.4 [2]pseudorotaxane 3.14. 
A mono ester functionalised dibenzylammonium ClO4
-
 thread 3.16 (Scheme 3.4) was also 
synthesised as a better reference model for a truer comparison of binding constants with 
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these ‘click’ threads. Having an electron withdrawing group attached to the aromatic rings 
has previously been shown to enhance binding between DB24C8 and axles so the 
unfunctionalised dibenzylammonium thread 3.09 is not a fair representation of the 
enhancement in binding.
46
 
 
Scheme 3.4 Synthesis of compound 3.16. Reagents and conditions a) CH2Cl2, HClO4, RT, 40%. 
The binding constant was measured between perchlorate thread 3.16 and DB24C8 at 2 mmol 
with one equivalent of DB24C8 and was found to be 687 M
-1
. The [2]pseudorotaxane 3.17 
formed is shown in Figure 3.5. 
 
Figure 3.5 [2]pseudorotaxane 3.17. 
The binding value observed was lower than that of the benzyl azide derived thread 3.08 and 
phenyl azide derived thread 3.13 again validating that the presence of the triazole does in 
fact enhance the binding interaction between axle and the crown ether macrocycle. Binding 
constant results for all pseudorotaxanes are shown in Table 3.1. Enhancement in the binding 
interaction is thought to be a result of improved hydrogen bonding between the two 
interlocked components. The triazole may increase the CH acidity of the adjacent CH2 and 
additionally the triazole hydrogen is able to take part in hydrogen bonding with DB24C8 
oxygens. It could also be postulated that incorporating this five membered aromatic ring in 
the binding site provides a better ‘fit’ in the cavity of the crown ether. Conjugating the two 
aromatic systems in the case of the phenyl azide derived thread 3.13 would provide a more 
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electron deficient triazole ring increasing the π stacking interaction with the catechol rings of 
the crown and making the triazole CH a better H bond donor. 
Pseudorotaxane Binding Constant in Acetonitrile at 2 
mmol concentration (M
-1
) 
Dibenzylammonium methyl ester 3.16 687 
Benzyl azide derived thread 3.08 820 
Phenyl azide derived thread 3.13 1060 
Table 3.1 Binding constant comparison of dibenzylammonium methyl ester thread 3.16, click threads 3.08 and 
3.13 (errors estimated at < 10%). 
3.3 Synthesis of Rotaxanes Using ‘CuAAC Click Chemistry’ and the Diels-Alder 
Reaction 
Having shown the advantages of the triazole derived threads, incorporating these templates 
into rotaxanes using the Diels-Alder ‘threading followed by stoppering’ approach was 
investigated. Synthesis of the rotaxane was carried out by reacting ester 2.20 with propargyl 
amine providing imine 3.18. Reduction of the imine 3.18 was first attempted using sodium 
borohydride but this lead to a mixture of products and it was believed that some over 
reduction occurred, reducing one of the carbonyls of the imide.
163
 Several sets of reaction 
conditions using sodium borohydride were attempted but reduction of the carbonyl was 
unavoidable. Using sodium cyanoborohydride overcame this predicament and after a few 
hours TLC analysis showed the disappearance of 3.18 and a new single spot. The amine 
(3.19) was isolated in a 76% yield with no evidence of side products (Scheme 3.5).  
 
Scheme 3.5 Reagents and conditions: a) MeOH, RT, 24h, 81%; b) MeOH, NaBH3CN, HOAc, RT, 1h, 76%. 
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It was then required to attach a bulky stopper forming group to the propargyl end of the axle 
using the ‘CuAAC’ approach. The bulky stopper group was synthesised from 3,5-
dimethylbenzybromide with sodium azide to provide the resulting azide 3.20. The propargyl 
(3.19) and azide (3.20) were reacted together using ‘CuAAC click chemistry’ conditions 
with CuSO4.5H2O and sodium ascorbate in a mixture of tert-butanol, THF and water to 
provide the neutral thread 3.21 (Scheme 3.6) in a 56% yield. 
 
Scheme 3.6 Reagents and conditions: a) EtOH, NaN3, RT, 24h, 65%; b) tert-Butanol, THF, H2O, CuSO4.5H2O, 
NaAsc, RT, 24h, 56%. 
Conversion to an ammonium salt was required in order for the macrocycle to bind with the 
axle. The neutral thread (3.21) was converted into ClO4
-
 salt 3.22 by treatment with HClO4 
and the retro Diels-Alder reaction was carried out to open the maleimide gate so as to allow 
the macrocycle to thread onto the axle. Microwave heating was used to induce the retro 
Diels-Alder reaction on the ClO4
- 
salt thread (3.22) in acetonitrile.  
Treatment of a solution of maleimide thread (3.23) with two equivalents of DB24C8 in 
deuterated acetonitrile produced pseudorotaxane 3.24. The excess of crown is required in 
order to push the equilibrium in favour of pseudorotaxane formation as monitored by 
1
H 
NMR and confirmation of pseudorotaxane formation observed by HRMS with the mass ion 
found at 922.4253 relating to the [3.24-ClO4]
+
 species. The final step to generate the 
rotaxane (3.25) required a few drops of freshly distilled cyclopentadiene and the excess was 
removed in vacuo giving only the kinetic endo isomer. 
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Solvent choice was again important to consider when creating a pseudorotaxane. 
Acetonitrile is commonly used as it can dissolve the ionic thread easily, but is not so polar as 
to it interfere with the weak interactions between the crown and thread and this was again 
the solvent used in the synthesis of pseudorotaxanes and rotaxanes.
61
  
 
Scheme 3.7 Reagents and conditions: a) CH3CN, MW, 110˚C, 3h, 86%; b) i) CD3CN, DB24C8 (excess), RT, 
48h; ii) CH3CN, cyclopentadiene, 37%. 
A similar approach provided the rotaxane formed from the thread derived from phenyl azide 
synthesised using the same reaction conditions. Reacting azide 3.11 with the propargyl 
amine 3.19 under ‘CuAAC click chemistry’ conditions to produce thread 3.26 was carried 
out. Conversion to ClO4
-
 salt 3.27 by treatment with HClO4 gave the resulting ammonium 
imide in a 68% yield and the retro Diels-Alder conducted under microwave conditions 
(Scheme 3.8) opened the maleimide ‘gate’ to give thread 3.28. 
The pseudorotaxane 3.29 was assembled using two equivalents of DB24C8 and rotaxane 
3.30 was generated on addition of freshly cracked cyclopentadiene. Excess cyclopentadiene 
was removed in vacuo and following purification, rotaxane 3.30 was isolated in a 62% yield. 
The characteristic shifts in the 
1
H NMR spectra in comparison to the free thread 3.36 and 
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DB24C8 indicated rotaxane formation with additional confirmation from HRMS finding a 
peak at 974.4550 corresponding to the expected [3.30-ClO4]
+
. IR spectroscopy of the 
rotaxane shows significant peaks at 1697 cm
-1
 indicating the presence of carbonyl groups 
and 1093 cm
-1
 relating to the ClO4.  
 
Scheme 3.8 Reagents and conditions: a) tert-Butanol, THF, H2O, CuSO4.5H2O, NaAsc, RT, 24h, 80%; b) 
CH2Cl2, HClO4, RT, 68%; c) CH3CN, MW, 110 ˚C, 3h, 92%; d) i) CD3CN, DB24C8 (excess), 48 h; ii) CH3CN, 
cyclopentadiene, 62%. 
The comparison ClO4
-
 threads were synthesised starting with the endo adduct of maleic 
anhydride and cyclopentadiene (2.14). Reacting with ethanolamine gave intermediate 
alcohol 2.15 and an esterification with 4-carboxybenzaldehyde formed the functionalised 
aldehyde 2.27. Synthesis of the imine (3.31) and reduction to the amine (3.32) were 
synthesised according to the same procedures as the furan alkyne 3.19 counterpart and this is 
shown in Scheme 3.9.  
  Chapter 3 
136 
 
 
Scheme 3.9 Reagents and conditions: i) MeOH, propargyl amine, RT, 24h; ii) NaBH3CN, HOAc, 24h, 85%. 
The new propargyl compound 3.32 was reacted with the azides 3.20 and 3.11 under 
‘CuAAC’ click conditions to provide neutral threads 3.33 and 3.34. Conversion to the ClO4
-
 
salt using HClO4 gave threads 3.35 and 3.36 in 59% and 66% yields respectively (Scheme 
3.10). 
 
Scheme 3.10 Reagents and conditions: a) HClO4, RT, 59%; b) HClO4, RT, 66%. 
Comparison of the 
1
H NMR of rotaxane (3.30), thread (3.36) and DB24C8 is shown in 
Figure 3.6. The aromatic hydrogens of the thread are shifted upfield due to the shielding 
effect from the close proximity of the aromatic ring currents of the benzo group of DB24C8. 
A reciprocal interaction with the π systems of the thread means the crown aromatic 
hydrogens are also shifted upfield. The crown ether CH2’s are recorded as complex 
multiplets as the interlocked crown now has two distinct faces due to the asymmetry of the 
thread. Both shielding and desheilding effects are observed on these protons. The 
CH2NH2
+
CH2 protons of the thread show a shift downfield as they are hydrogen bonding 
with the crown ether oxygen’s. They also become a complicated multiplet due to coupling 
with the NH2
+
, a further indication of being encompassed by the crown ether macrocycle.
32
 
The shift of protons associated with the imide stopper portion of the thread are relatively 
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unaffected in the rotaxane indicating the DB24C8 macrocycle is situated predominantly over 
the ammonium portion of the thread. 
 
Figure 3.6 
1H NMR spectra (400 MHz, CD3CN, 300K) stacking plot of; i) DB24C8; ii) [2]Rotaxane 3.30 and iii) 
Comparison thread 3.36. 
When first synthesising the neutral axles 3.21 and 3.26 via ‘CuAAC click chemistry’ the 
yields produced from the reaction were very low. ‘CuAAC click chemistry’ is reported to be 
high yielding without difficult purification steps so a detailed study of the reaction was 
undertaken in an attempt to improve the yield and gain information as to why yields were 
low. The investigation was primarily performed on the conjugated triazole thread 3.26. 
Using a variety of solvent systems and with varying equivalents of catalyst and reagents the 
yield of click thread 3.26 was successfully improved from 33% to 80% by using an excess of 
propargyl amine 3.19.  
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During this investigation it was found that an extra set of peaks were observed in the 
1
H 
NMR indicating there was a side reaction occurring. Isolation and characterisation of this 
new product was achieved via column chromatography. It became apparent that the azide 
3.11 was not only reacting with the propargyl moiety of compound 3.19 but it was also 
reacting with the strained double bond situated on the [2.2.1] bridged system of the protected 
maleimide shown in Scheme 3.11. A similar reaction has previously been reported by 
Reymond, but in this case it is suggested heating is required for the reaction to occur.
164-165
 
However Philp
166
 has also reported the reaction occurring at 30˚C in CDCl3 between an 
azide and a maleimide. From investigation with a variety of azides and [2.2.1] bridge imide 
systems this reaction was found to be occurring at room temperature in CDCl3 both with and 
without a copper catalyst present. Time periods of up to a month at room temperature were 
required before the product formation reached 100%. It was possible to overcome this 
problem, using an excess of the propargyl compound 3.19 and purification via column 
chromatography provided the required thread 3.26 only and no side product 3.37 was 
observed. So far assigning the relative stereochemistry of the new ring junction of thread 
3.37 has not been achieved.  
 
Scheme 3.11 Reagents and conditions: a) tert-butanol, THF, H2O, CuSO4.5H2O, NaAsc, RT, 24h. 
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3.4 Synthesis of Higher Order Rotaxanes Using ‘CuAAC Click Chemistry’ 
After showing the successful application of the chemistry to synthesise [2]rotaxanes, the 
synthesis of higher order rotaxanes was investigated. Taking the propargyl amine compound 
(3.17) with 1,10-diazidodecane 3.38 under ‘CuAAC’ click conditions, the neutral thread 
3.39 with two triazole ammonium binding motifs separated by a C10 chain was synthesised 
(Scheme 3.12). In this case using the previous solvent systems did not provide significant 
product formation and a two phase solvent system of CH2Cl2 and water was required. 
 
Scheme 3.12 Reagents and conditions: a) CH2Cl2, H2O, CuSO4.5H2O, NaAsc, RT, 24h, 10%. 
The thread was converted to the ClO4
-
 salt 3.40 by washing with HClO4 followed by the 
retro Diels-Alder reaction to deprotect the maleimide under microwave conditions. After 
following the reaction to completion by TLC, thread 3.41 was obtained in a quantitative 
yield. The [3]pseudorotaxane 3.42 was synthesised in deuterated acetonitrile this time by 
adding in four equivalents of DB24C8 to push equilibrium towards [3]pseudorotaxane 
formation. The threading was followed by 
1
H NMR until no further change in the spectra 
was observed. Cyclopentadiene was added to the pseudorotaxane performing the Diels-
Alder reaction with the maleimide double bond giving the endo Diels-Alder thread and 
trapping the macrocycles onto the axle. The [3]rotaxane 3.43 was successfully isolated in a 
58% yield and the mass ion relating to [3.43-2ClO4]
2+
 was observed at 939.9640 using ESI-
HRMS.  
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Scheme 3.13 Reagents and conditions: a) CH3CN, MW, 110˚C, 3h, 100%; b) CD3CN, DB24C8 (4 equiv), 48 h; 
c) CH3CN, cyclopentadiene, RT, 58%. 
Comparison thread 3.45 was also successfully synthesised from the cyclopentadiene 
stoppered propargyl amine 3.32. Reacting with diazide 3.38 provided the neutral thread 3.44 
and conversion to the ClO4
-
 salt washing with HClO4 gave thread 3.45 in a 30% yield.  
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Scheme 3.14 Synthesis of comparison thread 3.45. Reagents and conditions a) CH2Cl2, HClO4, 30% 
The 
1
H NMR of the [3]rotaxane 3.43 was carried out and revealed the characteristic shifts 
for rotaxane formation including the CH2NH2
+
CH2 shifts upfield in their distinctive splitting 
pattern.
32
 The aromatic protons of both axle and DB24C8 are shifted downfield as a result of 
shielding. The ethylene oxy units of the crown became complex multiplets as shown in 
Figure 3.7. Protons associated with the Diels-Alder stopper or the central alkyne chain of the 
thread remained relatively unaffected indicating the crown ethers are situated over the 
ammonium ion portions of the axle. 
 
Figure 3.7 
1H NMR spectra (400 MHz, CDCl3, 300K) [3]Rotaxane 3.43. 
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3.5 Research into the Synthesis of Multiple Component Rotaxanes 
 
Nature exploits weak supramolecular interactions to construct complex functional systems 
from simple starting materials. It was shown that by using a combination of ‘CuAAC click 
chemistry’ and the Diels-Alder threading followed by stoppering protocol, a [3]rotaxane was 
assembled. This approach was then used to synthesise a more complex interlocked system 
consisting of two different binding sites and two different macrocycles. Synthesis of higher 
order rotaxanes has proved challenging but it has been possible to synthesise rotaxanes with 
as many as 11 components.
70
 There has been some recent work by both Chiu
167
 and 
Schalley
168
 where higher order rotaxanes containing different macrocycle components have 
been assembled by “self sorting”. Additionally, Schalley169 has reported a hetero [3]rotaxane 
where the stopper size is such that it can only inhibit the dethreading of the smallest crown 
but the design of the thread is such that this crown/small stopper assembly acts to lock the 
larger crown on the thread (Scheme 3.15). 
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Scheme 3.15 Schalley’s hetero [3]rotaxane formed in a self sorting protocol. 
‘CuAAC click chemistry’ was then used in order to synthesise a thread providing a template 
with three potential binding sites for a higher order rotaxane. Synthesis of the following 
thread (Figure 3.8) which would contain a π-electron rich DNP recognition motif shown to 
have an excellent binding affinity for the Stoddart
170
 CBPQT
4+
 macrocycle 1.09 and two 
ammonium benzyl triazole units for hydrogen bonding with DB24C8 was attempted. 
Stopper formation of the terminal maleimide gates with cyclopentadiene will give the [2.2.1] 
endo Diels-Alder adduct. This is unlikely to act as a stopper for the CBPQT
4+
 macrocycle 
but will trap DB24C8. The crown/Diels-Alder adduct was considered to be a large enough 
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mechanically interlocked assembly to block the passage of the larger CBPQT
4+ 
macrocycle 
so acting as ‘mechanical stoppers’.  
 
Figure 3.8 Thread with two separate binding sites incorporated. 
The synthesis of the thread first started with the bis oxy naphthalene core. Naphthalene-1,5-
diol was reacted with 2-(2-chloroethoxy)ethanol in acetonitrile with potassium carbonate to 
produce the diol (3.49). Diol 3.49 was converted to the ditosylate in CH2Cl2 with tosyl 
chloride (3.50).
171
 Finally conversion of the ditosylate to the diazide (3.51) was carried out in 
DMF at 60°C and the product was purified via recrystallisation (Scheme 3.16).  
 
Scheme 3.16 Reagents and conditions: a) CH3CN, K2CO3, reflux, 48h, 62%; b) CH2Cl2, NEt3, TsCl, DMAP, 
0˚C→RT, 55%; c) DMF, NaN3, 60˚C, 69%. 
The axle was synthesised taking the propargyl amine compound 3.19 and reacting under 
‘CuAAC click conditions’ giving neutral thread 3.52. The previous solvent systems used in 
earlier ‘click’ reactions were again found to be unsuitable for the synthesis of this thread and 
in this case a two phase mixture of CH2Cl2 and water were used to give the product in a 34% 
yield. The synthesis of the ClO4
-
 salt 3.53 was done by washing the neutral thread in CH2Cl2 
with an aqueous solution of HClO4 shown in Scheme 3.17. 
  Chapter 3 
145 
 
 
Scheme 3.17 Reagents and conditions: a) CH2Cl2, H2O, CuSO4.5H2O, NaAsc, RT, 34%; b) CH2Cl2, HClO4, RT, 
54%. 
The retro Diels-Alder reaction was performed using the perchlorate thread 3.53 to produce 
the ‘open gate’ 3.54 (Figure 3.9). Finally threading of the axle with the CBPQT4+ 
macrocycle was investigated to form the pseudorotaxane as the first stage in synthesising the 
multi component rotaxane. 
 
Figure 3.9 Open gate axle 3.52. 
The CBPQT
4+ 
macrocycle (1.09) was synthesised according to the Stoddart group literature 
procedures.
170,172
 Taking 4,4-bipyridine, 1,4-bis(bromomethyl)benzene and refluxing in 
acetonitrile, intermediate 3.55 was obtained. The final stage was to perform template 
directed synthesis of the macrocycle. Diol 3.56, intermediate 3.55, 1,4-
bis(bromomethyl)benzene were heated in DMF to provide the CBPQT
4+ 
macrocycle 1.09 
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after an ion exchange with ammonium hexafluorophosphate. Characterisation of the product 
was consistent with literature values. 
 
Scheme 3.18 Reagents and conditions: a) CH3CN, 2h, reflux-RT, 70%; b) DMF, 40˚C, 5 d, NH4PF6, 31%. 
One equivalent of thread 3.54 and two equivalents of CBPQT
4+
 1.09 were dissolved in 
deuterated acetonitrile to form the pseudorotaxane. The CBPQT
4+
 1.09 was able to thread 
over the axle and distinctive shifts were seen in the 
1
H NMR indicating pseudorotaxane 
formation, however pushing the equilibrium towards pseudorotaxane formation ≥ 99% 
proved difficult. No such problems were associated with threading of the neutral thread 3.52 
with macrocycle 1.09 therefore the problem must lie with the presence of the ammonium 
salts located on both sides of the naphthalene moiety. The 4
+
 charge on the macrocycle is 
repelled by the 1
+
 charge on the ammonium ion making it difficult to slip over the group 
therefore threading was slow but it was also believed that their proximity to the DNP 
binding unit destabilised the pseudorotaxane.
173-175
 A thread with longer ether chains that 
sandwich the naphthalene group so moving the ammonium ion salt further away from the 
macrocycle binding site was synthesised. Longer ether chains are also known to enhance the 
binding interaction between thread and CBPQT
4+ 
1.09 by increasing the C-H···O hydrogen 
bonding between the α-bipyridinium hydrogen and the ether chain oxygen.176 Li et al have 
shown that increasing the ether chain length decreases the effect of the positively charged 
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ion on the encompassing CBPQT
4+
 1.09 giving a reduction in the electrostatic repulsion.
174
 
Taking diol 3.56 and reacting with tosyl chloride provided the ditosylate compound 3.57. A 
further reaction with sodium azide in DMF at 60˚C produced the diazide 3.58 in a 71% yield 
(Scheme 3.19).  
 
Scheme 3.19 Reagents and conditions: a) DMF, NaN3, 60˚C, 24h, 71%. 
The thread 3.59 was synthesised from the diazide 3.58 and the propargyl compound 3.19 
under ‘CuAAC’ conditions. Conversion to the ClO4
-
 salt was carried out by treating the 
neutral thread with HClO4 (3.60) and finally the retro Diels-Alder reaction was performed 
under microwave conditions giving axle 3.61.  
 
Again synthesis of the [2]pseudorotaxane using the multi binding site axle with CBPQT
4+ 
1.09 was attempted. This new thread 3.61 was dissolved in deuterated acetonitrile with just 
one equivalent of the CBPQT
4+
 1.09. Again [2]pseudorotaxane formation was observed by 
1
H NMR but even with adding additional CBPQT
4+
 1.09 the equilibrium could not be 
pushed towards generation of a favourable amount of pseudorotaxane.  
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Scheme 3.20 Reagents and conditions: a) HClO4, RT, 67%; b) CH3CN, (MW, 100W, 110˚C, 4 h), 95%. 
A secondary effect observed when trying to synthesise the pseudorotaxane was an ion 
exchange reaction between the thread 3.61 and CBPQT
4+
 1.09. The macrocycle (1.09) with 
ClO4
-
 counter ion precipitated out of the solution as proved by x-ray analysis. The ClO4
-
 salt 
macrocycle was extremely insoluble in solvents suitable for pseudorotaxane synthesis 
meaning that it could not be used in place of the PF6
- 
macrocycle 1.09.  
 
A different strategy was then attempted to synthesise the pseudorotaxane. Instead of using 
HClO4 to generate the ClO4
-
 counter ion, hexafluorophosphate was used in its place. 
Unfortunately this did not produce a suitable thread in sufficient purity to carry on with the 
synthesis. Carrying out the retro Diels-Alder reaction on the neutral threads 3.52 and 3.59 
was also investigated but again problems were encountered with this stage due to revealing 
the maleimides in the presence of the free amines which led to a mixture of polymeric 
material. Due to a lack of time, the attempted synthesis of a multicomponent [4]rotaxane 
was curtailed. 
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A different approach to incorporate the Diels-Alder ‘threading followed by stoppering’ 
protocol in the synthesis of rotaxanes derived from the CPBQT
4+
 1.09 was then exploited. A 
simple DNP functionalised thread was synthesised from the diol 3.56, by reacting with the 
Diels-Alder adduct 3.62 under Mitsonubu conditions. This provided the symmetrical thread 
3.63 incorporating two Diels-Alder gates. The retro Diels-Alder reaction was carried out 
under microwave conditions to unmask the maleimide units to give axle 3.64 in an 81% 
yield. 
 
Scheme 3.21 Reagents and conditions: a) THF, DEAD, PPh3, 0˚C→RT, 14%; b) CH3CN, (MW, 100W, 110˚C, 
3h), 81% 
Two equivalents of CBPQT
4+
 1.09 to thread 3.64 were then dissolved in deuterated 
acetonitrile to provide the intermediate pseudorotaxane 3.65. On addition of the macrocycle 
to the axle in acetonitrile, the reaction immediately changes from colourless to a deep purple 
solution. This is due to the charge transfer interaction between the π-electron deficient 
bispyridinium of the macrocycle and the π-electron rich DNP unit of the thread.177 The 
pseudorotaxane 3.65 formation was observed by 
1
H NMR with no unbound thread 3.64 
observed in the spectra. The naphthalene hydrogen’s were seen to shift both upfield and 
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downfield due to shielding and deshielding effects as a result of their close proximity to the 
macrocycle aromatic π-system. The aromatic protons of the macrocycle 1.09 are also shifted 
both upfield and downfield by a reciprocal effect. 
 
Scheme 3.22 Reagents and conditions: a) CD3CN, RT; b) CD3CN, 1,3 diphenylisobenzofuran (2 equiv), RT, 
70%. 
To trap the macrocycle onto the axle, cyclopentadiene is not bulky enough to use as a 
stopper. An initial experiment with thread 3.63 and CBPQT
4+ 
(1.09) provided evidence of 
pseudorotaxane formation and it was required to substitute cyclopentadiene for a larger 
diene. 1,3-Diphenylisobenzofuran reacts with the maleimide giving the endo isomer 
incorporating the [2.2.1] bicyclic bridge substituted at the bridge head with two phenyl 
groups. It was envisioned that this would then be large enough to prevent the macrocycle 
1.09 from slipping back off the axle. This stoppering step was carried out in acetonitrile at 
room temperature with the reaction occurring faster than the 
1
H NMR spectra could be 
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recorded. After purification the [2]rotaxane 3.66 was afforded in a 70% yield simply by two 
successive crystallisations. 
 
Comparison thread 3.67 was also synthesised taking the deprotected maleimide thread and 
carrying out the Diels-Alder reaction with 1,3-diphenylisobenzofuran giving the endo Diels-
Alder adduct shown in Scheme 3.23. 
 
Scheme 3.23 Reagents and conditions: a) CH3CN, 1,3 diphenylisobenzofuran (2 equiv), RT, 62%. 
Comparison of the thread 3.67, macrocycle 1.09 and rotaxane 3.66 are shown in Figure 3.10. 
From the 
1
H NMR, you can observe that the aromatic protons of the thread derived from the 
diphenylisobenzofuran portion are relatively unaffected. The naphthalene protons are 
significantly affected by the presence of the macrocycle. The naphthalene protons in C4 and 
C8 are shifted from 7.76 ppm downfield to 2.24 ppm. The naphthalene protons in the C2 and 
C6 position are shifted from 6.90 ppm to 6.30 ppm and the C3 and C7 are also shifted by a 
similar magnitude from 7.33 ppm to 6.02 ppm. Some of the ethylene protons of the thread 
undergo slight shifts. The protons of the macrocycle become very broad as they undergo a 
rocking/precessing motion relative to the thread axis that is slower than the NMR time 
scale.
178
 The rotaxane was also characterised via HRMS with the m/z found to be 547.5626 
corresponding to the [3.66-4PF6]
3+
 ion. 
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Figure 3.10 
1H NMR (400MHz, CD3CN, 300K) stacking plot of i) CBPQT
4+; ii) [2]rotaxane 3.66 and iii) 
comparison thread 3.67.  
The solid state structure of the [2]rotaxane 3.66 was also obtained and is shown in Figure 
3.11. You can observe that the Diels-Alder reaction with 1,3-diphenylisobenzofuran 
provides the endo isomer. This stereochemistry has a shielding effect on the hydrogens of 
the first ethylene glycol unit directly attached to the maleimide moiety in the 
1
H NMR. The 
protons associated with this ethylene oxy unit are shifted upfield by 3.19 ppm due to a 
shielding effect from the close proximity to the π system of the newly created benzene rings 
of the stopper group.  
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Figure 3.11 A view of the solid state structure of 3.66 highlighting the interlocked nature of the [2]rotaxane and 
the endo stereochemistry of the Diels-Alder stopper adduct. Hydrogens and minor disordered components have 
been removed for clarity. C white; O red, N blue. 
The relative orientation of the macrocycle and DNP unit of the thread are similar to other 
solid state structures reported by Stoddart.
175
 π Stacking interactions between the π  electron 
deficient CBPQT
4+
 1.09 and π electron rich DNP moiety are revealed in the solid state 
structure. 
To sharpen up the 
1
H NMR signals of the macrocycle, a sample in DMSO was heated to 
80˚C. Unfortunately, dethreading of the macrocycle was observed. We are presently unable 
to ascertain if this dethreading is due to slippage as the stopper is too small or opening and 
closing of the stopper gate by a retro Diels-Alder mechanism. The macrocycle 1.09 does not 
surmount the end group of thread 3.67 at room temperature as revealed by 
1
H NMR by 
following a mixture of two equivalents of macrocycle 1.09 and one equivalent of thread 3.67  
in acetonitrile over a period of a week. Unfortunately there was not the time to investigate 
this further and work focussed on completing the ammonium templates containing a triazole. 
3.6 Synthesis of Bistriazole Ammonium Threads Using ‘Click Chemistry’ 
With the success of the mono triazole functionalised ammonium thread, incorporating two 
triazoles into the binding site was investigated to observe the effect it would have on the 
binding interaction between crown ether macrocycles and the axle. The synthesis of this new 
binding template was carried out beginning with 2-nitrobenzenesulphonyl chloride and 
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propargyl amine providing compound 3.68. The 2-nitrobenzenesulphonyl group can act both 
as a protecting group for the amine but also activates the group towards base catalysed 
alkylation.
179-180
 A further reaction with propargyl bromide produces the dipropargyl 
sulphonamide 3.69. This was followed by a ‘CuAAC’ reaction with two equivalents of 
benzyl azide providing the amine protected thread 3.70. Deprotection was carried out using 
thiophenol and potassium carbonate in acetonitrile at 60˚C. For the macrocycle to bind with 
the template it was again converted to an ammonium ion with a weakly co-ordinating 
counter ion. As in previous examples neutral thread 3.71 was converted to the ClO4
-
 salt 
using HClO4 producing the bistriazole ammonium template thread 3.72 in a 66% yield. 
 
Scheme 3.24 Reagents and conditions: a) i) aq. NaHCO3, THF, RT, 24h, conc. HCl, 0˚C, 69%; b) CH3CN, 
K2CO3, propargyl bromide, RT, 48h, 64%; c) EtOH, THF, H2O, CuSO4.5H2O, NaAsc, phenyl azide, RT, 48h, 
51%; d) CH3CN, PhSH, K2CO3, 60˚C, 24h, 86%; e) CH2Cl2, HClO4, RT, 66%. 
Binding between the new thread and macrocycle was assessed using equimolar quantities of 
DB24C8 and the ClO4
- 
salt thread 3.72 at 2 mmol concentration. Pseudorotaxane (3.73) 
formation was observed by complexation induced shifts in the 
1
H NMR and HRMS which 
included a peak at 780.3715 corresponding to the expected [3.73-ClO4]
+
. The binding 
constant was found to be 864 M
-1
 calculated from the single point method.
129
 Incorporation 
of two triazoles into the ammonium binding motif gives a four times increase in the binding 
interaction between the thread and crown compared to the value of the binding interaction 
between dibenzylammonium thread and DB24C8 (237 M
-1
). The introduction of the two 
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triazole rings may increase the CH hydrogen binding ability of the benzylic CH2’s and 
provide enhanced π stacking interactions between aromatic moieties on crown and thread. It 
is possible that the crown cavity also has a better ‘fit’ over the binding motif with the five 
membered ring triazoles in the macrocycle cavity compared to the larger six membered 
benzene ring. The triazole C-H may also be involved in hydrogen bonding with the crown 
ether oxygens further stabilising the [2]pseudorotaxane complex.
161,181
 
 
Figure 3.12 [2]pseudorotaxane 3.73. 
Shown in Figure 3.13 is the 1H NMR stacking plot of [2]pseudorotaxane 3.73 with 
DB24C8 and ClO4
-
 salt 3.72. Observing the chemical shifts of the macrocycle, the aromatic 
protons are shifted slightly upfield due to shielding of these hydrogens. The first ethylene 
oxy group of the crown chain shifts upfield as a result of their close contact with the π 
system of the thread. The CH2NH2
+
CH2 protons of the thread are shifted upfield due to 
hydrogen bonding with the crown ether oxygens. They are also split into a multiplet as they 
now show coupling with the 
+
NH2 protons of the thread.
32
 When considering the aromatic 
protons of the thread 3.72, the phenyl ring protons are generally unaffected by the presence 
of the macrocycle encompassing the axle. The triazole proton however is shifted downfield 
by 0.4 ppm due to π stacking interactions of the conjugated system with the aromatics of the 
DB24C8. 
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Figure 3.13 Partial 1H NMR (400 MHz, CD3CN, 300K) stacking plot of i) DB24C8; ii) [2]pseudorotaxane 3.73 
and iii) Comparison thread 3.72. 
Incorporation of the bis triazole ammonium binding template into an axle with our ‘Diels-
Alder gates’ to synthesise a rotaxane in the threading followed by stoppering protocol was 
then carried out. Taking the dipropargyl 3.69 and reacting with the acid azide 3.74 under 
‘CuAAC click chemistry’ conditions new compound 3.75 was obtained. This was followed 
by an esterification reaction with the Diels-Alder alcohol 2.04 giving the neutral thread 
containing the protected amine 3.76. Deprotection was performed with thiophenol and 
potassium carbonate in acetonitrile to provide neutral thread 3.77. This was converted to 
ClO4
-
 ammonium salt 3.78 using HClO4 to give the salt which had rather low solubility in 
acetonitrile. 
  Chapter 3 
157 
 
 
Scheme 3.25 Reagents and conditions: a) EtOH, THF, H2O, CuSO4.5H2O, NaAsc, RT, 24h, 73%; b) CH2Cl2, 
Alcohol 2.04, NEt3, N,N,N',N'-tetramethylchloroformamidinium hexafluorophosphate, RT, 48h, 52%; c) i) 
CH3CN, PhSH, K2CO3, 60˚C, 24h, 54%; ii) CH2Cl2, HClO4, RT, 100%. 
The retro Diels-Alder reaction was carried out under microwave conditions to deprotect the 
maleimide this time in a mixture of acetonitrile and nitromethane. The retro Diels-Alder 
thread 3.79 had improved solubility in deuterated acetonitrile and adding 2.3 equivalents of 
DB24C8 induces the formation of the [2]pseudorotaxane 3.80. Once pseudorotaxane 
formation was complete when observing by 
1
H NMR, the macrocycle was trapped onto the 
thread with the addition of freshly cracked cyclopentadiene. [2]rotaxane 3.81 was obtained 
in a 57% yield following purification. 
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Scheme 3.26 Reagents and conditions: a) CH3CN, CH3NO2, MW (4h, 150W, 100°C), 96%; b) CD3CN, DB24C8 
(2.3 equiv.), RT, 48h; c) CH3CN, cyclopentadiene (excess), RT, 57%. 
Thread 3.84 was synthesised as a comparison to see the effect of the macrocycle 
encompassing the axle on the 
1
H NMR shifts. The reaction synthesis is shown in Scheme 
3.27 showing the protected amine 3.82 synthesised from the diacid 3.74 reacting it with 
alcohol 2.15. The deprotection was carried out using thiophenol and potassium carbonate to 
give neutral thread 3.83. Finally conversion to the ClO4
-
 salt was performed using HClO4 to 
produce thread 3.84. 
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Scheme 3.27 Reagents and conditions: a) CH3CN, K2CO3, PhSH, 60˚C, 24h, 74%; b) CH2Cl2, HClO4, 100% 
The 
1
H NMR comparison of DB24C8, [2]rotaxane 3.81 and thread 3.84 is shown in Figure 
3.14. The CH2NH2
+
CH2 are shifted downfield and are coupled with the ammonium 
hydrogens. Aromatic hydrogens of the thread are also deshielded and shift upfield. The 
Diels-Alder stopper portion of the axle is once again unaffected by the presence of the 
encompassing macrocycle. 
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Figure 3.14 
1H NMR (400 MHz, CD3CN, 300K) i) DB24C8; ii) [2]Rotaxane 3.81 and iii) ClO4
- thread 3.84. 
3.7 Synthesis of Rotaxanes in a One Pot Method Using ‘CuAAC Click Chemistry’ 
 
It has been reported that the click reaction using copper (I) salt Cu(MeCN)4PF6 can occur 
quantitatively in solvents compatible with crown rotaxane formation.
106
 The propargyl 3.86 
as an ammonium hexafluorophosphate salt and the azide with a pyridinium 
hexafluorophosphate salt 3.85 were ‘clicked’ in dry CH2Cl2 under nitrogen using 2,6-
lutidine as a base. This lead to the successful synthesis of a [2]rotaxane reported by Coutrot 
shown in Scheme 3.28. 
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Scheme 3.28 Synthesis of a [2]rotaxane molecular shuttle using ‘CuAAC click chemistry’.106 Reagents and 
conditions: a) DB24C8, [Cu(CH3CN)4]PF6, 2,6-lutidine, CH2Cl2, 75%. 
As discussed earlier, Takata
107
 had shown rotaxane formation using N-oxide click chemistry 
with the ammonium ion binding site very close to the reacting unit. The pseudorotaxane was 
trapped as the rotaxane when the click reaction was carried out under mild enough 
conditions giving high yields of the resulting rotaxanes. Synthesis of rotaxanes generating 
the ammonium triazole binding site during rotaxane formation was therefore investigated. 
The ammonium hexafluorophosphate propargyl unit (3.88), 3,5-dimethylbenzyl azide and 
DB24C8 were dissolved in dry CH2Cl2  and after 24 hours a new spot was visualised on the 
TLC. On purification via column chromatography the [2]rotaxane 3.89 was isolated in 30% 
yield. Some free thread was also isolated during the purification stage. 
 
Scheme 3.29 Reagents and conditions: a) CH2Cl2, DB24C8 (2 equiv), Cu(MeCN)4PF6, 2,6-lutidine, N2, 24 h, 
RT, 30% 
The free thread (3.90) was also synthesised using the same reaction conditions for 
comparison with the rotaxane. In this case, it was found beneficial to neutralise the reaction 
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before purification via flash chromatography then converting the isolated thread back to the 
PF6
-
 salt using hexafluorophosphoric acid.  
 
Scheme 3.30 Reagents and conditions: a) CH2Cl2, Cu(MeCN)4PF6, 2,6-lutidine, N2, 24 h, RT, 29% 
The 
1
H NMR of DB24C8, thread 3.90 and [2]rotaxane 3.89 is shown in Figure 3.15. The 
CH2NH2
+
CH2 hydrogens of the thread are shifted downfield and sharpen up taking on the 
usual coupling patterns associated with forming a rotaxane with the DB24C8.
32
 The signal 
for the ethylene oxy units of the crown ether become complex due to the unsymmetrical axle 
they are encompassing and are shifted slightly downfield.
182
 There are also complexation 
induced shifts in the aromatic hydrogen of the thread with all of these peaks seen to shift 
upfield due to shielding from the close proximity of the aromatic systems of DB24C8.  
 
Figure 3.15 
1H NMR (400 MHz, CD3CN, 300K) stacking plot of i) DB24C8 ii) [2]rotaxane 3.89 and iii) 
Comparison thread 3.90. 
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The possibility of using this approach to synthesise higher order rotaxanes was explored. In 
this case starting with two equivalents of the PF6
-
 salt 3.88 was reacted with the simple 
diazide 3.38 in the presence of four equivalents of DB24C8. The [3]rotaxane 3.91 shown in 
Scheme 3.31 was successfully synthesised using the same ‘CuAAC’ click conditions shown 
in the previous examples.  
 
Scheme 3.31 Reagents and conditions: a) i) CH2Cl2, DB24C8 (4 equiv), Cu(MeCN)4PF6, 2,6-lutidine, N2, RT, 24 
h, RT; ii) HPF6, 19%. 
The comparison thread was synthesised taking two equivalents of the PF6
-
 salt 3.88 and one 
equivalent of the diazide 3.38 under the same ‘CuAAC click’ conditions as before. The 
thread was again neutralised before column chromatography, then reprotonation was carried 
out with hexafluorophosphoric acid. This provided us with the new PF6
-
 salt 3.91 in a 26% 
yield shown in Scheme 3.32.  
 
Scheme 3.32 Reagents and conditions: a) CH2Cl2, Cu(MeCN)4PF6, 2,6-lutidine, N2, 24h, RT; ii) HPF6, RT, 26%. 
Again from comparing the 
1
H NMR of the free thread and DB24C8 with the rotaxane, a 
number of shifts indicative of rotaxane formation were observed. The encompassed 
  Chapter 3 
164 
 
CH2NH2
+
CH2 protons see a characteristic shift downfield due to hydrogen bonding 
interaction with the crown ether oxygens and become complex multiplet via coupling with 
the hydrogens of the ammonium salt (Figure 3.16). The crown ethylene oxy signals also 
become complex multiplets due to their asymmetric environment on the interlocked thread. 
 
Figure 3.16 
1H NMR of [3]rotaxane 3.91 (400MHz, CDCl3, 300K). 
In an attempt to increase the yields of the isolated rotaxanes different copper salt catalysts to 
perform the ‘CuAAC click’ reaction were investigated. There is literature precedent for 
‘CuAAC click’ reactions using CuBr(PPh3)3.
183-184
 This particular reagent is also 
commercially available and other groups have had success using it in rotaxane formation. 
Synthesis of the thread 3.90 was performed taking one equivalent of the PF6
- 
salt 3.88, one 
equivalent of azide 3.11 and a catalytic quantity of CuBr(PPh3)3 (0.1 equiv.) in acetonitrile. 
After 24 hours the reaction was worked up and purified to give the thread in an 8% yield 
(Scheme 3.33). The reaction seemed to occur using this copper complex but the yields were 
very low and no other products or starting materials could be isolated from the reaction. The 
synthesis was also attempted with longer reaction times with no improvement in yield of 
product. 
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Scheme 3.33 Reagents and conditions: a) CH2Cl2, CuBr(PPh3)3  (0.1 equiv.), N2, RT, 8% 
Even though we obtained a low yield of the thread using these conditions, the synthesis of 
the rotaxane was attempted for completeness. Using the same reaction conditions but with 
the two equivalents of DB24C8 added to the system, a small amount of [2]rotaxane 
formation was detected by TLC but the product was not able to be isolated. Examining the 
crude 
1
H NMR it appears that the yield is in fact < 5%. Following from this a full equivalent 
of the CuBr(PPh3)3 salt was tried as it seemed that using only a catalytic amount may have 
been a factor in producing the low yield. Unfortunately in this case no rotaxane formation 
was detected and the 
1
H NMR spectra showed only a mixture of starting materials and 
reagents. It is postulated that the presence of bromine may be having an effect on the 
formation of the rotaxane. This ion exchange may also influence the reactivity of the copper 
catalyst as no ‘click’ reaction was detected. There may also be some steric factors 
influencing the reaction as the large PPh3 ligands may inhibit rotaxane formation during the 
catalytic cycle. As a result this particular reagent was not pursued to undertake the ‘CuAAC 
click chemistry’ reactions. 
 
Scheme 3.34 Reagents and conditions: a) CH2Cl2, DB24C8 (2 equiv.), CuBr(PPh3)3  (0.1 equiv.), N2, RT, <5% or 
a) CH2Cl2, DB24C8 (2 equiv.), CuBr(PPh3)3  (1 equiv.), N2, RT, no product formed. 
3.8 Conclusion 
A simple but useful modification to the known dibenzylammonium binding motif for 
interactions with DB24C8 has been developed. The introduction of the triazole into the 
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binding site was found to enhance the interaction between axle and the DB24C8 macrocycle. 
A further increase in binding interaction was seen when the triazole was conjugated to a 
benzene ring. In comparison to the mono ester functionalised dibenzylammonium template 
3.13, there was almost a two fold increase in the binding constant observed at 2 mmol 
concentration. Synthesis of [2] and [3]rotaxanes were successfully carried out incorporating 
this binding template into axles and using the Diels-Alder approach to ‘threading followed 
by stoppering’.  
 
Synthesis of the desired multicomponent [4]rotaxane was unsuccessful so exploiting this 
chemistry could not be carried out due to a number of limiting factors. These included the 
proximity of the ammonium cations to the DNP binding site and solubility problems due to 
counter ion exchange.  A synthesis including only PF6
-
 salts or conducting the retro Diels-
Alder reaction on the free amine caused side reactions to occur.  
 
A binding motif with two triazoles incorporated either side of the ammonium ion was also 
successfully synthesised. It was found to enhance the binding interaction between the thread 
and DB24C8 even further. This new binding motif was introduced into an axle with two 
Diels-Alder type gates attached allowing us to synthesise a symmetrical [2]rotaxane.  
 
Finally generating the triazole binding motif in rotaxanes during the stopper formation was 
completed using the ‘CuAAC’ reaction conditions that have been employed by Coutrot.106 
Synthesis of a [2]rotaxane and a [3]rotaxane as well as free threads was achieved using this 
method.  
3.9 Experimental 
3.93 
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Methyl 4-formylbenzoate (1g, 6.10 mmol) was dissolved in MeOH and propargyl amine 
(0.42 mL, 6.70 mmol) was added. The solution was stirred at room temperature for 24 h. A 
precipitate formed which was filtered and washed with cold MeOH (800 mg, 3.98 mmol, 
66%). m.p. 124-125°C; 
1
H NMR (400 MHz, 298 K, CDCl3) δH 8.65 (s, 1H, CH=N), 8.10 (d, 
2H, J = 8.5 Hz, 2 ArCHCCO2), 7.84 (d, 2H, J = 8.5 Hz, 2 ArCHCCH), 4.57 (s, 2H, CH2N), 
3.94 (s, 3H, OCH3), 2.56 (s, 1H, C≡CH); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 166.6 
(COO), 161.4 (CH=CN), 139.6 (ArC), 132.1 (ArC), 129.9 (ArCHCCO2), 128.2 
(ArCHCC=N), 78.5 (C≡CH), 76.0 (C≡CH), 52.3 (OCH3), 47.2 (CH2); IR ν cm
-1
 3182 
(alkyne C-H), 2945 (saturated C-H), 1718 (ester C=O), 1651 (C=N); HRMS (ESI
+
): m/z 
found, 202.0865 calc for C12H12NO2 202.0863 [3.93+H]
+
. 
3.05 
 
Known compound data consistent with literature.
185
 The imine 3.91 (750 mg, 3.73 mmol) 
was dissolved in MeOH (10 mL). Sodium cyanoborohydride (258 mg, 4.1 mmol) and a few 
drops of HOAc were added to the stirring solution. The reaction was followed by TLC until 
completion (EtOAc). The MeOH was removed in vacuo and the residue diluted with water 
(20 mL) and extracted with CH2Cl2 (3 x 30 mL). The solvent was removed to provide a pale 
yellow solid (700 mg, 3.47 mmol, 93 %). m.p. 45-47°C; 
1
H NMR (400 MHz, 298 K, CDCl3) 
δH 8.00 (d, 2H, J = 8.0 Hz, 2 ArCHCCO2), 7.45 (d, 2H, J = 8.0 Hz, 2 ArCHCCH2), 3.95 (s, 
2H, CCH2NH), 3.92 (s, 3H, OCH3), 3.45 (s, 2H, CH2C≡CH), 2.28 (s, 1H, C≡CH); 
13
C NMR 
(100 MHz, 298 K, CDCl3\) δC 167.0 (C=O), 144.7 (ArC), 130.0 (ArCHCCO2), 129.0 (ArC), 
128.3 (ArCHCCH2), 81.8 (C≡CH), 71.8 (C≡CH), 52.7 (OCH3), 51.8 (CCH2NH), 37.4 
(CH2C≡CH); IR ν cm
-1
 3270 (alkyne C-H), 2917 (saturated C-H), 1707 (ester C=O); HRMS 
(ESI
+
): m/z found, 204.1017 calc for C12H14NO2 204.1019 [3.05+H]
+
. 
3.06 
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Known compound data consistent with literature.
186
 Benzyl chloride (0.5 mL, 4.9 mmol) was 
dissolved in EtOH (5 mL), sodium azide (355 mg, 5.4 mmol) was added and the solution 
stirred at room temperature overnight. Water (10 mL) was added to the mixture and it was 
extracted with CH2Cl2 (3 x 10 mL). The combined organic extracts were dried over MgSO4 
and the solvent removed in vacuo providing the product as a clear oil (400 mg, 3.00 mmol, 
61%); 
1
H NMR (400 MHz, 298 K, CDCl3) δH 7.37 (m, 5H, 5 ArCH), 4.38 (s, 2H, CH2); 
13
C 
NMR (75 MHz, 298 K, CDCl3) δC 137.4 (ArC), 128.8 (ArCH), 128.6 (ArCH), 128.1 
(ArCH), 54.8 (CH2); IR ν cm
-1
 3030 (saturated C-H), 2097 (N3). 
3.07 
 
To a solution of azide 3.06 (51 mg, 0.375 mmol) and alkyne 3.05 (76 mg, 0.375 mmol) in 
1:1 EtOH/water (5 mL) was added CuSO4.5 H2O (10 mg, 0.0375 mmol) and sodium 
ascorbate (25 mg, 0.113 mmol) in one portion. The resulting yellowish cloudy suspension 
was stirred at room temperature for 36 h. The mixture was partitioned between water (10 
mL) and EtOAc (10 mL), and the aqueous layer extracted with additional EtOAc (2 x 50 
mL). The combined organic layers were dried over MgSO4 and concentrated in vacuo. The 
yellow oil purified via column chromatography (SiO2: CH2Cl2 to CH2Cl2:MeOH; 95:5) (75 
mg, 0.255 mmol, 60 %). 
1
H NMR (400 MHz, 298 K, CDCl3) δH 7.97 (d, 2H, J = 8.0 Hz, 2 
ArCHCCO), 7.39-7.34 (m, 6H, 2 ArCHCCH2, 3 ArCH and triazole-CH), 7.26 (m, 2H, 2 
ArCH), 5.50 (s, 2H, CH2N-triazole), 3.90 (s, 3H, OCH3), 3.89 (br s, 2H, CH2NH), 3.87 (br s, 
2H, CH2NH), 1.99 (br s, 1H, NH); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 166.9 (C=O), 
146.8 (ArC), 145.0 (ArC), 134.6 (ArC), 129.8 (ArCH), 129.7 (ArCH), 129.1 (ArCH), 128.9 
(ArC), 128.1 (ArCH), 128.0 (ArCH), 121.5 (triazole-CH), 54.1 (CH2N-triazole), 52.9 
(CH2NH), 52.0 (OCH3), 44.1 (CH2NH); IR ν cm
-1
 2953 (saturated C-H), 1713 (ester C=O), 
1434 (N=N); HRMS (ESI
+
): m/z found 337.1657 cal for C19H21N4O2 337.1659 [3.06+H]
+
. 
 
  Chapter 3 
169 
 
3.08 
 
Compound 3.07 (50 mg, 0.13 mmol) was dissolved in MeOH (0.5 mL). A few drops of 
HClO4 (70%) were added to the solution followed by water to induce precipitation. The 
white solid formed was filtered and washed with water (31 mg, 0.07 mmol, 54%). m.p. 140-
141°C; 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.05 (d, 2H, J = 8.0 Hz, 2 ArCHCCO), 7.95 
(s, 1H, triazole-CH), 7.58 (d, 2H, J = 8.0 Hz, 2 ArCHCCH2), 7.35 (m, 5H, 5 ArCH), 5.60 (s, 
2H, CH2N-triazole), 4.35 (broad s, 4H, CH2NH2CH2) 3.89 (s, 3H, OCH3); 
13
C NMR (100 
MHz, 298 K, CD3CN) δC 165.8 (COO), 137.1 (ArC), 135.1 (ArC), 134.7 (ArC), 131.1 
(ArC), 130.1 (ArCH), 129.5 (ArCH), 129.12 (ArCH), 128.6 (ArCH), 128.2 (ArCH), 127.8 
(ArCH), 127.7 (ArCH), 125.3 (triazole-CH), 53.3 (CH2N-triazole), 51.7 (OCH3), 50.0 
(CH2NH2), 41.84 (CH2NH2); IR ν cm
-1
 3146 (NH2), 1721 (ester C=O), 1060 (ClO4); HRMS 
(ESI
+
): m/z found, 337.1656 calc. for C19H21N4O2 337.1659 [3.08-ClO4]
+
. 
3.10 
 
The thread 3.08 (10 mg, 0.02 mmol) and DB24C8 (10 mg, 0.02 mmol) were dissolved in 
deuterated acetonitrile (10 mL) and a new set of signals for pseudorotaxane formation was 
observed. Binding constant = 820 M
-1 
was calculated from the single point method
129
 by 
measuring the integration of triazole-CH protons for the free and bound thread at 8.05 ppm 
and 7.73 ppm respectively. Pseudorotaxane 3.10 
1
H NMR (400 MHz, 298 K, CD3CN) δH  
7.73 (s, 1H,  triazole-CH), 7.58 (d, 2H, J = 8.0 Hz,  2 ArCHCCO), 7.35 (m, 7 H  2 
ArCHCCH2 and  5 ArCH), 6.77 (m, 4H,  4 crown ArCH), 6.72 (m, 4H,  4 crown 
ArCH), 5.46 (s, 2H,  CH2N-triazole), 4.75 (m, 4H,  CH2NH2
+
CH2), 4.13-3.58 (m,  12 
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OCH2,  OCH3); Also contains unthreaded DB24C8 
1
H NMR (400 MHz, 298 K, CD3CN) 
δH 6.93 (m, 8H, 8 ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 8H, 4 OCH2), 3.72 (s, 8H, 4 
OCH2); and unthreaded Thread 3.08 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.05 (d, 2H, J 
= 8.0 Hz, 2 ArCHCCO), 7.95 (s, 1H, triazole-CH), 7.58 (d, 2H, J = 8.0 Hz, 2 ArCHCCH2), 
7.35 (m, 5H, 5 ArCH), 5.60 (s, 2H, CH2N-triazole), 4.35 (br s, 4H, CH2NH2
+
CH2) 3.89 (s, 
3H, OCH3); MS (ESI
+
): m/z 785.3 [3.10-ClO4]
+
. 
3.11 
 
Known compound synthesised according to a modified literature procedure.
187
 3,5-
Dimethylaniline (0.5 g, 4.1 mmol) was dissolved in 5M HCl (10 mL) and cooled to 0°C. 
Sodium nitrite (314 mg, 4.5 mmol) dissolved in water (10 mL) was added drop wise over 30 
minutes. Sodium azide (1.07 g, 16.5 mmol) was added portion wise over 30 minutes with 
some slight effervescence. The solution was stirred for 1 h, basified to pH 8 with the 
addition of sodium bicarbonate and extracted with EtOAc (3 x 20 mL). The combined 
organic extracts were washed with water (20 mL) and dried over MgSO4. The solvent was 
removed to provide an orange oil (390 mg, 2.63 mmol, 65%); 
1
H NMR (400 MHz, 298 K, 
CDCl3) δH 6.81 (s, 1H, ArCH), 6.69 (s, 2H, 2 ArCH), 2.34 (s, 6H, 2 CH3);  
13
C NMR (100 
MHz, 298 K, CDCl3) δC 139.7 (ArC), 139.6 (ArC), 126.8 (ArCH), 116.7 (ArCH), 21.3 
(CH3); IR ν cm
-1
 2919 (saturated C-H), 2099 (N3). 
3.12 
 
The propargyl 3.05 (83 mg, 0.41 mmol) was dissolved in tert-butanol (5 mL), water (5 mL) 
and THF (5 mL). The azide 3.11 (60 mg, 0.41 mmol) was added along with CuSO4.5H2O 
(10 mg, 0.041 mmol) and sodium ascorbate (24 mg, 0.12 mmol). The solution was stirred at 
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room temperature for 24 h. The solution was diluted with water (15 mL) and extracted with 
CH2Cl2 (3 x 15 mL). The combined organic extracts were dried over MgSO4, the solvent 
removed in vacuo and the crude product purified via flash chromatography (SiO2: CH2Cl2 to 
CH2Cl2/MeOH 9:1) to provide an orange oil (65 mg, 0.19 mmol, 45%); 
1
H NMR (400 MHz, 
298 K, CDCl3) δH  8.04 (d, 2H, J = 8.0 Hz, 2 ArCHCCO2), 7.89 (s, 1H, triazole-CH), 7.48 (d, 
2H, J = 8.0 Hz, 2 ArCHCCH2), 7.35 (s, 2H, 2 ArCH), 7.09 (s, 1H, ArCH), 3.93 (broad s, 7H, 
CH2NHCH2 and OCH3), 2.42 (s, 6H, 2 CH3); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 167.3 
(COO), 147.0 (ArC), 145.2 (ArC), 139.7 (ArC), 137.0 (ArC), 130.3 (ArCH), 129.8 (ArCH), 
129.0 (ArC), 128.1 (ArCH), 120.0 (triazole-CH), 118.3 (ArCH), 52.9 (CH2NH), 52.1 
(OCH3), 44.1 (CH2NH), 21.3 (CH3); IR ν cm
-1
 2953 (saturated C-H), 1715 (ester C=O), 
1614 (C-O); HRMS (ESI
+
): m/z found 351.1808 calc. for C20H23N4O2 351.1816 [3.12+H]
+
. 
3.13 
 
Compound 3.12 (45 mg, 0.13 mmol) was dissolved in CH2Cl2 (5 mL). The organic layer was 
washed with a 10% aqueous solution of HClO4 (3 x 10 mL). The organic layer was 
separated and dried by passing through filter paper and the solvent removed to provide a 
pale brown solid which was recrystallised from acetonitrile/Et2O to provide a white solid (57 
mg, 0.13 mmol, 100 %). m.p. 223-224°C; 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.33 (s, 
1H, triazole-CH), 8.07 (d, 2H, J = 8.0 Hz, 2 ArCHCCO2), 7.61 (d, 2H, J = 8.0 Hz, 2 
ArCHCCH2), 7.43 (s, 2H, 2 ArCH), 7.19 (s, 1H, ArCH), 4.43 (s, 2H, CH2NH2
+
), 4.37 (s, 2H, 
+
NH2CH2), 3.88 (s, 3H, OCH3), 2.41 (s, 6H, 2 CH3);  
13
C NMR (150 MHz, 298 K, CD3CN) 
δC 165.8 (C=O), 139.8 (ArC), 137.6 (ArC), 136.3 (ArC), 134.9 (ArC), 131.2 (ArC), 130.3 
(ArCH), 130.1 (ArCH), 129.6 (ArCH), 123.5 (triazole-CH), 117.9 (ArCH), 51.7 (OCH3), 
50.0 (CH2NH2), 41.7(CH2NH2), 20.0 (CCH3); IR ν cm
-1
 1687 (ester C=O), 1106 (ClO4); 
HRMS (ESI
+
): m/z found 351.1812 calc for C20H23N4O2 351.1816 [3.13-ClO4]
+
.  
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3.14 
 
The thread 3.13 (9 mg, 0.02 mmol) and DB24C8 (8.9 mg, 0.02 mmol) were dissolved in 
deuterated acetonitrile (10 mL). Binding constant = 1060 M
-1 
was calculated from the single 
point method
129
 by measuring the integration of triazole-CH protons for the free and bound 
thread at 8.33 ppm and 8.04 ppm respectively. The peaks of the pseudorotaxane are partially 
obscured by free DB24C8 and thread 3.13. Pseudorotaxane 3.14 
1
H NMR (400 MHz, 298 
K, CD3CN) δH 8.04 (m, 1H,  triazole-CH), 7.62 (m, 2H,  2 ArCHCCO2), 7.42 (m, 2H,   
2 ArCHCCH2), 7.23 (s, 2H,  2 ArCH), 7.15 (s, 1H,  ArCH), 6.92 (m, 4H,  4 crown 
ArCH), 6.76 (m, 4H,  4 crown ArCH), 4.85 (m, 4H,  CH2NH2
+
CH2), 4.12-3.68 (m, 27H, 
 12 OCH2,  OCH3) 2.38 (s, 6H,  2 CH3); Also observed for comparison DB24C8 
1
H 
NMR (400 MHz, 298 K, CD3CN) δH 6.93 (m, 8H, 8 ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 
8H, 4 OCH2), 3.72 (s, 8H, 4 OCH2); and Thread 3.13 
1
H NMR (400 MHz, 298 K, CD3CN) 
δH 8.33 (s, 1H, triazole-CH), 8.07 (d, 2H, J = 8.0 Hz, 2 ArCHCCO2), 7.61 (d, 2H, J = 8.0 Hz, 
2 ArCHCCH2), 7.43 (s, 2H, 2 ArCH), 7.19 (s, 1H, ArCH), 4.43 (s, 2H, CH2NH2), 4.37 (s, 
2H, NH2CH2), 3.88 (s, 3H, OCH3), 2.41 (s, 6H, 2 CH3); HRMS (ESI
+
): m/z found, 799.3934 
calc for C44H55N4O10 799.3913 [3.14-ClO4]
+
. 
3.15 
 
Known compound synthesised according to a modified literature procedure.
188
 Methyl 4-
(aminomethyl)benzoate (50 mg, 0.48 mmol) and benzaldehyde (0.031 mL, 0.48 mmol) were 
dissolved in MeOH (5 mL) and stirred at room temperature. After 24 h sodium borohydride 
(22 mg, 0.57 mmol) was added and stirred at room temperature for 1 h. The reaction was 
diluted with water (15 mL) and extracted with CH2Cl2 (3 x 10 mL). The combined organic 
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extracts were dried over MgSO4 and the solvent removed in vacuo and purified via column 
chromatography (SiO2: EtOAc) to give a clear oil (100 mg, 0.39 mmol, 82%). 
1
H NMR (400 
MHz, 298 K, CDCl3) δH 7.94 (d, 2H, J = 8.5 Hz, 2 ArCHCCO2), 7.36 (d, 2H, J = 8.5 Hz, 2 
ArCHCCH2), 7.28-7.27 (m, 4H, 4 ArCH), 7.21 (m, 1H, ArCH), 3.84 (s, 3H, OCH3), 3.80 (s, 
2H, CH2NH), 3.74 (s, 2H, CH2NH); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 167.0 (COO), 
144.9 (ArC), 139.2 (ArC), 129.8 (ArCH), 129.0 (ArC), 128.5 (ArCH), 128.3 (ArCH), 128.2 
(ArCH), 127.3 (ArCH), 52.9 (CH2NH), 52.4 (CH2NH), 52.0 (OCH3); HRMS (ESI
+
): m/z 
found, 256.1329 calc for C16H18NO2 256.1332 [3.15+H]
+
.  
3.16 
 
The neutral thread 3.15 (100 mg, 0.78 mmol) was dissolved in CH2Cl2 (10 mL) and washed 
with a 10% aqueous solution of HClO4 (3 x 10 mL). The organic layer was dried over 
MgSO4 and the solvent removed in vacuo. The crude product was recrystallised from 
acetonitrile/Et2O to give a white solid (110 mg, 0.31 mmol, 40 %). m.p. 179-180˚C; 
1
H 
NMR (400 MHz, 298 K, CD3CN) δH  8.05 (d, 2H, J = 8.0 Hz, 2 ArCHCCO2), 7.60 (d, 2H, J 
= 8.0 Hz, 2 ArCHCCH2), 7.50-7.45 (m, 5H, 5 ArCH), 4.32 (s, 2H, CH2NH2
+
), 4.27 (s, 2H, 
CH2NH2
+
), 3.88 (s, 2H, OCH3); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 165.8 (COO), 
135.3 (ArC), 131.4 (ArC), 130.5 (ArCH), 130.4 (ArC), 130.3 (ArCH), 129.9 (ArCH), 129.8 
(ArCH), 129.1 (ArCH), 52.0 (OCH3), 51.6 (CH2NH2
+
), 50.9 (CH2NH2
+); IR ν cm-1 3596 
(NH2), 1689 (ester C=O), 1278 (CH2), 1071 (ClO4); HRMS (ESI
+
): m/z found, 256.1332 calc 
for C16H18NO2 256.1332  [3.16-ClO4]
+
. 
3.17 
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Thread 3.16 (7.1 mg, 2 mmol) and DB24C8 (8.9 mg, 2 mmol) were dissolved in deuterated 
acetonitrile (10 mL). Binding constant = 688 M
-1 
was calculated from the single point 
method
129
 by measuring the integration of ArCH protons for the free and bound crown at 
6.93 ppm and 6.77 ppm respectively. Pseudorotaxane 3.17 
1
H NMR (400 MHz, 298 K, 
CD3CN) δH  7.66 (d, 2H, J = 8.0 Hz,  2 ArCHCCO2), 7.47 (s, 5H,  2 ArCHCCH2), 7.41-
7.40 (m, 3H,  3 ArCH), 7.28-7.27 (m, 2H,  2 ArCH), 6.77 (m, 8H,  8 crown ArCH), 
4.81 (m, 2H,  CH2NH2
+
), 4.66 (m, 2H,  CH2NH2
+
), 4.06-3.98 (m, 8H,  4 OCH2), 3.93 
(s, 3H,  OCH3), 3.69 (s, 8H,   4 OCH2), 3.62-3.52 (m, 8H,  4 OCH2); Also contains 
unthreaded DB24C8 
1
H NMR (400 MHz, 298 K, CD3CN) δH 6.93 (m, 8H, 8 ArCH), 4.14 
(m, 8H, 4 OCH2), 3.83 (m, 8H, 4 OCH2), 3.72 (s, 8H, 4 OCH2); and Thread 3.16 
1
H NMR 
(400 MHz, 298 K, CD3CN) δH 8.05 (d, 2H, J = 8.0 Hz, 2 ArCHCCO2), 7.60 (d, 2H, J = 8.0 
Hz, 2 ArCHCCH2), 7.50-7.45 (m, 5H, 5 ArCH), 4.32 (s, 2H, CH2NH2
+
), 4.27 (s, 2H, 
CH2NH2
+
), 3.88 (s, 2H, OCH3); MS (ESI
+
): m/z 704.1 [3.17-ClO4]
+
. 
3.18 
 
Aldehyde 2.20 (300mg, 0.9 mmol) was dissolved in MeOH (5 mL) and propargyl amine 
(0.069 mL, 1.2 mmol) and stirred overnight at room temperature. A precipitate formed 
which was filtered and washed with MeOH to provide a white solid (276 mg, 0.73 mmol, 
81%). m.p. 146-147°C; 
1
H NMR (400 MHz, 298 K, CDCl3) δH 8.63 (s, 1H, HC=N), 8.03 (d, 
2H, J = 8.2 Hz, 2 ArCHCCO2), 7.83 (d, 2H, J = 8.2 Hz, 2 ArCHCC=N), 6.49 (s, 2H, 
CH=CH), 5.23 (s, 2H, 2 CHO), 4.57 (s, 2H, CH2N), 4.46 (t, 2H, J = 5.2 Hz, CH2CH2O), 3.91 
(t, 2H, J = 5.2 Hz, CH2CH2N), 2.86 (s, 2H, CHCO), 2.55 (s, 1H, C≡CH); 
13
C NMR (100 
MHz, 298 K, CDCl3) δC 174.9 (imide C=O), 164.7 (COO), 160.3 (HC=N), 138.7 (CH=CH), 
135.5 (ArC), 130.7 (ArCH), 129.0 (ArC), 127.1 (ArCH), 79.9 (CHO), 77.5 (C≡CH), 74.9 
(C≡CH), 60.8 (CH2CH2O), 46.4 (CHCO), 46.2 (CH2N), 36.7 (CH2CH2N); IR ν cm
-1
 3182 
(alkyne C-H), 1718 (imide C=O), 1692 (ester C=O); MS (ESI
+
) : m/z 397.1 [3.18+H]
+
; CHN 
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Analysis Found: C 66.40; H 4.81; N 7.33. Calc. for C21H18N2O5: C, 66.66; H, 4.79; N, 
7.40%. 
3.19 
 
The imine 3.18 (300 mg, 0.75 mmol) was dissolved in MeOH (5 mL). Sodium 
cyanoborohydride (88 mg, 1.4 mmol) was added and on addition of a few drops of HOAc 
the solution clears. The reaction was followed by TLC (EtOAc). After 1 h the imine had 
been consumed and the product obtained by adding water (20 mL) and extracting with 
CH2Cl2 (3 x 15 mL). The combined organic extracts were dried over MgSO4 and the solvent 
removed to provide a yellow oil used without further purification (216 mg, 0.57 mmol, 
76%). m.p. 93-95°C; 
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.90 (d, 2H, J = 8.1 Hz, 2 
ArCHCCO2), 7.37 (d, 2H, J = 8.1 Hz, 2 ArCHCCH2), 6.45 (s, 2H, CH=CH), 5.19 (s, 2H, 2 
CHO), 4.40 (t, 2H, J = 5.5 Hz, CH2CH2O), 3.87 (m, 4H, ArCH2NH and CH2CH2N), 3.39 (s, 
2H, NHCH2C ≡), 2.82 (s, 2H, 2 CHCO), 2.26 (s, 1H, ≡CH); 
13
C NMR (100 MHz, 298 K, 
CD3CN) δC 176.0 (imide C=O), 166.1 (COO), 144.7 (ArC), 136.5 (CH=CH), 129.9 (ArCH), 
128.6 (ArC), 128.3 (ArCH), 81.6 (C≡CH), 80.9 (CHO), 72.0 (C≡CH), 61.2 (CH2CH2O), 
51.7 (CH2NH), 47.4 (CHCO), 37.8 (CH2NH), 37.2 (CH2CH2N); IR ν cm
-1
 3294 (alkyne C-
H), 1698 (ester and imide C=O), 1257 (C-O); HRMS (ESI
+
): m/z  found, 381.1445, calc for 
C21H21N2O5 381.1450 [3.19+H]
+
. 
3.20 
 
Known compound data consistent with literature.
189
 3,5 Dimethylbenzyl bromide (250 mg, 
1.26 mmol) was dissolved in EtOH (5 mL) and sodium azide (123 mg, 1.89 mmol) was 
added. It was stirred overnight and a white precipitate formed which was filtered. The 
liquors were diluted with water (25 mL) and extracted with CH2Cl2 (3 x 20 mL). The 
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combined organic extracts were dried over MgSO4 and solvent removed in vacuo to provide 
a clear oil (155 mg, 0.96 mmol, 78%). 
1
H NMR (400 MHz, 298 K, CDCl3) δH 7.00 (s, 1H, 
ArCH), 6.95 (s, 2H, 2 ArCH), 4.28 (s, 2H, CH2), 2.35 (s, 6H, 2 CH3); 
13
C NMR (100 MHz, 
298 K, CDCl3) δC 138.5 (ArC), 135.2 (ArC), 129.9 (ArCH), 126.0 (ArCH), 54.9 (CH2), 
21.27 (CH3); IR ν cm
-1
 2922 (saturated C-H), 1460 (N=N stretching). 
3.21 
 
CuSO4.5H2O (6.5 mg, 0.026 mmol) and sodium ascorbate (15 mg, 0.078 mmol) were 
dissolved in THF (3 mL), t-Butanol (3 mL) and water (3 mL). The propargyl amine (3.19) 
(100 mg, 0.26 mmol) and the azide (3.20) (42 mg, 0.23 mmol) were added and the solution 
stirred at room temperature for 24 h. The solution was diluted with water (20 mL) and 
extracted with CH2Cl2 (3 x 15 mL). The combined organic extracts were dried over MgSO4 
and the solvent removed in vacuo to give a pale orange oil purified via flash chromatography 
(SiO2: EtOAc to EtOAc:MeOH; 4:1) (70 mg, 0.13 mmol, 56%). 
1
H NMR (400 MHz, 298 K, 
CDCl3) δH 7.95 (d, 2H, J = 8.0 Hz, 2 ArCHCCO), 7.39 (m, 3H, triazole-CH and 2 
ArCHCCH2), 6.98 (s, 1H, ArCH), 6.89 (s, 2H, 2 ArCH), 6.49 (s, 2H, CH=CH), 5.42 (s, 2H, 
CH2N-triazole), 5.23 (s, 2H, 2 CHO), 4.43 (t, 2H, J = 5.0 Hz, CH2CH2O), 3.80 (br m, 6H, 
CH2NHCH2 and CH2CH2N), 2.87 (s, 2H, 2 CHCO), 2.30 (s, 6H, 2 CH3); 
13
C NMR (100 
MHz, 298 K, CDCl3) δC 176.0 (imide C=O), 166.1 (COO), 146.8 (ArC), 145.4 (ArC), 138.8 
(ArC), 136.5 (CH=CH), 134.5 (ArC), 130.3 (ArCH), 129.8 (ArCH), 128.6 (ArC), 128.1 
(ArCH), 125.4 (ArCH), 121.6 (triazole-CH), 81.2 (CHO), 61.1 (CH2CH2O), 54.1 (CH2N-
triazole), 52.9 (CH2NH), 47.5 (CHCO), 44.2 (CH2NH), 37.8 (CH2CH2N), 21.2 (CH3); IR ν 
cm
-1
 2918 (saturated C-H), 1698 (imide C=O), 1690 (ester C=O), 1270 (C-O); HRMS 
(ESI
+
): m/z found, 542.2403 calc for C30H32N5O5 542.2398 [3.21+H]
+
. 
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3.22 
 
Compound 3.21 (50 mg, 0.98 mmol) was dissolved in a 10% aqueous solution of HClO4 (5 
mL) and extracted with CH2Cl2 (3 x 5 mL). The combined organic layers were washed with 
an aqueous solution of the HClO4 (5 mL). The organic layer was dried through filter paper 
and the solvent removed in vacuo. The crude yellow solid obtained was purified by 
precipitation from acetonitrile/Et2O to provide a pale yellow solid (35 mg, 0.55 mmol, 59%). 
m.p. 95-97˚C; 1H NMR (400 MHz, 298 K, CD3CN) δH 7.98 (d, 2H, J = 8.0 Hz, 2 
ArCHCCO2), 7.96 (s, 1H, triazole-CH), 7.57 (d, 2H, J = 8.0 Hz, 2 ArCHCCH2), 7.38 (broad 
s, 2H, NH2), 7.01 (s, 1H, ArCH), 6.94 (s, 2H, 2 ArCH), 6.49 (s, 2H, CH=CH), 5.50 (s, 2H, 
CH2N-triazole), 5.08 (s, 2H, 2 CHO), 4.37 (m, 6H, CH2NH2
+
CH2 and CH2CH2O), 3.80 (t, 
2H, J = 5.0 Hz, CH2CH2N), 2.87 (s, 2H, 2 CHCO), 2.27 (s, 6H, 2 CH3); 
13
C NMR (100 
MHz, 298 K, CD3CN) δC 176.6 (imide C=O), 165.3 (COO), 138.7 (ArC), 136.5 (CH=CH), 
135.3 (ArC), 135.4 (ArC), 135.2 (ArC), 131.27 (ArC), 130.4 (ArCH), 129.9 (ArCH), 129.6 
(ArCH), 127.9 (CH-triazole), 125.4 (ArCH), 80.9 (CHO), 61.5 (CH2CH2O), 53.7 (CH2N-
triazole), 50.4 (CH2NH2
+
), 47.5 (CHCO), 42.2 (CH2NH2
+
), 37.3 (CH2CH2N), 20.2 (CH3); IR 
ν cm-1 3010 (saturated C-H), 1698 (imide and ester C=O), 1272 (C-O); HRMS (ESI+): m/z 
found, 542.2395 calc for C30H32N5O5 542.2398 [3.22-ClO4]
+
. 
3.23 
 
Compound 3.22 (40 mg, 0.06 mmol) was dissolved in acetonitrile (3 mL). The solution was 
subjected to microwave irradiation (150 W, 3 h, 110°C) the solvent was removed to provide 
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the retro Diels-Alder product as a pale yellow solid which was recrystallised from 
acetonitrile/Et2O (31 mg, 0.05 mmol, 86%).  m.p. 204-205°C; 
1
H NMR (400 MHz, 298 K, 
CD3CN) δH 7.97 (m, 3H, triazole-CH and 2 ArCHCCO), 7.59 (d, 2H, J = 8.0 Hz, 2 
ArCHCCH2), 7.51 (br s, 2H, NH2), 7.00 (s, 1H, ArCH), 6.93 (s, 2H, 2 ArCH), 6.77 (s, 2H, 
CH=CH), 5.49 (s, 2H, CH2N-triazole), 4.38 (m, 6H, CH2NH2CH2 and CH2CH2O), 3.84 (t, 
2H,
 
J = 5.0 Hz, CH2CH2N), 2.26 (s, 6H, 2 CH3);  
13
C NMR (100 MHz, 298 K, CD3CN) δC 
170.6 (imide C=O), 165.1 (COO), 138.4 (ArC), 137.1 (ArC), 136.1 (CH=CH), 135.0 (ArC), 
134.9 (ArC), 134.1 (ArCH), 130.9 (ArC), 130.2 (ArCH), 129.6 (ArCH), 125.4 (ArCH), 
125.3 (triazole CH), 62.2 (CH2CH2O), 53.3 (CH2N-triazole), 47. 1 (CH2NH2), 41.9 
(CH2NH2), 36.2 (CH2CH2N), 19.9 (CH3); IR ν cm
-1 
3100 (NH2), 1710 (imide C=O), 1063 
(ClO4); HRMS (ESI
+
): m/z found, 474.2134 calc. for C26H28N5O4 474.2136 [3.23-ClO4]
+
. 
3.24 
 
Compound 3.23 (20 mg, 0.035 mmol) was dissolved in deuterated acetonitrile (1 mL) and 
DB24C8 (63 mg, 0.14 mmol, 4 equiv) was added. After 72 h threading was in favour of 
pseudorotaxane formation (35.7 mg, 0.035 mmol). Pseudorotaxane 3.24 
1
H NMR (400 
MHz, 298 K, CD3CN) δH 8.01 (br s, 2H, NH2), 7.71 (s, 1H,  CH-triazole), 7.48 (d, 2H, J = 
8.0 Hz,  2 ArCHCCO2), 7.29 (d, 2H, J = 8.0 Hz,  2 ArCHCCH2), 6.98 (s, 1H,  ArCH), 
6.94 (s, 2H,  2 ArCH), 6.81 (s, 2H,  CH=CH), 6.75 (m, 4H,  4 crown ArCH), 6.69 (m, 
4H,  4 crown ArCH), 5.37 (s, 2H,  CH2N-triazole), 4.75 (m, 4 H,  CH2NH2
+
CH2), 4.31 
(t, 2H,  CH2CH2O), 4.02-3.56 (m, 26 H,  CH2CH2N and 12 OCH2), 2.23 (s, 6H,  2 
CH3); Also contains unbound DB24C8 
1
H NMR (400 MHz, 298 K, CD3CN) δH 6.93 (m, 8H, 
8 ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 8H, 4 OCH2), 3.72 (s, 8H, 4 OCH2); HRMS 
(ESI
+
): m/z found, 922.4253 calc for C50H60N5O12 922.4233 [3.24-ClO4]
+
.  
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3.25 
 
To a solution of pseudorotaxane 3.24 in acetonitrile a few drops of freshly distilled 
cyclopentadiene were added. The solution was stirred and the solvent and excess 
cyclopentadiene were removed immediately in vacuo. The crude reaction was purified via 
flash chromatography (SiO2: CH2Cl2:acetone 95:5 to CH2Cl2:MeOH 95:5) to give the 
[2]rotaxane (14 mg, 0.013 mmol, 37 %). 
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.69 (s, 
1H,  triazole-CH), 7.53 (d, 2H, J = 8.0 Hz,  2 ArCHCCO), 7.31 (d, 2H, J = 8.0 Hz,  2 
ArCHCCH2), 6.98 (s, 1H,  ArCH), 6.94 (s, 2H,  2 ArCH), 6.80-6.71 (m, 8H,  8 crown 
ArCH), 5.88 (s, 2H,  CH=CH), 5.36 (s, 2H,  CH2N-triazole), 4.74 (m, 4 H,  
CH2NH2
+
CH2), 4.31 (t, 2H, J = 5.3 Hz  CH2CH2O), 4.29-4.15 (m, 8H,  4 OCH2), 3.80-
3.53 (m, 18H,  CH2CH2N and 8 OCH2), 3.27 (broad s, 2H, 2 CHCO), 3.23 (broad s, 2H, 2 
CHCH2), 2.23 (s, 6H,  2 CH3), 1.58 (d, 1H, J = 8.5 Hz,  CHH), 1.55 (d, 1H, 
 
J = 8.5 Hz, 
 CHH);  13C NMR (125 MHz, 298 K, CD3CN) δC 177.4 (imide C=O), 165.4 (COO), 147.2 
(ArC), 138.3 (ArC), 138.1 (ArC), 137.1 (ArC), 135.3 (ArC), 134.3 (CH=CH), 130.0 
(ArCH), 129.8 (ArC), 129.7 (ArCH), 129.4 (ArCH), 126.1 (ArCH), 125.8 (ArCH), 121.5 
(triazole-CH), 112.5 (ArCH), 70.9 (OCH2), 70.3 (OCH2), 67.8 (OCH2), 61.8 (CH2CH2O), 
54.0 (CH2N-triazole), 52.2 (bridgehead CH2), 51.8 (CH2NH2
+
), 45.8 (CHCH2), 45.0 
(CHCO), 43.9 (CH2NH2
+
), 37.1 (CH2CH2N), 21.2 (CH3); IR ν cm
-1 
2918 (saturated C-H), 
1698 (imide and ester C=O), 1252 (C-O), 1091 (ClO4); HRMS (ESI
+
): m/z found, 988.4726 
calc for C55H66N5O12 988.4702 [3.25-ClO4]
+
. 
 
3.26 
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CuSO4.5H2O (6.5 mg, 0.03 mmol) and sodium ascorbate (15 mg, 0.08 mmol) were dissolved 
in tert-butanol (5 mL), water (5 mL) and THF (5 mL). The propargyl 3.19 (100 mg, 0.26 
mmol) and azide 3.11 (35 mg, 0.23 mmol) were added and stirred at room temperature for 
24 h. The reaction mixture was diluted with water (20 mL) and extracted with CH2Cl2 (3 x 
15 mL). The combined organic extracts were washed with brine (20 mL), dried over MgSO4 
and concentrated in vacuo. The crude reaction mixture was purified via flash 
chromatography (SiO2: EtOAc to EtOAc:MeOH; 85:15) to give a colourless oil (97 mg, 0.18 
mmol, 80%). 
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.97 (d, 2H, J = 8.0 Hz, 2 ArCHCCO), 
7.87 (s, 1H, triazole-CH), 7.44 (d, 2H, J = 8.0 Hz, 2 ArCHCCH2), 7.34 (broad s, 2H, 2 
ArCH), 7.09 (s, 1H, ArCH), 6.50 (s, 2H, CH=CH), 5.25 (s, 2H, 2 CHO), 4.45 (t, 2H, J = 5.0 
Hz, CH2CH2O), 3.91 (broad m, 6H, CH2NH2CH2 and CH2CH2N), 2.89 (s, 2H, 2 CHCO), 
2.41 (s, 6H, 2 CH3); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 175.9 (imide C=O), 166.1 
(COO), 147.1 (ArC), 145.4 (ArC), 139.7 (ArC), 137.0 (ArC), 136.5 (CH=CH), 130.3 
(ArCH), 130.0 (ArCH), 128.6 (ArC), 128.1 (ArCH), 120.0 (triazole-CH), 118.3 (ArCH), 
80.9 (CHO), 61.2 (CH2CH2O), 52.9 (CH2NH), 47.5 (CHCO), 44.1 (CH2NH), 37.8 
(CH2CH2N), 21.3 (CH3); IR ν cm
-1
 2914 (saturated C-H), 1698 (imide and ester C=O), 1271 
(C-O); HRMS (ESI
+
) : m/z found, 528.2238 calc for C29H30N5O5 528.2241 [3.26+H]
+
. 
3.27 
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Compound 3.26 (100 mg, 0.2 mmol), was dissolved in CH2Cl2 (5 mL) and washed with a 
10% aqueous solution of HClO4 (2 x 10 mL). The organic layer was dried over MgSO4 and 
the solvent removed in vacuo. The crude solid was recrystallised from acetonitrile/Et2O to 
provide a yellow solid (80 mg, 0.13 mmol, 68%). m.p. 150-151°C; 
1
H NMR (400 MHz, 298 
K, CD3CN) δH 8.35 (s, 1H, triazole CH), 8.02 (d, 2H, J = 8.0 Hz, 2 ArCHCCO2), 7.60 (d, 
2H, J = 8.0 Hz, 2 ArCHCCH2), 7.43 (broad s, 4H, NH2 and 2 ArCH), 7.19 (s, 1H, ArCH), 
6.49 (s, 2H, CH=CH), 5.09 (s, 2H, 2 CHO), 4.45 (broad s, 2H, CH2NH2), 4.38 (m, 4H, 
CH2NH2 and CH2CH2O), 3.80 (t, 2H, J = 5.0 Hz, CH2CH2N), 2.87 (s, 2H, 2 CHCO), 2.41 (s, 
6H, 2 CH3); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 176.3 (imide C=O), 165.0 (COO), 
139.8 (ArC), 137.6 (ArC), 136.3 (ArC), 136.1 (ArC) 135.0 (CH=CH), 134.1 (ArC), 130.8 
(ArCH), 130.0 (ArCH), 129.6 (ArCH), 123.4 (triazole-CH), 117.9 (ArCH), 80.6 (CHO), 
61.6 (CH2CH2O), 49.9 (CH2NH2), 47.1 (CHCO), 41.7 (CH2NH2), 36.9 (CH2CH2N), 20.0 
(CH3); IR ν cm
-1
 3163 (NH stretching), 1700 (imide C=O stretching), 1061 (ClO4); HRMS 
(ESI
+
): m/z found, 528.2239 calc for C29H30N5O5
+
 528.2241 [3.27-ClO4]
+
. 
3.28 
 
Compound 3.27 (50 mg, 0.08 mmol) was dissolved in acetonitrile (1 mL) and reacted under 
microwave irradiation (150W, 110 °C, 3 h). The solvent and furan were removed in vacuo to 
provide a beige solid (41 mg, 0.073 mmol, 92%). m.p 204-205°C; 
1
H NMR (400 MHz, 298 
K, CD3CN) δH 8.36 (s, 1H, triazole-CH), 8.01 (d, 2H, J = 8.0 Hz, 2 ArCHCCO), 7.61 (d, 2H, 
J = 8.0 Hz, 2 ArCHCCH2), 7.43 (s, 2H, 2 ArCH), 7.18 (s, 1H, ArCH), 6.77 (s, 2H, CH=CH), 
4.45 (broad s, 2H, CH2NH2
+
), 4.39 (m, 4H, CH2NH2
+
 and CH2CH2O), 3.84 (t, 2H, J = 5.3 
Hz, CH2CH2N), 2.41 (s, 6H, 2 CH3); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 170.9 (imide 
C=O), 165.4 (COO), 140.1 (ArC), 137.9 (ArC), 136.6 (ArC), 136.5 (CH=CH), 135.3 (ArC), 
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131.2 (ArC), 130.7 (ArCH), 130.5 (ArCH), 130.2 (ArCH), 123.8 (triazole CH), 118.3 
(ArCH), 62.5 (CH2CH2O), 50.4 (CH2NH2
+
), 42.1 (CH2NH2
+
), 36.6 (CH2CH2N), 20.3 (CH3); 
IR ν cm-1 3092 (saturated C-H), 1723 (imide C=O), 1072 (ClO4); HRMS (ESI
+
): found, 
460.1990 calc for C25H26N5O4 460.1979 [3.28-ClO4]
+
; CHN Analysis Found: C 53.13; H 
4.65; N 12.10. Calc. for C25H26N5O8Cl: C, 53.62; H, 4.68; N, 12.51%. 
3.29 
 
Thread 3.28 (10mg, 0.018 mmol) was dissolved in deuterated acetonitrile. DB24C8 (40 mg, 
4 equivalents, 0.072 mmol) was added to the mixture. Pseudorotaxane formation was 
monitored by 
1
H NMR. Pseudorotaxane 3.29 
1
H NMR (400 MHz, 298 K, CD3CN) δH  8.05 
(s, 1H,  triazole-CH), 7.91 (broad s,  NH2), 7.59 (m, 2H,  2 ArCHCCO), 7.40 (d, 2H, J 
= 8.0 Hz,  2 ArCHCCH2), 7.23 (s, 2H,   2 ArCH), 7.14 (s, 1H,  ArCH), 6.80 (s, 2H,  
CH=CH), 6.75 (m, 8H,  8 crown ArCH), 4.89 (m, 2H,  CH2NH2
+
), 4.82 (m, 2H,  
CH2NH2), 4.34 (t, 2H, J = 5.0 Hz,  CH2CH2O), 4.09-4.06 (m, 8H,  4 OCH2), 3.94 -3.86 
(m, 10H,  4 OCH2,  CH2CH2N), 3.76  (s, 8H,  4 OCH2), 2.38 (s, 6H,  2 CH3); Also 
contains unthreaded DB24C8 
1
H NMR (400 MHz, 298 K, CD3CN) δH 6.93 (m, 8H, 8 
ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 8H, 4 OCH2), 3.72 (s, 8H, 4 OCH2). 
3.30 
 
To the pseudorotaxane 3.29 in acetonitrile was added a few drops of freshly distilled 
cyclopentadiene. Excess cyclopentadiene and acetonitrile were removed in vacuo. The solid 
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was extracted with hot benzene (3 x 5 mL) to remove excess crown leaving [2]rotaxane (12 
mg, 0.11 mmol, 62 %). 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.05 (s, 1H,  triazole-CH), 
7.97 (broad s, 2H,  NH2), 7.68 (d, 2H, J = 8.0 Hz,  2 ArCHCCO), 7.49 (d, 2H, J = 8.0 
Hz,  2 ArCHCCH2), 7.25 (s, 2H,  2 ArCH), 7.18 (s, 1H,  ArCH), 6.81 (s, 8H,  8 
crown ArCH), 5.93 (s, 2H,  CH=CH), 4.90 (m, 4H,  CH2NH2
+
CH2), 4.27 (t, 2H,  
CH2CH2O), 4.09 (m, 8H,  4 OCH2), 3.90 (m, 4H,  2 OCH2), 3.84 (m, 4H,  2 OCH2), 
3.75 (s, 8H,  4 OCH2), 3.68 (t, 2H,  CH2CH2N), 3.30 (s, 2H,  2 CHCO), 3.26 (s, 2H,  
2 CHCH2), 2.24 (s, 6H,  2 CH3), 1.60 (d, 1H, J = 9.0 Hz,  CHH), 1.57 (d, 1H, J = 9.0 Hz, 
 CHH); 13C NMR (100 MHz, 298 K, CD3CN) δC 178.9 (imide C=O), 166.5 (COO), 148.6 
(ArC), 141.2 (ArC), 140.9 (ArC), 138.1 (ArC), 137.8 (ArC), 135.6 (CH=CH), 131.8 
(ArCH), 131.5 (ArC), 131.3 (ArCH), 130.7 (ArCH), 123.9 (ArCH), 122.5 (triazole-CH), 
119.6 (ArCH), 113.7 (ArCH), 72.1 (OCH2), 71.6 (OCH2), 69.0 (OCH2), 62.9 (CH2CH2O), 
53.4 (bridgehead CH2), 53.1 (CH2NH2
+
), 47.0 (CHCH2), 46.1 (CHCO), 44.9 (CH2NH2
+
), 
38.2 (CH2CH2N), 21.6 (CH3); IR ν cm
-1 
2924 (saturated C-H), 1697 (imide and ester C=O), 
1251 (C-O), 1093 (ClO4); HRMS (ESI
+
): m/z found, 974.4550 calc for, C54H64N5O12 
974.4546 [3.30-ClO4]
+
. 
3.31 
 
To 2.27 (100 mg, 0.29 mmol) in MeOH (5 mL), propargyl amine (0.023 mL, mmol) was 
added. The solution was stirred at room temperature overnight. The reaction mixture was 
diluted with water (20 mL) and extracted with CH2Cl2 (3 x 15 mL). The combined organic 
extracts were dried over MgSO4 and the solvent removed in vacuo to provide a yellow oil 
used without further purification (95 mg, 0.25 mmol, 86%). 
1
H NMR (300 MHz, 298 K, 
CDCl3) δH 8.63 (s, 1H, CH=N), 8.03 (d, 2H, J = 8.0 Hz, 2 ArCHCCO), 7.84 (d, 2H, J = 8.0 
Hz, 2 ArCHCCH), 5.96 (s, 2H, CH=CH), 4.56 (s, 2H, CH2N), 4.33 (t, 2H, J = 5.0 Hz, 
CH2CH2O), 3.77 (t, 2H, J = 5.0 Hz, CH2CH2N), 3.34 (s, 2H, 2 CHCO), 3.27 (broad s, 2H, 2 
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CHCH2), 2.56 (s, 1H, C≡CH), 1.66 (d, 1H, J = 9.0 Hz, CHH), 1.52 (d, 1H, J = 9.0 Hz, 
CHH); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 177.9 (imide C=O), 165.5 (COO), 161.1 
(CH=N), 139.6 (ArC), 134.1 (CH=CH), 131.4 (ArC), 129.8 (ArCH), 128.1 (ArCH), 78.5 
(C≡CH), 76.1 (C≡CH), 61.9 (CH2CH2O), 52.2 (bridgehead CH2), 47.2 (CH2N), 45.8 
(CHCH2), 44.9 (CHCO), 37.1 (CH2CH2N); IR ν cm
-1
 2946 (saturated C-H), 1693 (imide and 
ester C=O), 1647 (C=N), 1268 (C-O); MS (ESI
+
): m/z 377.2 [3.31+H]
+
. 
3.32 
 
To the imine 3.31 (100mg, 0.27 mmol) in MeOH (3 mL), sodium cyanoborohydride (20 mg, 
0.3 mmol) and HOAc (2 drops) were added. The solution was stirred at room temperature 
for 2 h. The mixture was diluted with water (10 mL) and extracted with CH2Cl2 (3 x 10 mL). 
The combined organic extracts were dried over MgSO4 and the solvent removed in vacuo. 
The crude product was purified via flash chromatography (SiO2: CH2Cl2:MeOH; 95:5) to 
provide a yellow oil (87 mg, 0.23 mmol, 85%). 
1
H NMR (400 MHz, 298 K, CDCl3) δH 7.93 
(d, 2H, J = 8.0 Hz, 2 ArCHCCO), 7.40 (d, 2H, J = 8.0 Hz, 2 ArCHCCH), 5.96 (s, 2H, 2 
CH=CH), 4.29 (t, 2H, J = 5.0 Hz, CH2CH2O), 3.92 (s, 2H, CH2NH), 3.75 (t, 2H, J = 5.0 Hz, 
CH2CH2N), 3.41 (s, 2H, CH2C≡CH), 3.33 (s, 2H, 2 CHCO), 3.25 (broad s, 2H, 2 CHCH2), 
2.27 (s, 1H, C≡CH), 1.65 (d, 1H, J = 9.0 Hz, CHH), 1.49 (d, 1H, J = 9.0 Hz, CHH); 13C 
NMR (100 MHz, 298 K, CDCl3) δC 177.5 (imide C=O), 166.1 (COO), 144.7 (ArC), 134.5 
(CH=CH), 129.8 (ArC), 128.9 (ArCH), 128.7 (ArCH), 81.5 (C≡CH), 72.05 (C≡CH), 61.7 
(CH2CH2O), 53.5 (bridgehead CH2), 52.2 (CH2C≡CH), 51.7 (CH2NH), 45.8 (CHCH), 44.8 
(CHCO), 37.26 (CH2CH2N); IR ν cm
-1 
3267 (N-H), 2987 (saturated C-H), 1692 (imide and 
ester C=O); HRMS (ESI
+
): m/z found, 379.1648 calc for C22H23N2O4 379.1652 [3.32+H]
+
.  
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3.33 
 
CuSO4.5H2O (6 mg, 0.02 mmol) and sodium ascorbate (14 mg, 0.08 mmol) were dissolved 
in tert-butanol (5 mL), THF (5 mL) and water (5 mL). The propargyl amine 3.32 (90 mg, 
0.24 mmol) and azide 3.06 (38 mg, 0.24 mmol) were added and the solution stirred at room 
temperature for 48 h. The solution was diluted with water (20 mL) and extracted with 
CH2Cl2 (3 x 15 mL). The combined organic extracts were dried over MgSO4 and the solvent 
removed in vacuo. The crude product was purified via column chromatography (SiO2: 
CH2Cl2 to CH2Cl2:MeOH; 95:5) to give a yellow oil (80 mg, 0.15 mmol, 63%). 
1
H NMR 
(400 MHz, 298 K, CD3Cl) δH 7.97 (d, 2H, J = 8.0 Hz, 2 ArCHCCO), 7.41 (m, 3H, 2 
ArCHCCH2 and triazole-CH), 7.01 (s, 1H, ArCH), 6.92 (s, 2H, 2 ArCH), 6.01 (s, 2H,  
CH=CH), 5.45 (s, 2H, CH2N-triazole), 4.34 (t, 2H, J = 5.0 Hz, CH2CH2O), 3.91-3.90 (broad 
m, 4H, CH2NHCH2), 3.80 (t, 2H, J = 5.0 Hz, CH2CH2N), 3.39 (s, 2H, 2 CHCO), 3.30 (s, 2H, 
2 CHCH2), 2.32 (s, 6H, 2 CH3), 1.72 (d, 1H, J = 9.0 Hz, CHH), 1.54 (d, 1H, J = 9.0 Hz, 
CHH); 
13
C NMR (100 MHz, 298 K, CD3Cl) δC 177.4 (imide C=O), 166.1 (COO), 146.8 
(ArC), 145.4 (ArC), 138.8 (ArC), 134.5 (ArC), 134.3 (CH=CH), 130.4 (ArCH), 129.9 
(ArCH), 128.5 (ArC), 128.2 (ArCH), 126.0 (ArCH), 121.6 (triazole-CH), 61.7 (CH2CH2O), 
54.2 (CH2N-triazole), 53.0 (CH2NH), 52.2 (bridgehead CH2), 45.8 (CHCH2), 45.0 (CHCO), 
44.2 (CH2NH), 37.2 (CH2CH2N), 21.2 (CH3); IR ν cm
-1 
2994 (saturated C-H), 1694 (imide 
and ester C=O), 1609 (C-O); HRMS (ESI
+
): m/z 540.2608 calc for C31H34N5O4 540.2605 
[3.33+H]
+
. 
3.35 
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The neutral thread (50 mg, 0.093 mmol) was dissolved in CH2Cl2 (5 mL). The organic layer 
was washed with a 10% aqueous solution of HClO4 (3 x 10 mL) and dried through filter 
paper. The solvent was removed and the crude solid recrystallised from acetonitrile/Et2O to 
give an off white solid (30 mg, 0.055 mmol, 59%). m.p. 144-146°C;
 1
H NMR (400 MHz, 
298 K, CD3CN) δH 8.02 (d, 2H, J = 8.0 Hz, 2 ArCHCCO), 7.97 (s, 1H, triazole-CH), 7.59 (d, 
2H, J = 8.0 Hz, 2 ArCHCCH2), 7.40 (br s, 2H, NH2), 7.01 (s, 1H, ArCH), 6.94 (s, 2H, 2 
ArCH), 5.93 (s, 2H, CH=CH), 5.50 (s, 2H, CH2N-triazole), 4.36 (br m, 4H, CH2NH2
+
CH2), 
4.29 (t, 2H, J = 5.0 Hz, CH2CH2O), 3.67 (t, 2H, J = 5.0 Hz, CH2CH2N), 3.28 (s, 2H, 2 
CHCO), 3.24 (s, 2H, 2 CHCH2), 2.27 (s, 6H, 2 CH3), 1.59 (d, 1H, J = 8.5 Hz, CHH), 1.56 (d, 
1H, J = 8.5 Hz, CHH);  
13
C NMR (100 MHz, 298 K, CD3CN) δC 177.8 (imide C=O), 165.0 
(COO), 138.4 (ArC), 137.1 (ArC), 135.0 (ArC), 134.9 (ArC), 133.9 (CH=CH), 131.2 (ArC), 
130.1 (ArCH), 129.6 (ArCH), 125.3 (ArCH), 125.1 (ArCH), 120.1 (triazole-CH), 61.7 
(CH2CH2O), 53.3 (CH2N-triazole), 51.5(bridgehead CH2), 50.0 (CH2NH2
+
), 45.3 (CHCH2), 
44.3 (CHCO), 41.8 (CH2NH2
+
), 36.6 (CH2CH2N), 19.9 (CH3); IR ν cm
-1
 3151 (saturated C-
H), 1701 (ester and imide C=O), 1102 (ClO4); HRMS (ESI
+
): m/z found, 540.2607 calc for, 
C31H34N5O4 540.2605 [3.35-ClO4]
+
.  
3.34 
 
CuSO4.5H2O (21 mg, 0.08 mmol) and sodium ascorbate (51 mg, 0.25 mmol) were dissolved 
in tert-butanol (5 mL), THF (5 mL) and water (5 mL). The propargyl amine 3.32 (300 mg, 
0.8 mmol) and azide 3.11 (114 mg, 0.8 mmol) were added and the solution stirred at room 
temperature for 48 h. The solution was diluted with water (20 mL) and extracted with 
CH2Cl2 (3 x 15 mL). The combined organic extracts were dried over MgSO4 and the solvent 
removed in vacuo. The crude product was subjected to column chromatography (SiO2: 
CH2Cl2 to CH2Cl2:MeOH; 95:5) to give a yellow oil (150 mg, 0.29 mmol, 36%). 
1
H NMR 
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(400 MHz, 298 K, CDCl3) δH 7.98 (d, 2H, J = 8.0 Hz, 2 ArCHCCO2), 7.90 (s, 1H, triazole-
CH), 7.46 (d, 2H, J = 8.0 Hz, 2 ArCHCCH2), 7.35 (s, 2H, 2 ArCH), 7.07 (s, 1H, ArCH), 
6.06 (s, 2H, CH=CH), 4.33 (t, 2H, J = 5.3 Hz, CH2CH2O), 4.02 (br s, 2H, CH2NH), 3.96 (br 
s, 2H, CH2NH), 3.79 (t, 2H, J = 5.0 Hz, CH2CH2N), 3.37 (s, 2H, 2 CHCO), 3.28 (s, 2H, 2 
CHCH2), 2.41 (s, 6H, 2 CH3), 1.69 (d, 1H, J = 9.0 Hz, CHH), 1.55 (d, 1H, J = 9.0 Hz, 
CHH); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 177.4 (imide C=O), 166.0 (COO), 145.6 
(ArC), 137.7 (ArC), 139.6 (ArC), 136.9 (ArC), 134.4 (CH=CH), 134.3 (ArCH), 130.3 
(ArCH), 129.9 (ArCH), 128.7 (ArC), 128.4 (ArCH), 118.3 (triazole-CH), 61.6 (CH2CH2O), 
53.1 (CH2NH), 52.1 (bridgehead CH2), 45.8 (CHCH2), 44.9 (CHCO), 41.2 (CH2NH), 37.2 
(CH2CH2N), 21.3 (CH3); IR ν cm
-1 
2943 (saturated C-H), 1700 (ester and imide C=O), 1613 
(C≡C); HRMS (ESI+): m/z found, 526.2448 calc for C30H32N5O4 526.2449 [3.34+H]
+
. 
3.36 
 
The neutral thread (50 mg, 0.095 mmol) was dissolved in CH2Cl2 (5 mL). The organic layer 
was washed with a 10% aqueous solution of HClO4 10% (3 x 10 mL) and dried over 
MgSO4. The solvent was removed in vacuo and the crude product recrystallised from 
acetonitrile/Et2O to give a cream solid (40 mg, 0.06 mmol, 67%). m.p. 145-146°C;
 1
H NMR 
(400 MHz, 298 K, CD3CN) δH 8.34 (s, 1H, CH-triazole), 8.04 (d, 2H, J = 8.0 Hz, 2 
ArCHCCO2), 7.62 (d, 2H, J = 8.5 Hz, 2 ArCHCCH2), 7.43 (s, 2H, 2 ArCH), 7.19 (s, 1H, 
ArCH), 5.94 (s, 2H, CH=CH), 4.44 (br s, 2H, CH2NH2
+
), 4.38 (br s, 2H, CH2NH2
+
), 4.29 (t, 
2H, J = 5.3 Hz, CH2CH2O), 3.67 (t, 2H, J = 5.0 Hz, CH2CH2N), 3.27 (s, 2H, 2 CHCO), 3.24 
(s, 2H, 2 CHCH2), 2.41 (s, 6H, 2 CH3), 1.60 (d, 2H, J = 8.5 Hz, CHH), 1.57 (d, 2H, J = 8.5 
Hz, CHH); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 177.7 (imide C=O), 165.4 (COO), 
140.1 (ArC), 136.6 (ArC), 135.4 (ArC), 134.3 (CH=CH), 131.2 (ArC), 130.7 (ArCH), 130.5 
(ArCH), 130.0 (ArCH), 128.0 (ArC), 123.8 (triazole-CH), 118.3 (ArCH), 62.0 (CH2CH2O), 
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51.8 (bridgehead CH2), 50.3 (CH2NH2
+
), 45.6 (CHCH2), 44.7 (CHCO), 42.0 (CH2NH2
+
), 
36.9 (CH2CH2N), 20.3 (CH3); IR ν cm
-1
 3305 (NH), 1686 (imide and ester C=O); HRMS 
(ESI
+
): m/z found, 526.2450 calc for, 526.2449 [3.36-ClO4]
+
. 
3.38 
 
Known compound data consistent with literature.
190
 1,10-dibromodecane (2.5 g, 8.42 mmol) 
was dissolved in DMF (25 mL). Sodium azide (2.9 g, 44.6 mmol) was added and the 
solution heated to 60°C for 24 h. The DMF was removed in vacuo and the residue diluted 
with water (20 mL). The solution was extracted with CH2Cl2 (3 x 20 mL), the combined 
organic extracts were washed with water and dried over MgSO4 and the oil purified via flash 
chromatography (SiO2: petroleum ether/EtOAc 95:5) to provide a clear liquid (1.88 g, 8.40 
mmol, 100%). 
1
H NMR (400 MHz, 298 K, CDCl3) δH 3.27 (t, 4H, J = 7.0 Hz, 2 CH2N3), 
1.60 (m, 4H, 2 CH2), 1.39-1.31 (m, 12H, CH2(CH2)6CH2); 
13
C NMR (100 MHz, 298 K, 
CDCl3) δC 51.4 (CH2N3), 29.3 (CH2), 29.0 (CH2), 28.8 (CH2), 26.6 (CH2); IR ν cm
-1
 2927 
(C-H stretching), 2087 (-N3).  
3.39 
 
Propargyl amine 3.19 (650 mg, 1.7 mmol) and 1,10-diazidodecane 3.38 (250 mg, 1.02 
mmol) were dissolved in a two phase solution of CH2Cl2 (10  mL) and water (10 mL). 
Sodium ascorbate (75 mg, 0.37 mmol) and CuSO4.5H2O (28 mg, 0.11 mmol) were added 
and the solution was stirred at room temperature for 24 h. The organic layer was removed 
and the aqueous was further extracted with CH2Cl2 (2 x 10 mL). The combined organic 
extracts were dried over MgSO4, filtered and the solvent removed in vacuo. The crude 
residue was purified via flash chromatography (SiO2: gradient elution CH2Cl2:MeOH; 100:0 
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to 90:10) to give a pale orange solid (100 mg, 0.07 mmol, 10%). m.p. 124-125 °C; 
1
H NMR 
(400 MHz, 298 K, CDCl3) δH 7.95 (d, 4H, J = 8.0 Hz, 4 ArCHCCO2), 7.46 (s, 2H, 2 triazole-
CH), 7.39 (d, 4H, J = 8.0 Hz, 4 ArCHCCH2), 6.49 (s, 4H, 2 CH=CH), 5.23 (s, 4H, 4 CHO), 
4.43 (t, 4H, J = 5.0 Hz, 2 CH2CH2O), 4.32 (t, 4H, J = 7.0 Hz, 2 CH2N-triazole), 3.91-3.88 
(m, 12H, 2 CH2CH2N and 2 CH2NHCH2), 2.99 (br s, 2H, 2 NH), 2.86 (s, 4H, 4 CHCO), 1.87 
(br m, 4H, 2 triazole-NCH2CH2), 1.29-1.25 (br m, 12H, CH2(CH2)6CH2); 
13
C NMR (100 
MHz, 298 K, CDCl3) δC 176.0 (imide C=O), 166.1 (COO), 146.0 (ArC), 144.9 (ArC), 136.6 
(CH=CH), 129.9 (ArCH), 128.7 (ArC), 127.8 (ArCH), 121.7 (triazole-CH),  80.9 (CHO), 
61.2 (CH2CH2O), 53.4 (CH2NH), 50.7 (CH2N-triazole), 47.5 (CHCO), 43.9 (CH2NH), 37.8 
(CH2CH2N), 30.2 (CH2), 29.2 (CH2), 28.9 (CH2), 26.4 (CH2); IR ν cm
-1
 2957 (saturated C-
H), 1699 (imide C=O), 1431 (C-O); HRMS (ESI
+
): m/z 985.4603 calc for C52H61N10O10 
985.4567 [3.39+H]
+
. 
3.40 
 
The neutral thread 3.39 (100 mg, 0.1 mmol) was dissolved in CH2Cl2 (5 mL). The organic 
layer was washed with a 10% aqueous solution of HClO4 (3 x 10 mL) and dried over 
MgSO4. The solvent was removed in vacuo and the crude solid recrystallised from 
acetonitrile/Et2O to provide a white solid (120 mg, 0.1 mmol, 100 %). m.p.176-177°C 
(decomp.); 
1
H NMR (400 MHz, 298 K, CD3CN) δH  8.01 (d, 4H, J = 8.0 Hz, 4 ArCHCCO2), 
7.93 (s, 2H, 2 triazole-CH), 7.78 (br s, 4H, 2 NH2), 7.62 (d, 4H, J = 8.0 Hz, 4 ArCHCCH2), 
6.49 (s, 4H, 2 CH=CH), 5.08 (s, 4H, 4 CH-O), 4.66-4.60 (m, 8H, 2 CH2N-triazole, 2 
CH2NH2
+
), 4.45 (broad s, 4H, 2 CH2NH2
+
), 4.38 (t, 4H, J = 5.0 Hz, 2 CH2CH2O), 3.80 (t, 
4H, J = 5.0 Hz, 2 CH2CH2N), 2.87 (s, 4H, 4 CHCO), 1.95 (br m, 4H, 2 NCH2CH2), 1.32-
1.28 (br m, 12H, CH2(CH2)6CH2); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 176.3 (imide 
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C=O), 164.9 (COO), 136.5 (CH=CH), 134.5 (ArC), 133.3 (ArC), 131.5 (ArC), 130.7 
(triazole-CH), 130.4 (ArCHCCO2), 130.1 (ArC), 80.9 (CHO), 61.5 (CH2CH2O), 54.1 
(CH2NH2
+
), 51.5 (CH2NH2
+
), 47.5 (CHCO), 39.3 (triazole-NCH2), 37.3 (CH2CH2N), 28.9 
(CH2), 28.7 (CH2), 28.4 (CH2), 25.5 (CH2); IR ν cm
-1
 1694 (imide and ester C=O), 1276 (C-
O), 1057 (ClO4). 
3.41 
 
The perchlorate salt 3.40 (120 mg, 0.10 mmol) was dissolved in acetonitrile (3 mL) and 
reacted under microwave irradiation (150 W, 180 minutes, 110°C). The solvent and furan 
were removed under reduced pressure to provide a yellow solid (98 mg, 0.10 mmol, 100 %). 
m.p. 72-73°C; 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.02-8.00 (m, 6H, 4 ArCHCCO2 and 
2 triazole-CH), 7.64 (d, 4H, J = 8.0 Hz, 4 ArCHCCH2), 6.81 (s, 4H, 2 CH=CH), 4.46-4.37 
(m, 16H, 2 CH2NH2
+
CH2, 2 CH2CH2O and 2 CH2N-triazole), 3.87 (t, 4H, J = 5.3 Hz, 2 
CH2CH2N), 1.86 (br m, 4H, 2 NCH2CH2), 1.30-1.25 (br m, 12H, CH2(CH2)6CH2); 
13
C NMR 
(100 MHz, 298 K, CD3CN) δC 170.6 (imide C=O), 165.1 (COO), 134.9 (ArC), 134.1 
(CH=CH), 130.9 (ArC), 130.2 (ArCH), 129.6 (ArCH), 127.3 (ArC), 125.0 (triazole-CH), 
62.2 (CH2CH2O), 50.0 (CH2NH2
+
), 49.9 (CH2NH2
+
), 41.9 (CH2N-triazole), 36.2 
(CH2CH2N), 29.5 (CH2), 28.5 (CH2), 28.1 (CH2), 25.6 (CH2); IR ν cm
-1
 2930 (saturated C-
H), 1704 (imide and ester C=O), 1273 (C-O), 1071 (ClO4); HRMS (ESI
+
) : m/z 425.2053 
calc for C44H54N10O8 425.2058 [3.41-2ClO4]
2+
. 
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3.42 
 
Thread 3.41 (10 mg, 0.01 mmol) was dissolved in deuterated acetonitrile along with 
DB24C8 (36 mg, 0.08 mmol). Pseudorotaxane formation was monitored by 
1
H NMR. 
Pseudorotaxane 3.42 
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.74 (s, 2H,  2 triazole-CH), 
7.49 (d, 4H, J = 8.0 Hz,  4 ArCHCCO2), 7.33 (d, 4H, J = 8.0 Hz,  4 ArCHCCH2), 6.81 (s, 
4H,  2 CH=CH), 6.93-6.88 (m, 16H,  16 crown ArCH), 4.80-4.79 (m, 8H,  2 
CH2NH2
+
CH2), 4.32 (t, 4H, J = 5.3 Hz,  2 CH2CH2O), 4.25 (t, 4H, J = 7.0 Hz,  2 CH2N-
triazole), 4.04-3.95 (m, 16H,  8 OCH2), 3.88-3.68 (m, 36H,  16 OCH2 and  2 
CH2CH2N), 1.75 (m, 4H,  2 triazole-NCH2CH2), 1.21-1.17 (m, 12H,  CH2(CH2)6CH2); 
Also contains unthreaded DB24C8 
1
H NMR (400 MHz, 298 K, CD3CN) δH 6.93 (m, 8H, 8 
ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 8H, 4 OCH2), 3.72 (s, 8H, 4 OCH2). 
3.43 
 
To the pseudorotaxane 3.42 (19 mg, 0.01 mmol) in acetonitrile, 2 drops of freshly distilled 
cyclopentadiene were added and the solvent immediately removed in vacuo. The orange oil 
was extracted with hot benzene (5 x 2 mL) to leave a white solid (12 mg, 0.006 mmol, 58%). 
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.79 (br s, 4H,  2 NH2
+
), 7.71 (s, 2H,  2 triazole-
CH), 7.56 (d, 4H, J = 8.0 Hz,  4 ArCHCCO), 7.39 (d, 4H, J = 8.0 Hz,  4 ArCHCCH2), 
6.82-6.73 (m, 16H,  16 crown ArCH), 5.89 (s, 4H,  2 CH=CH), 4.83-4.75 (m, 8H,  2 
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CH2NH2
+
CH2), 4.25-4.21 (m, 8H,  2 CH2CH2O and  2 CH2N-triazole), 4.08-3.98 (m, 
16H,  8 OCH2), 3.75 (m, 32H,  16 OCH2), 3.64 (t, 4H, J = 5.3 Hz,  2 CH2CH2N), 3.27 
(br s, 4H,  4 CHCH2), 3.23 (br s, 4H,  4 CHCO), 1.75 (m, 4H,  2 NCH2CH2), 1.59 (d, 
2H, J = 9.0 Hz,  2 CHH), 1.54 (d, 2H, J = 9.0 Hz,  2 CHH), 1.23-1.19 (m, 12H,  
CH2(CH2)6CH2); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 177.2 (imide C=O), 164.8 (COO), 
146.8 (ArC), 138.4 (ArC), 136.4 (CH=CH), 130.2 (ArC), 129.6 (ArCH), 128.8 (ArCH), 
128.0 (ArCH), 123.8 (ArCH), 121.0 (triazole-CH), 111.9 (ArCH), 70.3 (OCH2), 69.8 
(OCH2), 67.3 (OCH2), 61.7 (CH2CH2O), 51.6 (bridgehead CH2), 51.4 (CH2NH2
+
), 49.6 
(CH2NH2
+
), 45.3 (CHCH2), 44.4 (CHO), 43.4 (CH2N-triazole), 36.5 (CH2CH2N), 29.5 
(CH2), 28.7 (CH2), 28.2 (CH2), 25.7 (CH2); HRMS (ESI
+
): m/z found, 939.9640 calc for 
C102H130N10O24 939.9640 [3.43-2ClO4]
2+
. 
3.44 
 
CuSO4.5H2O (6 mg, 0.06 mmol) and sodium ascorbate (15 mg, 0.08 mmol) were dissolved 
in CH2Cl2 (10 mL) and water (10 mL). The propargyl amine 3.19 (135 mg, 0.36 mmol) and 
azide 3.38 (36 mg, 0.16 mmol) were added and the reaction stirred at room temperature for 
24 h. The reaction was diluted with water (20 mL) and extracted with CH2Cl2 (3 x 20 mL). 
The combined organic layers were dried over MgSO4 and solvent removed in vacuo. The 
crude was purified via flash chromatography (SiO2: CH2Cl2 to CH2Cl2 /MeOH 9:1) to give a 
viscous oil (60 mg, 0.06 mmol, 38%). 
1
H NMR (400 MHz, 298 K, CDCl3) δH 7.94 (d, 4H, J 
= 8.0 Hz, 4 ArCHCOO2), 7.45 (s, 2H, 2 triazole-CH), 7.41 (d, 4H, J = 8.0 Hz, 4 
ArCHCCH2), 5.95 (s, 4H, 2 CH=CH), 4.33-4.29 (m, 8H, 2 CH2CH2O and 2 CH2N-triazole), 
3.89 (m, 8H, 2 CH2NHCH2), 3.79 (t, 4H, J = 8.0 Hz, 2 CH2CH2N), 3.34 (br s, 4H, 4 
CHCH2), 3.26 (br s, 4H, 4 CHCO), 2.45 (br s, 2H, 2 NH), 1.87 (m, 4H, 2 triazole-N-
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CH2CH2), 1.68 (d, 2H, J = 9.0 Hz, 2 CHH), 1.50 (d, 2H, J = 9.0 Hz, 2 CHH), 1.29-1.24 (m, 
12H, CH2(CH2)6CH2); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 177.4 (imide C=O), 166.1 
(COO), 146.3 (ArC), 145.3 (ArC), 134.3 (CH=CH), 129.9 (ArCH), 128.5 (ArC), 126.2 
(ArCH), 121.5 (triazole-CH), 61.6 (CH2CH2O), 52.9 (CH2NH), 52.2 (bridgehead CH2), 50.3 
(CH2), 45.8 (CHCH2), 44.9 (CHCO), 44.1 (CH2N-triazole), 37.2 (CH2CH2N), 30.3 (CH2), 
29.2 (CH2NH), 28.9 (CH2), 26.4 (CH2); IR ν cm
-1
 2931 (saturated C-H), 1694 (ester and 
imide C=O), 1270 (C-O). 
3.45 
 
The neutral thread 3.44 (70 mg, 0.07 mmol) was dissolved in MeOH (1 mL) and a few drops 
of 70% HClO4 were added, the reaction mixture was diluted with water (10 mL) and 
extracted with CH2Cl2 (3 x 5 mL). The combined organic layers were dried over MgSO4 and 
the solvent removed in vacuo providing a white solid recrystallised from acetonitrile/Et2O 
(25 mg, 0.021 mmol, 30%). m.p. 89-90°C (decomp.); 
1
H NMR (400 MHz, 298 K, CD3CN) 
δH 8.02 (d, 4H, J = 8.0 Hz, 4 ArCHCCO2), 7.94 (s, 2H, 2 triazole-CH), 7.62 (d, 4H, J = 8.0 
Hz, 4 ArCHCCH2), 5.94 (t, 4H, J = 1.8 Hz, 2 CH=CH), 4.39-4.36 (m, 12H, 2 CH2N-triazole 
and 2 CH2NH2
+
CH2), 4.29 (t, 4H, J = 5.0 Hz, CH2CH2O), 3.68 (t, 4H, J = 5.0 Hz, 
CH2CH2N), 3.29 (br s, 4H, 4 CHCO), 3.24 (br s, 4H, 4 CHCH2), 1.86 (m, 4H, 2 triazole-
NCH2CH2), 1.60 (d, 2H, J = 9.0 Hz, CHH), 1.54 (d, 2H, J = 9.0 Hz, CHH), 1.28-1.25 (m, 
12H, CH2(CH2)6CH2); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 179.0 (imide C=O), 168.0 
(COO), 136.7 (ArC), 136.7 (ArC), 134.0 (CH=CH), 132.5 (ArC), 131.8 (ArCH), 131.3 
(ArCH), 126.7 (triazole-CH), 62.1 (CH2CH2O), 53.1 (CH2NH2
+
), 51.7 (bridgehead CH2), 
51.5 (CH2NH2
+
), 47.0 (CHCH2), 46.0 (CHCO), 43.6 (CH2N-triazole), 38.2 (CH2CH2N), 31.2 
(CH2), 30.2 (CH2), 29.8 (CH2), 27.2 (CH2); IR ν cm
-1
 2932 (saturated C-H), 1693 (imide and 
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ester C=O), 1273 (C-O), 1096 (ClO4); HRMS (ESI
+
): m/z found, 491.2529 calc for 
C54H66N10O8 491.2527 [3.45-2ClO4]
2+
.  
3.49 
 
Known compound synthesised according to literature procedure.
171
 Naphthalene-1,5-diol 
(4.0 g, 25 mmol) and potassium carbonate (34.5 g, 25.2 mmol) were dissolved in acetonitrile 
(200 mL). 2-(2-Chloroethoxy)ethanol (5.05 mL, 50 mmol) was dissolved in acetonitrile (40 
mL) and added dropwise to the suspension over 30 minutes. The resulting solution was 
heated to reflux overnight, allowed to cool and filtered through celite. The solvent was 
removed and the resulting brown solid recyrstallised from toluene to provide pale brown 
crystals (5.2 g, 15.3 mmol, 62 %). m.p. 95-97°C; 
1
H NMR (400 MHz, 298 K, CDCl3) δH 
7.87 (d, 2H, J = 8.0 Hz, 2 NaphthCH), 7.36 (t, 2H, J = 8.0 Hz, 2 NaphthCH), 6.84 (d, 2H, J 
= 8.0 Hz, 2 NaphthCH), 4.30 (t, 4H, J = 5.0 Hz, OCH2), 4.00 (t, 4H, J = 5.0 Hz, OCH2), 3.75 
(br s, 8H, OCH2), 2.12 (br s, 2H, 2 OH); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 153.9 
(ArC), 126.4 (ArC), 124.8 (NaphthCH), 114.3 (NaphthCH), 105.5 (NaphthCH), 72.3 
(OCH2), 69.4 (OCH2), 67.6 (OCH2), 61.5 (OCH2); IR ν cm
-1
 3505 (O-H), 2931 (saturated C-
H); MS (ESI
+
): m/z 359.1 [3.49+Na]
+
. 
3.50 
 
Known compound synthesised according to literature procedure.
171
 Tosyl chloride (2.54 g, 
5.8 mmol), NEt3 (1.07 mL, 7.7 mmol) and DMAP (20 mg, cat.) were dissolved in CH2Cl2 
(10 mL) and added dropwise to a stirring solution of 3.49 (1 g, 2.9 mmol) at 0°C over 30 
minutes. The solution was allowed to warm to room temperature and stirred for 24 h. The 
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organic layer was washed in dilute HCl (50 mL), concentrated sodium carbonate (2 x 50 
mL) and water (2 x 50 mL). The organic layer was dried over MgSO4, filtered over silica 
and washed with CH2Cl2. The solvent was removed and the crude product recrystallised 
from CH2Cl2/petroleum ether to provide a pale beige solid (1 g, 1.55 mmol, 55%). m.p. 122-
126°C (decomp.);
 1
H NMR (400 MHz, 298 K, CD3CN) δH  7.83 (d, 2H, J = 8.0 Hz, 
NaphthCH), 7.78 (d, 4H, J = 8.0 Hz, ArCHSO2), 7.35 (t, 2H,
 
J = 8.0 Hz, NaphthCH), 7.24 
(d, 4H, J = 8.0 Hz, ArCHCH3), 6.82 (d, 2H, J = 8.0 Hz, NaphthCH), 4.21 (br s,  8H, 4 
OCH2), 3.92 (t, 4H, J = 4.5 Hz, 2 OCH2), 3.83 (t, 4H, J = 4.5 Hz, 2 OCH2), 2.36 (s, 6H, 2 
CH3); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 154.2 (ArCO), 144.8 (ArC), 138.1 (ArC), 
129.8 (ArCH), 127.9 (ArCH), 126.8 (ArC), 125.2 (NaphthCH), 114.7 (NaphthCH), 105.8 
(NaphthCH), 70.0 (CH2), 69.4 (CH2), 69.0 (CH2), 67.9 (CH2), 21.6 (CH3); IR ν cm
-1
 1596 
(ether C-O), 1348 (SO2), 1086 (ether C-O); HRMS (ESI
+
): found, 667.1642 calc for. 
C32H36NaO10S2 667.1648 [3.50+Na]
+
. 
3.51 
 
The ditosylate 3.50 (200 mg, 0.3 mmol) was dissolved in DMF (3mL). Sodium azide (355 
mg, 5.5 mmol) was added and the solution heated to 60°C for 48 h followed by TLC (Et2O). 
The solution was cooled and partitioned between water (30 mL) and Et2O (20 mL). The 
aqueous layer was extracted with Et2O (2 x 20 mL). The combined organic extracts were 
dried over MgSO4, filtered and the solvent removed in vacuo. The brown oil was 
recrystallised from MeOH/water to provide a cream solid (80 mg, 0.21 mmol, 69%). 
1
H 
NMR (400 MHz, 298 K, CDCl3) δH 7.90 (s, 2H, J = 8.0 Hz, 2 NaphthCH), 7.39 (dd, 2H, J = 
8.0 Hz + J = 7.5 Hz, 2 NaphthCH), 6.89 (d, 2H, J = 7.5 Hz, 2 NaphthCH), 4.35 (4H, t, J = 
5.0 Hz, 2 CH2CH2), 4.05 (t, 4H, J = 5.0 Hz, 2 CH2CH2), 3.86 (t, 4H, J = 5.0 Hz, 2 CH2CH2), 
3.47 (t, 4H, J = 5.0 Hz, 2 N3-CH2CH2); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 154.3 (ArC), 
126.8 (ArC), 125.1 (NaphthCH), 114.7 (NaphthCH), 105.8 (NaphthCH), 70.4 (CH2CH2), 
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69.9 (CH2CH2), 68.0 (CH2CH2), 50.9 (CH2CH2); IR ν cm
-1
 2157 (-N3); HRMS (ESI
+
): found, 
409.1595 calc for C18H22N6NaO4 409.1600 [3.51+Na]
+
. 
3.52 
 
Propargyl amine 3.19 (500 mg, 1.32 mmol) and azide 3.51 (200 mg, 0.51 mmol) were 
dissolved in CH2Cl2 (10 mL). Sodium ascorbate (51 mg, 0.26 mmol) and CuSO4.5H2O (26 
mg, 0.10 mmol) were dissolved in water (10 mL) added to the solution and stirred at room 
temperature for 48 h. The organic layer was collected and the aqueous layer was extracted 
with CH2Cl2 (2 x 10 mL), the combined organic extracts were dried over MgSO4 and the 
solvent removed in vacuo to provide a pale orange solid. The crude product was purified via 
column chromatography (SiO2: EtOAc to CH2Cl2:MeOH; 95:5) providing the thread as a 
pale yellow oil (200mg, 0.17 mmol, 34%). 
1
H NMR (400 MHz, 298 K, CDCl3) δH 7.93 (d, 
4H, J = 8.0 Hz, 4 ArCHCCO2), 7.80 (d, 2H,  J = 8.5 Hz, 2 NaphthCH), 7.64 (s, 2H, 2 
triazole-CH), 7.35-7.29 (m, 6H, 4 ArCHCCH2 and 2 NaphthCH), 6.84 (d, 2H, J = 7.5 Hz, 2 
NaphthCH), 6.49 (s, 4H, 2 CH=CH), 5.24 (s, 4H, 4 CHO), 4.58 (t, 4H, J = 4.8 Hz, 
CH2CH2N-triazole), 4.45 (t, 4H, J = 5.3 Hz, CH2CH2O), 4.27 (t, 4H, J = 4.5 Hz, 
OCH2CH2O), 4.02 (t, 4H, J = 4.8 Hz, NCH2CH2O), 3.97 (br t, 4H, J = 4.5 Hz, OCH2CH2O), 
3.91 (t, 4H, J = 5.3 Hz, CH2CH2N-imide), 3.78 (broad s, 4H, 2 NH2), 2.86 (s, 4H, 4 CHCO); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 175.6 (imide C=O), 165.8 (COO), 153.9 (ArC), 
145.8 (ArC), 144.9 (ArC), 136.1 (CH=CH), 129.5 (ArCH), 128.1 (ArC), 127.7 (ArCH), 
126.3 (ArC), 124.9 (NaphthCH), 122.5 (triazole-CH), 114.1 (NaphthCH), 105.4 
(NaphthCH), 80.5 (CHO), 69.5 (CH2), 69.4 (CH2), 67.3 (CH2), 60.8 (CH2CH2O), 52.3 
(CH2), 50.0 (CH2), 47.1 (CHCO), 43.5 (CH2), 37.5 (CH2CH2N-imide); HRMS (ESI
+
): m/z 
found, 574.2301 calc for C60H64N10O14 547.2296 [3.52+2H]
2+
. 
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3.53 
 
Neutral thread 3.52 (100 mg, 0.087 mmol) was dissolved in CH2Cl2 (5 mL) and washed with 
a 10% aqueous solution of HClO4 (2 x 10 mL). A precipitate appeared in the aqueous phase 
which was filtered and recrystallised from acetonitrile/Et2O to provide the product as a pale 
grey solid (70 mg, 0.05 mmol, 60%). m.p. 128-129°C;
 1
H NMR (400 MHz, 298 K, CD3CN) 
δH 8.74 (s, 2H, 2 triazole-CH), 7.98 (d, 4H, J = 8.5 Hz, 4 ArCHCCOO), 7.86 (broad s, 4H, 2 
NH2), 7.72 (d, 2H, J = 8.5 Hz,  2 NaphthCH), 7.59 (d, 4H, J = 8.5 Hz, 4 ArCHCCH2), 7.38 
(dd, 2H, J = 8.5 Hz + J = 7.5 Hz, 2 NaphthCH), 6.94 (d, 2H, J = 7.5 Hz, 2 NaphthCH), 6.49 
(s, 4H, 2 CH=CH), 5.10 (s, 4H, 4 CHO), 4.89 (t, 4H, J = 5.0 Hz, 2 OCH2CH2N-triazole), 
4.56 (t, 4H, J = 5.5 Hz, 2 CH2CH2O), 4.42-4.37 (m, 8H, 2 CH2NH2
+
CH2), 4.37 (m, 4H, 2 
NCH2CH2O), 4.28 (t, 4H, J = 5.0 Hz, 2 OCH2CH2N-triazole), 4.14 (t, 4H, J = 5.0 Hz, 2 
OCH2CH2O), 3.99 (t, 4H, J = 5.0 Hz, 2 OCH2CH2O), 3.81 (t, 4H, J = 5.5 Hz, 2 OCH2CH2N-
imide), 2.89 (s, 4H, 4 CHCO); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 177.9 (imide CO), 
166.7 (COO), 155.5 (ArC), 137.8 (CH=CH), 137.5 (ArC), 132.6 (ArC), 131.1 (ArCH), 
131.3 (ArCH), 128.4 (triazole-CH), 127.7 (ArC), 126.9 (NaphthCH), 115.4 (NaphthCH), 
107.2 (NaphthCH), 82.3 (CHO), 70.6 (CH2), 70.2 (CH2), 69.2 (CH2), 62.8 (CH2CH2O), 52.4 
(CH2), 51.8 (CH2NH2
+
), 48.4 (CHCO), 42.7 (CH2NH2
+
), 38.6 (CH2CH2N-imide); IR ν cm
-1
 
3537 (NH), 1697 (ester and imide C=O), 1072 (ClO4); HRMS (ESI
+
): m/z found, 574.2303 
calc for C60H64N10O14 574.2296 [3.53-2ClO4]
2+
. 
3.54 
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Thread 3.53 (60 mg, 0.045 mmol) was dissolved in acetonitrile (2 mL) and reacted under 
microwave irradiation (150W, 110 °C, 3 h). The solvent and furan were removed in vacuo to 
provide the retro Diels-Alder thread (53 mg, mmol, 98%). 
1
H NMR (400 MHz, 298 K, 
CD3CN) δH 8.04 (s, 2H, 2 triazole-CH), 7.94 (d, 4H, J = 8.5 Hz, 4 ArCHCCOO), 7.66 (d, 
2H, J = 8.5 Hz,  2 NaphthCH), 7.51 (d, 4H, J = 8.5 Hz, 4 ArCHCCH2), 7.31 (dd, 2H , J = 8.5 
+ 7.5 Hz, 2 NaphthCH), 6.87 (d, 2H, J = 7.5 Hz, 2 NaphthCH), 6.75 (s, 4H, 2 CH=CH), 4.61 
(t, 4H, J = 4.8 Hz, 2 OCH2CH2N), 4.38 (t, 4H, J = 5.3 Hz, 2 CH2CH2O), 4.24 (broad 2, 4H, 2 
CH2NH2), 4.21-4.18 (m, 8H, 2 CH2NH2 and 2 OCH2CH2N), 4.01 (t, 4H, J = 4.8 Hz, 2 
OCH2CH2O), 3.92 (t, 4H, J = 4.8 Hz, 2 OCH2CH2O), 3.82 (t, 4H, J = 5.3 Hz, 2 CH2CH2N-
imide); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 170.6 (imide C=O), 165.1 (COO), 153.8 
(ArC), 136.5 (ArC), 134.9 (ArC), 134.1 (CH=CH), 130.7 (ArC), 130.1 (4 ArCH) , 129.6 
(ArCH), 126.1 (triazole-CH), 126.0 (ArC), 125.2 (NaphthCH), 113.7 (NaphthCH), 105.5 
(NaphthCH), 68.9 (CH2), 68.6 (CH2), 67.4 (CH2), 62.2 (imide-NCH2CH2O), 50.2 (CH2), 
50.0 (CH2NH2), 41.5 (CH2NH2), 36.2 (OCH2CH2N-imide); HRMS (ESI
+
): m/z found, 
506.2032 calc for C52H56N10O12 506. 2034 [3.53-2ClO4]
2+
. 
3.56 
 
Known compound synthesised according to literature procedure.
191
 1,5-
Dihydroxynaphthalene (4.0 g, 25 mmol) and potassium carbonate (3.45 g, 25.2 mmol) were 
dissolved in acetonitrile (200 mL). 2-(2-[2-Chloroethoxy]ethoxy)ethanol (7.97 mL, 55 
mmol) was dissolved in acetonitrile (40 mL) and added drop wise to the suspension over 30 
minutes. The resulting solution was heated to reflux overnight; allowed to cool and filtered 
through celite. The solvent was removed and the resulting brown oil was purified via flash 
chromatography (SiO2: Et2O to Et2O:MeOH; 9:1) to provide the diol 3.56 (2.5 g, 5.8 mmol, 
24%). m.p. 67-69 °C ; 
1
H NMR (400 MHz, 298 K, CDCl3) δH 7.84 (d, 2H, J = 8.5 Hz, 2 
NaphthCH), 7.32 (dd, 2H, J = 8.5 + 7.5 Hz, 2 NaphthCH), 6.79 (d, 2H, J = 7.5 Hz, 2 
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NaphthCH), 4.23 (t, 4H, J = 5.0 Hz, OCH2CH2O), 3.92 (t, 4H, J = 4.5 Hz, OCH2CH2O), 
3.74 (t, 4H, J = 5.0 Hz, OCH2CH2O), 3.68-3.62 (m, 8H, 4 OCH2CH2O), 3.55 (t, 4H, J = 5.0 
Hz, OCH2CH2O), 3.04 (broad s, 2H, 2 OH); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 154.3 
(ArC), 126.7 (ArC), 125.4 (NaphthCH), 114.9 (NaphthCH), 105.7 (NaphthCH), 72.6 
(OCH2CH2OH), 70.9 (CH2), 70.3 (CH2), 69.8 (CH2), 67.8 (CH2), 61.6 (CH2OH); IR ν cm
-1 
3508 (OH), 2930 (saturated C-H); HRMS (ESI
+
) : m/z 425.2177 calc for C22H33O8 425.2170 
[3.56+H]
+
. 
3.55 
 
Known compound synthesised according to literature procedure.
172
 4,4’-Bipyridine (3.12 g, 
20 mmol) was dissolved in dry acetonitrile (40 mL) and added drop wise to a refluxing 
solution of 1,4-bis(bromomethyl)benzene (2.2 g, 8.33 mmol) overnight. It was refluxed for a 
further 2 h then cooled to room temperature. The suspension was filtered and partitioned 
between CH2Cl2 (20 mL) and water (20 mL). The layers were separated and to the aqueous 
layer a saturated solution of aqueous NH4PF6 was added until no further precipitate was 
seen. The precipitate was filtered and washed with water (10 mL) and the yellow solid 
recrystallised from acetonitrile/Et2O to provide an off white solid (4.09 g, 5.8 mmol, 70%). 
m.p. 132-133˚C; 1H NMR (400 MHz, 298 K, CD3CN) δH 8.83 (m, 4H, 4 PyrCHN
+
 and 4 
PyrCHN), 8.33 (d, 4H, J = 7.0 Hz, 4 PyrCH), 7.79 (m, 4H, 4 PyrCH), 7.56 (s, 4H, 4 ArCH), 
5.78 (s, 4H, 2 CH2); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 154.5 (ArC), 150.9 (ArCH), 
144.7 (ArCH), 140.8 (ArC), 134.3 (ArC), 130.0 (ArCH), 126.0 (ArCH), 121.4 (ArCH), 63.1 
(CH2). 
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1.09 
 
Known compound synthesised according to literature procedure.
170
 3.55 (706 mg, 1 mmol), 
1,4-bisbromomethylbenzene (264 mg, 1 mmol) and 3.56 (1092 mg, 3.3 mmol) were 
dissolved in anhydrous DMF (30 mL) and stirred at room temperature under N2 for 5 days. 
The DMF was removed in vacuo and the purple solid obtained, dissolved in a concentrated 
aqueous solution of NH4Cl (100 mL) and extracted for 72 h with CH2Cl2 (200 mL). The 
aqueous layer was reduced in vacuo and the crude solid purified via flash chromatography 
(SiO2: MeOH:H2O:NH4Cl; 60:30:10). The combined fractions containing product were 
reduced in vacuo and the solid dissolved in water (20 mL). An aqueous solution of NH4PF6 
was added carefully added until precipitation ceased. The solid was filtered and washed with 
water to provide the macrocycle as a white solid (345 mg, 0.31 mmol, 31%). m.p. 272-
273˚C; 1H NMR (400 MHz, 298 K, CD3CN) δH 8.85 (m, 8H, 8 PyrCHN
+
), 8.19 (m, 8H, 8 
PyrCH), 7.54 (s, 8H, 8 ArCH), 5.77 (s, 8H, 4 CH2); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 
149.1 (ArC), 144.9 (ArCH), 135.7 (ArC), 130.1 (ArCH), 127.0 (ArCH), 64.4 (CH2). 
3.57 
 
Known compound synthesised according to literature procedure.
191
 The diol 3.56 (1 g, 2.36 
mmol) was dissolved in CH2Cl2 (10 mL), p-toluenesulphonyl chloride (742 mg, 3.91 mmol) 
was added to the stirring solution and it was cooled to 0°C. DMAP (20 mg, cat.) and NEt3 
(0.72 ml, 5.19 mmol) in CH2Cl2 (10 mL) were added drop wise and the solution was stirred 
for 48 h. The solution was diluted with CH2Cl2 (20 mL) and the organic layer washed with 
water (3 x 20 mL) dried over MgSO4 and concentrated in vacuo. The crude material was 
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purified via flash chromatography (SiO2: Hexane/Et2O, 100:0, 90:10, 0:100) providing a 
white solid (1.5 g, 2.05 mmol, 87%). m.p. 74-75°C; 
1
H NMR (400 MHz, 298 K, CDCl3) δH 
7.87 (d, 2H, J = 8.5 Hz, 2 NaphthCH), 7.80 (d, 4H, J = 8.0 Hz, 4 ArCHCSO2), 7.37 (dd, 2H, 
J = 8.5 Hz + 8.0 Hz, 2 NaphthCH), 7.32 (d, 4H, J = 8.0 Hz, 4 ArCHCCH3), 6.86 (d, 2H, J = 
8.0 Hz, 2 NaphthCH), 4.30 (t, 4H, J = 5.5 Hz, 2 OCH2CH2O), 4.17 (t, 4H, J = 5.0 Hz, 
OCH2CH2O), 3.98 (t, 4H, J = 5.0 Hz, 2 OCH2CH2O), 3.77-3.71 (m, 8H, 4 OCH2CH2O), 3.65 
(t, 4H, J = 5.0 Hz, 2 OCH2CH2O), 2.42 (s, 6H, 2 CH3); 
13
C NMR (100 MHz, 298 K, CDCl3) 
δC 154.3 (ArC), 144.8 (ArC), 133.0 (ArC), 129.8 (ArCHCCH3), 127.9 (ArCHCS), 126.8 
(ArC), 125.1 (NaphthCH), 114.6 (NaphthCH), 105.7 (NaphthCH), 70.9 (CH2), 69.9 (CH2), 
69.2 (CH2), 68.7 (CH2), 67.9 (CH2), 65.9 (CH2), 21.6 (CH3); IR ν cm
-1
 2889 (saturated C-H), 
1594 (C-O), 1349 (-SO2-O-); HRMS (ESI
+
): m/z found, 755.2166 calc for C36H44O12S2Na 
755.2166 [3.57+Na]
+
.  
3.58 
 
Known compound synthesised according to literature procedure.
192
 The ditosylate 3.57 (1.1 
g, 1.50 mmol) was dissolved in DMF (10 mL) and sodium azide (2.6 g, excess) was added. 
The solution was heated to 60˚C for 24 h and the reaction followed by TLC (CH2Cl2:Et2O; 
7:3). The solution was cooled, diluted with water (20 mL) and extracted with CH2Cl2 (3 x 20 
mL). The combined organic extracts were washed with brine (2 x 20 mL) and dried over 
MgSO4. The solvent was removed in vacuo and purified via flash chromatography (SiO2: 
CH2Cl2/Et2O; 7:3) giving a pale solid. (500mg, 1.06 mmol, 71%). 
1
H NMR (400 MHz, 298 
K, CDCl3) δH  7.88 (d, 2H, J = 8.0 Hz, 2 NaphthCH), 7.36 (dd, 2H, J = 8.0 + 7.5 Hz, 2 
NaphthCH), 6.86 (d, 2H, J = 7.5 Hz, 2 NaphthCH), 4.32 (t, 4H, J = 4.8 Hz, 2 OCH2CH2O), 
4.02 (t, 4H, J = 5.0 Hz, 2 N3-CH2CH2O) 3.83 (t, 4H, J = 4.8 Hz, 2 OCH2CH2O), 3.73-3.68 
(m, 8H, 4 OCH2CH2O), 3.38 (t, 4H, J = 5.0 Hz, 2 N3-CH2CH2O); 
13
C NMR (100 MHz, 298 
K, CDCl3) δC 154.3 (ArC), 126.8 (ArC), 125.1 (NaphthCH), 114.6 (NaphthCH), 105.7 
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(NaphthCH), 71.1 (CH2CH2), 70.8 (CH2CH2), 70.1 (CH2CH2), 69.9 (CH2CH2), 67.9 
(CH2CH2), 50.7 (CH2CH2); IR ν cm
-1
 2896 (saturated C-H), 2097 (-N3), 1593 (C-O), 1264 
(C-O); HRMS (ESI
+
): m/z found, 497.2135 calc for C22H30N6O6Na 497.2119 [3.58+H]
2+
. 
3.59 
 
The propargyl amine 3.19 (842 mg, 2.23 mmol) and diazide 3.58 (350 mg, 0.74 mmol) were 
dissolved in CH2Cl2 (10 mL). Sodium ascorbate (139 mg, 0.70 mmol), CuSO4.5H2O (52 mg, 
0.21 mmol) were dissolved in water (10 mL) and added to the organic layer. The solution 
was stirred for 72 h. The organic layer was collected and the aqueous extracted with CH2Cl2 
(2 x 20 mL). The combined organic layers were dried over MgSO4, filtered and the solvent 
removed in vacuo. The crude orange solid obtained was purified via flash chromatography 
(SiO2: EtOAc to CH2Cl2/MeOH 95:5) to give a pale yellow solid (455 mg, 0.37 mmol, 
50%). m.p. 50-5˚C; 1H NMR (400 MHz, 298 K, CDCl3) δH 7.89 (d, 4H, J = 8.0 Hz, 4 
ArCHCCO2), 7.81 (d, 2H, J = 8.5 Hz, 2 NaphthCH), 7.59 (s, 2H, 2 triazole-CH), 7.34 (d, 
4H, J = 8.0 Hz, 4 ArCHCCH2), 7.30 (dd, 2H, J = 8.5 + 7.5 Hz, 2 NaphthCH), 6.79 (d, 2H, J 
= 7.5 Hz, 2 NaphthCH), 6.43 (s, 4H, 2 CH=CH), 5.18 (s, 4H, 4 CHO), 4.46 (t, 4H, J = 4.8 
Hz, 2 CH2CH2O), 4.39 (t, 4H, J = 5.3 Hz, 2 imide-NCH2CH2O), 4.23 (t, 4H, J = 4.3 Hz, 2 
CH2CH2), 3.91 (t, 4H, J = 4.3 Hz, 2 CH2CH2), 3.86-3.71 (m, 20H, 6 CH2CH2 and 2 
CH2NHCH2), 3.62 (t, 4H, J = 4.8 Hz, 2 CH2CH2), 2.80 (s, 4H, 4 CHCO); 
13
C NMR (100 
MHz, 298 K, CDCl3) δC 176.0 (imide C=O), 165.6 (COO), 153.7 (ArC), 145.7 (ArC), 145.0 
(ArC), 136.0 (CH=CH), 129.3 (ArCH), 127.9 (ArC), 127.5 (ArCH), 126.1 (ArC), 124.6 
(NaphthCH), 122.3 (triazole-CH), 114.0 (NaphthCH), 105.1 (NaphthCH), 80.3 (CHO), 70.8 
(CH2), 70.6 (CH2), 69.8 (CH2), 69.5 (CH2), 67.9 (CH2), 61.2 (imide-NCH2CH2O), 52.8 
(CH2), 50.1 (CH2NH), 47.4 (CHCO), 44.0 (CH2NH), 37.8 (CH2CH2N-imide); IR ν cm
-1
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2873 (saturated CH), 1697 (imide and ester C=O), 1266 (C-O); HRMS (ESI
+
): m/z found 
618.2593 calc for C64H72N10O16 618.2558 [3.59+H]
2+
. 
3.60 
 
Thread 3.59 (100 mg, 0.081 mmol) was dissolved in CH2Cl2 (10 mL) and washed with a 
10% aqueous solution of HClO4 (3 x 10 mL). The organic layer was dried over MgSO4, 
filtered and the solvent removed in vacuo to give a pale yellow solid (77 mg, 0.054 mmol, 
67%). m.p. 52-53°C; 
1
H NMR (400 MHz, 298 K, CD3CN) δH  7.90 (d, 4H, J = 8.5 Hz, 4 
ArCHCCO2), 7.86 (s, 2H, 2 triazole-CH), 7.73 (d, 2H, J = 8.5 Hz, 2 NaphthCH), 7.39 (d, 
4H, J = 8.0 Hz, 4 ArCHCCH2), 7.34 (dd, 2H, J = 8.5 + 7.5 Hz, 2 NaphthCH), 6.89 (d, 2H, J 
= 7.5 Hz, 2 NaphthCH), 6.47 (s, 4H, 2 CH=CH), 5.07 (s, 4H, 4 CHO),  4.50 (t, 4H, J = 5.0 
Hz, 2 CH2CH2), 4.36 (t, 4H, J = 5.3 Hz, 2 imide-NCH2CH2O), 4.21 (t, 4H, J = 5.0 Hz, 2 
CH2CH2), 4.01 (broad s, 4H, 2 NH2), 3.88-3.83 (m, 8H, 2 CH2NH2
+
CH2), 3.79 (t, 4H, J = 5.3 
Hz, OCH2CH2N-imide), 3.69-3.66 (m, 4H, 2 CH2CH2), 3.62 (m, 4H, 2 CH2CH2), 2.85 (s, 
4H, 4 CHCO); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 176.6 (imide C=O), 168.8 (COO), 
154.3 (ArC), 141.1 (ArC), 138.4 (ArC), 136.5 (CH=CH), 129.9 (ArCH), 129.7 (ArCH), 
127.9 (ArC), 126.5 (triazole-CH), 125.5 (NaphthCH), 124.3 (ArC), 114.1 (NaphthCH), 
106.0 (NaphthCH), 80.9 (CHO), 70.3 (CH2), 70.1 (CH2), 69.4 (CH2), 68.9 (CH2), 68.1 
(CH2), 61.4 (imide-NCH2CH2O), 52.7 (CH2), 50.2 (CH2NH2
+
), 47.5 (CHCO), 43.6 
(CH2NH2
+
), 37.3 (CH2CH2N-imide); IR ν cm
-1
 3499 (NH), 2926 (saturated CH), 1694 
(imide and ester C=O stretching), 1067 (ClO4); HRMS (ESI
+
): m/z found, 618.2565 calc for 
C64H72N10O16 618.2558 [3.60-2HClO4]
2+
. 
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3.61 
 
 
Thread 3.60 (60 mg, 0.042 mmol) was dissolved in acetonitrile (2 mL) and reacted under 
microwave irradiation (150 W, 4h, 110˚C) followed by TLC (EtOAc:MeOH; 9:1). The 
solvent was removed in vacuo to provide the retro Diels-Alder thread (52 mg, 0.040 mmol, 
95%). 
1
H NMR (400 MHz, 298 K, CD3CN) δH  8.09 (s, 2H, 2 triazole-CH), 7.91 (d, 4H, J = 
8.5 Hz, 4 ArCHCCO2), 7.75 (d, 2H, J = 8.5 Hz, 2 NaphthCH), 7.51 (d, 4H, J = 8.5 Hz, 4 
ArCHCCH2), 7.34 (dd, 2H, J = 8.5 + 7.5 Hz, 2 NaphthCH), 6.91 (d, 2H, J = 7.5 Hz, 2 
NaphthCH), 6.78 (s, 4H, 2 CH=CH), 4.60 (t, 4H, J = 5.0 Hz, 2 CH2CH2), 4.46 (t, 4H, J = 5.3 
Hz, imide-NCH2CH2O), 4.32 (br s, 8H, 2 CH2NH2
+
CH2), 4.24 (m, 4H, 2 CH2CH2), 3.90 (t, 
4H, J = 5.3 Hz, 2 CH2CH2N-imide), 3.70 (m, 4H, 2 CH2CH2), 3.63 (m, 4H, 2 CH2CH2); 
13
C 
NMR (100 MHz, 298 K, CD3CN) δC  170.6 (imide C=O), 165.1 (COO), 153.9 (ArC), 136.6 
(ArC), 134.9 (ArC), 134.1 (CH=CH), 130.7 (ArC), 130.1 (ArCH), 129.6 (ArCH), 126.1 
(ArC), 125.9 (ArCH), 125.1 (triazole-CH), 113.7 (ArCH), 105.6 (ArCH), 69.9 (CH2), 69.7 
(CH2), 69.5 (CH2), 69.0 (CH2), 65.4 (CH2), 62.2 (imide-NCH2CH2O), 54.0 (CH2NH2
+
), 50.0 
(CH2N), 41.6 (CH2NH2
+
), 36.2 (OCH2CH2N-imide); HRMS (ESI
+
): m/z found, 550.2305 
calc for C56H64N10O14 550.2296 [3.61-2HClO4]
2+
. 
3.62 
 
Known compound synthesised according to literature procedure.
193
 Maleimide (286 mg, 2.9 
mmol) and furan (0.37 mL, 5.1 mmol) were dissolved in water (3 mL) and subjected to 
microwave irradiation (1h, 100W, 90°C). On cooling a white precipitate formed which is 
filtered and washed with water (2 x 5 mL). The white solid was dried in the desiccator 
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overnight (200 mg, 1.21 mmol, 42%). m.p. 164-166°C; 
1
H NMR (400 MHz, 298 K, CDCl3) 
δH 6.53 (s, 2H, CH=CH), 5.33 (m, 2H, 2 CHO), 2.90 (s, 2H, 2 CHCO); 
13
C NMR (100 MHz, 
298 K, CDCl3) δC 175.9 (C=O), 136.6 (CH=CH), 81.0 (CHO), 48.7 (CHCO); MS (ESI
+
): 
m/z 188.1 [3.62+Na]
+
. 
3.63 
 
The imide 3.62 (100 mg, 0.6 mmol), naphthyl diol 3.58 (123 mg, 0.29 mmol) and PPh3 (168 
mg) were dissolved in dry THF (10 mL) and cooled to 0°C. DEAD (0.1 mL, 0.6 mmol) was 
dissolved in dry THF (5 mL) and added dropwise over 10 minutes. The solution was 
allowed to warm to room temperature and stirred for 48 h. The THF was removed in vacuo 
and the residue partitioned between EtO2 and water. The aqueous layer was extracted with 
CHCl3 (3 x 15 mL) and the combined organic extracts dried over MgSO4, and solvent 
removed in vacuo. The crude product purified via silica gel flash chromatography (SiO2: 
Petroleum ether:EtOAc 1:1 to EtOAc:MeOH; 95:5) to give the product as a yellow oil (30 
mg, 0.04 mmol, 14%). 
1
H NMR (400 MHz, 298 K, CDCl3) δH  7.86 (d, 2H, J = 8.0 Hz, 
NaphthCH), 7.35 (t, 2H, J = 8.0 Hz, NaphthCH), 6.87 (d, 2H, J = 8.0 Hz, NaphthCH), 6.35 
(s, 4H, 2 CH=CH), 5.20 (m, 4H, 4 CHO), 4.28 (t, 4H, J = 5.0 Hz, 2 NCH2CH2O), 3.97 (t, 
4H, J = 4.5 Hz, 2 OCH2CH2O), 3.76-3.64 (m, 16H, 6 OCH2CH2O and 2 OCH2CH2N), 2.73 
(s, 4H, CHCO); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 176.1 (imide C=O), 154.3 (ArC), 
136.4 (CH=CH), 126.7 (ArC), 125.1 (NaphthCH), 114.6 (NaphthCH), 105.7 (NaphthCH), 
80.8 (CHO), 70.9 (CH2CH2O), 70.2 (CH2CH2O), 69.8 (CH2CH2O), 67.9 (CH2CH2O), 67.1 
(CH2CH2O), 47.4 (CHCO), 38.2 (OCH2CH2N); IR ν cm
-1
 2987 (saturated C-H), 1698 (imide 
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C=O), 1227 (C-O); HRMS (ESI
+
): m/z found, 741.2628 calc for C38H42N2NaO12 741.2630 
[3.63+Na]
+
. 
3.64 
 
Thread 3.63 (30 mg, 0.042 mmol) was dissolved in acetonitrile (3 mL) and subjected to 
microwave irradiation (100W, 110°C, 3 h). The solvent was removed in vacuo to provide the 
product as beige solid used without further purification (20 mg, 0.034 mmol, 81%). 
1
H NMR 
(400 MHz, 298 K, CD3CN) δH  7.79 (d, 2H, J = 8.0 Hz, 2 NaphthCH), 7.39 (dd, 2H, J = 8.0 
Hz + 7.5 Hz, 2 NaphthCH), 6.94 (d, 2H, J = 7.5 Hz, 2 NaphthCH), 6.69 (s, 4H, 2 CH=CH), 
4.24 (t, 4H, J = 5.5 Hz, 2 NCH2CH2O), 3.88 (t, 4H, J = 4.5 Hz, 2 OCH2CH2O), 3.96-3.55 
(m, 16H, 6 OCH2CH2O and 2 OCH2CH2N); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 172.3 
(imide C=O), 155.7 (ArC), 135.6 (CH=CH), 127.9 (ArC), 126.8 (NaphthCH), 115.5 
(NaphthCH), 107.3 (NaphthCH), 71.7 (CH2CH2), 71.4 (CH2CH2), 70.7 (CH2CH2), 69.4 
(CH2CH2), 68.8 (CH2CH2), 38.5 (OCH2CH2N); IR ν cm
-1
 2913 (saturated C-H), 1728 (imide 
C=O), 1272 (C-O); HRMS (ESI
+
): m/z found, 605.2113 calc for C30H34N2NaO10 605.2106 
[3.64+Na]
+
.  
3.66 
 
CBPQT
4+
 1.09 (10 mg, 0.009 mmol) and thread 3.64 (6 mg, 0.01 mmol) were dissolved in 
acetonitrile to form the intermediate pseudorotaxane 3.77. 1,3-Diphenylisobenzofuran (5.4 
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mg, 0.02 mmol) was added and the reaction stirred for 30 minutes. The solvent was removed 
in vacuo and the crude solid extracted with CHCl3 (3 x 5 mL) and CH2Cl2 (3 x 5 mL) to 
leave a purple solid. This was recrystallised twice from acetonitrile to give the [2]rotaxane as 
a purple solid (14 mg, 0.006 mmol, 70%). 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.95 (br 
s, 4H,  4 PyrCHN+), 8.68 (br s, 4H,  4 PyrCHN+), 8.10 (br s, 8H,  8 macro ArCH), 7.87 
(d, 8H, J = 6.5 Hz,  8 thread ArCH), 7.52-7.43 (m, 16 H,  4 macro PyrCH and  12 
thread ArCH), 7.25 (br s, 4H,  4 macro PyrCH), 7.20 (m, 4H,  4 thread ArCH), 6.80 (m, 
4H,  4 thread ArCH), 6.30 (d, 2H, J = 8.0 Hz,  2 NaphthCH), 6.02 (t, 2H, J = 8.0 Hz,  2 
NaphthCH), 5.74 (br s, 8H,  4 CH2), 4.30 (m, 4H,  2 CH2O), 4.20 (m, 4H,  2 CH2O), 
4.04 (s, 4H,  4 CHCO), 3.95 (m, 4H,  2 CH2O), 3.71 (m, 4H,  2 CH2O), 3.03 (t, 4H, J = 
6.5 Hz,  2 NCH2CH2O), 2.88 (t, 4H, J = 6.5 Hz,  2 NCH2CH2O), 2.44 (d, 2H, J = 8.0 Hz, 
 2 NaphthCH); 13C NMR (100 MHz, 298 K, CD3CN) δC 175.5 (imide C=O), 152.4 (ArC), 
146.6 (ArC), 145.6 (ArC), 137.9 (ArC), 137.8 (ArC), 136.5 (ArCH), 135.6 (ArCH), 132.7 
(ArCH), 130.1 (ArCH), 129.9 (ArCH), 129.5 (ArCH), 128.5 (ArCH), 127.6 (ArCH), 125.7 
(ArC), 121.7 (ArCH), 109.7 (ArCH), 105.7 (ArCH), 91.4 (Ar-CO), 72.2 (CH2), 71.8 (CH2), 
71.1 (CH2), 69.7 (CH2), 67.9 (CH2), 66.6 (CH2), 55.2 (CHCO), 38.7 (CH2); HRMS (ESI
+
): 
m/z found, 547.5626 calc for C106H93N6O12 547.5623 [3.66-4PF6]
3+
. 
3.67 
 
Retro Diels-Alder thread 3.64 (30 mg, 0.05 mmol) was dissolved in acetonitrile (2 mL) and 
1,3 diphenylisobenzofuran (29 mg, 0.11 mmol) was added. The reaction was stirred for 30 
minutes then the solvent removed in vacuo. The crude mixture was purified via flash 
chromatography (SiO2: Petroleum ether to petroleum ether:EtOAc; 1:1 to EtOAc) to give the 
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product as a yellow solid (35 mg, 0.031 mmol, 62%). 
1
H NMR (400 MHz, 298 K, CD3CN) 
δH 7.98 (m, 8H, 8 ArCH), 7.76 (d, 2H, J = 8.5 Hz, 2 NaphthCH), 7.56-7.46 (m, 12H, 12 
ArCH), 7.33 (dd, 2H, J = 8.5 + 7.5 Hz, 2 NaphthCH), 7.15 (m, 4H, 4 ArCH), 6.90 (d, 2H, J 
= 7.5 Hz, 2 NaphthCH), 6.82 (m, 4H, 4 ArCH), 4.21 (t, 4H, J = 5.3 Hz, 2 CH2CH2), 4.05 (s, 
4H, 4 CHCO), 3.86 (t, 4H, J = 5.3 Hz, 2 CH2CH2), 3.38 (t, 4H, J = 5.5 Hz, 2 CH2CH2), 3.58 
(t, 4H, J = 5.5 Hz, 2 CH2CH2), 3.08 (t, 4H,
 
J = 6.8 Hz, 2 NCH2CH2O), 2.37 (t, 4H, J = 6.8 
Hz, 2 OCH2CH2N); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 175.4 (imide C=O), 155.7 
(ArC), 145.6 (ArC), 138.1 (ArC), 130.1 (ArCH), 129.9 (ArCH), 129.5 (ArCH), 128.5 
(ArCH), 127.9 (ArC), 126.8 (ArCH), 121.8 (ArCH), 115.5 (ArCH), 107.3 (ArCH), 91.4 (Ar-
CO), 71.6 (CH2), 71.3 (CH2), 70.7 (CH2), 69.4 (CH2), 67.5 (CH2), 55.3 (CHCO), 38.6 
(OCH2CH2N); IR ν cm
-1
 3061 (saturated C-H), 1698 (imide C=O), 1265 (C-O); HRMS 
(ESI
+
): m/z found, 1145.4196 calc for C70H62N2O12 1145.4195 [3.67+H]
+
. 
3.68 
 
Known compound synthesised according to a modified literature procedure.
194
 2-
Nitrobenzenesulphonyl chloride (150 mg, 0.67 mmol) and propargyl amine (0.05 mL, 0.78 
mmol) were dissolved in a saturated aqueous sodium bicarbonate solution (3 mL). THF (0.5 
mL) was added to the stirring solution and the mixture stirred at room temperature for 24 h. 
The solution was cooled to 0°C and acidified to pH 1 with concentrated HCl. A precipitate 
formed which was filtered and washed with water to provide a pale yellow solid (110mg, 
0.46 mmol, 69%). m.p. 95-97˚C; 1H NMR (400 MHz, 298 K, CDCl3) δH  8.21 (m, 1H, 
ArCH), 7.93 (m, 1H, ArCH), 7.78-7.76 (m, 2H, 2 ArCH), 5.70 (br s, 1H, NH), 4.03 (dd, 2H, 
J = 6.5 + 2.5 Hz, CH2), 1.96 (d, 1H, J = 2.5 Hz, C≡CH); 
13
C NMR (100 MHz, 298 K, 
CDCl3) δC 147.9 (ArC), 133.6 (ArC), 133.5 (ArCH), 132.6 (ArCH), 131.3 (ArCH), 125.2 
(ArCH), 76.9 (C≡CH), 72.9 (C≡CH), 33.1 (CH2); IR ν cm
-1
 3343 (NH), 3294 (alkyne C-H), 
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2126 (C≡C), 1525 (NO), 1340 (SO2); HRMS (ESI
+
): m/z found 263.0097 calc for 
C9H8N2O4SNa 263.0102 [3.68+Na]
+
. 
3.69 
 
Propargyl sulphonamide 3.68 (320 mg, 1.3 mmol) was dissolved in acetonitrile (2 mL). 
Potassium carbonate (202 mg, 1.5 mmol) and propargyl bromide (0.162 mL, 1.5 mmol) 
were added. The solution was stirred at room temperature for 48 h and the reaction followed 
by TLC (CH2Cl2:MeOH; 9:1). The mixture was diluted with water (10 mL) and extracted 
with CH2Cl2 (3 x 10 mL). The combined organic extracts were dried over MgSO4 and 
solvent removed in vacuo to give a pale orange oil (230 mg, 0.83 mmol, 64%). 
1
H NMR 
(400 MHz, 298 K, CDCl3) δH  8.06 (d, 1H, J = 7.5 Hz, ArCH), 7.76-7.66 (m, 3 H, 3 ArCH), 
4.30 (d, 4H, J = 2.0 Hz, CH2NCH2), 2.24 (t, 2H, J = 2.0 Hz, 2 C≡CH); 
13
C NMR (100 MHz, 
298 K, CDCl3) δC 146.3 (ArC), 132.3 (ArCH), 130.4 (ArC), 130.0 (ArCH), 129.4 (ArCH), 
122.5 (ArCH), 74.4 (C≡CH), 72.3 (C≡CH), 34.7 (NCH2); IR ν cm
-1
 3293 (alkyne C-H), 
2123 (C≡C), 1543 (NO), 1360 (SO2); HRMS (ESI
+
): m/z found, 301.0265 calc for 
C12H10N2O4S 301.0264 [3.69+H]
+
.  
3.70 
 
The propargyl 3.69 (100 mg, 0.036 mmol) and phenyl azide (90 mg, 0.075 mmol) were 
dissolved in EtOH (3 mL) and THF (3 mL). Sodium ascorbate (43 mg, 0.022 mmol) and 
CuSO4.5H2O (18 mg, 0.007 mmol) were dissolved in water (3mL) and added to the stirring 
solution. The reaction was stirred at room temperature for 48 h then diluted with CH2Cl2 (10 
mL) and washed with water (10 mL), 1M HCl (10 mL) and brine (10 mL). The organic layer 
was dried over MgSO4 and the solvent removed in vacuo. The crude product was taken up in 
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MeOH and filtered to provide a yellow solid (95 mg, 0.018 mmol, 51%). m.p. 178-179˚C; 
1
H NMR (400 MHz, 298 K, CDCl3) δH 8.27 (d, 1H, J = 7.0 Hz, ArCH), 8.18 (s, 2H, triazole-
CH), 7.73-7.76 (m, 7H, 7 ArCH), 7.55-7.44 (m, 6H, 6 ArCH), 4.75 (s, 4H, CH2NCH2); 
13
C 
NMR (100 MHz, 298 K, CDCl3) δC 165.5 (ArC), 156.9 (ArC), 136.8 (ArC), 133.7 (ArCH), 
133.5 (ArC), 132.2 (ArCH), 131.3 (ArCH), 129.8 (ArCH), 124.2 (ArCH), 122.2 (triazole-
CH), 121.0 (ArCH), 120.6 (ArCH), 50.9 (CH2NCH2); IR ν cm
-1
 3142 (saturated C-H), 1548 
(C-NO2); HRMS (ESI
+
): m/z found, 517.1405 calc for C24H21N8O4S 517.1401 [3.70+H]
+
. 
3.71 
 
The ditriazole 3.70 (70 mg, 0.14 mmol) was dissolved in acetonitrile (2 mL). Potassium 
carbonate (83 mg, 0.6 mmol) and thiophenol (0.05 mL, 0.46 mmol) was added and the 
solution heated to 50°C and followed by TLC (CH2Cl2:MeOH; 19:1) to completion. The 
crude reaction mixture was purified via flash chromatography (SiO2: CH2Cl2 to 
CH2Cl2:MeOH; 19:1) to provide the amine (40 mg, 0.12 mmol, 86%). m.p. 136-137°C; 
1
H 
NMR (400 MHz, 298 K, CD3OD) δH 8.47 (s, 2H, 2 triazole-CH), 7.87-7.84 (m, 4H, 4 
ArCH), 7.62-7.48 (m, 6H, 6 ArCH), 4.05 (broad s, 4H, CH2NHCH2); 
13
C NMR (100 MHz, 
298 K, CD3OD) δC 147.7 (ArC), 140.6 (ArC), 130.8 (ArCH), 129.9 (ArCH), 122.5 (triazole-
CH), 121.4 (ArCH), 44.0 (CH2NHCH2); IR ν cm
-1
 3276 (N-H), 3125 (saturated C-H), 1501 
(C=C); HRMS (ESI
+
): m/z found, 332.1612 calc for C18H18N7 332.1618 [3.71+H]
+
. 
3.72 
 
Neutral thread 3.71 (30 mg, 0.091 mmol) was dissolved in CH2Cl2 (5 mL) and washed with 
an aqueous solution of HClO4 (10%) (3 x 10 mL). A precipitate formed in the aqueous layer 
which was filtered and recrystallised from acetonitrile/Et2O to provide a white solid (26 mg, 
0.06 mmol, 66%). m.p. 198-199˚C; 1H NMR (400 MHz, 298 K, CD3CN) δH 8.44 (s, 2H, 2 
triazole-CH), 7.82 (d, 4H, J = 8.0 Hz, 4 ArCH), 7.63-7.52 (m, 6H, 6 ArCH), 4.53 (s, 4H, 
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CH2NH2
+
CH2); 
13
C NMR (150 MHz, 298 K, CD3CN) δC 138.0 (ArC), 136.7 (ArC), 129.9 
(ArCH), 129.3 (ArCH), 124.0 (triazole-CH), 120.7 (ArCH), 41.7 (CH2NH2CH2); IR ν cm
-1 
3142 (saturated C-H), 1427 (N=N), 1056 (ClO4), HRMS (ESI
+
): m/z found, 332.1619 calc 
for C18H18N7 332.1618 [3.72-ClO4]
+
. 
3.73 
 
Thread 3.72 (8.6 mg, 2 mmol) and DB24C8 (9 mg, 2 mmol) were dissolved in deuterated 
acetonitrile (10 mL). Binding constant = 864 M
-1 
was calculated from the single point 
method
129
 by measuring the integration of triazole-CH protons for the free and bound thread 
at 8.44 ppm and 8.05 ppm respectively. Pseudorotaxane  
1
H NMR (400 MHz, 298 K, 
CD3CN) δH 8.05 (s, 2H,  2 triazole-CH), 7.54-7.45 (m, 10H,  10 ArCH), 6.81-6.73 (m, 
8H,  8 crown ArCH), 4.95 (m, 4H,  CH2NH2CH2), 4.10 (m, 8H,  4 OCH2), 3.87 (m, 8H, 
 4 OCH2), 3.77 (s, 8H,  4 OCH2); Also contains unthreaded DB24C8 
1
H NMR (400 
MHz, 298 K, CD3CN) δH 6.93 (m, 8H, 8 ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 8H, 4 
OCH2), 3.72 (s, 8H, 4 OCH2); and Thread 3.72 
1
H NMR (400 MHz, 298 K, CD3CN) δH 
8.44 (s, 2H, 2 triazole-CH), 7.82 (d, 4H, J = 8.0 Hz, 4 ArCH), 7.63-7.52 (m, 6H, 6 ArCH), 
4.53 (s, 4H, CH2NCH2); HRMS (ESI
+
): m/z found, 780.3715 calc for C42H50N7O8 780.3715 
[3.73-ClO4]
+
.  
3.74 
 
Known compound synthesised according to literature procedure.
195
 4-Aminobenzoic acid 
(0.3g, 2.19 mmol) was dissolved in TFA (10 mL) and cooled to 0°C. Sodium nitrite (298 
mg, 4.4 mmol) was added portion wise over 5 minutes and the solution was stirred for a 
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further 30 minutes. After this time sodium azide (1.43 g, 21.9 mmol) was added carefully in 
portions over 5 minutes then Et2O (5 mL) and stirring continued for 1 h. The solution was 
partitioned between Et2O (15 mL) and water (15 mL) and the organic layer dried over 
MgSO4 and the solvent removed in vacuo. The excess TFA was removed by azeotrope with 
benzene to give a white powder (230 mg, 1.4 mmol, 64%). 
1
H NMR (400 MHz, 298 K, 
CD3OD) δH 8.03 (d, 2H, J =8.5 Hz, 2 ArCHCCO2), 7.15 (d, 2H, J =8.5 Hz, 2 ArCHCN3); 
13
C 
NMR (100 MHz, 298 K, CD3OD) δC 167.6 (COO), 144.8 (ArC), 131.3 (ArCH), 127.1 
(ArC), 118.5 (ArCH); IR ν cm-1 2941 (saturated C-H), 2100 (N3), 1668 (acid C=O). 
3.75 
 
The propargyl 3.69 (243.7 mg, 0.88 mmol) and azide 3.74 (300 mg, 1.8 mmol) were 
dissolved in THF (3 mL) and EtOH (3 mL). To the stirring solution CuSO4.5H2O (22 mg, 
0.09 mmol) and sodium ascorbate (53 mg, 0.26 mmol) in water (3 mL) was added. The 
solution was stirred at room temperature for 48 h. The reaction mixture was diluted with 
water and extracted with CH2Cl2 (3 x 10 mL). A precipitate was found in the CH2Cl2 layer 
which was filtered and washed with CH2Cl2 to provide a pale green solid (350 mg, 0.65 
mmol, 73%). m.p. 240-241°C (decomp.); 
1
H NMR (400 MHz, 298 K, DMSO-d6) δH 8.77 (s, 
2H, 2 triazole-CH), 8.12-8.07 (m, 5H, 5 ArCH), 7.99-7.94 (m, 5H, 5 ArCH), 7.83 (t, 1H, J = 
7.5 Hz, ArCH), 7.77 (t, 1H, J = 7.5 Hz, ArCH), 4.78 (broad s, 4H, CH2NCH2); 
13
C NMR 
(100 MHz, 298 K, DMSO-d6) δC 168.2 (COOH), 147.9 (ArC), 143.6 (ArC), 139.7 (ArC), 
135.0 (ArCH), 132.8 (ArCH), 132.7 (ArC), 132.5 (ArC), 130.6 (ArCH), 124.8 (ArCH), 
124.7 (ArCH), 123.0 (triazole-CH), 121.1 (ArCH), 42.5 (CH2NCH2); IR ν cm
-1 
2991 
(saturated C-H), 1683 (acid C=O), 1540 (NO), 1430 (weak N=N), 1341 (SO2); HRMS 
(ESI
+
): m/z found, 605.1205 calc for C27H27NO13S 605.1198 [3.75+H]
+
. 
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3.76 
 
Acid 3.75 (230 mg, 0.43 mmol) was dissolved in CH2Cl2 (3 mL). NEt3 (0.18 mL, 1.3 mmol) 
was added to solubilise 3.75. The alcohol 2.04 (187 mg, 0.89 mmol) was added along with 
the N,N,N',N'-tetramethylchloroformamidinium hexafluorophosphate (299  mg, 1.1 mmol) 
and DMAP (13 mg, 0.11 mmol). The solution was stirred at room temperature for 48 h. The 
reaction was followed by TLC (EtOAc:MeOH:H2O; 40:15:3) to completion. The reaction 
mixture was diluted with CH2Cl2 (15 mL) and washed with water (10 mL), citric acid (10 
mL), sodium bicarbonate (10 mL), water (10 mL) and brine (10 mL). The organic layer was 
dried over MgSO4 and the solvent removed in vacuo to provide an orange solid (210 mg, 
0.22 mmol, 52%). m.p. 73-74°C; 
1
H NMR (400 MHz, 298 K, CDCl3) δH 8.26-8.23 (m, 3H, 2 
triazole-CH and ArCH), 8.16 (d, 4H, J = 8.0 Hz, 4 ArCHCCO2), 7.81 (d, 4H, J = 8.0 Hz, 4 
ArCHCN), 7.75-7.70 (m, 3H, 3 ArCH), 6.52 (s, 4H, 2 CH=CH), 5.25 (s, 4H, 4 CHO), 4.75 
(s, 4H, CH2NCH2), 4.50 (t, 4H, J = 5.0 Hz, 2 CH2CH2O), 3.94 (t, 4H, J = 5.0 Hz, 2 
CH2CH2N), 2.90 (s, 4H, 4 CHCO);  
13
C NMR (100 MHz, 298 K, CDCl3) δC 176.1 (imide 
C=O), 164.9 (COO), 143.5 (ArC), 142.9 (ArC), 139.7 (ArC), 136.5 (CH=CH), 133.9 
(ArCH), 133.4 (ArC), 132.2 (ArCH), 131.6 (ArCH), 131.2 (ArCH), 130.1 (ArC), 124.3 
(ArCH), 122.0 (triazole-CH), 119.9 (ArCH), 80.9 (CHO), 61.7 (CH2CH2O), 47.5 (CHCO), 
41.7 (CH2NCH2), 37.8 (CH2CH2N); IR ν cm
-1 
2948 (saturated C-H), 1695 (imide and ester 
C=O), 1541 (NO), 1337 (SO2).  
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3.77 
 
Thread 3.76 (150 mg, 0.16 mmol) was dissolved in acetonitrile (5 mL). Potassium carbonate 
(88 mg, 0.64 mmol) and thiophenol (0.05 mL, 0.49 mmol) were added. The solution was 
heated to 50°C and the reaction followed by TLC (MeOH:CH2Cl2; 1:9) to completion. The 
crude material was purified via flash chromatography. (SiO2: MeOH:CH2Cl2; 1:9) to provide 
a pale yellow solid (70 mg, 0.087 mmol, 54%). 
1
H NMR (700 MHz, 298 K, CDCl3) δH 8.16 
(d, 4H, J = 8.5 Hz, 4 ArCHCCO2), 8.06 (broad s, 2H, 2 triazole-CH), 7.84 (broad d, 4H, , J = 
8.5 Hz, 4 ArCHCN), 6.51 (s, 4H, 2 CH=CH), 5.25 (s, 4H, 4 CHO), 4.50 (t, 4H, J = 5.5 Hz, 2 
CH2CH2O), 4.10 (broad s, 4H, CH2NHCH2), 3.94 (t, 4H, J = 5.5 Hz, 2 CH2CH2N), 2.89 (s, 
4H, 4 CHCO); 
13
C NMR (175 MHz, 298 K, CDCl3) δC 176.0 (imide C=O), 165.0 (COO), 
147.3 (ArC), 140.1 (ArC), 136.5 (CH=CH), 131.5 (ArCHCCO2), 129.8 (ArC), 120.1 
(triazole-CH), 119.8 (ArCHCN), 80.9 (CHO), 61.7 (CH2CH2O), 47.5 (CHCO), 43.6 
(CH2NHCH2), 37.8 (CH2CH2N); HRMS (ESI
+
): m/z found, 802.2588 calc for C40H36N9O10 
802.2580 [3.77+H]
+
. 
3.78 
 
Thread 3.77 (40 mg, 0.05 mmol) was dissolved in CH2Cl2 (5 mL) and washed with a 
concentrated aqueous solution of HClO4 (10%) (2 x 10 mL). The organic layer was dried 
over MgSO4 and solvent removed in vacuo to give a white solid (46 mg, 0.5 mmol, 100%). 
m.p. 221-222°C; 
1
H NMR (400 MHz, 298 K, CD3NO2) δH 8.50 (s, 2H, 2 triazole-CH), 8.08 
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(d, 4H, J = 8.5 Hz, 4 ArCHCCO2), 7.87 (d, 4H, J = 8.5 Hz, 4 ArCHCN), 6.43 (s, 4H, 2 
CH=CH), 5.03 (s, 4H, 4 CHO), 4.67 (s, 4H, CH2NH2
+
CH2), 4.35 (t, 4H, J = 5.5 Hz, 2 
CH2CH2O), 3.78 (t, 4H, J = 5.5 Hz, 2 CH2CH2N), 2.83 (s, 4H, 4 CHCO); 
13
C NMR (100 
MHz, 298 K, DMSO-d6) δC 176.5 (imide C=O), 164.5 (COO), 150.9 (ArC), 139.5 (ArC), 
136.4 (CH=CH), 131.2 (ArCH), 129.7 (ArC), 124.2 (ArCH), 120.1 (ArCH), 80.4 (CHO), 
61.4 (CH2CH2O), 47.2 (CHCO), 40.6 (CH2NH2
+
CH2), 37.0 (CH2CH2N); IR ν cm
-1
 3072 
(saturated C-H), 1699 (imide and ester C=O), 1607 (C-O), 1097 (ClO4); HRMS (ESI
+
): m/z 
found, 802.2573 calc for C40H36N9O10 802.2580 [3.78-ClO4]
+
.  
3.79 
 
Perchlorate thread 3.78 (25 mg, 0.028 mmol) was dissolved in acetonitrile (3 mL) and 
nitromethane (1 mL) and subjected to microwave irradiation (4h, 150W, 100 °C) and the 
reaction followed by TLC (CH2Cl2:MeOH; 9:1). The solvent was removed in vacuo to give 
the retro Diels-Alder thread as a white solid (21 mg, 0.027 mmol, 96%). 
1
H NMR (400 
MHz, 298 K, CD3CN) δH 8.53 (s, 2H, 2 triazole-CH), 8.14 (d, 4H, J = 8.5 Hz, 4 
ArCHCCO2), 7.94 (d, 4H, J = 8.5 Hz, 4 ArCHCN), 6.78 (s, 4H, 2 CH=CH), 4.54 (s, 4H, 
CH2NH2
+
CH2), 4.43 (t, 4H, J = 5.5 Hz, 2 CH2CH2O), 3.87 (t, 4H, J = 5.5 Hz, 2 CH2CH2N); 
13
C NMR (150 MHz, 298 K, , CD3CN) δC 172.3 (imide C=O), 166.3 (COO), 141.2 (ArC), 
139.7 (ArC), 135.8 (CH=CH), 132.6 (ArCH), 131.9 (ArC), 125.4 (ArCH), 121.8 (triazole-
CH), 64.0 (CH2CH2O), 42.9 (CH2NH2
+
CH2), 37.9 (CH2CH2N); IR ν cm
-1
 1711 (imide and 
ester C=O), 1608 (C-O), 1276 (C-O), 1109 (ClO4); HRMS (ESI
+
): m/z found, 666.2059 calc 
for C32H28N9O8 666.2055 [3.79-ClO4]
+
. 
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3.80 
 
Perchlorate thread 3.79 (10 mg, 0.013 mmol) and DB24C8 (15 mg, 0.039 mmol) were 
dissolved in deuterated acetonitrile (1 mL). The reaction was followed by 
1
H NMR until no 
change in the spectrum was observed. Pseudorotaxane 
1
H NMR (400 MHz, 298 K, 
CD3CN) δH 8.25 (broad s, 2H,  NH2), 8.18 (s, 2H,  2 triazole-CH), 8.11 (d, 4H, J = 8.5 
Hz,  4 ArCHCCO2), 7.70 (d, 4H, J = 8.5 Hz,  4 ArCHCN), 6.83 (s, 4H,  2 CH=CH), 
6.82-6.72 (m, 8H,  8 crown ArCH), 5.00 (m, 4H,  CH2NH2
+
CH2), 4.47 (t, 4H, J = 6.0 Hz, 
  2 CH2CH2O), 4.10-4.08 (m, 8H,  4 OCH2), 3.91 (m, 12H,  2 CH2CH2N and 4 OCH2), 
3.72-3.70 (m, 8H,  4 OCH2); Also contains unthreaded DB24C8 
1
H NMR (400 MHz, 298 
K, CD3CN) δH 6.93 (m, 8H, 8 ArCH), 4.14 (m, 8H, 4 OCH2), 3.83 (m, 8H, 4 OCH2), 3.72 (s, 
8H, 4 OCH2); HRMS (ESI
+
): m/z found, 1114.4167 calc for C56H60N9O16 1114.4153 [3.80-
ClO4]
+
.  
3.81 
 
To the pseudorotaxane 3.80 in acetonitrile, freshly distilled cyclopentadiene (0.1 mL, 
excess) was added. The solvent and excess cyclopentadiene were removed in vacuo. The 
solid obtained was extracted with hot benzene (3 x 5 mL) providing [2]rotaxane 3.81 (10 
mg, 0.007 mmol, 57 %). 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.19 (s, 2H,  2 triazole 
CH), 8.09 (d, 4H, J = 8.5 Hz,  4 ArCHCCO2), 7.71 (d, 4H, J = 8.5 Hz,  4 ArCHCN), 6.78 
(m, 4H,  4 crown ArCH), 6.68 (m, 4H,  4 crown ArCH), 5.96 (s, 4H,  2 CH=CH), 4.98 
(m, 4H,  CH2NH2
+
CH2), 4.32 (t, 4H, J = 5.5 Hz,  2 CH2CH2O), 4.10-4.09 (m, 8H,  4 
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OCH2), 3.89-3.87 (m, 8H,  4 OCH2), 3.81 (s, 8H,  4 OCH2), 3.70 (t, 4H, J = 5.5 Hz,  
CH2CH2N), 3.29 (m, 4H,  4 CHCO), 3.26 (m, 4H,  4 CHCH2), 1.61 (d, 2H, J = 9.0 Hz,  
CHH), 1.55 (d, 2H, J = 9.0 Hz,  CHH); 13C NMR (175 MHz, 298 K, CD3CN) δC 179.1 
(imide C=O), 166.3 (COO), 148.5 (ArC), 141.2 (ArC), 140.9 (ArC), 135.6 (CH=CH), 132.3 
(ArCH), 131.5 (ArC), 124.2 (ArCH), 122.5 (ArCH), 121.7 (ArCH), 113.5 (ArCH), 72.0 
(OCH2), 71.5 (OCH2), 68.9 (OCH2), 63.4 (CH2CH2O), 53.1 (bridgehead CH2), 46.9 
(CHCH2), 46.0 (CHCO), 44.5 (CH2NH2
+
CH2), 38.2 (CH2CH2N); HRMS (ESI
+
): m/z found, 
1246.5090 calc for C66H72N9O16 1246.5092 [3.81-ClO4]
+
. 
3.82 
 
Diacid 3.69 (100 mg, 0.17 mmol) was dissolved in CH2Cl2 (10 mL). The alcohol 2.15 (72 
mg, 0.35mmol) was added along with N,N,N',N'-tetramethylchloroformamidinium 
hexafluorophosphate (105 mg, 0.37 mmol), DMAP (4 mg, 0.04 mmol) and NEt3 (0.07 mL, 
0.5 mmol). The solution was stirred at room temperature for 48 h. CH2Cl2 (10 mL) was 
added to the mixture, and the organic layer was washed with water (10 mL), citric acid (10 
mL), sodium bicarbonate (10 mL) and brine (10 mL). The organic layer was dried over 
MgSO4 and the solvent removed in vacuo. The crude yellow solid was recrystallised from 
CH2Cl2/Et2O to provide a pale yellow solid (90 mg, 0.09 mmol, 54%). m.p. 108-109°C; 
1
H 
NMR (400 MHz, 298 K, CDCl3) δH 8.28-8.15 (m, 6H, 6 ArCH), 7.86-7.11 (m, 8H, 8 ArCH), 
6.01 (s, 4H, 2 CH=CH), 4.79 (br s, 4H, 2 CH2NCH2), 4.38 (t, 4H, J = 5.3 Hz, 2 CH2CH2O), 
3.82 (t, 4H, J = 5.3 Hz, 2 CH2CH2N), 3.39 (br s, 4H, 4 CHCO), 3.31 (br s, 4H, 4 CHCH2), 
1.72 (d, 2H, J = 8.7 Hz, 2 CHH), 1.55 (d, 2H, J = 8.7 Hz, 2 CHH); 
13
C NMR (100 MHz, 298 
  Chapter 3 
218 
 
K, CDCl3) δC 177.4 (imide C=O), 164.9 (COO), 152.5 (ArC), 143.5 (ArC), 139.9 (ArC), 
134.3 (CH=CH), 133.9 (ArCH), 132.1 (ArCH), 131.5 (ArCH), 131.2 (ArCH), 130.0 (ArC), 
124.3 (ArCH), 122.0 (ArCH), 120.0 (ArCH), 62.3 (CH2CH2O), 52.3 (bridgehead CH2), 45.8 
(CHCH2), 44.9 (CHCO), 41.7 (CH2NCH2), 37.2 (CH2CH2N); IR ν cm
-1
 1694 (imide and 
ester C=O), 1542 (C-O), 1272 (C-O); HRMS (ESI
+
): m/z found, 1005.2638 calc for 
C48H42N10O12SNa 1005.2597 [3.82+Na]
+
. 
3.83 
 
Thread 3.82 (50 mg, 0.05 mmol) was dissolved in acetonitrile (5 mL). Thiophenol (0.016 
mL, 0.15 mmol) and potassium carbonate (28 mgs, 0.2 mmol) were added and the reaction 
mixture was heated to 60°C and stirred for 24 h. The crude reaction mixture was purified via 
flash chromatography (SiO2: CH2Cl2 to CH2Cl2:MeOH; 9:1) to provide a pale yellow solid 
(30 mgs, 0.04 mmol, 74%). m.p. 85-86 C (decomp.); 1H NMR (700 MHz, 298 K, CDCl3) δH 
8.18 (d, 4H, J = 8.5 Hz, 4 ArCHCCO2), 8.08 (s, 2H, 2 triazole-CH), 7.86 (d, 4H, J = 8.5 Hz, 
4 ArCHCN), 6.01 (s, 4H, 2 CH=CH), 4.38 (t, 4H, J = 5.0 Hz, 2 CH2CH2O), 4.11 (br s, 4H, 
CH2NHCH2), 3.81 (t, 4H, J = 5.0 Hz, 2 CH2CH2N), 3.39 (br s, 4H, 4 CHCH2), 3.30 (br s, 
4H, 4 CHCO), 1.73-1.54 (m, 4H, 2 x bridgehead CH2);  
13
C NMR (175 MHz, 298 K, CDCl3) 
δC 177.4 (imide C=O), 165.0 (COO), 147.2 (ArC), 140.2 (ArC), 134.3 (CH=CH), 131.5 
(ArCH), 129.8 (ArC), 120.1 (triazole-CH), 119.9 (ArCH), 62.3 (CH2CH2O), 52.3 
(bridgehead CH2), 45.9 (CHCH2), 45.0 (CHCO), 45.3 (CH2NHCH2), 37.2 (CH2CH2N); IR ν 
cm
-1
 1728 (imide and ester C=O stretching), 1613 (C-O).  
 
 
  Chapter 3 
219 
 
3.84 
 
Neutral thread 3.83 (10 mg, 0.013 mmol) was dissolved in CH2Cl2 (10 mL) and washed with 
an aqueous solution of HClO4 (10%) (2 x 10 mL). The organic layer was dried over MgSO4 
and the solvent removed in vacuo. The crude solid was recrystallised from acetonitrile/Et2O 
to give a white solid (12 mg, 0.013 mmol, 100%). m.p. 151-152°C; 
1
H NMR (700 MHz, 298 
K, CD3CN) δH 8.48 (s, 2H, 2 triazole CH), 8.14 (d, 4H, J = 8.4 Hz, 4 ArCHCCO2), 7.95 (d, 
4H, J = 8.4 Hz, 4 ArCHCN), 5.96 (s, 4H, 2 CH=CH), 4.47 (s, 4H, CH2NH2
+
CH2), 4.32 (t, 
4H, J = 5.6 Hz, 2 CH2CH2O), 3.69 (t, 4H, J = 4.8 Hz, 2 CH2CH2N), 3.29 (s, 4H, 4 CHCO), 
3.25 (s, 4H, 4 CHCH2), 1.61 (d, 2H, J = 8.8 Hz, 2 CHH), 1.55 (d, 2H, J = 8.8 Hz, 2 CHH); 
13
C NMR (175 MHz, 298 K, CD3CN) δC 177.7 (imide C=O), 164.8 (COO), 139.9 (ArC), 
139.8 (ArC), 134.3 (CH=CH), 131.2 (ArCH), 130.4 (ArC), 123.5 (triazole CH), 120.4 
(ArCH), 62.1 (CH2CH2O), 51.8 (bridgehead CH2), 45.7 (CHCH2), 44.7 (CHCO), 41.8 
(CH2NH2
+
CH2), 36.9 (CH2CH2N); IR ν cm
-1
 3052 (saturated C-H), 1685 (ester and imide 
C=O), 1092 (ClO4); HRMS (ESI
+
): m/z found, 798.3013 calc for C42H40N9O8 798.2994 
[3.93-ClO4]
+
. 
3.94 
 
Known compound synthesised according to literature procedure.
107
 3,5-
Dimethylbenzaldehyde (250 mg, 1.9 mmol) and propargyl amine (0.12 mL, 1.9 mmol) were 
heated to reflux in CHCl3 (3 mL) for 1 h. The solution was cooled to room temperature and 
solvent removed in vacuo. The crude oil was dissolved in MeOH (5 mL) and cooled to 0°C, 
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sodium borohydride (72 mg, 1.9 mmol) was added and the solution stirred for 1 h. Water (10 
mL) was added to quench the reaction and solvent removed in vacuo. THF (10 mL) was 
added and the precipitate formed was removed by filtration. The liquors were reduced in 
vacuo to give a pale yellowish oil used without further purification (303 mg, 1.75 mmol, 
92%). 
1
H NMR (400 MHz, 298 K, CDCl3) δH 6.98 (s, 2H, 2 ArCH), 6.92 (s, 1H, ArCH), 
3.83 (d, 2H, J = 7.0 Hz, ArCH2NH), 3.44 (dd, 2H, J = 6.0 Hz, J = 2.5 Hz, C≡CCH2NH), 
2.32 (s, 6H, 2 CH3), 2.27 (t, 1H, J = 2.5 Hz, C≡CH); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 
139.3 (ArC), 138.0 (ArC), 128.8 (ArCH), 126.6 (ArCH), 124.8 (C≡CH), 71.6 (C≡CH), 52.3 
(ArCH2NH), 37.4 (C≡CCH2NH), 21.3 (CH3); HRMS (ESI
+
): m/z found, 174.1276 calc for 
C12H16N 174.1277 [3.94+H]
+
. 
3.88 
 
Known compound synthesised according to literature procedure.
107
 The propargyl compound 
3.92 (303 mg, 1.75 mmol) was dissolved in acetonitrile (5 mL). NH4PF6 (304 mg, 2.1 mmol) 
was added to the solution and it was stirred at room temperature overnight. The crude 
reaction mixture was reduced in vacuo and the residue taken up in THF. Et2O was added to 
the solution and left to precipitate out excess NH4PF6, then filtered. The liquors were 
concentrated in vacuo providing an off white solid (550 mg, 1.72 mmol, 98%). 
1
H NMR 
(400 MHz, 298 K, CD3OD) δH 7.04 (broad s, 3H, 3 ArCH), 4.05 (broad s, 2H, ArCH2NH2
+
), 
3.72 (d, 2H, J = 3.0 Hz, C≡CCH2NH2), 3.05 (t, 1H, J = 3.0 Hz, C≡CH), 2.32 (s, 6H, 2 CH3); 
13
C NMR (100 MHz, 298 K, CD3OD) δC 139.8 (ArC), 131.4 (ArC), 128.2 (ArCH), 128.1 
(ArCH), 122.6 (C≡CH), 77.6 (C≡CH), 51.7 (ArCH2NH2
+
), 36.9 (C≡CCH2NH2
+
), 21.2 
(CH3); HRMS (ESI
+
): m/z found, 174.1275 calc for C12H16N 174.1277 [3.88-PF6]
+
. 
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3.89 
 
The propargyl 3.88 (100 mg, 0.31 mmol) and the 3,5-dimethylphenyl azide 3.11 (51 mg, 
0.35mmol) were dissolved in CH2Cl2 (10 mL). DB24C8 (281 mg, 0.63 mmol) was added 
followed by Cu(MeCN)4PF6 (117 mg, 0.31 mmol) and 2,6-lutidine (0.004 mL, 0.013 mmol) 
and the solution stirred at room temperature for 48 h. The solution was reduced in vacuo and 
the crude mixture purified via flash chromatography (SiO2: CH2Cl2 to CH2Cl2:acetone 5:1) 
to give the rotaxane as an oil. (85 mg, 0.093 mmol, 30%). 
1
H NMR (400 MHz, 298 K, 
CDCl3) δH 7.94 (s, 1H,  triazole CH), 7.86 (s, 2H,  NH2), 7.20 (s, 2H,  2 ArCH), 7.03 (s, 
1H,  ArCH), 6.89 (s, 2H,  2 ArCH), 6.85-6.76 (m, 9H,  8 crown ArCH and  ArCH), 
4.86 (m, 2H,  ArCH2NH2
+
), 4.60 (m, 2H,  triazole-CH2NH2
+
), 4.18-4.14 (m, 4H,  2 
CH2O), 4.08-4.04 (m, 4H,  2 CH2O), 3.94-3.90 (m, 4H,  2 CH2O), 3.82-3.72 (m, 8H,  4 
CH2O), 3.65-3.60 (m, 4H,  2 CH2O), 2.38 (s, 6H,  2 CH3), 2.12 (s, 6H,  2 CH3); 
13
C 
NMR (100 MHz, 298 K, CDCl3) δC 147.4 (ArC), 139.7 (ArC), 138.0 (ArC), 136.2 (ArC), 
135.1 (ArC), 131.3 (ArC), 130.4 (ArCH), 127.3 (ArCH), 123.5 (triazole-CH), 121.7 (ArCH), 
121.5 (ArCH), 117.8 (ArCH), 112.4 (ArCH), 70.8 (CH2O), 70.2 (CH2O), 67.9 (CH2O),  52.7 
(CH2NH2
+
), 43.4 (CH2NH2
+
), 21.2 (CH3), 21.1 (CH3); IR ν cm
-1
 2926 (saturated C-H), 1725 
(ether C-O), 1250 (ether C-O), 838 (PF6); HRMS (ESI
+
): m/z found, 769.4174 calc for 
C44H57N4O8 769.4171 [3.89-PF6]
+
. 
3.90 
 
Propargyl amine 3.88 (100 mg, 0.31 mmol) and 3,5-dimethyl azide 3.11 (52 mg, 0.35 mmol) 
were dissolved in dry CH2Cl2 (10 mL). Cu(MeCN)4PF6 (117 mg, mmol) and 2,6-lutidine 
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(0.004 mL, 0.03 mmol) were added and the reaction stirred at room temperature for 24 h 
under N2. The reaction was diluted with CH2Cl2 (20 mL) and washed with ammonia (2 x 20 
mL), water (20 mL), and brine (20 mL) and aqueous hexafluorophosphoric acid (10%) (20 
mL). The organic layer was dried over MgSO4 and solvent removed in vacuo (40 mg, 0.09 
mmol, 29 %). m.p. 214-215°C; 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.22 (s, 1H, triazole-
CH), 7.39 (s, 2H, 2 ArCH), 7.15 (s, 1H, ArCH), 7.04 (s, 1H, ArCH), 7.02 (s, 2H, 2 ArCH), 
4.74 (br s, 2H, NH2), 4.20 (br s, 4H, CH2NH2
+
CH2), 2.38 (s, 6H, 2 CH3), 2.28 (s, 6H, 2 
CH3); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 141.4 (ArC), 140.0 (ArC), 138.0 (ArC), 
131.8 (ArCH), 131.7 (ArCH), 128.6 (ArCH), 124.2 (triazole-CH), 119.5 (ArCH), 52.3 
(CH2NH2
+
), 43.1 (CH2NH2
+
), 21.7 (CH3), 21.6 (CH3); IR ν cm
-1
 2919 (saturated C-H), 1602 
(NH2), 1435 (N=N), 840 (PF6); HRMS (ESI
+
): m/z found, 321.2072 calc. for C20H25N4 
321.2074 [3.90-PF6]
+
. 
3.91 
 
The propargyl amine 3.88 (160 mg, 0.50 mmol) was dissolved in dry CH2Cl2 (10 mL) with 
DB24C8 (430 mg, 0.96 mmol). After 5 minutes the Cu(MeCN4)PF6 (178 mg, 4.80 mmol) 
and 2,6-lutidine (0.01 mL, 0.048 mmol) were added followed by diazide 3.38 (54 mg, 0.240 
mmol). The solution was stirred for 72 h. The solvent was removed and the crude mixture 
purified via flash chromatography (SiO2: CH2Cl2 to CH2Cl2:MeOH; 97:3) to give a pale oil 
(82 mg, 0.047 mmol, 19%). 
1
H NMR (400 MHz, 298 K, CDCl3) δH 7.72 (br s, 4H,  2 NH2), 
7.66 (s 2H,  2 triazole-CH), 6.87-6.77 (m, 20H,  16 crown ArCH and  4 ArCH), 6.72 (s, 
2H,  2 ArCH), 4.78 (m, 4H,  2 triazole-CH2NH2CH2), 4.52 (m, 4H,  2 triazole-
CH2NH2CH2), 4.31-4.28 (m, 4H,  2 OCH2), 4.23 (t, 4H, J = 7.3 Hz,  CH2N-triazole), 
4.17-4.13 (m, 4H,  2 OCH2), 4.07-4.03 (m, 8H,  4 OCH2), 3.91-3.87 (m, 8H,  4 OCH2), 
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3.80-3.76 (m, 8H,  4 OCH2), 3.73-3.69 (m, 8 H,  4 OCH2), 3.66-3.60 (m, 8H,  4 OCH2), 
1.78-1.75 (m, 4H,  2 CH2CH2CH2), 1.23-1.20 (br m, 12H,  CH2(CH2)6CH2); 
13
C NMR 
(100 MHz, 298 K, CD3CN) δC 140.4 (ArC), 139.4 (ArC), 132.7 (ArC), 131.5 (ArCH), 128.7 
(ArCH), 122.9 (ArCH), 122.6 (ArCH), 120.8 (ArC), 113.7 (ArCH), 70.7 (OCH2), 70.2 
(OCH2), 67.8 (OCH2), 53.8 (CH2NH2
+
), 51.3 (CH2N-triazole), 44.8 (CH2NH2
+
), 31.9 (CH2), 
30.4 (CH2), 29.9 (CH2), 27.5 (CH2), 21.6 (CH3); IR ν cm
-1
 2914 (saturated C-H), 2848 
(saturated C-H), 1728 (ether C-O), 1254 (C-O), 841 (PF6); HRMS (ESI
+
): m/z found, 
734.4247 calc for C82H116N8O16 734.4249 [3.91-2PF6]
2+
. 
3.92 
 
Propargyl amine 3.88 (178 mg, 0.56 mmol) and diazide 3.38 (50 mg, 0.22 mmol) were 
dissolved in dry CH2Cl2. The Cu(MeCN)4PF6 (166 mg, 0.45 mmol) and 2,6-lutidine (14 mg, 
0.045 mmol) were added, the system flushed with N2 and stirred at room temperature for 24 
h. The reaction was diluted with CH2Cl2 (20 mL) and washed with ammonia (3 x 15 mL), 
water (20 mL) and brine (20 mL). The crude oil was purified via flash chromatography 
(SiO2: CH2Cl2 to CH2Cl2:MeOH; 9:1). The combined fractions were reduced in vacuo, 
dissolved in CH2Cl2 (10 mL) and washed with and aqueous solution of 
hexafluorophosphoric acid (10%) (3 x 10 mL). The organic layer was dried over MgSO4 and 
solvent removed in vacuo to provide a white solid (50 mg, 0.058 mmol, 26%). m.p. 148-
149°C; 
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.86 (s, 2H, 2 triazole-CH), 7.45 (br s, 4H, 2 
NH2), 7.11 (s, 2H, 2 ArCH), 7.06 (s, 4H, 4 ArCH), 4.36 (t, 4H, J = 7.0 Hz, 2 CH2N-triazole), 
4.29 (s, 4H, 2 CH2NH2
+
), 4.16 (s, 4H, 2 CH2NH2
+
), 2.32 (s, 12H, 4 CH3), 1.85 (m, 4H, 2 
CH2CH2N), 1.28-1.26 (m, 12H, CH2(CH2)6CH2); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 
140.3 (ArC), 138.5 (ArC), 132.5 (ArCH), 131.5 (ArC), 129.1 (ArCH), 126.5 (triazole-CH), 
52.2 (NH2CH2), 51.5 (CH2-N), 43.1 (CH2NH2), 31.2 (CH2), 30.3 (CH2), 29.9 (CH2) 27.3 
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(CH2), 21.6 (CH3); IR ν cm
-1
 2924 (saturated C-H), 1458 (N=N), 821 (PF6); HRMS (ESI
+
): 
m/z found 571.4233 calc for C34H51N8 571.4231 [3.92- H.2PF6]
+
. 
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Chapter 4 - Synthesis of [2]Pseudorotaxanes and 
[2]Rotaxanes Using Novel Macrocycles. 
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4. Synopsis 
 
In the previous chapters, work focussed on using the Diels-Alder approach to ‘threading 
followed by stoppering’ to synthesise novel rotaxanes. Both existing and new templates were 
transformed into rotaxanes using this approach. In this chapter modifications to the 
DB24C8 macrocycle in order to enhance the binding interactions were investigated. 
DB24C8 is a crown ether macrocycle that has been shown to have excellent binding 
affinities to templates such as dibenzylammonium and bispyridinium ethane. Modifications 
to this macrocycle and the effects on binding and their transformation into rotaxanes was 
explored. 
 
Replacement of one of the ethylene oxy units in DB24C8 with an acetal provided two novel 
macrocycles (Figure 4.1). These macrocycles were subjected to binding studies with a 
variety of templates in order to see the effects of reducing macrocycle size but retaining the 
oxygen H bond acceptors. The results of which are discussed within the chapter. 
 
Figure 4.1 Macrocycle 4.01 and 4.02. 
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4.1 Introduction 
There are a variety of possible templates that can form axles to interact with crown 
macrocycles for rotaxane formation.
31-33,46,120
 These enhancements can include changing the 
macrocycle cavity size or incorporating additional functionality into a macrocycle in order to 
modify the binding interaction. Herein we look at how changes to the macrocycle can also 
play a role in effecting the binding affinity to axle templates. 
 
There are many examples of crown ethers threading over a variety of axles with various 
recognition sites including secondary dialkylammonium salts
196-197
 and bispydridiniums.
46
 
Previously it was assumed that macrocycles required a minimum of 24 atoms to encompass 
a simple alkyl chain into its central cavity.
21,32,198
 There have been many examples of 
DB24C8 showing excellent binding with secondary dialkylammonium salts.
31,61,199
 However 
Huang et al
200
 have reported the threading of benzo-21-crown-7 4.03 over secondary 
dialkylammonium salts giving improved binding to provide [2]pseudorotaxanes and 
[2]rotaxane complexes. The interaction of the macrocycle with a series of secondary dialkyl 
ammonium salts was followed by 
1
H NMR and the two complexes formed with threads 4.04 
and 4.05 had slow exchange on the NMR time scale (Figure 4.2). The cavity of macrocycle 
4.03 was found to be unable to thread over dibenzylammonium thread 3.09 and no 
pseudorotaxane formation was seen in this case. The binding constants for threads 4.04 and 
4.05 were calculated in acetone and both showed a higher binding with macrocycle 4.03 
than DB24C8. Pseudorotaxane formation was also characterised by the use of ESI mass 
spectrometry. It was reported that benzo-21-crown-7 4.03 is the smallest cavity a secondary 
dialkylammonium salt is able to thread through as similar investigations with benzo-18-
crown-6 showed no complex formed. 
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Figure 4.2 Benzo-21-crown-7 binding studies with three ammonium binding templates. 
Huang et al have also synthesised [2]pseudorotaxanes with secondary dialkylammonium 
ions using pyrido-21-crown-7 (Figure 4.3).
201
 It has been found that crowns containing 
pyridine show an enhanced complexation with threads due to the pyridyl nitrogen being a 
better hydrogen bond acceptor than the aliphatic or phenolic ether oxygens. Likewise, this 
pyrido macrocycle was complexed with the threads shown in Figure 4.2. The 
pseudorotaxanes were again in a slow-exchange in the 
1
H NMR time scale enabling the 
binding constant to be calculated using the single point method.
129
 The Ka values were found 
to be higher with each thread than those with the benzo-21-crown-7 macrocycle in acetone. 
[2]rotaxanes were obtained using the threading followed by stoppering approach with phenyl 
groups acting as stoppers (Figure 4.3). The rotaxane architecture was characterised by x-ray 
crystallography and ESI-MS as well as NMR. 
 
Figure 4.3 [2]rotaxane formed from a secondary dialkylammonium and a pyrido-21-crown-7. 
More recently Wu et al have synthesised a [2]rotaxane with just 20 atoms in the macrocycle 
surrounding an ammonium ion.
202
 In this case a trifluoromethyl group is utilised to both 
enhance the templating effect and act as a stopper. Using a clipping strategy a diolefin 
polyether cyclised by a ring closing metathesis (RCM) step provided the [2]rotaxane 4.07 in 
a 54% yield (Figure 4.4). 
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Figure 4.4 Synthesis of [2]rotaxane 4.07 via a RCM clipping strategy. 
Synthesis of interlocked molecules can prove challenging as they usually rely on 
supramolecular assistance from weak interactions such as π-stacking, ion-dipole and 
hydrogen bonding. The electrostatic attraction between oppositely charged ions is a stronger 
more robust interaction. Loeb reported the use of these electrostatic interactions in the 
formation of [2]pseudorotaxanes (Figure 4.5).
131
 These were prepared using a positively 
charged 1,2-bis(pyridinium)ethane axle and a negatively charged DB24C8 ether macrocycle 
with sulphonic (SO3
-
) groups attached to each aromatic moiety (Figure 4.5). The interactions 
between the axle and macrocycle providing the [2]pseudorotaxane 4.08 were driven by 
hydrogen bonds, π-stacking and ion-dipole interactions as well as the electrostatic ion-ion 
interactions. It was found that the interaction of the sulphonated crown macrocycle were 
greater than for the neutral crown in polar solvents such as MeOH. Comparing Ka values of 
the neutral and charged crown highlighted the significance of this added electrostatic 
interaction in providing an overall stronger attraction between the wheel and axle. 
 
Figure 4.5 Loeb’s [2]pseudorotaxane 4.08 containing additional ionic interactions. 
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Other groups have investigated the effect of increasing macrocycle size on the binding 
interactions between crown and axle. Chiu et al have taken bis-p-xylyl[26]crown-6 
(BPX26C6) with a larger macrocycle cavity than DB24C8 and shown it can bind with 
bispyridinium cations.
203
 Taking equimolar quantities of this crown and N,N’-dimethyl-4,4’-
bipyridinium it was seen to form [3]rotaxanes with a stoichiometry of 2:1. Chiu has also 
successfully incorporated this macrocycle towards the synthesis of molecular shuttles in one 
pot reactions with bispyridinium binding templates.
203-204
 
4.2 Synthesis of Novel 23 Atom Cavity Macrocycles. 
As shown, there are many examples of modifying macrocycle size as well as changing 
functionality to moderate the interactions between macrocycle and axle.
131,200-201
 Herein we 
report on modifications to the DB24C8 macrocycle with a reduction of the crown ether 
macrocycle cavity size first investigated. To achieve this, an ethyl oxy bridge (OCH2CH2O) 
was replaced with an acetal moiety (OCH2O). This reduced the macrocycle from a 24 atom 
cavity to a 23 atom cavity but retained the number of oxygen acceptors. Introduction of the 
acetal would also allow us to introduce functionality to the macrocycle whilst retaining a 
degree of symmetry of the macrocycle. Previous examples by Loeb had shown that lowering 
the symmetry of the crown makes analysis of resulting pseudorotaxanes and rotaxanes more 
challenging.
131
  
A macrocycle with a cavity of 23 atoms was successfully synthesised by initially reacting 
catechol and triethylene glycol chlorohydrin to give the corresponding diol 4.09. The diol 
was then reacted in high dilution in CH2Cl2 with sodium hydroxide to provide the 
macrocycle 4.01 in a 39% yield shown in Scheme 4.1.
205
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Scheme 4.1 Reagents and conditions: a) DMF, K2CO3, N2, 100˚C, 24h, 47%; b) CH2Cl2, NaOH (excess), RT, 5d, 
39%. 
The binding ability of this macrocycle was then investigated with known and novel binding 
templates that have shown interactions with crown ether type macrocycles. Loeb has 
previously reported that bispyridinium salts have excellent binding with DB24C8 
macrocycles and this was the first binding template investigated.
46
 The known bispyridnium 
salts were synthesised from ethyl isonicotinate and ethyl nicotinate as starting materials. 
This was carried out in an excess of dibromoethane heating at 100°C overnight to give the 
corresponding bromide salts 4.10 and 4.12. Ion exchange by treatment with ammonium 
hexafluorophosphate gave the two bis pyridinium PF6 salts 4.11 and 4.13 shown in Scheme 
4.2.  
 
Scheme 4.2 Reagents and conditions: a) 100˚C, 24h, 44%; b) MeOH, NH4PF6, RT, 36%; c) 100˚C, 24h, 40%; d) 
MeOH, NH4PF6, RT, 40%. 
The binding of the new macrocycle was examined in comparison to the known DB24C8 
values. Initially performing these binding experiments at 2 mmol was attempted but at this 
concentration there was only a small extent of pseudorotaxane formation observed. All 
binding studies were then carried out with these novel macrocycles performed at a 15 mmol 
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concentration. Taking an equimolar solution of the bispyridinium threads (4.11 and 4.13) 
and novel macrocycle 4.01 in deuterated acetonitrile a slow exchange in the 
1
H NMR 
timescale was observed. The binding constants were able to be calculated by the single point 
method for each of the complexes.
129
 These were found to be 11 M
-1
 for the interactions of 
isonicotinate thread 4.13 and crown 4.01 to give pseudorotaxane 4.14 and 55 M
-1
 for 
nicotinate thread 4.11 and crown 4.01 to give pseudorotaxane 4.15. These binding constants 
are vastly different to the observed binding constants reported by Loeb
131
 with DB24C8 
which are 1940 M
-1
 and 4750 M
-1
 respectively. The reasons for this two orders of magnitude 
difference probably include the loss of a benzene ring meaning there is a decrease in the π-
stacking interactions as well as a detrimental change of hydrogen bonding capabilities from 
the change of the -OCH2CH2O- unit. Previously the bispyridinium threads have been found 
to rely predominantly on π-stacking interaction in pseudorotaxane formation so the loss of 
the benzene ring from the macrocycle was expected to have a detrimental effect on the 
interaction.
46
 It was hoped however that the reduction in ring size would provide a better fit 
between thread and crown and maximise the H-bonding capabilities between the two 
components.
200
  
 
Scheme 4.3 Reagents and conditions: a) CD3CN, RT. 
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Comparison of the 
1
H NMR spectra of free thread 4.11 and macrocycle 4.01 and rotaxane 
(4.15) is shown in Figure 4.6. The α-pyridinium hydrogen’s of the thread are seen to shift 
downfield due to hydrogen bonding with the crown ether oxygens. The other hydrogens of 
the pyridinium are shifted upfield as are the aromatic’s of the macrocycle due to shielding 
effects of the interacting π system. The central ethylene group situated in the bispyridinium 
binding motif are seen also to shift downfield due to hydrogen bonding with the crown ether 
oxygen’s. The signals for the crown ether CH2’s become complicated multiplets shifting 
both upfield and downfield as a result of their proximity to the thread 4.11. An NOE 
interaction was observed between the crown and thread confirming the interlocked nature of 
pseudorotaxane 4.15. On irradiation of the two encompassed CH2N
+ hydrogen’s at 5.60 ppm, 
an enhancement of the signal from the ethylene units of the crown was observed confirming 
these hydrogen’s are close in space. There is also an NOE observed between the α-
pyridinium protons and the crown ethoxy methylenes. 
 
Figure 4.6 
1H NMR Spectra (400 MHz, CD3CN, 300K) stacking plot i) Macrocycle 4.01; ii) [2]Pseudorotaxane 
4.15; iii) Bispyridinium thread 4.11. 
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The 
1
H NMR of pseudorotaxane 4.14 shown in Figure 4.7 exhibits very similar shifts to the 
isonicotinic pseudorotaxane 4.15 with the α-pyridinium hydrogen’s again shifted downfield 
and β aromatic protons shifted upfield due to shielding and deshielding effects of the 
encompassing macrocycle. Again the central ethylene
 
group of the bispyridinium binding 
motif are seen to shift downfield as a result of hydrogen bonding with the oxygens of 
macrocycle 4.01. The aromatic protons of the macrocycle shift upfield and the CH2’s of the 
bound crown ether become a complex set of multiplets further indicating the presence of the 
interlocked structure.  
 
Figure 4.7 
1H NMR Spectra (400 MHz, CD3CN, 300K) stacking plot i) Macrocycle 4.01; ii) [2]Pseudorotaxane 
4.14; iii) Bispyridinium thread 4.13. 
4.3 Threading of the 23 Atom Macrocycle with Dialkylammonium Salts 
As there was some success with the ability to form pseudorotaxanes with bispyridinium 
threads 4.11 and 4.13, binding of the benzo-23-crown macrocycle 4.01 with 
dialkylammonium salts was also investigated. This was carried out by synthesising the 
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dibenzylammonium hexafluorophosphate salt 3.09. Equimolar quantities of macrocycle 4.01 
and thread 3.09 were dissolved in deuterated acetonitrile at 15 mmol. A new set of peaks 
were observed in the 
1
H NMR due to slow exchange on the NMR timescale allowing 
calculation of the binding constant by the single point method.
129
 The aromatic hydrogens of 
the thread are shifted slightly upfield and the central ethylene CH2NH2
+
 hydrogens show a 
shift downfield because of hydrogen bonding with the crown ether oxygen’s (Figure 4.8). 
The aromatic protons of the crown also show a slight shift upfield due to π-stacking 
interactions with the thread. The pseudorotaxane 4.16 was also observed by ESI-MS with a 
peak at 584.4 corresponding to the [4.16-PF6]
+
 complex.  
 
Figure 4.8 
1H NMR Spectra (400 MHz, CD3CN, 300K) stacking plot i) Macrocycle 4.01; ii) [2]Pseudorotaxane 
4.16; iii) Dibenzylammonium hexafluorophosphate thread 4.16. 
The binding constant of pseudorotaxane 4.16 was found to be 27 M
-1
 in comparison to 200 
M
-1
 for the same dialkylammonium salt with DB24C8.
162
 In this case there is only one order 
of magnitude difference between the two values as these recognition sites rely mainly on the 
hydrogen bonding between crown and axle. However the large decrease in binding 
suggested the H-bonding capabilities of the crown ether have been compromised. 
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Figure 4.9 [2]Pseudorotaxane 4.16. 
The solid state structure of pseudorotaxane 4.16 shown in Figure 4.10 was obtained from 
crystals grown from an acetonitrile solution of crown 4.01 and thread 3.09 slowly saturated 
with diethyl ether. Several of the ethylene oxy groups and the acetal of the crown are 
disordered over two positions in a ratio of 55:45. This variable orientation adopted by about 
half of the crown chain highlights the lack of any dominant interactions and a poor fit 
between the thread and the oxygen acceptors of the crown in the solid state and by 
implication in solution.  
 
Figure 4.10 Solid state structure of [2]pseudorotaxane 4.16 showing the disordered conformation of the crown 
chain about the dibenzylammonium ion 3.09. The two disordered components are in a 55:45 ratio with the bonds 
of the minor component of the disorder chain shown in dotted lines. Hydrogen atoms have been removed for 
clarity.  
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The removal of one -OCH2CH2O- and replacement with -OCH2O- does not affect the 
smaller crowns ability to thread over the templates. It does however dramatically alter the 
‘ideal’ positioning of the polyethylene oxy chains and their oxygen acceptors around the 
ammonium ion recognition motif giving a poor fit and reduced complementarity (Figure 
4.11). The advantages of this ‘ideal’ orientation of the oxygens provided by the -
OCH2CH2O- motif is also prevalent in the binding of metal ions by crowns.
162,206
 
 
Figure 4.11 A cartoon representation of the ‘ideal’ H bonding situation of the polyethylene oxy chain of 
DB24C8 with an ammonium ion and the poorer fit of the methylene acetal containing chain in the solid state 
structure of pseudorotaxane 4.16. 
The binding constant of the benzo-23-crown macrocycle 4.01 was also investigated with the 
novel perimidine benzimidazole thread 2.52. This thread has shown an enhanced binding 
interaction with DB24C8 presumably by increased π stacking ability and better H bonding. 
Taking equimolar quantities of thread 2.52 and macrocycle 4.01 in deuterated acetonitrile 
the binding interaction between the two components was measured at a 15 mmol 
concentration. The value was found to be 44 M
-1
 which is greatly reduced when comparing 
to DB24C8 which gave a binding constant of 755 M
-1 
(Figure 4.12). It is however larger than 
the interaction with the dibenzyl ammonium thread 3.09 so the more favourable binding 
interaction seen for DB24C8 is mirrored to a lesser extent in its interaction with 4.01. The 
binding constants observed are summarised in Table 4.1. In comparison with DB24C8 the 
greatest difference in binding with macrocycle 4.01 is seen for the bispyridinium threads 
where the interaction is known to rely heavily on π stacking.  
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Figure 4.12 [2]Pseudorotaxane 4.17. 
[2]Pseudorotaxanes 23 atom cavity crown 
Binding constant (15 mM) 
DB24C8 
binding constant (2 mM) 
Dibenzylammonium 
4.16 
27 M
-1
 200 M
-1
 
Perimidine benzimidazole 
4.17 
44 M
-1
 755 M
-1
 
Nicotinate bis pyridinium 
4.15 
55 M
-1
 4750 M
-1
 
Isonicotinate bispyridinium 
4.14 
11 M
-1
 1940 M
-1
 
Table 4.1 Summary of binding constants of benzo-23-crown macrocycle 4.01 and DB24C8 with various binding 
motifs.46,162 
4.4 Synthesis of Dibenzo-23-crown Macrocycle. 
A 23 atom macrocycle was then designed that still contains the 8 oxygen acceptors and 
retained a similar π stacking ability to DB24C8. This was achieved taking triethylene glycol 
and activating the alcohols with tosyl groups to provide 4.19. A second reaction heating 
catechol and ethylene carbonate to 160°C provided the diol (4.18). These two compounds 
were heated together at reflux in acetonitrile with potassium carbonate under N2 to provide 
4.20. Finally the macrocycle (4.02) was synthesised in CH2Cl2 with an excess of sodium 
hydroxide and purified via column chromatography (Scheme 4.4). Confirmation of the 
structure was provided by ESI-MS with a peak at 452.1 corresponding to the [4.02+NH4]
+
 
ion. 
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Scheme 4.4 Reagents and conditions: a) TBAI, 160˚C, 18h, 52%; b) THF, aq. NaOH, H2O, TsCl, 24h, 77%; c) 
Acetone, K2CO3, N2, reflux; 24h, 29%; d) CH2Cl2, NaOH (excess), RT, 5d, 41%. 
This new dibenzo-23-crown macrocycle 4.02 was then investigated in the assembly of 
pseudorotaxanes. Binding with both the bispyridinium threads 4.11, 4.13 and equimolar 
quantities of macrocycle 4.02 in deuterated acetonitrile was first attempted at 15 mmol 
concentration. Unfortunately no pseudorotaxane formation was seen after several days of 
observation at room temperature. Heating the samples to 40˚C for 72 hours was carried out 
but still no threading of the macrocycle occurred. It was then attempted to assemble the 
pseudorotaxane using the macrocycle 4.02 with dibenzyl ammonium thread 3.09 and in this 
case a very small amount of pseudorotaxane 4.21 formation was detected. This took several 
days before reaching equilibrium as observed via 
1
H NMR. The pseudorotaxane 4.21 was 
also identified by HRMS with peak seen at 632.3222 for the expected [4.21-PF6]
+
 species. In 
this case the binding constant was calculated to be 9 M
-1
, even lower than with the previous 
benzo-23-crown macrocycle 4.01 (Scheme 4.5) which was 27 M
-1
. It is found that 
incorporation of the second benzene ring into the macrocycle has a detrimental effect on 
both the threading and binding with typical axles. Pseudorotaxane formation was also 
observed with the perimidine benzimidazole thread 3.09 which suggests that the lack of 
complete binding with bispyridinium threads 4.11 and 4.13 may be a result of the change in 
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shape of the macrocycle cavity. Threading appears to be hindered by the presence of the 
ester units on these two threads. 
 
Scheme 4.5 Synthesis of [2]rotaxane 4.21. Reagents and conditions: a) CD3CN, RT. 
To gain a fair comparison of the binding of the dibenzo-23 atom cavity macrocycle 4.02 
with that of the benzo-23-crown macrocycle 4.01 a different binding template was 
investigated. It was observed in Chapter 3 that incorporating a five membered triazole ring 
into the binding template can enhance the interaction between the axle and DB24C8. A 
dibenzyl ammonium thread was synthesised where one of the aromatic rings was a five 
membered heterocycle. The reduced ring size allows threading through both macrocycle 
cavities to enable comparison of the two crown ethers. Reaction of benzaldehyde and 
furfurylamine provided the intermediate imine. Reduction of the imine with one equivalent 
of sodium borohydride provided the neutral thread 4.22, which was converted to the ClO4
-
 
salt on treating with HClO4 (Scheme 4.6). 
 
Scheme 4.6 Reagents and conditions: a) i) MeOH, RT, 24 h; ii) MeOH, NaBH4, 0˚C, 67%; c) HClO4, 51%. 
The binding interaction between new thread 4.23 and the two novel macrocycles was then 
compared. Equimolar quantities of macrocycle 4.01 and thread 4.23 were dissolved in 
deuterated acetonitrile at 15 mmol. Formation of pseudorotaxane 4.24 (Scheme 4.7) was 
observed by 
1
H NMR and ESI-MS at 574.1 for the expected [4.24-ClO4]
+
. The binding 
constant between these two components was found to be 114 M
-1
,
 
the highest binding 
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interaction we had seen using this macrocycle. This enhancement is thought to be a result of 
a better ‘fit’ between the two components. 
 
Scheme 4.7 Reagents and conditions a) CD3CN, RT. 
With these encouraging results the binding interaction was next measured between thread 
4.23 and the dibenzo-23 macrocycle 4.02. Again equimolar amounts of thread 4.23 and 
macrocycle 4.02 were dissolved in deuterated acetonitrile at 15 mmol concentration giving 
pseudorotaxane 4.25 (Scheme 4.8). In this case the binding was found to be 10 M
-1
, one 
order of magnitude less than pseudorotaxane 4.24.  This was surprising as it was expected 
that the binding would be increased for the dibenzo-23-crown 4.02 as it has the added 
benzene ring able to take part in π-stacking interactions. Again this provided evidence that 
addition of a second benzene ring does in fact have a detrimental effect on the binding with 
ammonium axles. It is thought that the additional benzene moiety adds extra rigidity to the 
crown ether removing its ability to adapt an ideal binding conformation. Also there is an 
increase in the number of weaker H bond accepting aromatic ethers compromising the 
hydrogen bond accepting capability of the macrocycle.
207
 Unfortunately a solid state 
structure was not obtained of this macrocycle or any pseudorotaxane so the unfavourable 
effects that are operating in the dibenzo-23 crown 4.02 are difficult to clarify.  
 
Scheme 4.8 Reagents and conditions a) CD3CN, RT. 
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4.5 Pseudorotaxane Formation with Novel 23 Atom Macrocycles and Triazole 
Binding Templates 
From the results obtained in binding investigations with the novel macrocycles and a variety 
of threads, the binding interaction was found to be best with the furfuryl ammonium thread 
4.23. Having discovered the beneficial effect of incorporating a triazole into a 
dibenzylammonium binding motif enhancing the binding interaction between threads 3.08 
and 3.13 and DB24C8, investigating interactions between this novel binding motif and the 
23 atom cavity macrocycle (4.01) was performed.  The binding between the benzyl azide 
derived thread 3.08 and the benzo-23-crown macrocycle 4.01 was first investigated. Taking 
equimolar quantities of these two compounds at 15 mmol concentration it was pleasing to 
see the presence of a new set of peaks corresponding to pseudorotaxane (4.26) formation via 
1
H NMR (Scheme 4.9). Once the reaction had reached equilibrium the binding constant was 
measured between the components. It was found to be 112 M
-1
 comparable with the binding 
between macrocycle 4.01 and furfuryl thread 4.23 which was 114 M
-1
. Incorporation if this 
five membered ring system again had a positive effect on the interaction with the 23 atom 
cavity macrocycles. Pseudorotaxane formation was also observed by HRMS seeing a peak at 
723.3559 corresponding to the expected [4.26-ClO4]
+
 species. 
 
Scheme 4.9 Reagents and conditions: a) CD3CN, RT, 4 d. 
After gaining these promising results, the interaction between macrocycle 4.01 and the 
phenyl azide derived thread 3.13 was next considered. Taking the thread 3.13 with 
equimolar quantity of macrocycle 4.01 at 15 mmol, a new set of peaks appeared in the 
1
H 
NMR indicating pseudorotaxane (4.27) formation (Scheme 4.10). This was confirmed by a 
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peak seen at 737.3757 in the HRMS relating to the expected [4.27-ClO4]
+
. The reaction took 
4 days to reach equilibrium at which point the binding constant was calculated and found to 
be 122 M
-1
. This value is very similar to the previous benzyl azide derived pseudorotaxane 
4.26 and it appears that the conjugated system does not have a great effect on the binding 
between these novel macrocycles and axles. Having a five membered ring system such as 
the triazole or the furfuryl group is the greatest factor in enhancing the binding of these two 
components suggesting the cavity shape is the limiting factor. It is thought the 23 atom 
macrocycles ‘fit’ better around the reduced bulk of this binding template rather than an 
enhancement of the hydrogen bonding ability of the thread. 
 
Scheme 4.10 Reagents and conditions: a) CD3CN, RT, 4 d. 
As it was found that insertion of a five membered ring can enhance the binding interactions 
between ammonium containing axles and novel benzo-23 macrocycle 4.01 incorporating 
two triazoles in the binding site was investigated to observe any enhancements to these 
delicate interactions. Taking ditriazole thread 3.72 discussed in Chapter 3 with one 
equivalent of macrocycle 4.01 at 15 mmol in deuterated acetonitrile the reaction took four 
days to reach equilibrium. Pseudorotaxane (4.28) formation was monitored via 
1
H NMR 
(Scheme 4.11). The binding constant was calculated to be 151 M
-1
, a slight increase in the 
interaction between this thread compared to the pseudorotaxane 4.27 which gave a binding 
constant of 122 M
-1
. This indicates that incorporating two triazoles in the binding template 
of an axle provides an even better fit with this 23 atom cavity macrocycle 4.01. This 
enhances the intermolecular interactions between these components and the binding appears 
to be more sensitive to the size of the groups adjacent to the ammonium ion centre.  
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Scheme 4.11 Reagents and conditions: a) CD3CN, RT. 
Axles with triazoles incorporated have shown the best binding interactions with these novel 
23 atom macrocycles. Synthesis of rotaxanes using this novel binding template was carried 
out using the Coutrot
106
 ‘CuAAC click chemistry’ conditions previously seen in Chapter 3. 
A [2]rotaxane 4.29 was synthesised containing the mono triazole binding motif and benzo-
23-crown macrocycle 4.01. Taking one equivalent of the PF6
-
 salt 3.88 and four equivalents 
of macrocycle 4.01 in CH2Cl2 with Cu(MeCN4)PF6, 2,6-lutidine and azide 3.11 rotaxane 
formation was observed by TLC. Purification via column chromatography afforded the final 
product 4.29 in a 12% yield. The rotaxane was characterised by 
1
H and 
13
C NMR and 
HRMS with peak seen at 707.4024 relating to the [4.29-PF6]
+
 species.  
 
Figure 4.13 Synthesis of [2]pseudorotaxane 4.29. Reagents and conditions a) CH2Cl2, Cu(MeCN4)PF6, 2,6-
lutidine, RT, 24h, 4.01 (4 equiv). 
The 
1
H NMR spectra is shown in Figure 4.14. The two CH2NH2
+
 exhibit the familiar shift 
downfield due to hydrogen bonding with the macrocycle 4.01 crown ether oxygens and 
  Chapter 4 
245 
 
show coupling with the ammonium ion hydrogens.
32
 The acetal CH2 of the macrocycle is 
shifted slightly downfield and these hydrogens become diastereotopic due to the asymmetry 
of the thread and couple with each other to appear as two doublets. The macrocycle ethylene 
CH2’s become very complex as a result of encompassing the asymmetric thread. The 
aromatic hydrogen’s are only slightly affected on being encompassed by the macrocycle 
suggesting the π stacking interactions are not as great as they are with DB24C8 macrocycle.  
 
Figure 4.14 
1H NMR (400 MHz, CD3CN, 300K) stacking plot of i) Macrocycle 4.01; ii) [2]Rotaxane 4.29; ii) 
thread 3.90. 
Finally attempts were made to synthesise a [2]rotaxane with this thread and the dibenzo-23 
macrocycle 4.02. A very small amount of [2]rotaxane was formed as observed by 
1
H NMR 
and also by ESI-MS with a peak at 755.2 that indicated the presence [4.30-PF6]
+
 ion. Due to 
the low extent of threading we were however unable to isolate and purify the [2]rotaxane but 
the findings were encouraging.  
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4.7 Conclusion 
Two novel macrocycles have been successfully synthesised with cavities of 23 atoms and 
used to create a variety of pseudorotaxanes and a [2]rotaxane. We found that when 
comparing binding interactions between these new macrocycles with typical templates for 
rotaxane formation, a large decrease in binding affinity was found with respect to similar 
interactions with DB24C8. 
 
The study of benzo-23-crown 4.01 and bispyridinium threads 4.11 and 4.13 showed the 
binding interaction was vastly different in comparison to the reported interactions with 
DB24C8. Some of this loss in binding interaction was accounted for as these templates rely 
heavily on π stacking interactions and one benzene ring was lost, but when modifying the 
macrocycle to contain two benzene rings (4.02) the macrocycle was no longer capable of 
threading onto the axle. 
 
The binding studies were also carried out between these macrocycles and a dibenzyl 
ammonium axle 3.09 and perimidine benzimidazole axle 2.52. Again values obtained were 
very low in comparison to the same threads binding with DB24C8. However some 
improvement was found when incorporating a five membered ring system into the binding 
template. Values of binding interactions with benzo-23-crown 4.01 were found to be as high 
as 150 M
-1
 with the ditriazole thread 3.72 but the dibenzo-23-crown 4.02 did not show any 
significant improvement in binding. It appears the change in shape of the cavity and 
replacing an ethylene unit with an acetal reduces its ability to form strong intermolecular 
interactions with typical rotaxane forming templates. Although the 23 atom cavity 
macrocycles showed  reduced binding with known and novel templates, a [2]rotaxane 4.29 
was successfully isolated and characterised using the Coutrot click conditions.
106
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4.8 Experimental 
4.09 
 
Known compound synthesised according to literature procedure.
208
 A solution of catechol 
(1.5 g, 13.6mmol) and triethylene glycol chlorohydrin (4.3 mL, 25 mmol) in DMF (30 mL), 
along with potassium carbonate (6 g, 60 mmol) was stirred at 100°C for 12 h under N2. After 
cooling to room temperature, the solution was filtered and concentrated under reduced 
pressure. The residue was diluted in water (10 mL) and extracted with CHCl3 (3 x 20 mL). 
The extracts were dried over MgSO4, filtered and solvent removed in vacuo. The crude 
product was purified via flash chromatography (EtOAc:CH2Cl2; 2:1) to provide a colourless 
oil (2.4 g, 6.4 mmol, 47%). 
1
H NMR (400 MHz, 298 K, CDCl3) δH 6.68 (m, 4H, 4 ArCH), 
4.13 (m, 4H, 2 OCH2CH2O-Ar), 3.85 (m, 4H, 2 OCH2CH2O-Ar), 3.80 (m, 4H, 2 CH2O), 
3.71 (m, 4H, 2 CH2O), 3.64 (m, 4H, 2 CH2CH2OH), 3.58 (m, 4H, 2 CH2CH2OH); 
13
C NMR 
(100 MHz, 298 K, CDCl3) δC 148.9 (ArC), 121.7 (ArCH), 114.9 (ArCH), 72.6 (CH2O), 70.8 
(CH2O), 70.4 (CH2O), 69.8 (CH2O), 68.9 (CH2OH), 61.6 (CH2O); IR ν cm
-1
 3438 (OH), 
2874 (saturated C-H), 1503 (ether C-O); HRMS (ESI
+
): m/z found, 397.1830 calc for 
C18H30NaO8 397.1833 [3.09+Na]
+
. 
4.01 
 
4.09 (500 mg, 1.34 mmol) was dissolved in CH2Cl2 (25 mL) and added dropwise to a rapidly 
stirred mixture of sodium hydroxide (25 mg, 0.6 mmol) in CH2Cl2 (250 mL). The reaction 
was followed by TLC (EtOAc:MeOH:H2O; 40:5:1) until completion. The solution was 
concentrated in vacuo to around 30 mL then washed with water (3 x 20 mL). The organic 
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layer was dried over MgSO4, filtered and concentrated in vacuo. The product was then 
purified via flash chromatography (SiO2: EtOAc to EtOAc:MeOH 9:1) providing a 
colourless oil (0.4g, 1.04 mmol, 78%). 
1
H NMR (400 MHz, 298 K, CDCl3) δH 6.89 (br s, 
4H, 4 ArCH), 4.73 (s, 2H, OCH2O), 4.15 (t, 4H, J = 5.0 Hz, 2 Ar-OCH2CH2O), 3.90 (t, 4H, 
J = 5.0 Hz, 2 Ar-OCH2CH2O), 3.78-3.71 (m, 16H, 8 OCH2); 
13
C NMR (100 MHz, 298 K, 
CDCl3) δC 148.6 (ArC), 121.2 (ArCH), 114.1 (ArCH), 95.3 (acetal CH2), 71.1 (O-CH2), 
71.1’ (O-CH2), 70.6 (O-CH2), 69.9 (O-CH2), 69.1 (O-CH2), 66.9 (O-CH2); HRMS (ESI
+
): 
m/z found, 409.1834 calc for C19H30NaO8 409.1833 [4.01+Na]
+; IR ν cm-1 2870 (saturated C-
H), 1500 (ether C-O). 
4.10 
 
Known compound synthesised according to modified literature procedure.
132
 Ethyl 
nicotinate (2 mL, 14.7 mmol) was dissolved in dibromoethane (10 mL) and heated to 100 °C 
for 24 h. The solution was cooled, filtered and the solid washed with acetone (3 mL) to give 
a white solid (3.2 g, 6.53 mmol, 44%). m.p. 250-251°C (decomp.); 
1
H NMR (400 MHz, 298 
K, CD3OD) δH  9.82 (s, 2H, 2 PyrCHN), 9.43 (d, 2H, J = 6.5 Hz, 2 PyrCH), 9.18 (d, 2H, J = 
8.0 Hz, 2 PyrCH), 8.35 (dd, 2H, J = 6.5 + 8.0 Hz, 2 PyrCH), 5.50 (s, 4H, NCH2CH2N), 4.55 
(q, 4H, J = 7.5 Hz, 2 OCH2CH3), 1.47 (t, 6H, J = 7.5 Hz, 2 OCH2CH3); 
13
C NMR (100 MHz, 
298 K, CD3OD) δC 162.8 (C=O), 149.9 (PyrCH), 148.7 (PyrCH), 148.4 (PyrCH), 133.5 
(PyrC), 130.6 (PyrCH), 64.8 (OCH2CH3), 61.4 (NCH2CH2N), 14.8 (OCH2CH3); MS (ESI
+
): 
m/z 308.0 [4.10-Br]
+; IR ν cm-1 2990 (saturated C-H), 1723 (ester C=O). 
4.11 
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Known compound synthesised according to modified literature procedure.
132
 Dibromide salt 
4.10 (1g, 2.04 mmol) was dissolved in MeOH (1 mL). A concentrated solution of 
ammonium hexafluorophosphate in MeOH (2.5 mL) was added followed by the dropwise 
addition of water to induce precipitation. The solid was filtered and recrystallised from 
acetonitrile/Et2O to provide a light brown solid (460 mg, 0.74 mmol, 36%). m.p. 238-239°C; 
1
H NMR (400 MHz, 298 K, CD3CN) δH  9.34 (s, 2H, 2 PyrCHN), 9.06 (d, 2H, J = 8.0 Hz, 2 
PyrCH), 8.85 (d, 2H, J = 6.0 Hz, 2 PyrCH), 8.25 (dd, 2H, J = 8.0 + 6.0 Hz, 2 PyrCH), 5.17 
(s, 4H, NCH2CH2N), 4.49 (q, 4H, J = 7.3 Hz, 2 OCH2CH3), 1.42 (t, 6H, J = 7.3 Hz, 2 
OCH2CH3); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 162.4 (C=O), 149.4 (PyrCH), 148.5 
(PyrCH), 147.9 (PyrCH), 133.3 (CCO), 130.9 (PyrCH), 64.8 (OCH2CH3), 60.9 
(NCH2CH2N), 14.7 (OCH2CH3); MS (ESI
+
): m/z 475.0 [4.11-PF6]
+; IR ν cm-1 3094 
(saturated C-H), 1732 (ester C=O), 822 (P-F). 
4.12 
 
Known compound synthesised according to modified literature procedure.
132
 Ethyl 
isonicotinate (2 mL, 13 mmol) was dissolved in dibromoethane (10 mL, excess) and heated 
at 70°C for 24 h. Acetone (50 mL) was added to the hot stirring solution and it was then 
allowed to cool. The white solid precipitate (1.2g, 2.45 mmol, 40%) was filtered and washed 
with acetone (3 mL). m.p. 237-238°C (decomp.); 
1
H NMR (400 MHz, 298 K, CDCl3) δH 
9.20 (d, 4H, J = 6.7 Hz, 4 α-PyrCH), 8.67 (d, 4H, J = 6.7 Hz, 4 PyrCH), 5.52 (s, 4H, 
NCH2CH2N), 4.57 (q, 4H, J = 7.0 Hz, 2 OCH2CH3), 1.47 (t, 6H, J = 7.0 Hz, 2 OCH2CH3); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 162.8 (C=O), 146.7 (CCO), 146.3 (PyrCH), 128.5 
(PyrCH), 64.4 (OCH2CH3), 60.0 (NCH2CH2N), 13.2 (OCH2CH3); IR ν cm
-1
 3018 (saturated 
C-H), 1723 (ester C=O). 
 
  Chapter 4 
250 
 
4.13 
 
Known compound synthesised according to literature procedure.
132
 Dibromide salt 4.12 (100 
mg, 0.20 mmol) was dissolved in MeOH (1 mL) and a concentrated MeOH solution of 
ammonium hexafluorophosphate (1 mL) was added. A precipitate formed which was filtered 
and washed with water (3 mL) (50 mg, 0.08 mmol, 40%). m.p. 208-209 °C (decomp.); 
1
H 
NMR (400 MHz, 298 K, CD3CN) δH  9.34 (d, 4H, J = 7.0 Hz, 4 α-PyrCH), 9.02 (d, 4H, J = 
7.0 Hz, 4 PyrCH), 5.69 (s, 4H, NCH2CH2N), 5.02 (q, 4H, J = 7.0 Hz, OCH2CH3), 1.94 (t, 
6H, J = 7.0 Hz, 2 OCH2CH3); 
13
C NMR (100 MHz, 298 K, CD3CN) δC 162.4 (C=O), 148.0 
(CCO), 147.8 (PyrCH), 129.8 (PyrCH), 65.0 (OCH2CH3), 61.2 (NCH2CH2N), 14.5 
(OCH2CH3); MS (ESI
+
): m/z 164.1 [4.13-2PF6]
2+; IR ν cm-1 3084 (saturated C-H), 1732 
(ester C=O), 817 (P-F). 
4.15 
 
Thread 4.11 (18 mg, 0.03 mmol) and crown 4.01 (12 mg, 0.03 mmol) were dissolved in 
deuterated acetonitrile (2 mL) and pseudorotaxane formation observed by 
1
H NMR. Binding 
constant = 55 M
-1 
was calculated from the single point method
129
 by measuring the 
integration of α-PyrCCHN protons for the free and bound thread at 9.34 ppm and 9.60 ppm 
respectively. Pseudorotaxane 4.15 
1
H NMR (400 MHz, 298 K, CD3CN) δH 9.60 (s, 2H,  2 
PyrCHN), 9.25 (d, 2H, J = 6.0 Hz,  2 PyrCH), 8.75 d, 2H, J = 8.0 Hz,  2 PyrCH), 8.09 
(dd, 2H, J = 6.0 + 8.0 Hz,  2 PyrCH), 6.83 (m, 2H, crown  2 ArCH), 6.69 (m, 2H, crown 
 2 ArCH), 5.57 (s, 4H,  NCH2CH2N), 4.50-4.45 (m, 6H,  O-CH2-O and  2 OCH2CH3), 
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4.05-3.98 (m, 8H,  4 crown OCH2), 3.89-3.88 (m, 4H,  2 crown OCH2), 3.72-3.70 (m, 
4H,  2 crown OCH2), 3.50-3.48 (m, 4H,  2 crown OCH2), 3.41-3.40 (m, 4H,  2 crown 
OCH2), 1.43 (m, 6H,  2 OCH2CH3); Also contains for comparison Crown 4.01 
1
H NMR 
(400 MHz, 298 K, CD3CN) δH 6.89 (br s, 4H, ArCH), 4.73 (s, 2H, O-CH2-O), 4.15 (t, 4H, J 
= 5.0 Hz, Ar-O-CH2CH2-O), 3.90 (t, 4H, J = 5.0 Hz, Ar-O-CH2CH2-O), 3.77 (m, 16H, 8 
CH2); and Thread 4.11 
1
H NMR (400 MHz, 298 K, CD3CN) δH  9.34 (s, 2H, 2 PyrCHN), 
9.06 (d, 2H, J = 8.0 Hz, 2 PyrCH), 8.85 (d, 2H, J = 6.0 Hz, 2 PyrCH), 8.25 (dd, 2H, J = 8.0 
Hz + 6.0 Hz, 2 PyrCH), 5.17 (s, 4H, CH2CH2), 4.49 (q, 4H, J = 7.0 Hz, 2 OCH2CH3), 1.42 (t, 
6H, J = 7.0 Hz, 2 OCH2CH3); MS (ESI
+
): m/z 861.1 [4.15-PF6]
+
, 358.2 [4.15-2PF6]
2+
. 
4.14 
 
Thread 4.13 (18 mg, 0.03 mmol) and crown 4.01 (12 mg, 0.03 mmol) were dissolved in 
deuterated acetonitrile (2 mL) and pseudorotaxane formation observed by 
1
H NMR. Binding 
constant = 11 M
-1 
was calculated from the single point method
129
 by measuring the 
integration of α-PyrCHN protons for the free and bound thread at 8.90 ppm and 9.20 ppm 
respectively. Pseudorotaxane 4.14 
1
H NMR (400 MHz, 298 K, CD3CN) δH 9.20 (d, 4H, J = 
6.0 Hz,  4 α-PyrCHN), 8.30 (d, 4H, J = 6.0 Hz,  4 PyrCH), 6.81-6.80 (m, 2H,  2 crown 
ArCH), 6.73 (m, 2H,  2 crown ArCH), 5.55 (s, 4H,  CH2CH2), 4.65 (s, 2H,  O-CH2-O),  
4.47 (m, 4H  2 CH2CH3), 4.11-4.05 (m, 8H,  4 crown OCH2), 3.97-3.92 (m, 8H,  4 
crown OCH2), 3.72-3.70 (m, 4H,  2 crown OCH2), 3.43-3.42 (m, 4H,  2 crown OCH2), 
1.43 (m, 6H,  2 CH2CH3); Also for comparison Crown 4.01 
1
H NMR (400 MHz, 298 K, 
CDCl3) δH  6.89 (br s, 4H, ArCH), 4.73 (s, 2H, O-CH2-O), 4.15 (t, 4H, J = 5.0 Hz, Ar-O-
CH2CH2O), 3.90 (t, 4H, J = 5.0 Hz, Ar-OCH2CH2O), 3.77 (m, 16H, 8 CH2); Thread 4.13 
1
H 
NMR (400 MHz, 298 K, CD3CN) δH 8.90 (d, 4H, J = 7.0 Hz, 4 α-PyrCHN), 8.51 (d, 4H, J = 
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7.0 Hz, 4 PyrCH), 5.23 (s, 4H, CH2CH2), 4.49 (q, 4H, J = 7.0 Hz, 2 OCH2CH3), 1.42 (t, 6H, 
J = 7.0 Hz, 2 OCH2CH3); MS (ESI
+
): 358.1 [4.14-2PF6]
2+
. 
4.16 
 
Thread 3.09 (15 mg, 0.03 mmol) and crown 4.01 (12 mg, 0.03 mmol) were dissolved in 
deuterated acetonitrile (2 mL) and pseudorotaxane formation observed by 
1
H NMR. Binding 
constant = 27 M
-1 
was calculated from the single point method
129
 by measuring the 
integration of the 10 ArCH protons for the free and bound thread at 7.47 ppm for free thread 
7.45-7.43 and 7.34 ppm for the bound thread. Pseudorotaxane 4.16 
1
H NMR (400 MHz, 
298 K, CD3CN) δH 7.45-7.43 (m, 4H,  4 thread ArCH), 7.34 (m, 6H,  6 thread ArCH), 
6.94-6.96 (m, 4H,  4 crown ArCH), 4.67-4.63 (m, 6H,  CH2NH2
+
CH2 and  O-CH2-O), 
4.13-4.10 (m, 4H,  2 OCH2), 3.55-3.33 (m, 8H,  4 OCH2), 3.49-3.47 (m, 8H,  4 OCH2), 
3.39-3.37 (m, 4H,  2 OCH2); Also for comparison Crown 4.01 
1
H NMR (400 MHz, 298 K, 
CDCl3) δH  6.89 (br s, 4H, ArCH), 4.73 (s, 2H, O-CH2-O), 4.15 (t, 4H, J = 5.0 Hz, Ar-O-
CH2CH2-O), 3.90 (t, 4H, J = 5.0 Hz, Ar-O-CH2CH2-O), 3.77 (m, 16H, 8 CH2); Thread 3.09 
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.47 (m, 10H, 10 ArCH), 4.24 (s, 4H, 
CH2NH2
+
CH2); MS (ESI
+
): m/z  584.4 [4.16-PF6]
+
. 
4.17 
 
Thread 2.52 (15 mg, 0.03 mmol) and crown 4.01 (12 mg, 0.03 mmol) were dissolved in 
deuterated acetonitrile (2 mL) and the binding constant was measured. Binding constant = 
44 M
-1 
was calculated from the single point method
129
 by measuring the integration of acetal 
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CH2 protons for the free and bound crown at 4.73 ppm for free crown and 4.44 and 4.36 ppm 
for bound. Pseudorotaxane 4.17 
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.92-7.84 (m, 2H, 
 2 thread ArCH), 7.69-7.67 (m, 2H,  2 thread ArCH), 7.27-7.22 (m, 4H,  4 NaphthCH), 
6.71-6.69 (m, 2H,  2 NaphthCH), 6.56 (br s, 4H,  4 crown ArCH), 4.44 (d, 1H, J = 4.0 
Hz,  acetal CHH), 4.36 (d, 1H, J = 4.0 Hz,  acetal CHH), 4.24-4.19 (m, 2H,  OCH2), 
4.11-4.09 (m, 8H,  4 OCH2), 4.02-3.96 (m, 4H,  2 OCH2), 3.94-3.90 (m, 4H,  OCH2 and 
 C-CH2CH2-C), 3.56-3.53 (m, 8H,  4 OCH2), 3.46-3.42 (m, 2H,  C-CH2CH2-C); Also 
for comparison Crown 4.01 
1
H NMR (400 MHz, 298 K, CD3CN) δH 6.89 (br s, 4H, ArCH), 
4.73 (s, 2H, O-CH2-O), 4.15 (t, 4H, J = 5.0 Hz, Ar-O-CH2CH2-O), 3.90 (t, 4H, J = 5.0 Hz, 
Ar-O-CH2CH2-O), 3.77 (m, 16H, 8 CH2); Thread 2.52 
1
H NMR (400 MHz, 298 K, CD3CN) 
δH 12.34 (br s, 2H, 2 NH), 10.56 (br s, 2H, 2 NH), 7.84-7.82 (m, 2H, 2 ArCH), 7.65-7.62 (m, 
2H, ArCH), 7.47 (d, 2H, J = 8.5 Hz, 2 NaphthCH), 7.37 (dd, 2H, J = 8.5 + 7.5 Hz, 2 
NaphthCH), 6.82 (d, 2H, J = 7.5 Hz, 2 NaphthCH), 3.71 (t, 2H, J = 7.5 Hz, CH2CH2), 3.17 
(t, 2H, J = 7.5 Hz, CH2CH2); MS (ESI
+
): m/z 700.7 [4.17-ClO4]
+
. 
4.18 
 
Known compound synthesised according to literature procedure.
209
 Catechol (5.5 g, 50 
mmol), ethylene carbonate (4.4g, 55 mmol) and tetrabutylammonium iodide (0.6 g, 1.9 
mmol) were heated to 160°C for 24 h. The reaction was followed by TLC (EtOAc) until 
completion. The reaction was purified via flash chromatography (SiO2: CH2Cl2/EtOAc; 3:1) 
to give a brown solid (4g, 25.9 mmol, 52%). m.p. 98-99°C; 
1
H NMR (400 MHz, 298 K, 
CD3OD) δH 6.90 (d, 1H, J = 7.0 Hz, ArCHCOH), 6.81-6.74 (m, 3H, 3 ArCH), 4.04 (t, 2H, J 
= 6.5 Hz, CH2CH2OH), 3.88 (t, 2H, J = 6.5 Hz, CH2CH2OH); 
13
C NMR (100 MHz, 298 K, 
CD3OD) δC 148.1 (ArC), 147.9 (ArC), 122.7 (ArCH), 120.9 (ArCH), 116.6 (ArCH), 114.2 
(ArCH), 71.4 (CH2CH2OH), 59.5 (CH2CH2OH); IR ν cm
-1
 3275 (O-H), 2946 (saturated C-
H), 1609 (ether C-O); HRMS (ESI
+
): m/z found, 177.0513 calc for C8H10NaO3 177.0522 
[4.18+Na]
+
. 
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4.19 
 
Known compound synthesised according to literature procedure.
210
 Triethylene glycol 
(10mL, 60.6 mmol) was dissolved in THF (15 mL) and distilled water (15 mL). The solution 
was cooled to 0°C and sodium hydroxide (4.68g, 121 mmol) was added. To the cooled 
solution toluene-p-sulphonyl chloride (24 g, 126 mmol) in THF (80 mL) was added 
dropwise over 1.5 h. The solution was warmed to room temperature, and stirred for a further 
24 h. THF was removed in vacuo and the residue diluted with water (30 mL) and extracted 
with CHCl3 (3 x 40 mL). The organic layer was dried over MgSO4, filtered and concentrated 
in vacuo. The crude material was purified via flash chromatography (SiO2: EtOAc) to give a 
white solid (15.7 g, 46.7 mmol, 77%). m.p. 82-83˚C; 1H NMR (400 MHz, 298 K, CDCl3) δH 
7.79 (d, 4H, J = 8.0 Hz, 4 ArCH), 7.34 (d, 4H, J = 8.0 Hz, 4 ArCH), 4.14 (t, 4H, J = 4.5 Hz, 
2 OCH2CH2OSO2), 3.65 (t, 4H, J = 4.5 Hz, 2 OCH2CH2OSO2), 3.52 (s, 4H, 2 CH2), 2.44 (s, 
6H, 2 CH3); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 144.9 (ArC), 132.9 (ArC), 129.8 
(ArCH), 127.9 (ArCH), 70.7 (CH2), 69.2 (CH2), 68.7 (CH2), 21.6 (CH3); IR ν cm
-1
 1624 
(ether C-O), 1173 (-SO2-O-); MS (ESI
+
): m/z 359.1 [4.19+Na]
+
; CHN Analysis Found: C 
52.33; H 5.66. Calc. for C20H26O8S2: C, 52.39; H, 5.72%. 
4.20 
 
Known compound synthesised according to literature procedure.
211
 The diol 4.18 (200 mg, 
1.3 mmol) and ditosylate 4.19 (270 mg, 0.6 mmol) were dissolved in acetone (30 mL) and 
potassium carbonate (2 g, 15.6mmol) was added. The solution was stirred at reflux under N2 
for 48 h. The solution was cooled, filtered and washed with acetone (10 mL). The solvent 
was removed and the residue dissolved in CH2Cl2 (20 mL). The solution was washed with 
concentrated aqueous sodium hydroxide solution (3 x 15 mL), dried over MgSO4 and the 
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solvent removed in vacuo. The product was purified via flash chromatography (SiO2: 9:1, 
EtOAc:MeOH) to provide a pale brown oil (160 mg, 0.38 mmol, 29%). m.p. 76-77°C; 
1
H 
NMR (400 MHz, 298 K, CDCl3) δH 6.91 (s, 8H, 8 ArCH), 4.14 (t, 4H, J = 5.0 Hz, 2 O-
CH2CH2-O), 4.07 (t, 4H, J = 5.0 Hz, 2 O-CH2CH2-O), 3.90-3.88 (m, 8H, 4 O-CH2CH2-O), 
3.77 (br s, 4H, O-CH2CH2-O); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 149.0 (ArC), 148.9 
(ArC), 123.8 (ArCH), 121.8 (ArCH), 116.3 (ArCHCO), 115.7 (ArCHCO), 71.6 (OCH2), 
70.0 (OCH2), 68.8 (OCH2), 68.0 (OCH2), 61.5 (OCH2); IR ν cm
-1
 3563 (O-H), 2916 
(saturated C-H), 1252 (ether C-O); HRMS (ESI
+
): m/z found, 445.1854 calc for C22H30NaO8 
445.1833 [4.20+Na]
+
. 
4.02 
 
To a stirring mixture of  sodium hydroxide (36 mg, 0.9 mmol) in CH2Cl2 (250 mL), 4.20 
(150 mg, 0.35 mmol) in CH2Cl2 (25 mL) was added dropwise over 2 h. The reaction was 
followed by TLC (EtOAc). The solution was concentrated to around 30 mL and washed with 
water (3 x 20 mL). The product was purified via flash chromatography (SiO2: EtOAc) to 
provide a white solid (65 mg, 0.15 mmol, 41%). m.p. 113-114°C; 
1
H NMR (400 MHz, 298 
K, CDCl3) δH 6.89 (m, 8H, 8 ArCH), 4.95 (s, 2H, O-CH2-O), 4.18 (m, 4H, 2 Ar-O-CH2CH2), 
4.15 (m, 4H, 2 Ar-O-CH2CH2-O), 3.97 (m, 4H, 2 O-CH2CH2-O), 3.91 (m, 4H, 2 O-CH2CH2-
O), 3.83 (br s, 4H, O-CH2CH2-O); 
13
C NMR (100 MHz, 298 K, CDCl3) δC 149.2 (ArC), 
148.7 (ArC), 121.7 (ArCH), 114.5 (ArCH), 95.9 (O-CH2-O), 71.4 (O-CH2CH2-O), 69.8 (O-
CH2CH2-O), 69.3 (O-CH2CH2-O), 68.8 (O-CH2CH2-O), 66.1 (O-CH2CH2-O); HRMS 
(ESI
+
): m/z found, 457.1831 calc for C23H30NaO8, 457.1838 [4.02+Na]
+; IR ν cm-1 3073 
(saturated C-H). 
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4.21 
 
Crown 4.02 (13 mg, 0.03 mmol) and thread 3.09 (10 mg, 0.03 mmol) were dissolved in 
deuterated acetonitrile (2 mL) and pseudorotaxane formation monitored by 
1
H NMR. 
Binding constant = 9 M
-1 
was calculated from the single point method
129
 by measuring the 
integration of the 10 ArCH protons for the free and bound thread at 7.47 ppm for the free 
and 7.38-7.35 ppm and 7.19-7.18 ppm for the bound. Pseudorotaxane 4.21 
1
H NMR (400 
MHz, 298 K, CD3CN) δH 7.38-7.35 (m, 4H,  4 thread ArCH), 7.19-7.18 (m, 6H,  6 thread 
ArCH), 6.95-6.87 (m 8H,  8 crown ArCH), 4.79-4.76 (m, 4H,  CH2NH2
+
CH2), 4.75 (s, 
2H,  O-CH2-O), 4.20-4.29 (m, 4H,  2 O-CH2CH2-O), 4.05-4.02 (m, 8H,  4 O-CH2CH2-
O), 3.95-3.93 (m, 4H,  2 O-CH2CH2-O), 3.85-3.81 (m, 4H,  2 O-CH2CH2-O), 3.74-3.71 
(m, 4H,  2 O-CH2CH2-O); Also contains for comparison Crown 4.02 
1
H NMR (400 MHz, 
298 K, CD3CN) δH 6.89 (m, 8H, 8 ArCH), 4.95 (s, 2H, O-CH2-O), 4.18 (m, 4H, 2 Ar-O-
CH2CH2-O), 4.15 (m, 4H, 2 Ar-O-CH2CH2-O), 3.97 (m, 4H, 2 O-CH2CH2-O), 3.91 (m, 4H, 
2 O-CH2CH2-O), 3.83 (br s, 4H, 2 O-CH2CH2-O); Thread 3.09 
1
H NMR (400 MHz, 298 K, 
CD3CN) δH 7.47 (m, 10H, 10 ArCH), 4.24 (s, 4H, CH2NH2
+
CH2); HRMS (ESI
+
): m/z found, 
632.3222 calc for C37H46N2NO8 632.3218 [4.21-PF6]
+
. 
4.22 
 
Known compound synthesised according to literature procedure.
212
 Furfurylamine (0.87 mL, 
9.8 mmol) and benzaldehyde (1 mL, 9.8 mmol) were dissolved in MeOH (10 mL) and 
stirred at room temperature for 24 h. The reaction was cooled to 0˚C and sodium 
borohydride (400 mg, 10 mmol, 1 equiv.) was added portion wise and the solution stirred for 
15 minutes. The solution was allowed to warm to room temperature, stirred for 12 h, diluted 
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with water (50 mL) and acidified to pH 1 with 4M HCl. The aqueous layer was extracted 
with CH2Cl2 (3 x 20 mL) then basified to pH 10 with 2M sodium hydroxide. The aqueous 
layer was extracted with CH2Cl2 (3 x 20 mL) and the combined organic extracts were dried 
over MgSO4, filtered and solvent removed in vacuo (1.2 g, 7.27 mmol, 67%). 
1
H NMR (400 
MHz, 298 K, CDCl3) δH  7.43 (m, 1H, Fufuryl-CH), 7.40 (m, 5H, 5 ArCH), 6.38 (m, 1H, 
Fufuryl-CH), 6.25 (m, 1H, Fufuryl-CH) , 3.85 (br s, 4H, CH2NHCH2); 
13
C NMR (100 MHz, 
298 K, CDCl3) δC 154.0 (ArC), 141.9 (Furfuryl-CH), 140.1 (ArC), 128.5 (ArCH), 128.3 
(ArCH), 127.1 (ArCH), 110.2 (Furfuryl-CH), 107.0 (Furfuryl-CH), 52.8 (CH2NH), 45.4 
(CH2NH); IR ν cm
-1
 3031 (saturated C-H); MS (ESI
+
): m/z 188.0 [4.22+Na]
+
. 
4.23 
 
Furfurylbenzyl amine (0.25 g, 1.34 mmol) was dissolved in MeOH (0.5 mL). A 70% 
aqueous  solution of HClO4 (0.25 mL) was added cautiously to the solution. Distilled water 
was then added dropwise to the solution to induce precipitation. This was filtered and 
washed with cold water (3 mL) and dried in a desiccator overnight (200 mg, 0.70 mmol, 
51%). m.p. 125-126°C; 
1
H NMR (400 MHz, 298 K, CD3CN) δH  7.60 (m, 1H, Furfuryl-CH), 
7.47 (br s, 5H, ArCH), 6.64 (m, 1H, Furfuryl-CH), 6.50 (m, 1H, Furfuryl-CH), 4.28 (s, 2H, 
CH2NH2
+
), 4.21 (s, 2H, CH2NH2
+
), 2.17 (br s, 2H, NH2); 
13
C NMR (100 MHz, 298 K, 
CD3CN) δC 146.2 (Furfuryl-CH), 136.5 (ArC), 131.6 (ArC), 131.5 (ArCH), 131.2 (ArCH), 
130.5 (ArCH), 114.7 (Furfuryl-CH), 112.6 (Furfuryl-CH), 52.3 (CH2), 44.6 (CH2); HRMS 
(ESI+): m/z found, 188.1070 calc for C12H14NO 188.1070 [4.23-ClO4]
+; IR ν cm-1 3103 
(saturated C-H), 1418 (CH deformations), 1064 (ClO4). 
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4.24 
 
Crown 4.01 (12 mg, 0.03 mmol) and thread 4.23 (8.6 g, 0.03 mmol) were dissolved in 
deuterated acetonitrile (2 mL) and the binding constant measured. Binding constant = 114 
M
-1 
was calculated from the single point method
129
 by measuring the integration of furfuryl-
CH protons for the free and bound thread at 6.64 ppm and 6.44 ppm respectively. 
Pseudorotaxane 4.23 - Some peaks obscured by free crown: 
1
H NMR (400 MHz, 298 K, 
CD3CN) δH 7.84 (br s, 2H,  NH2), 7.47-7.44 (m, 1H,  Furfuryl-CH), 7.42-7.40 (m, 2H,  
2 ArCH), 7.34-7.31 (m, 3H,  3 ArCH), 6.99-6.88 (m, 4H,  4 crown ArCH), 6.44 (d, 1H, J 
= 3.0 Hz,  Furfuryl-CH), 6.37 (dd, 1H, J = 3.0 + 2.0 Hz,  Furfuryl-CH), 4.70 (m, 2H,  
CH2NH2
+
), 4.69 (m, obscured by free crown, 1H,  acetal CHH), 4.63 (d, 1H, J = 4.5 Hz,  
acetal CHH), 4.55-4.52 (m, 2H,  CH2NH2
+
), 4.10-4.09 (m, 4H,  2 OCH2), 3.61-3.58 (m, 
8H,  4 OCH2), 3.55-3.48 (m, 12H,  6 OCH2); Also for comparison Crown 4.01 
1
H NMR 
(400 MHz, 298 K, CD3CN) δH 6.89 (br s, 4H, ArCH), 4.73 (s, 2H, O-CH2-O), 4.15 (t, 4H, J 
= 5.0 Hz, Ar-O-CH2CH2-O), 3.90 (t, 4H, J = 5.0 Hz, Ar-O-CH2CH2-O), 3.77 (m, 16H, 8 
CH2); and Thread 4.23 
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.60 (m, 1H, Furfuryl-CH), 
7.47 (br s, 5H, ArCH), 6.64 (m, 1H, Furfuryl-CH), 6.50 (m, 1H, Furfuryl-CH), 4.28 (s, 2H, 
CH2NH2
+
), 4.21 (s, 2H, CH2NH2
+
), 2.17 (br s, 2H, NH2); MS (ESI
+
): m/z 574.1 [4.24-ClO4]
+
.  
4.25 
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Crown 4.02 (12 mg, 0.03 mmol) and thread 4.23 (8.6g, 0.03 mmol) were dissolved in 
deuterated acetonitrile (2 mL) and the binding constant measured. Binding constant = 10 M
-1 
was calculated from the single point method
129
 by measuring the integration of furfuryl-CH 
protons for the free and bound thread at 6.64 ppm and 6.41 ppm respectively. 
Pseudorotaxane 4.25 
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.35-7.33 (m, 2H,  2 
ArCH), 7.27 (br s, 1H,  Furfuryl-CH), 7.16-7.15 (m, 3H,  3 ArCH), 6.41 (m, 1H,  
Furfuryl-CH), 6.23 (m, 1H,  Furfuryl-CH), 4.74 (s, 2H,  O-CH2-O), 4.87 (m 2H,  
CH2NH2
+
), 4.64 (m, 2H,  CH2NH2
+
), 4.07-4.04 (m, 8H,  4 OCH2), 3.97 (d, 4H, J = 4.0 
Hz,  2 OCH2), 3.84-3.82 (m, 4H,  2 OCH2), 3.74-3.70 (m, 8H,  4 OCH2); Also for 
comparison Crown 4.02 
1
H NMR (400 MHz, 298 K, CD3CN) δH 6.89 (m, 8H, 8 ArCH), 
4.95 (s, 2H, O-CH2-O), 4.18 (m, 4H, 2 Ar-O-CH2CH2-O), 4.15 (m, 4H, 2 Ar-O-CH2CH2-O), 
3.97 (m, 4H, 2 O-CH2CH2-O), 3.91 (m, 4H, 2 O-CH2CH2-O), 3.83 (br s, 4H, 2 O-CH2CH2-
O); and Thread 4.23 
1
H NMR (400 MHz, 298 K, CD3CN) δH 7.60 (m, 1H, Furfuryl-CH), 
7.47 (br s, 5H, ArCH), 6.64 (m, 1H, Furfuryl-CH), 6.50 (m, 1H, Furfuryl-CH), 4.28 (s, 2H, 
CH2NH2
+
), 4.21 (s, 2H, CH2NH2
+
), 2.17 (br s, 2H, NH2); MS (ESI
+
): m/z 622.1 [4.25-ClO4]
+
. 
4.26 
 
Thread 3.08 (13 mg, 0.03 mmol) and crown 4.01 (12 mg, 0.03 mmol) were dissolved in 
deuterated acetonitrile (2 mL). Pseudorotaxane formation was monitored by 
1
H NMR over 4 
days. Binding constant = 112 M
-1 
was calculated from the single point method
129
 by 
measuring the integration of CH2NH2
+
CH2 protons for the free and bound thread at 4.35 ppm 
for free and 4.90 and 4.75 ppm for bound. Pseudorotaxane 4.26 
1
H NMR (400 MHz, 298 
K, CD3CN) δH 8.34 (s, 1H,  triazole-CH), 7.94-7.89 (m, 2H,  2 ArCH), 7.60-7.54 (m, 2H, 
 2 ArCH), 7.48-7.42 (m, 3H,  3 ArCH), 7.19-7.17 (m, 2H,  2 ArCH), 6.92-6.83 (m, 4H, 
 4 crown ArCH), 5.53 (s, 2H,  CH2N-triazole), 4.90 (m, 2H,  CH2NH2
+
), 4.75 (m, 2H,  
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CH2NH2
+
), 4.64 (d, 1H, JHH = 4.0,   acetal CHH), 4.55 (d, 1H, JHH = 4.0,   acetal CHH), 
3.86 (s, 3H,  OCH3), 3.62-3.59 (m, 16H,  8 crown O-CH2CH2-O), 3.50-3.49 (m, 8H,  8 
crown O-CH2CH2-O). Also contains for comparison Macrocycle 4.01 
1
H NMR (400 MHz, 
298 K, CD3CN) δH 6.89 (br s, 4H, ArCH), 4.73 (s, 2H, O-CH2-O), 4.15 (t, 4H, J = 5.0 Hz, O-
CH2CH2-O), 3.90 (t, 4H, J = 5.0 Hz, 2 O-CH2CH2-O), 3.77 (m, 16H, 8 O-CH2CH2-O); 
Thread 3.08 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.05 (d, 2H, J = 8.0 Hz, 2 ArCHCCO), 
7.95 (s, 1H, triazole-CH), 7.58 (d, 2H, J = 8.0 Hz, 2 ArCHCCH2), 7.35 (m, 5H, 5 ArCH), 
5.60 (s, 2H, CH2N-triazole), 4.35 (br s, 4H, CH2NH2
+
CH2) 3.89 (s, 3H, OCH3); HRMS 
(ESI
+
): found, 723.3559 calc for C38H51N4O10 723.3600 [4.26-ClO4]
+
. 
4.27 
 
Thread 3.13 (14 mg, 0.03 mmol) and crown 4.01 (12 mg, 0.03 mmol) were dissolved in 
deuterated acetonitrile (2 mL). Pseudorotaxane formation was observed using 
1
H NMR. 
After 4 days the reaction reached equilibrium. Binding constant = 122 M
-1 
was calculated 
from the single point method
129
 by measuring the integration of CH2NH2
+
 protons for the 
free and bound thread at 4.43 ppm and 4.97 ppm respectively. Pseudorotaxane 4.27 – Some 
peaks obscured by free thread and macrocycle. 
1
H NMR (400 MHz, 298 K, CD3CN) 8.16 
(s, 1H,  triazole-CH), 7.89 (d, 2H, J = 7.5 Hz,  2 ArCHCCOO), 7.55 (d, 2H, J = 7.5 Hz, 
 2 ArCHCCH2), 7.33 (s, 2H,  2 ArCH), 7.19 (s, 1H,  ArCH), 6.95-6.88 (br s, 4H,  4 
crown ArCH), 4.89 (m, 2H,  CH2NH2
+
), 4.77 (m, 2H,  CH2NH2
+
), 4.72 (s, 2H,  O-CH2-
O), 3.87 (s, 3H,  OCH3), 3.86-3.58 (m, 20H,  10 crown O-CH2CH2-O), 3.55-3.47 (m, 4H, 
 2 crown O-CH2CH2-O), 2.40 (s, 6H,  2 CCH3); Also contains for comparison 
Macrocycle 4.01 
1
H NMR (400 MHz, 298 K, CD3CN) δH  6.89 (br s, 4H, ArCH), 4.73 (s, 
2H, O-CH2-O), 4.15 (t, 4H, J = 5.0 Hz, 2 O-CH2CH2-O), 3.90 (t, 4H, J = 5.0 Hz, 2 O-
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CH2CH2-O), 3.77 (m, 16H, 8 O-CH2CH2-O); and Thread 3.13 
1
H NMR (400 MHz, 298 K, 
CD3CN) δH 8.33 (s, 1H, triazole-CH), 8.07 (d, 2H, J = 8.0 Hz, 2 ArCHCCOO), 7.61 (d, 2H, 
J = 8.0 Hz, 2 ArCHCCH2), 7.43 (s, 2H, 2 ArCH), 7.19 (s, 1H, ArCH), 4.43 (s, 2H, 
CH2NH2
+
), 4.37 (s, 2H, CH2NH2
+
), 3.88 (s, 3H, OCH3), 2.41 (s, 6H, 2 CH3); HRMS (ESI
+
): 
found, 737.3757 calc for C39H53N4O10 737.3756 [4.27-ClO4]
+
. 
4.28 
 
Crown 4.02 (12 mg, 0.03 mmol) and thread 3.72 (13 mg, 0.03mmol) were dissolved in 
deuterated acetonitrile (2 mL). Pseudorotaxane formation was monitored using 
1
H NMR. 
Binding constant = 151 M
-1 
was calculated from the single point method
129
 by measuring the 
integration of triazole-CH protons for the free and bound thread at 8.44 ppm and 8.23 ppm 
respectively. Pseudorotaxane 4.28 
1
H NMR (400 MHz, 298 K, CD3CN) δH 8.36 (br s, 2H, 
 NH2), 8.23 (s, 2H,  2 triazole-CH), 7.64-7.50 (m, 10H,  10 ArCH), 6.96-6.80 (m, 4H, 
 4 crown ArCH), 4.96-4.90 (m, 4H,  CH2NH2
+
CH2), 4.68 (s, 2H,  O-CH2-O), 4.11-4.10 
(m, 4H,  2 crown OCH2), 3.81-3.79 (m, 4H,  2 crown OCH2), 3.72-3.70 (m, 4H,  2 
crown OCH2), 3.68-3.59 (m, 12H,  8 crown OCH2); Also contains for comparison 
Macrocycle 4.01 
1
H NMR (400 MHz, 298 K, CD3CN) δH 6.89 (br s, 4H, ArCH), 4.73 (s, 
2H, O-CH2-O), 4.15 (t, 4H, J = 5.0 Hz, O-CH2CH2-O), 3.90 (t, 4H, J = 5.0 Hz, O-CH2CH2-
O), 3.77 (m, 16H, O-CH2CH2-O); and Thread 3.72 
1
H NMR (400 MHz, 298 K, CD3CN) δH 
8.44 (s, 2H, 2 triazole-CH), 7.82 (d, 4H, J =8.0 Hz, 4 ArCH), 7.63-7.52 (m, 6H, 6 ArCH), 
4.53 (s, 4H, CH2NH2
+
CH2). 
4.29 
  Chapter 4 
262 
 
 
Thread 3.88 (50 mg, 0.16 mmol) and crown 4.01 (247 mg, 0.64 mmol) were dissolved in 
CH2Cl2 (5 mL) and stirred at room temperature for 5 minutes. The 3,5-dimethylphenylazide 
3.11 (26 mg, 0.18 mmol), Cu(MeCN4)PF6 (60 mg, 0.16 mmol) and 2,6-lutidine (0.02 mL, 
0.02 mmol) were added and the reaction was stirred under N2 for 24 h. The crude reaction 
mixture was concentrated in vacuo and purified via flash chromatography (SiO2: EtOAc to 
EtOAc:MeOH; 9:1 to CH2Cl2:MeOH; 9:1) to provide the rotaxane as a clear oil (15 mg, 0.02 
mmol, 12%). 
1
H NMR (400 MHz, 298 K, CD3CN) δH  8.21 (s, 1H,  triazole CH), 7.91 (br 
s, 2H,  NH2), 7.34 (s, 2H,  2 ArCH), 7.16 (s, 1H,  ArCH), 6.99 (s, 2H,  2 ArCH), 6.93 
(s, 1H,  ArCH), 6.89 (s, 4H,  4 crown ArCH), 4.92 (m, 2H,  CH2NH2
+
), 4.72 (d, 1H, J = 
4.5Hz,  acetal CHH), 4.67 (d, 1H, J = 4.5Hz,  acetal CHH), 4.52 (m, 2H,  CH2NH2
+
), 
4.13 (t, 4H, J = 3.8Hz,  2 OCH2), 3.86-3.81 (m, 2H,  2 OCH2), 3.76-3.67 (m, 6H,  3 
OCH2), 3.65-3.48 (m, 12H,  6 OCH2), 2.39 (s, 6H,  2 CH3), 2.21 (s, 6H,  2 CH3); 
13
C 
NMR (150 MHz, 298 K, CD3CN) δC 148.5 (ArC), 141.4 (ArC), 141.2 (ArC), 139.8 (ArC), 
137.9 (ArC), 133.0 (ArC), 131.9 (ArCH), 131.8 (ArCH), 128.9 (ArCH), 124.3 (ArCH), 
122.8 (triazole-CH), 119.6 (ArCH), 113.8 (ArCH), 97.2 (O-CH2-O), 72.3 (OCH2), 72.0 
(OCH2), 71.7 (OCH2), 71.5 (OCH2), 69.8 (OCH2), 68.4 (OCH2), 53.5 (CH2NH2
+
), 44.1 
(CH2NH2
+
), 21.6 (CH3), 21.5 (CH3); HRMS (ESI
+
): m/z found, 707.4024 calc for 
C39H55N4O8 707.4014 [4.29-PF6]
+
.  
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Chapter 5 
5.1  Conclusion 
Using the Diels-Alder reaction [n]rotaxanes have been successfully synthesised via the 
‘threading followed by stoppering’ protocol. This has been performed with a variety of 
binding motifs incorporated into the axles. Using known ammonium ion and bispyridinium 
templates, [2] and [3]rotaxanes were constructed utilising this approach.  Using the 1,2-
pyridinium ethane motif, a [2]rotaxane was synthesised and the solid state crystal structure 
was obtained proving the endo conformation of the cyclopentadiene functionalised 
maleimide Diels-Alder adduct. 
 
Investigation of the Diels-Alder stopper size was also performed. Replacing the bridged six 
membered ring, with the flat sp
2
 hybridised phthalimide moiety the ability to act as a stopper 
for a DB24C8 macrocycle was removed. When subjected to unfavourable conditions that 
disrupted the delicate binding interactions between the two components the macrocycle was 
able to unthread from the axle.  
 
Synthesis of novel binding motifs has also been shown which demonstrate promising 
binding affinities with crown ether macrocycles. Substituting a perimidine moiety into the 
bisbenzimidazole template gave a two fold increase in the binding interaction between the 
axle and crown ether macrocycle. Introduction of both one and two triazoles into the 
dibenzylammonium binding site was also found to enhance the interaction between axle and 
the DB24C8 macrocycle demonstrating how simple modifications can improve binding 
interactions between components. Synthesis of [n]rotaxanes was carried out using these 
novel binding templates in the Diels-Alder approach to ‘threading followed by stoppering’.  
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Novel macrocycles were also synthesised with cavities of 23 atoms and used to create a 
variety of interlocked architectures using known and novel binding motifs. In this case the 
modification of a crown ether macrocycle has shown a detrimental effect on the binding 
interaction between the interlocked components. The change in shape of the cavity by 
replacing an ethylene unit with an acetal reduced its ability to form strong intermolecular 
interactions with typical binding motifs for rotaxane formation. Although the binding was 
not as desirable as expected a number of [2]pseudorotaxanes were synthesised as well as a 
[2]rotaxane using the Coutrot click conditions.
106
 
 
Future work within the group would include the focus on development and synthesis of 
known and novel binding motifs in order to further enhance binding interactions between 
these complexes. This would enable the synthesis of more intricate intermolecular 
complexes including multicomponent rotaxanes as well as the synthesis of molecular 
machines using the novel binding motifs developed.  
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Appendix 
Determination of Association Constants 
Peaks are observed for both complexed and uncomplexed species in all pseudorotaxanes 
described in this thesis. As chemical exchange is slow on the NMR timescale association 
constants were determined by integration of a 1:1 mixture using 
1
H NMR calculated via the 
single point method. 
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